:TYPE,:START_ID,:END_ID,publication_year:float,pmid:int,hdac6:boolean,autophagy:boolean,anatabine:boolean,evidence:string,document:string,pmc:string,citation:string,annotation:string,tau:boolean
CAUSES_NO_CHANGE,11611,3197,2014.0,24227736,False,False,False,"Although no Siglece mRNA was detected in primary neurons, primary microglia and a microglial line showed gene transcripts of Siglece (Fig. 1A).",#57:0,PMC3828472,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2014-01-06"", ""ref"": ""24227736"", ""pub_year"": 2014, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Claude J"", ""Linnartz-Gerlach B"", ""Kudin AP"", ""Kunz WS"", ""Neumann H""], ""title"": ""Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst."", ""doi"": ""10.1523/JNEUROSCI.2211-13.2013""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cells, Cultured"", ""Coculture Techniques"", ""Female"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Microglia"", ""Neurons"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Protein Binding"", ""Respiratory Burst"", ""Sialic Acid Binding Ig-like Lectin 3""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cd33 protein, mouse"", ""Neuroprotective Agents"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Siglece protein, mouse""]}",False
CAUSES_NO_CHANGE,1411,39573,2016.0,27013968,False,False,False,"In control conditions total Erk1/2 and phospho-Erk1/2 levels were similar in WT and R6/2 cultures (Figures 4A,C). Acute exposure to BDNF increased phospho-Erk1/2 levels over control conditions in both WT and R6/2 cultures (Figures 4A,E).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,20746,37879,2005.0,15597323,False,False,False,"Cognate siRNA duplex did not affect the expression of other monocyte surface markers including CD11b and CD14, thus proving specificity (Fig. 2A).",#57:0,,"{""full_journal_name"": ""European journal of immunology"", ""pub_date"": ""2005-02-23"", ""ref"": ""15597323"", ""pub_year"": 2005, ""last_author"": ""Chizzolini C"", ""type"": ""PubMed"", ""author_list"": [""Lajaunias F"", ""Dayer JM"", ""Chizzolini C""], ""title"": ""Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Gene Silencing"", ""Humans"", ""Immunity, Innate"", ""In Vitro Techniques"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-8"", ""Monocytes"", ""N-Acetylneuraminic Acid"", ""Phosphatidylinositol 3-Kinases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Signal Transduction"", ""Tumor Necrosis Factor-alpha"", ""p38 Mitogen-Activated Protein Kinases""], ""substances"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Interleukin-1"", ""Interleukin-8"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Tumor Necrosis Factor-alpha"", ""Phosphatidylinositol 3-Kinases"", ""p38 Mitogen-Activated Protein Kinases"", ""N-Acetylneuraminic Acid""]}",False
CAUSES_NO_CHANGE,40161,822,2009.0,19277525,False,False,False,"By contrast, several recent studies using purified, recombinant proteins showed that the methylation status of the catalytic subunit did not play a decisive role for the in vitro assembly of PP2A holoenzymes involving the B and B′ subunit",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""High""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,26554,342,2018.0,27671637,False,False,False,"Having observed that 64627 restores presynaptic functioning (i.e., PPF, Fig. 4F), neuronal activity (induction of Fos, Fig. 4D), and dendritic spine levels in proaggregant Tau transgenic organotypic slices (Fig. 5 A and B), we tested whether we could restore long-term spatial memory in proaggregant Tau transgenic mice as well",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Axons""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,41007,25454,2017.0,28148553,False,False,False,"None of the lentiviral models significantly increased PERK or pPERK, showing that tau overload per se is not sufficient to activate the UPR.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,11615,12491,2019.0,29590627,False,False,False,"Conversely, dynamin inhibition significantly reduced the entry of aggregated tau, with no significant effects of Cytochalasin D (Figure S6) at this relatively high molar concent of aggregated tau",#57:66,PMC5896171,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2019-11-05"", ""ref"": ""29590627"", ""pub_year"": 2019, ""last_author"": ""Livesey FJ"", ""type"": ""PubMed"", ""author_list"": [""Evans LD"", ""Wassmer T"", ""Fraser G"", ""Smith J"", ""Perkinton M"", ""Billinton A"", ""Livesey FJ""], ""title"": ""Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways."", ""doi"": ""10.1016/j.celrep.2018.03.021""}","{""mesh"": [""Cerebral Cortex"", ""Dynamins"", ""Endocytosis"", ""Human Embryonic Stem Cells"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregation, Pathological"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,1411,2312,2016.0,27013968,False,False,False,"Counts of DAPI+ staining, a DNA label that identifies all cell nuclei in culture, revealed that total cell density was similar in WT and R6/2 cultures (211 ± 22 and 208 ± 14 cells/mm2, respectively; Figures 2A,B) after 7 DIV in basal media. Concurrently, MAP2+ staining (microtubule associated protein 2; a neuron-specific cytoskeletal protein) indicated a similar sized population of neuronal cells in WT and R6/2 cultures (100 ± 14 and 103 ± 7 cells/mm2, respectively; Figures 2A,B).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,2017,36907,2011.0,21482353,False,False,False,"While chronic nicotine does not change the abundance or function of alpha4* nAChRs in the somata of substantia nigra pars compacta dopaminergic neurons, it does suppress baseline firing rates of these DA neurons.",#70:39,PMC4418790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-06-07"", ""ref"": ""21482353"", ""pub_year"": 2011, ""last_author"": ""Lester HA"", ""type"": ""PubMed"", ""author_list"": [""Miwa JM"", ""Freedman R"", ""Lester HA""], ""title"": ""Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses."", ""doi"": ""10.1016/j.neuron.2011.03.014""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Pars Compacta""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Cholinergic Fibers"", ""Humans"", ""Nervous System Diseases"", ""Neural Pathways"", ""Neurons"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,38407,44067,2009.0,19713215,False,False,False,"Arhgef5 can strongly activate RhoA and RhoB and weakly RhoC and RhoG, but not Rac1, RhoQ, RhoD, or RhoV, in transfected human embryonic kidney 293 cells.",#59:5,PMC2781403,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2009-11-24"", ""ref"": ""19713215"", ""pub_year"": 2009, ""last_author"": ""Wu D"", ""type"": ""PubMed"", ""author_list"": [""Wang Z"", ""Kumamoto Y"", ""Wang P"", ""Gan X"", ""Lehmann D"", ""Smrcka AV"", ""Cohn L"", ""Iwasaki A"", ""Li L"", ""Wu D""], ""title"": ""Regulation of immature dendritic cell migration by RhoA guanine nucleotide exchange factor Arhgef5."", ""doi"": ""10.1074/jbc.M109.047282""}","{""CellLine"": [""HEK293""], ""Subgraph"": [""RhoA subgraph""], ""mesh"": [""Animals"", ""Asthma"", ""Cell Culture Techniques"", ""Cell Movement"", ""Chemotaxis"", ""Dendritic Cells"", ""Gene Expression Regulation"", ""Guanine Nucleotide Exchange Factors"", ""Humans"", ""Luciferases"", ""Mice"", ""Mice, Transgenic"", ""Ovalbumin"", ""Proto-Oncogene Proteins"", ""Rho Guanine Nucleotide Exchange Factors"", ""rhoA GTP-Binding Protein""], ""substances"": [""ARHGEF5 protein, human"", ""Guanine Nucleotide Exchange Factors"", ""Proto-Oncogene Proteins"", ""Rho Guanine Nucleotide Exchange Factors"", ""Ovalbumin"", ""Luciferases"", ""rhoA GTP-Binding Protein""]}",False
CAUSES_NO_CHANGE,11560,1174,2015.0,25639674,False,False,False,"The α4β2 nAChR PAM, NS-9283, administered alone did not affect mechanical allodynia in the spinal nerve ligation test (a model of neuropathic pain), nor on nociception and inflammation in various rodent models of pain [185, 186].",#60:18,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""MeSHAnatomy"": [""Neurons"", ""Spinal Cord""], ""MeSHDisease"": [""Pain""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,4126,7242,2012.0,22107728,False,False,False,"Several genetic association studies examined IDE gene as a susceptibility gene for Alzheimer's disease (AD), however with controversial results.We examined associations of three IDE polymorphisms (IDE2, rs4646953; IDE7, rs2251101 and IDE9, rs1887922) with AD, Abeta42 plasma level and T2DM risk in the longitudinal Vienna Transdanube Aging (VITA) study cohort.The upstream polymorphism IDE2 was found to influence AD risk and to trigger the Abeta42 plasma level, whereas the downstream polymorphism IDE7 modified the T2DM risk; no associations were found for the intronic variant IDE9.Based on our SNP and haplotype results, we delineate the model that IDE promoter and 3' untranslated region/downstream variation may have different effects on IDE expression, presumably a relevant endophenotype with disorder-specific effects on AD and T2DM susceptibility.",#64:44,PMC3266204,"{""full_journal_name"": ""BMC medical genetics"", ""pub_date"": ""2012-03-12"", ""ref"": ""22107728"", ""pub_year"": 2012, ""last_author"": ""Gr\u00fcnblatt E"", ""type"": ""PubMed"", ""author_list"": [""Bartl J"", ""Scholz CJ"", ""Hinterberger M"", ""Jungwirth S"", ""Wichart I"", ""Rainer MK"", ""Kneitz S"", ""Danielczyk W"", ""Tragl KH"", ""Fischer P"", ""Riederer P"", ""Gr\u00fcnblatt E""], ""title"": ""Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene."", ""doi"": ""10.1186/1471-2350-12-151""}","{""Confidence"": [""Medium""], ""Subgraph"": [""Amyloidogenic subgraph""], ""mesh"": [""3' Untranslated Regions"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Cohort Studies"", ""Diabetes Mellitus, Type 2"", ""Genetic Association Studies"", ""Genotype"", ""Haplotypes"", ""Humans"", ""Insulysin"", ""Longitudinal Studies"", ""Peptide Fragments"", ""Polymorphism, Single Nucleotide"", ""Promoter Regions, Genetic"", ""Risk""], ""substances"": [""3' Untranslated Regions"", ""Amyloid beta-Peptides"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""Insulysin""]}",False
CAUSES_NO_CHANGE,2142,1870,2013.0,23484434,False,False,False,Pyrogallol generic substitution pattern commonly found in multiple polyphenolic Tau aggregation inhibitors such as 12 and 19. Note the structural overlap with the inactive pyrocatechol-substituted epicatechin,#58:53,,"{""full_journal_name"": ""Journal of medicinal chemistry"", ""pub_date"": ""2013-08-20"", ""ref"": ""23484434"", ""pub_year"": 2013, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Bulic B"", ""Pickhardt M"", ""Mandelkow E""], ""title"": ""Progress and developments in tau aggregation inhibitors for Alzheimer disease."", ""doi"": ""10.1021/jm3017317""}","{""ArticleCompoundNumber"": [""18""], ""Confidence"": [""High""], ""Figure"": [""8""], ""Page"": [""H""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Clinical Trials as Topic"", ""Humans"", ""Hydrogen Bonding"", ""Models, Molecular"", ""Protein Binding"", ""Protein Conformation"", ""Structure-Activity Relationship"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,21196,21289,2017.0,28760828,False,False,False,"Of note, whereas mimicking acetylation at most non-KXGS sites had minimal impact on tau aggregation, K274Q also significantly decreased tau assembly in vitro, albeit to a lesser extent than K321Q (Fig. 1b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,7040,12449,2017.0,28408124,False,False,False,"Tau46 was the only antibody that did not show a statistically significant reduction in neuronal tau uptake (Figure 4, B and C). Tau46 bound with high apparent affinity to both recombinant and paired helical filament tau by ELISA (Table 2), demonstrating the binding of the antibody to full-length tau.",#59:9,PMC5455060,"{""full_journal_name"": ""The American journal of pathology"", ""pub_date"": ""2017-08-08"", ""ref"": ""28408124"", ""pub_year"": 2017, ""last_author"": ""Takeda S"", ""type"": ""PubMed"", ""author_list"": [""Nobuhara CK"", ""DeVos SL"", ""Commins C"", ""Wegmann S"", ""Moore BD"", ""Roe AD"", ""Costantino I"", ""Frosch MP"", ""Pitstick R"", ""Carlson GA"", ""Hock C"", ""Nitsch RM"", ""Montrasio F"", ""Grimm J"", ""Cheung AE"", ""Dunah AW"", ""Wittmann M"", ""Bussiere T"", ""Weinreb PH"", ""Hyman BT"", ""Takeda S""], ""title"": ""Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in\u00a0Vitro."", ""doi"": ""10.1016/j.ajpath.2017.01.022""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""TextLocation"": [""Results""], ""mesh"": [""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Antibodies, Monoclonal"", ""Brain"", ""Cells, Cultured"", ""Epitopes"", ""Female"", ""Humans"", ""Interneurons"", ""Male"", ""Mice, Transgenic"", ""Microfluidic Analytical Techniques"", ""Molecular Targeted Therapy"", ""Neurofibrillary Tangles"", ""Neurons"", ""Phosphorylation"", ""tau Proteins""], ""substances"": [""Antibodies, Monoclonal"", ""Epitopes"", ""MAPT protein, human"", ""Mapt protein, mouse"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11560,1334,2015.0,25639674,False,False,False,"The α4β2 nAChR PAM, NS-9283, administered alone did not affect mechanical allodynia in the spinal nerve ligation test (a model of neuropathic pain), nor on nociception and inflammation in various rodent models of pain [185, 186].",#59:10,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons"", ""Spinal Cord""], ""MeSHDisease"": [""Pain""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,35177,43753,2015.0,25069841,False,False,False,"Western blot analysis revealed that, consistent with the detergent extractable preparations, TFEB efficiently reduced the CP13- and PHF1-positive pTau while leaving Tau1-positive unphosphorylated Tau intact in both fractions (Fig 2A and quantified in B and C).",#72:5,PMC4197862,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2015-05-22"", ""ref"": ""25069841"", ""pub_year"": 2015, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Polito VA"", ""Li H"", ""Martini-Stoica H"", ""Wang B"", ""Yang L"", ""Xu Y"", ""Swartzlander DB"", ""Palmieri M"", ""di Ronza A"", ""Lee VM"", ""Sardiello M"", ""Ballabio A"", ""Zheng H""], ""title"": ""Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB."", ""doi"": ""10.15252/emmm.201303671""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain""], ""MeSHDisease"": [""Amyloid Neuropathies""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Gene Expression Regulation"", ""Lysosomes"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""PTEN Phosphohydrolase"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Mapt protein, mouse"", ""Tcfeb protein, mouse"", ""tau Proteins"", ""PTEN Phosphohydrolase"", ""Pten protein, mouse""]}",False
CAUSES_NO_CHANGE,33654,24527,2000.0,10887109,False,False,False,These authors found that a change in the amino acid −2 relative to the phosphotyrosine from valine to either isoleucine or leucine did not show significant difference in the phosphatase activity of the peptides.,#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,6709,40648,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,11900,7616,2007.0,17009926,False,False,False,"Results show that genistein does not alter the surface expression of nAChRs, but rather it modiﬁes nAChRs in the cell membrane (71).",#59:80,,"{""full_journal_name"": ""Annual review of pharmacology and toxicology"", ""pub_date"": ""2007-04-10"", ""ref"": ""17009926"", ""pub_year"": 2007, ""last_author"": ""Bertrand D"", ""type"": ""PubMed"", ""author_list"": [""Dani JA"", ""Bertrand D""], ""title"": ""Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Epilepsy"", ""Humans"", ""Memory"", ""Neurotransmitter Agents"", ""Receptors, Nicotinic"", ""Substance-Related Disorders""], ""substances"": [""Neurotransmitter Agents"", ""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,6709,36216,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,6836,6965,2013.0,22530628,False,False,False,"For example, some compounds such as curcumin inhibit oligomerization but not ﬁbrillation [105], and other compounds such as o-vanillin inhibit the formation of both oligomers and ﬁbrils [106]. Other molecules such as the naphthalene sulfonates inhibit ﬁbrillation but not oligomerization [107].",#57:51,PMC6493450,"{""full_journal_name"": ""CNS neuroscience & therapeutics"", ""pub_date"": ""2013-05-20"", ""ref"": ""22530628"", ""pub_year"": 2013, ""last_author"": ""Zeitlin R"", ""type"": ""PubMed"", ""author_list"": [""Echeverria V"", ""Zeitlin R""], ""title"": ""Cotinine: a potential new therapeutic agent against Alzheimer's disease."", ""doi"": ""10.1111/j.1755-5949.2012.00317.x""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cotinine"", ""Drug Delivery Systems"", ""Humans"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic"", ""Cotinine""]}",False
CAUSES_NO_CHANGE,1822,10722,2019.0,28391535,False,False,False,"This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",#63:58,,"{""full_journal_name"": ""Current topics in behavioral neurosciences"", ""pub_date"": ""2019-01-31"", ""ref"": ""28391535"", ""pub_year"": 2019, ""last_author"": ""Young R"", ""type"": ""PubMed"", ""author_list"": [""Rosecrans JA"", ""Young R""], ""title"": ""Discriminative Stimulus Properties of S(-)-Nicotine: \""A Drug for All Seasons\""."", ""doi"": ""10.1007/7854_2017_3""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Central Nervous System Stimulants"", ""Humans"", ""Nicotine"", ""Nicotinic Agonists"", ""Smoking Cessation"", ""Stereoisomerism"", ""Tobacco""], ""substances"": [""Central Nervous System Stimulants"", ""Nicotinic Agonists"", ""Nicotine""]}",False
CAUSES_NO_CHANGE,7981,13666,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,14217,33326,2020.0,30686764,False,False,False,"Activation of homologous nuclear receptors such as PPARa (by GW50156) and PPARg (by Rosiglitazone), which regulate fatty acid metabolism but not cholesterol export, did not decrease pThr231Tau/tTau (Figures 2C, S2F, and S2G).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,11205,30862,2017.0,27594586,False,False,False,ERK phosphorylation is also not affected by A152T mutation in 3R tau (Figure S4D),#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""CellLine"": [""HEK293""], ""Confidence"": [""Medium""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,11655,44220,2019.0,29844403,False,False,False,"MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",#71:1,PMC5974403,"{""full_journal_name"": ""Cell death & disease"", ""pub_date"": ""2019-12-10"", ""ref"": ""29844403"", ""pub_year"": 2019, ""last_author"": ""Yang CR"", ""type"": ""PubMed"", ""author_list"": [""Fan SJ"", ""Huang FI"", ""Liou JP"", ""Yang CR""], ""title"": ""The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model."", ""doi"": ""10.1038/s41419-018-0688-5""}","{""CellLine"": [""Neuro-2a cell"", ""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Benzamides"", ""Cell Line, Tumor"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3 beta"", ""Histone Deacetylase Inhibitors"", ""Memory Disorders"", ""Models, Biological"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Aggregates"", ""Proteolysis"", ""Quinolines"", ""Rats, Sprague-Dawley"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Benzamides"", ""Histone Deacetylase Inhibitors"", ""MPT0G211"", ""Neuroprotective Agents"", ""Protein Aggregates"", ""Quinolines"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,11460,39422,2019.0,30108137,False,False,False,"Following fractionation, immunoblotting for phospho and total tau species in the soluble pool similarly showed a significant reduction in phospho-tau species recog- nized by CP13 and PHF1 antibodies, with no change in total tau",#64:12,PMC6122971,"{""full_journal_name"": ""The Journal of experimental medicine"", ""pub_date"": ""2019-09-04"", ""ref"": ""30108137"", ""pub_year"": 2019, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Martini-Stoica H"", ""Cole AL"", ""Swartzlander DB"", ""Chen F"", ""Wan YW"", ""Bajaj L"", ""Bader DA"", ""Lee VMY"", ""Trojanowski JQ"", ""Liu Z"", ""Sardiello M"", ""Zheng H""], ""title"": ""TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading."", ""doi"": ""10.1084/jem.20172158""}","{""Cell"": [""astrocyte""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Astrocytes"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Disease Models, Animal"", ""Gene Knockdown Techniques"", ""Hippocampus"", ""Lysosomes"", ""Mice"", ""Synapses"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Tcfeb protein, mouse"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,41743,2457,2013.0,23356410,False,False,False,"The deletion of both HDAC1 and 2 during early synaptic development caused a facilitation of excitatory synapse maturation and a modest increase in synapse numbers, which were not observed in the specific deletion of HDAC1 or 2 alone.",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Hippocampus""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,36762,1650,2016.0,26751493,False,False,False,"A PSEN1 mutation causes a Pick’s disease phenotype including FTD tau pathology without deposition of Abeta [145]; some MAPT single nucleotide polymorphisms have also been linked to sporadic Parkinson’s disease (PD, [146]);",#60:23,PMC4808800,"{""full_journal_name"": ""Biomolecules"", ""pub_date"": ""2016-10-13"", ""ref"": ""26751493"", ""pub_year"": 2016, ""last_author"": ""Hof PR"", ""type"": ""PubMed"", ""author_list"": [""\u0160imi\u0107 G"", ""Babi\u0107 Leko M"", ""Wray S"", ""Harrington C"", ""Delalle I"", ""Jovanov-Milo\u0161evi\u0107 N"", ""Ba\u017eadona D"", ""Bu\u00e9e L"", ""de Silva R"", ""Di Giovanni G"", ""Wischik C"", ""Hof PR""], ""title"": ""Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies."", ""doi"": ""10.3390/biom6010006""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Neurofibrillary Tangles"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""MAPT protein, human"", ""Neuroprotective Agents"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,32628,1588,2020.0,30837838,False,False,False,"Several mutations in the RRMs are shown to disrupt the RNA binding capability while not significantly interfering with the RNA recognition (Lukavsky et al., 2013).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,11479,2190,2007.0,17640819,False,False,False,"Twice per day, 1 mg/kg injections of 4OH-GTS-21 conferred significant protection on these septal neurons in the wild type mice but had no protective effect in PS1 or APP/PS1 mice",#65:41,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""Assay"": [""Immunochemistry""], ""Dosage"": [""1 mg/kg""], ""MeSHAnatomy"": [""Septal Nuclei""], ""MouseStrain"": [""K670N/M671L/PS1M146L"", ""PS1M146L""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,41670,9685,2009.0,19277525,False,False,False,"For example, the small tumor antigen derived from the DNA tumor viruses SV40 and polyoma viruses was shown to only interact with the PP2A core enzyme, but not the holoenzyme",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""High""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,11587,2234,2007.0,17095583,False,False,False,"In immunoblotting analysis, nefiracetam treatment increased the PKCalpha activity with a bell-shaped dose-response relationship peaking at 10 nM, thereby increasing phosphorylation of PKC substrate and NMDA receptor. Nefiracetam treatment did not affect the PKA activity.",#59:5,,"{""full_journal_name"": ""Molecular pharmacology"", ""pub_date"": ""2007-03-01"", ""ref"": ""17095583"", ""pub_year"": 2007, ""last_author"": ""Narahashi T"", ""type"": ""PubMed"", ""author_list"": [""Moriguchi S"", ""Shioda N"", ""Maejima H"", ""Zhao X"", ""Marszalec W"", ""Yeh JZ"", ""Fukunaga K"", ""Narahashi T""], ""title"": ""Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor.""}","{""Subgraph"": [""GABA subgraph"", ""NMDA receptor""], ""mesh"": [""Allosteric Regulation"", ""Animals"", ""Cells, Cultured"", ""Dose-Response Relationship, Drug"", ""Electrochemistry"", ""Glycine"", ""Magnesium"", ""N-Methylaspartate"", ""Neurons"", ""Patch-Clamp Techniques"", ""Phosphorylation"", ""Protein Kinase C"", ""Pyrrolidinones"", ""Rats"", ""Receptors, N-Methyl-D-Aspartate""], ""substances"": [""Pyrrolidinones"", ""Receptors, N-Methyl-D-Aspartate"", ""nefiracetam"", ""N-Methylaspartate"", ""Protein Kinase C"", ""Magnesium"", ""Glycine""]}",False
CAUSES_NO_CHANGE,29218,7260,2009.0,18986241,False,False,False,"NGF therapy has been tested in clinical trials of diabetic peripheral neuropathy and HIV-associated neuropathy, as well as patients with AD [177]. Each of these clinical trials met with disappointment owing to lack of efficacy, toxicity or both.",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,12733,36837,2014.0,23871825,False,False,False,"Depending on the treatment received, a distinct inflammatory and oxidative stress profile was observed: in Rivastigmine-treated group, IL6 levels were 47% lower than the average value of the remaining AD patients; homocysteine and glutathione reductase were statistically unchanged in the Rivastigmine and Donepezil-Memantine, respectively Donepezil group.",#59:5,,"{""full_journal_name"": ""Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association"", ""pub_date"": ""2014-10-06"", ""ref"": ""23871825"", ""pub_year"": 2014, ""last_author"": ""Kouretas D"", ""type"": ""PubMed"", ""author_list"": [""Gubandru M"", ""Margina D"", ""Tsitsimpikou C"", ""Goutzourelas N"", ""Tsarouhas K"", ""Ilie M"", ""Tsatsakis AM"", ""Kouretas D""], ""title"": ""Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers."", ""doi"": ""10.1016/j.fct.2013.07.013""}","{""Species"": [""9606""], ""Subgraph"": [""Glutathione reductase subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Antioxidants"", ""Arginine"", ""Biomarkers"", ""Case-Control Studies"", ""Endothelium, Vascular"", ""Female"", ""Glutathione"", ""Homocysteine"", ""Humans"", ""Inflammation"", ""Interleukin-6"", ""Male"", ""Oxidative Stress"", ""Protein Carbonylation"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Antioxidants"", ""Biomarkers"", ""Interleukin-6"", ""Tumor Necrosis Factor-alpha"", ""dimethylarginine"", ""Homocysteine"", ""Arginine"", ""Glutathione""]}",False
CAUSES_NO_CHANGE,1791,11690,2007.0,17640819,False,False,False,"4OH-GTS-21 had no protective effect on GABAergic neuronal number in this strain, with FFX lesions causing a 34±9% reduction compared with contralateral controls (n=10; P<0.05 compared with unlesioned side, one-way ANOVA).",#57:56,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,4126,7260,2012.0,22107728,False,False,False,"Several genetic association studies examined IDE gene as a susceptibility gene for Alzheimer's disease (AD), however with controversial results.We examined associations of three IDE polymorphisms (IDE2, rs4646953; IDE7, rs2251101 and IDE9, rs1887922) with AD, Abeta42 plasma level and T2DM risk in the longitudinal Vienna Transdanube Aging (VITA) study cohort.The upstream polymorphism IDE2 was found to influence AD risk and to trigger the Abeta42 plasma level, whereas the downstream polymorphism IDE7 modified the T2DM risk; no associations were found for the intronic variant IDE9.Based on our SNP and haplotype results, we delineate the model that IDE promoter and 3' untranslated region/downstream variation may have different effects on IDE expression, presumably a relevant endophenotype with disorder-specific effects on AD and T2DM susceptibility.",#64:44,PMC3266204,"{""full_journal_name"": ""BMC medical genetics"", ""pub_date"": ""2012-03-12"", ""ref"": ""22107728"", ""pub_year"": 2012, ""last_author"": ""Gr\u00fcnblatt E"", ""type"": ""PubMed"", ""author_list"": [""Bartl J"", ""Scholz CJ"", ""Hinterberger M"", ""Jungwirth S"", ""Wichart I"", ""Rainer MK"", ""Kneitz S"", ""Danielczyk W"", ""Tragl KH"", ""Fischer P"", ""Riederer P"", ""Gr\u00fcnblatt E""], ""title"": ""Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene."", ""doi"": ""10.1186/1471-2350-12-151""}","{""Confidence"": [""Medium""], ""Subgraph"": [""Amyloidogenic subgraph""], ""mesh"": [""3' Untranslated Regions"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Cohort Studies"", ""Diabetes Mellitus, Type 2"", ""Genetic Association Studies"", ""Genotype"", ""Haplotypes"", ""Humans"", ""Insulysin"", ""Longitudinal Studies"", ""Peptide Fragments"", ""Polymorphism, Single Nucleotide"", ""Promoter Regions, Genetic"", ""Risk""], ""substances"": [""3' Untranslated Regions"", ""Amyloid beta-Peptides"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""Insulysin""]}",False
CAUSES_NO_CHANGE,44316,2211,2017.0,27574109,False,False,False,"hT40, hT34, hT24, hT37 and hT23 aggregates did not significantly impair retrograde FAT when compared to the respective monomers, but hT39 aggregates elicited a mild inhibitory effect on retrograde FAT (Fig. 4B)",#70:49,PMC5075521,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-10-17"", ""ref"": ""27574109"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Cox K"", ""Combs B"", ""Abdelmesih B"", ""Morfini G"", ""Brady ST"", ""Kanaan NM""], ""title"": ""Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition."", ""doi"": ""10.1016/j.neurobiolaging.2016.07.015""}","{""mesh"": [""Alzheimer Disease"", ""Animals"", ""Axonal Transport"", ""Decapodiformes"", ""Humans"", ""In Vitro Techniques"", ""Polymerization"", ""Protein Aggregates"", ""Protein Domains"", ""Protein Isoforms"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Protein Aggregates"", ""Protein Isoforms"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,3473,6994,2017.0,28148553,False,False,False,"Cells transduced with 4R tau-overexpressing lentivirus showed increased levels in CP13-, AD2-, and HT7 tau (but not MC1). CP13- but not AD2- and HT7 tau were normalized by simultaneous PERK activator treatment (Fig 3G and H).",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,34694,36139,2018.0,28528849,False,False,False,We did not observe any increase in the phosphorylation of the tau repeat domain (as seen by the antibody 12E8) after treating the neurons with TauRDΔK oligomers.,#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""High""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,1411,2312,2016.0,27013968,False,False,False,"Counts of DAPI+ staining, a DNA label that identifies all cell nuclei in culture, revealed that total cell density was similar in WT and R6/2 cultures (211 ± 22 and 208 ± 14 cells/mm2, respectively; Figures 2A,B) after 7 DIV in basal media. Concurrently, MAP2+ staining (microtubule associated protein 2; a neuron-specific cytoskeletal protein) indicated a similar sized population of neuronal cells in WT and R6/2 cultures (100 ± 14 and 103 ± 7 cells/mm2, respectively; Figures 2A,B).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Cell"": [""neuron""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,20982,14963,2017.0,27209302,False,False,False,The results indicated that microglia with TFEB-K116Q overexpression could neither facilitate fAβ degradation (Fig. S5B) nor upregulate the lysosomal biogenesis and function (Fig. S5C and S5D).,#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,43823,38227,2010.0,19933700,False,False,False,"Notably, global levels of di-methylated histone H3K27 were not altered in huntingtin null EBs (Supplementary Material, Fig. S3B), indicating that lack of huntingtin specifically affected H3K27 tri-methylation.",#57:7,PMC2807366,"{""full_journal_name"": ""Human molecular genetics"", ""pub_date"": ""2010-03-29"", ""ref"": ""19933700"", ""pub_year"": 2010, ""last_author"": ""MacDonald ME"", ""type"": ""PubMed"", ""author_list"": [""Seong IS"", ""Woda JM"", ""Song JJ"", ""Lloret A"", ""Abeyrathne PD"", ""Woo CJ"", ""Gregory G"", ""Lee JM"", ""Wheeler VC"", ""Walz T"", ""Kingston RE"", ""Gusella JF"", ""Conlon RA"", ""MacDonald ME""], ""title"": ""Huntingtin facilitates polycomb repressive complex 2."", ""doi"": ""10.1093/hmg/ddp524""}","{""MeSHAnatomy"": [""Embryoid Bodies""], ""mesh"": [""Animals"", ""Disease Models, Animal"", ""Female"", ""Histones"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Male"", ""Mice"", ""Mice, Knockout"", ""Molecular Sequence Data"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Polycomb-Group Proteins"", ""Protein Binding"", ""Repressor Proteins"", ""Sequence Homology, Amino Acid""], ""substances"": [""HTT protein, human"", ""Histones"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Polycomb-Group Proteins"", ""Repressor Proteins""]}",False
CAUSES_NO_CHANGE,11790,2226,2009.0,19237574,False,False,False,"Taken together, these results indicate that metformin likely augments Abeta production through mechanisms independent of insulin signaling and glucose metabolism",#59:5,PMC2656178,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2009-03-26"", ""ref"": ""19237574"", ""pub_year"": 2009, ""last_author"": ""Liao FF"", ""type"": ""PubMed"", ""author_list"": [""Chen Y"", ""Zhou K"", ""Wang R"", ""Liu Y"", ""Kwak YD"", ""Ma T"", ""Thompson RC"", ""Zhao Y"", ""Smith L"", ""Gasparini L"", ""Luo Z"", ""Xu H"", ""Liao FF""], ""title"": ""Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription."", ""doi"": ""10.1073/pnas.0807991106""}","{""Subgraph"": [""Insulin signal transduction""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Base Sequence"", ""Binding Sites"", ""Enzyme Activation"", ""Glucose"", ""Hypoglycemic Agents"", ""Insulin"", ""Metformin"", ""Mice"", ""Molecular Sequence Data"", ""Peptides"", ""Promoter Regions, Genetic"", ""Rats"", ""Signal Transduction"", ""Transcription, Genetic"", ""Up-Regulation""], ""substances"": [""Amyloid beta-Peptides"", ""Hypoglycemic Agents"", ""Insulin"", ""Peptides"", ""Metformin"", ""AMP-Activated Protein Kinases"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Glucose""]}",False
CAUSES_NO_CHANGE,14472,7115,2017.0,27794524,False,False,False,"However, in EAE, idebenone failed to affect disease incidence or onset when applied preventively, or to reduce disease severity when applied therapeutically.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,11660,21292,2015.0,25546293,False,False,False,"In the presence of the HDAC6 inhibitor ACY-1215, the increased levels of Ac-Lys49 β-catenin had no effect on the levels for β-catenin phosphorylated at Ser33, Ser37, and Thr41 (Figure 3A, B).",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,42916,11874,2020.0,30985105,False,False,False,"ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",#70:0,,"{""full_journal_name"": ""ACS chemical neuroscience"", ""pub_date"": ""2020-05-21"", ""ref"": ""30985105"", ""pub_year"": 2020, ""last_author"": ""Rudrawar S"", ""type"": ""PubMed"", ""author_list"": [""Ryan P"", ""Xu M"", ""Davey AK"", ""Danon JJ"", ""Mellick GD"", ""Kassiou M"", ""Rudrawar S""], ""title"": ""O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease."", ""doi"": ""10.1021/acschemneuro.9b00143""}","{""Confidence"": [""Medium""], ""mesh"": [""Acetylglucosamine"", ""Animals"", ""Brain"", ""Humans"", ""Neurodegenerative Diseases"", ""Protein Aggregation, Pathological"", ""Protein Folding"", ""Protein Processing, Post-Translational""], ""substances"": [""Acetylglucosamine""]}",False
CAUSES_NO_CHANGE,3459,12394,2019.0,30046111,False,False,False,"Independently of the model, the level of CSF tracer drained into the dCLNs was comparable between transgenic mice with Alzheimer’s disease and age-matched wild-type littermates (Extended Data Fig. 8p–s)",#67:25,PMC6085146,"{""full_journal_name"": ""Nature"", ""pub_date"": ""2019-02-08"", ""ref"": ""30046111"", ""pub_year"": 2019, ""last_author"": ""Kipnis J"", ""type"": ""PubMed"", ""author_list"": [""Da Mesquita S"", ""Louveau A"", ""Vaccari A"", ""Smirnov I"", ""Cornelison RC"", ""Kingsmore KM"", ""Contarino C"", ""Onengut-Gumuscu S"", ""Farber E"", ""Raper D"", ""Viar KE"", ""Powell RD"", ""Baker W"", ""Dabhi N"", ""Bai R"", ""Cao R"", ""Hu S"", ""Rich SS"", ""Munson JM"", ""Lopes MB"", ""Overall CC"", ""Acton ST"", ""Kipnis J""], ""title"": ""Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease."", ""doi"": ""10.1038/s41586-018-0368-8""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebrospinal Fluid"", ""Hippocampus""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid"", ""Amyloid beta-Peptides"", ""Animals"", ""Brain"", ""Cognition"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Extracellular Fluid"", ""Female"", ""Homeostasis"", ""Humans"", ""Lymph Nodes"", ""Lymphatic Vessels"", ""Male"", ""Meninges"", ""Mice"", ""Mice, Transgenic"", ""Perfusion""], ""substances"": [""Amyloid"", ""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,37679,12053,2020.0,30606258,False,False,False,"We were unable to detect phosphorylation (activation) of inositol- requiring enzyme 1α (IRE1α) in any of the three cell lines and there were no differences in the total amount of IRE1α present (Fig. 6c, d), suggesting that this branch of the UPR is not activated by either Tau35 or FL-tau.",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,1934,1484,2020.0,30837838,False,False,False,"Notably, the zinc ions could induce inclusion bodies formation and aggregation in the neuronal cell cultures, and this effect was not observed with copper or iron, indicating zinc-specific effects (Caragounis et al., 2010).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Cell"": [""neuron""]}",False
CAUSES_NO_CHANGE,11660,37983,2015.0,25546293,False,False,False,Total ubiquitination levels in cell lysates was unaffected by ACY-1215 pretreatment suggesting that the effects of ACY-1215 on ubiquitination are specific rather than global (Figure 4).,#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,3473,4941,2015.0,25374103,False,False,False,Toxicity assays revealed that neither CHIP nor any of the tau constructs caused cell death compared to the control GFP vector (Supplementary Fig. 1).,#63:21,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-10-26"", ""ref"": ""25374103"", ""pub_year"": 2015, ""last_author"": ""Spires-Jones TL"", ""type"": ""PubMed"", ""author_list"": [""Saidi LJ"", ""Polydoro M"", ""Kay KR"", ""Sanchez L"", ""Mandelkow EM"", ""Hyman BT"", ""Spires-Jones TL""], ""title"": ""Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes."", ""doi"": ""10.3233/JAD-142094""}","{""Confidence"": [""High""], ""mesh"": [""Caspase 3"", ""Cell Line, Tumor"", ""Cell Proliferation"", ""Gene Expression Regulation"", ""Green Fluorescent Proteins"", ""HSP70 Heat-Shock Proteins"", ""Humans"", ""Mitochondria"", ""Mutation"", ""Neuroblastoma"", ""Protein Binding"", ""Transfection"", ""Ubiquitin-Protein Ligases"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""STUB1 protein, human"", ""Ubiquitin-Protein Ligases"", ""Caspase 3""]}",False
CAUSES_NO_CHANGE,2070,573,2018.0,28901280,False,False,False,"whereas phosphocholine (PC) does not evoke ion current responses in Xenopus oocytes expressing functional ho- momeric α9 or heteromeric α9-α10 nAChRs [121]. How- ever, preincubation with PC attenuates choline-induced ion current changes, thus suggesting that PC is a silent agonist of these two subtypes",#61:2,PMC6018187,"{""full_journal_name"": ""Current neuropharmacology"", ""pub_date"": ""2018-09-13"", ""ref"": ""28901280"", ""pub_year"": 2018, ""last_author"": ""Gotti C"", ""type"": ""PubMed"", ""author_list"": [""Zoli M"", ""Pucci S"", ""Vilella A"", ""Gotti C""], ""title"": ""Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors."", ""doi"": ""10.2174/1570159X15666170912110450""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Binding Sites"", ""Humans"", ""Neurons"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,1849,43753,2020.0,30686764,False,False,False,"Activation of homologous nuclear receptors such as PPARa (by GW50156) and PPARg (by Rosiglitazone), which regulate fatty acid metabolism but not cholesterol export, did not decrease pThr231Tau/tTau (Figures 2C, S2F, and S2G).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,2721,7487,2019.0,30116051,False,False,False,"Tau, α-synuclein and TDP43 are substrates for CMA degradation, as are amyloid precursor protein (APP) but not amyloid-β fragment 42 (Aβ42) itself 3,45–47,48 .",#63:7,PMC6456907,"{""full_journal_name"": ""Nature reviews. Drug discovery"", ""pub_date"": ""2019-07-08"", ""ref"": ""30116051"", ""pub_year"": 2019, ""last_author"": ""Millan MJ"", ""type"": ""PubMed"", ""author_list"": [""Boland B"", ""Yu WH"", ""Corti O"", ""Mollereau B"", ""Henriques A"", ""Bezard E"", ""Pastores GM"", ""Rubinsztein DC"", ""Nixon RA"", ""Duchen MR"", ""Mallucci GR"", ""Kroemer G"", ""Levine B"", ""Eskelinen EL"", ""Mochel F"", ""Spedding M"", ""Louis C"", ""Martin OR"", ""Millan MJ""], ""title"": ""Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing."", ""doi"": ""10.1038/nrd.2018.109""}","{""Confidence"": [""High""], ""mesh"": [""Aging"", ""Animals"", ""Autophagy"", ""Humans"", ""Neurodegenerative Diseases"", ""Neurotoxins"", ""Proteasome Endopeptidase Complex"", ""Ubiquitin""], ""substances"": [""Neurotoxins"", ""Ubiquitin"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,6673,1484,2020.0,30837838,False,False,False,"Notably, the zinc ions could induce inclusion bodies formation and aggregation in the neuronal cell cultures, and this effect was not observed with copper or iron, indicating zinc-specific effects (Caragounis et al., 2010).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Cell"": [""neuron""], ""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,1854,8382,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Dopaminergic subgraph""]}",False
CAUSES_NO_CHANGE,14453,7307,2020.0,30697142,False,False,False,"Cotinine does not cause tachyphylaxis, addiction, or nicotine like withdrawal symptoms, and it has no negative cardiovascular eﬀects as opposed to nicotine (Terry et al., 2005; Benowitz et al., 2009; Zeitlin et al., 2012).",#59:13,PMC6341027,"{""full_journal_name"": ""Frontiers in neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30697142"", ""pub_year"": 2020, ""last_author"": ""Gjedde A"", ""type"": ""PubMed"", ""author_list"": [""Majdi A"", ""Kamari F"", ""Sadigh-Eteghad S"", ""Gjedde A""], ""title"": ""Molecular Insights Into Memory-Enhancing Metabolites of Nicotine in Brain: A Systematic Review."", ""doi"": ""10.3389/fnins.2018.01002""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,43292,21784,2007.0,17293005,False,False,False,These results suggest that BACE1 derived peptides do not directly inhibit BACE activities in vitro when the fluorogenic peptides are used as a substrate.,#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,4920,8696,,27299292,,False,,"Conversely, constitutively active versions of Rags lead to TFEB retention in the cytoplasm, irrespective of the nutrient status of the cell.[28]",#69:80,PMC5032832,"{""full_journal_name"": ""Annals of the New York Academy of Sciences"", ""pub_date"": ""2017-07-19"", ""ref"": ""27299292"", ""pub_year"": 2017, ""last_author"": ""Sardiello M"", ""type"": ""PubMed"", ""author_list"": [""Sardiello M""], ""title"": ""Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases."", ""doi"": ""10.1111/nyas.13131""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Humans"", ""Lysosomal Storage Diseases"", ""Lysosomes"", ""Models, Biological"", ""Molecular Targeted Therapy"", ""Signal Transduction""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors""]}",
CAUSES_NO_CHANGE,1808,27049,2011.0,20847424,False,False,False,"Aβ40 inhibits cultured neuron death caused by Cu2+, Fe2+, and Fe3+ but does not protect neurons against H2O2-induced damage [94].",#63:63,PMC3079354,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2011-06-09"", ""ref"": ""20847424"", ""pub_year"": 2011, ""last_author"": ""Brewer GJ"", ""type"": ""PubMed"", ""author_list"": [""Parihar MS"", ""Brewer GJ""], ""title"": ""Amyloid-\u03b2 as a modulator of synaptic plasticity."", ""doi"": ""10.3233/JAD-2010-101020""}","{""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Neuronal Plasticity"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,7294,12892,2001.0,11230871,False,False,False,"Interestingly, a reduction in the protein level of alpha7 has also been measured in the frontal cortex of patients with schizophrenia (Guan et al 1999), whereas no decrease was measured in the alpha4 nAChR protein level (Guan et al 1999)",#65:45,,"{""full_journal_name"": ""Biological psychiatry"", ""pub_date"": ""2001-06-07"", ""ref"": ""11230871"", ""pub_year"": 2001, ""last_author"": ""Nordberg A"", ""type"": ""PubMed"", ""author_list"": [""Nordberg A""], ""title"": ""Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Frontal Lobe""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Brain"", ""Cholinergic Agents"", ""Humans"", ""Receptors, Nicotinic"", ""Treatment Outcome""], ""substances"": [""Cholinergic Agents"", ""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,29022,2136,2015.0,25171717,False,False,False,"We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",#67:28,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-08-18"", ""ref"": ""25171717"", ""pub_year"": 2015, ""last_author"": ""Karsdal MA"", ""type"": ""PubMed"", ""author_list"": [""Henriksen K"", ""Byrjalsen I"", ""Christiansen C"", ""Karsdal MA""], ""title"": ""Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease."", ""doi"": ""10.3233/JAD-140984""}","{""mesh"": [""Aged"", ""Alzheimer Disease"", ""Biomarkers"", ""Clinical Trials, Phase III as Topic"", ""Disease Progression"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Humans"", ""Linear Models"", ""Male"", ""Mental Status Schedule"", ""Severity of Illness Index"", ""Time Factors"", ""tau Proteins""], ""substances"": [""Biomarkers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,26554,12009,2018.0,27671637,False,False,False,"Indeed, the reduced level of spines seen in proaggregant Tau transgenic slices are normalized when treated with 64627, whereas no significant changes are found in antiaggregant Tau transgenic slices or littermate controls (Fig. 5 A and B)",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,6709,36877,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,29165,11577,2017.0,28083634,False,False,False,"Expression of the candidate deubiquitinases Otub1, USP5, and USP9x in this assay demonstrated significantly increased Tau aggregation following expression of Otub1 (Fig. 2a; Fig. S3), not observed following expression of USP5 or USP9x (Fig. S3).",#64:64,PMC5390007,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2017-04-20"", ""ref"": ""28083634"", ""pub_year"": 2017, ""last_author"": ""Dewachter I"", ""type"": ""PubMed"", ""author_list"": [""Wang P"", ""Joberty G"", ""Buist A"", ""Vanoosthuyse A"", ""Stancu IC"", ""Vasconcelos B"", ""Pierrot N"", ""Faelth-Savitski M"", ""Kienlen-Campard P"", ""Octave JN"", ""Bantscheff M"", ""Drewes G"", ""Moechars D"", ""Dewachter I""], ""title"": ""Tau interactome mapping\u00a0based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo."", ""doi"": ""10.1007/s00401-016-1663-9""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Deubiquitinating Enzymes"", ""Humans"", ""Mice, Transgenic"", ""Neurofibrillary Tangles"", ""Neurons"", ""Tauopathies"", ""Ubiquitin"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Ubiquitin"", ""tau Proteins"", ""Deubiquitinating Enzymes"", ""Cysteine Endopeptidases"", ""Otub1 protein, mouse""]}",False
CAUSES_NO_CHANGE,34770,15007,2004.0,14657037,False,False,False,"XIAP expression in motor neurons significantly slows disease progression, whereas p35, a broad caspase inhibitory protein, does not. However, p35, which potently inhibits capase-3, does not slow disease progression in mouse ALS. There are two explanations for this apparent discrepancy. Since caspase-9 remains active in the presence of p35, procaspase-3 may be continuously processed into active caspase-3, finally overriding inhibition by p35. Alternatively, caspase-9 may utilize a substrate other than caspase-3, leading to caspase-3-independent cell death",#59:5,PMC291829,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2004-03-02"", ""ref"": ""14657037"", ""pub_year"": 2004, ""last_author"": ""Takahashi R"", ""type"": ""PubMed"", ""author_list"": [""Inoue H"", ""Tsukita K"", ""Iwasato T"", ""Suzuki Y"", ""Tomioka M"", ""Tateno M"", ""Nagao M"", ""Kawata A"", ""Saido TC"", ""Miura M"", ""Misawa H"", ""Itohara S"", ""Takahashi R""], ""title"": ""The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.""}","{""Species"": [""10090""], ""Subgraph"": [""Caspase subgraph"", ""Electron transport chain"", ""XIAP subgraph""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Base Sequence"", ""Cysteine Proteinase Inhibitors"", ""DNA Primers"", ""Disease Models, Animal"", ""Genotype"", ""Immunohistochemistry"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Proteins"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""Spinal Cord"", ""Superoxide Dismutase"", ""Superoxide Dismutase-1"", ""X-Linked Inhibitor of Apoptosis Protein""], ""substances"": [""Cysteine Proteinase Inhibitors"", ""DNA Primers"", ""Proteins"", ""SOD1 protein, human"", ""X-Linked Inhibitor of Apoptosis Protein"", ""Sod1 protein, mouse"", ""Superoxide Dismutase"", ""Superoxide Dismutase-1""]}",False
CAUSES_NO_CHANGE,29218,7101,2009.0,18986241,False,False,False,"NGF therapy has been tested in clinical trials of diabetic peripheral neuropathy and HIV-associated neuropathy, as well as patients with AD [177]. Each of these clinical trials met with disappointment owing to lack of efficacy, toxicity or both.",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,43753,41371,2011.0,21339331,False,False,False,"The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",#62:7,PMC3044115,"{""full_journal_name"": ""The Journal of cell biology"", ""pub_date"": ""2011-04-25"", ""ref"": ""21339331"", ""pub_year"": 2011, ""last_author"": ""Brandt R"", ""type"": ""PubMed"", ""author_list"": [""Gauthier-Kemper A"", ""Weissmann C"", ""Golovyashkina N"", ""Seb\u00f6-Lemke Z"", ""Drewes G"", ""Gerke V"", ""Heinisch JJ"", ""Brandt R""], ""title"": ""The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner."", ""doi"": ""10.1083/jcb.201007161""}","{""Confidence"": [""Medium""], ""Method"": [""Confocal Microscopy, Laser Scanning"", ""Immunocytochemistry"", ""Mass Spectrometry"", ""Pull-down Assay, GFP"", ""RNA Interference, shRNA"", ""Tandem Affinity Purification, TAP""], ""mesh"": [""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Animals"", ""Annexin A2"", ""Binding Sites"", ""Cell Membrane"", ""Humans"", ""Microtubules"", ""Molecular Sequence Data"", ""Neurites"", ""PC12 Cells"", ""Phosphorylation"", ""Rats"", ""tau Proteins""], ""substances"": [""Annexin A2"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,6595,5073,2018.0,30027901,False,False,False,"Verbessem and colleagues treated 26 HD patients with 5mg/kg creatine and 15 patients with placebo for one year and found no significant differences in measures of strength, neurological status, or cognitive function (Verbessem et al. 2003).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,11492,5277,2011.0,21745645,False,False,False,"When cholinergic input was activated 10 ms before SC stimulation, STD was induced, which was also sensitive to MLA but not to DHβE or atropine (Figures 5J and 5H).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,11165,822,2009.0,19277525,False,False,False,Neither mutation of the carboxy-terminal Leu residue nor removal of the carboxy-terminal 14 amino acids of the catalytic subunit prevented formation of heterotrimeric holoenzymes involving the B or B′ subunits,#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""Medium""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,6709,35828,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,2017,7260,2009.0,19126755,False,False,False,"In human trials, nicotine showed little efficacy in ameliorating AD symptoms (437). However, treatment was initiated after diagnosis of symptoms, and there is both epidemiological data and direct evidence from animal models that this is too late (106, 346, 396).",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,41520,12212,2019.0,30008470,False,False,False,"As shown in Fig. 3e, f, we found no difference between genotypes in saccharin or quinine intake, suggesting that the effect of Adnp deficiency is specific to alcohol, and does not apply to sweet reinforcers or bitter-taste solutions",#65:46,PMC6300527,"{""full_journal_name"": ""Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"", ""pub_date"": ""2019-02-11"", ""ref"": ""30008470"", ""pub_year"": 2019, ""last_author"": ""Barak S"", ""type"": ""PubMed"", ""author_list"": [""Ziv Y"", ""Rahamim N"", ""Lezmy N"", ""Even-Chen O"", ""Shaham O"", ""Malishkevich A"", ""Giladi E"", ""Elkon R"", ""Gozes I"", ""Barak S""], ""title"": ""Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice."", ""doi"": ""10.1038/s41386-018-0132-7""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alcohol Drinking"", ""Animals"", ""Disease Models, Animal"", ""Ethanol"", ""Female"", ""Gene Expression"", ""Haploinsufficiency"", ""Hippocampus"", ""Homeodomain Proteins"", ""Male"", ""Mice"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Sex Factors""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Ethanol""]}",False
CAUSES_NO_CHANGE,7180,1604,2017.0,27794524,False,False,False,"In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,15419,14223,2019.0,30232325,False,False,False,"Dkk1 resulted in substantial loss of dendritic spines, which was blocked by 10µM fasudil treatment (Fig. 3e, f).",#60:10,PMC6145937,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-03-14"", ""ref"": ""30232325"", ""pub_year"": 2019, ""last_author"": ""Killick R"", ""type"": ""PubMed"", ""author_list"": [""Elliott C"", ""Rojo AI"", ""Ribe E"", ""Broadstock M"", ""Xia W"", ""Morin P"", ""Semenov M"", ""Baillie G"", ""Cuadrado A"", ""Al-Shawi R"", ""Ballard CG"", ""Simons P"", ""Killick R""], ""title"": ""A role for APP in Wnt signalling links synapse loss with \u03b2-amyloid production."", ""doi"": ""10.1038/s41398-018-0231-6""}","{""Confidence"": [""High""], ""mesh"": [""1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"", ""Alzheimer Disease"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Cells, Cultured"", ""Disease Models, Animal"", ""Female"", ""HEK293 Cells"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Intracellular Signaling Peptides and Proteins"", ""Low Density Lipoprotein Receptor-Related Protein-6"", ""Male"", ""Membrane Proteins"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Neurons"", ""Protein Kinase Inhibitors"", ""Rats"", ""Rats, Sprague-Dawley"", ""Synapses"", ""Wnt Signaling Pathway""], ""substances"": [""Amyloid beta-Protein Precursor"", ""DKK1 protein, human"", ""Intercellular Signaling Peptides and Proteins"", ""Intracellular Signaling Peptides and Proteins"", ""LRP6 protein, human"", ""Low Density Lipoprotein Receptor-Related Protein-6"", ""Membrane Proteins"", ""Protein Kinase Inhibitors"", ""VANGL2 protein, human"", ""1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"", ""fasudil""]}",False
CAUSES_NO_CHANGE,7981,38551,2016.0,26702100,False,False,False,"In our observations, knockdown of TDP-43 significantly increased wild- type (WT) TFEB, but not TFEBD30 or TFEB-Q10A/L11A lysosomal localization (Figs 3E and EV3C and D), suggesting that Rag GTPases, but not TDP-43, are critical for the association of TFEB with lysosomes",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,3634,11430,2019.0,29844403,False,False,False,"As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",#71:1,PMC5974403,"{""full_journal_name"": ""Cell death & disease"", ""pub_date"": ""2019-12-10"", ""ref"": ""29844403"", ""pub_year"": 2019, ""last_author"": ""Yang CR"", ""type"": ""PubMed"", ""author_list"": [""Fan SJ"", ""Huang FI"", ""Liou JP"", ""Yang CR""], ""title"": ""The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model."", ""doi"": ""10.1038/s41419-018-0688-5""}","{""CellLine"": [""Neuro-2a cell"", ""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Benzamides"", ""Cell Line, Tumor"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3 beta"", ""Histone Deacetylase Inhibitors"", ""Memory Disorders"", ""Models, Biological"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Aggregates"", ""Proteolysis"", ""Quinolines"", ""Rats, Sprague-Dawley"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Benzamides"", ""Histone Deacetylase Inhibitors"", ""MPT0G211"", ""Neuroprotective Agents"", ""Protein Aggregates"", ""Quinolines"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,37823,4941,2015.0,25374103,False,False,False,Toxicity assays revealed that neither CHIP nor any of the tau constructs caused cell death compared to the control GFP vector (Supplementary Fig. 1).,#63:21,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-10-26"", ""ref"": ""25374103"", ""pub_year"": 2015, ""last_author"": ""Spires-Jones TL"", ""type"": ""PubMed"", ""author_list"": [""Saidi LJ"", ""Polydoro M"", ""Kay KR"", ""Sanchez L"", ""Mandelkow EM"", ""Hyman BT"", ""Spires-Jones TL""], ""title"": ""Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes."", ""doi"": ""10.3233/JAD-142094""}","{""Confidence"": [""High""], ""mesh"": [""Caspase 3"", ""Cell Line, Tumor"", ""Cell Proliferation"", ""Gene Expression Regulation"", ""Green Fluorescent Proteins"", ""HSP70 Heat-Shock Proteins"", ""Humans"", ""Mitochondria"", ""Mutation"", ""Neuroblastoma"", ""Protein Binding"", ""Transfection"", ""Ubiquitin-Protein Ligases"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""STUB1 protein, human"", ""Ubiquitin-Protein Ligases"", ""Caspase 3""]}",False
CAUSES_NO_CHANGE,11660,41815,2015.0,25546293,False,False,False,"In the presence of the HDAC6 inhibitor ACY-1215, the increased levels of Ac-Lys49 β-catenin had no effect on the levels for β-catenin phosphorylated at Ser33, Ser37, and Thr41 (Figure 3A, B).",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,43753,5120,2017.0,27373205,False,False,False,"As previously reported, perfusion of hT40 monomer had no effect on the rate of anterograde FAT in the squid axoplasm (Fig. 5A), whereas perfusion of hT40 aggregates significantly inhibited anterograde FAT as compared to hT40 monomer (Fig. 5B; Fig. 6A; p = 0.003) (LaPointe et al., 2009b). Neither hT40 monomers nor hT40 aggregates altered the rate of retrograde FAT (Fig. 5A, B; Fig. 6B).",#69:78,PMC4992631,"{""full_journal_name"": ""Experimental neurology"", ""pub_date"": ""2017-05-05"", ""ref"": ""27373205"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Tiernan CT"", ""Combs B"", ""Cox K"", ""Morfini G"", ""Brady ST"", ""Counts SE"", ""Kanaan NM""], ""title"": ""Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport."", ""doi"": ""10.1016/j.expneurol.2016.06.030""}","{""Confidence"": [""Medium""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Axonal Transport"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Frontal Lobe"", ""Humans"", ""Male"", ""Phosphorylation"", ""Serine"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""Serine""]}",False
CAUSES_NO_CHANGE,3459,7213,2019.0,30046111,False,False,False,"Similarly, the morphology and coverage of meningeal lymphatic vessels did not differ between wild-type and 5xFAD mice at 3–4 months of age (Extended Data Fig. 8t, u)",#67:25,PMC6085146,"{""full_journal_name"": ""Nature"", ""pub_date"": ""2019-02-08"", ""ref"": ""30046111"", ""pub_year"": 2019, ""last_author"": ""Kipnis J"", ""type"": ""PubMed"", ""author_list"": [""Da Mesquita S"", ""Louveau A"", ""Vaccari A"", ""Smirnov I"", ""Cornelison RC"", ""Kingsmore KM"", ""Contarino C"", ""Onengut-Gumuscu S"", ""Farber E"", ""Raper D"", ""Viar KE"", ""Powell RD"", ""Baker W"", ""Dabhi N"", ""Bai R"", ""Cao R"", ""Hu S"", ""Rich SS"", ""Munson JM"", ""Lopes MB"", ""Overall CC"", ""Acton ST"", ""Kipnis J""], ""title"": ""Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease."", ""doi"": ""10.1038/s41586-018-0368-8""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Meninges""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid"", ""Amyloid beta-Peptides"", ""Animals"", ""Brain"", ""Cognition"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Extracellular Fluid"", ""Female"", ""Homeostasis"", ""Humans"", ""Lymph Nodes"", ""Lymphatic Vessels"", ""Male"", ""Meninges"", ""Mice"", ""Mice, Transgenic"", ""Perfusion""], ""substances"": [""Amyloid"", ""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,6630,14838,2011.0,21745645,False,False,False,"The LTP induced by pairing the SC 10 ms before the SO was blocked by atropine, but not by MLA or DHbE.",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""after SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,1458,1491,2017.0,27794524,False,False,False,"Notably, follicle- like structures are probably able to sustain a high level of humoral response, as well as other autoimmune mechanisms within the CNS, in a manner independent of peripheral inflammation.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,36060,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Dopaminergic subgraph""]}",False
CAUSES_NO_CHANGE,1851,5073,2014.0,24511233,False,False,False,"Current treatments include both typical (eg, haloperidol and chlorpromazine) and atypical (eg, risperidone and clozapine) antipsychotics, which act on the dopaminergic system and D2 dopamine receptors in particular. These treatments show partial efficacy in reducing psychotic or positive symptoms;30 however, they demonstrate little to no efficacy in addressing negative symptoms and cognitive impairments, which can prevent patients from participating fully and productively in society",#69:34,PMC3913542,"{""full_journal_name"": ""Neuropsychiatric disease and treatment"", ""pub_date"": ""2014-06-24"", ""ref"": ""24511233"", ""pub_year"": 2014, ""last_author"": ""Rook JM"", ""type"": ""PubMed"", ""author_list"": [""Foster DJ"", ""Choi DL"", ""Conn PJ"", ""Rook JM""], ""title"": ""Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia."", ""doi"": ""10.2147/NDT.S55104""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,7161,36416,2002.0,12218646,False,False,False,"Sera from patients with Alzheimer disease and non-demented elderly subjects caused an increase in IL-2 and a decrease in IL-10 production by PBMC from middle-aged control subjects but did not affect IL-1beta, IL-6, and TNFalpha secretion, indicating alterations of the immune system related to aging.",#59:5,,"{""full_journal_name"": ""Alzheimer disease and associated disorders"", ""pub_date"": ""2002-12-04"", ""ref"": ""12218646"", ""pub_year"": 2002, ""last_author"": ""Bessler H"", ""type"": ""PubMed"", ""author_list"": [""Bergman M"", ""Salman H"", ""Beloosesky Y"", ""Djaldetti M"", ""Bessler H""], ""title"": ""Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli?""}","{""MeSHAnatomy"": [""Serum""], ""MeSHDisease"": [""Alzheimer Disease""], ""Species"": [""9606""], ""Subgraph"": [""Tumor necrosis factor subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Apoptosis"", ""Female"", ""Humans"", ""Interleukin-1"", ""Interleukin-10"", ""Interleukin-2"", ""Interleukin-6"", ""Male"", ""Monocytes"", ""Reference Values"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Interleukin-1"", ""Interleukin-2"", ""Interleukin-6"", ""Tumor Necrosis Factor-alpha"", ""Interleukin-10""]}",False
CAUSES_NO_CHANGE,14453,7235,2020.0,30697142,False,False,False,"Cotinine does not cause tachyphylaxis, addiction, or nicotine like withdrawal symptoms, and it has no negative cardiovascular eﬀects as opposed to nicotine (Terry et al., 2005; Benowitz et al., 2009; Zeitlin et al., 2012).",#59:13,PMC6341027,"{""full_journal_name"": ""Frontiers in neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30697142"", ""pub_year"": 2020, ""last_author"": ""Gjedde A"", ""type"": ""PubMed"", ""author_list"": [""Majdi A"", ""Kamari F"", ""Sadigh-Eteghad S"", ""Gjedde A""], ""title"": ""Molecular Insights Into Memory-Enhancing Metabolites of Nicotine in Brain: A Systematic Review."", ""doi"": ""10.3389/fnins.2018.01002""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,37099,38622,2007.0,17293005,False,False,False,"Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,14467,12108,2017.0,27794524,False,False,False,"It reduces both pro- and anti-inflammatory cytokine levels, while growth factor secretion remains high.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,41600,43310,2017.0,28148553,False,False,False,"None of the lentiviral models significantly increased PERK or pPERK, showing that tau overload per se is not sufficient to activate the UPR.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,39699,14208,2018.0,27671637,False,False,False,"MC-1–positive Tau accumulates in the axonal grains of proaggregant Tau as described above (arrowheads), whereas antiaggregant slices remain unstained",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Axons""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,1411,38804,2016.0,27013968,False,False,False,"Striatal BDNF and fl-TrkB levels were found to be similar in R6/2 and WT mice (Figures 1C,D).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,1682,32270,2015.0,25125464,False,False,False,"CRF-OE mice had significantly elevated tau-P compared to wild type (WT) mice at the AT8 (S202/T204), PHF-1 (S396/404), S262, and S422 sites. Treating CRF-OE mice with R121919 blocked phosphorylation at the AT8 (S202/T204) and PHF-1 (S396/404) sites, but not at the S262 and S422 sites and reduced phosphorylation of c-Jun N Terminal Kinase (JNK).",#60:23,PMC4258165,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-08-21"", ""ref"": ""25125464"", ""pub_year"": 2015, ""last_author"": ""Rissman RA"", ""type"": ""PubMed"", ""author_list"": [""Campbell SN"", ""Zhang C"", ""Monte L"", ""Roe AD"", ""Rice KC"", ""Tach\u00e9 Y"", ""Masliah E"", ""Rissman RA""], ""title"": ""Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor."", ""doi"": ""10.3233/JAD-141281""}","{""Anatomy"": [""hippocampal formation""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Corticotropin-Releasing Hormone"", ""Hippocampus"", ""Mice"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Aggregation, Pathological"", ""Receptors, Corticotropin-Releasing Hormone"", ""tau Proteins""], ""substances"": [""Receptors, Corticotropin-Releasing Hormone"", ""tau Proteins"", ""CRF receptor type 1"", ""Corticotropin-Releasing Hormone""]}",False
CAUSES_NO_CHANGE,1411,13073,2018.0,30027901,False,False,False,"Apart from striatum decreased levels of GABA have been found in hippocampus and cerebral cortex (Reynolds and Pearson 1987). Significant decrease in levels of GAD were observed throughout the brain, but most markedly in the striatum and GPe (Spokes 1980). GABA receptors were decreased in striatum but unchanged in the cortex (Lloyd et al. 1977).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Anatomy"": [""cerebral cortex""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,11492,28785,2011.0,21745645,False,False,False,"The LTP induced by the preceding SO stimulation (100 ms) was completely blocked by MLA (10 nM), whereas DHβE (1 μM) and atropine (5 μM) were ineffective(Figure 2A).Similarly the induction of STD by SO 10 ms before SC was also blocked by MLA, with DHβE and atropine also having no effect(Figure 2B).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""100 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,40161,6064,2009.0,19277525,False,False,False,"By contrast, several recent studies using purified, recombinant proteins showed that the methylation status of the catalytic subunit did not play a decisive role for the in vitro assembly of PP2A holoenzymes involving the B and B′ subunit",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""High""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,6709,33686,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,7464,13718,2019.0,30562574,False,False,False,"We biochemically verified the reduction of CRMP-2 protein levels (37±8%) upon LAMP2A downregulation (Fig. 4A), which was accompanied by no detectable changes in Dpysl2/Crmp2 mRNA levels (Fig. 4B).",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,11470,7161,2008.0,18854539,False,False,False,High-dose B vitamin supplementation in individuals with normal levels of B vitamins was effective in reducing homocysteine levels. This regimen of high-dose B vitamin supplements does not slow cognitive decline in individuals with mild to moderate AD.,#59:5,PMC2684821,"{""full_journal_name"": ""JAMA"", ""pub_date"": ""2008-10-20"", ""ref"": ""18854539"", ""pub_year"": 2008, ""last_author"": ""Thal LJ"", ""type"": ""PubMed"", ""author_list"": [""Aisen PS"", ""Schneider LS"", ""Sano M"", ""Diaz-Arrastia R"", ""van Dyck CH"", ""Weiner MF"", ""Bottiglieri T"", ""Jin S"", ""Stokes KT"", ""Thomas RG"", ""Thal LJ""], ""title"": ""High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial."", ""doi"": ""10.1001/jama.300.15.1774""}","{""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Cognition"", ""Cognition Disorders"", ""Dietary Supplements"", ""Female"", ""Folic Acid"", ""Homocysteine"", ""Humans"", ""Male"", ""Methylenetetrahydrofolate Reductase (NADPH2)"", ""Psychiatric Status Rating Scales"", ""Vitamin B 12"", ""Vitamin B 6"", ""Vitamin B Complex""], ""substances"": [""Homocysteine"", ""Vitamin B Complex"", ""Vitamin B 6"", ""Folic Acid"", ""Methylenetetrahydrofolate Reductase (NADPH2)"", ""Vitamin B 12""]}",False
CAUSES_NO_CHANGE,29218,1101,2009.0,18986241,False,False,False,"NGF therapy has been tested in clinical trials of diabetic peripheral neuropathy and HIV-associated neuropathy, as well as patients with AD [177]. Each of these clinical trials met with disappointment owing to lack of efficacy, toxicity or both.",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,41605,6690,2013.0,23211705,False,False,False,"Notably, CRH did not affect the amount of progesterone released into the incubation medium up to d 9, whereas it suppressed pro- gesterone levels on d 11 (d 11 progesterone 0.030 􏰅 0.000 ng/ml, P 􏰃 0.001).",#62:4,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""2013-02-22"", ""ref"": ""23211705"", ""pub_year"": 2013, ""last_author"": ""Loutradis D"", ""type"": ""PubMed"", ""author_list"": [""Dinopoulou V"", ""Partsinevelos GA"", ""Mavrogianni D"", ""Anagnostou E"", ""Drakakis P"", ""Makrigiannakis A"", ""Chrousos GP"", ""Loutradis D""], ""title"": ""The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis."", ""doi"": ""10.1210/en.2012-1838""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Chorionic Gonadotropin, beta Subunit, Human"", ""Corticotropin-Releasing Hormone"", ""Embryonic Development"", ""Estradiol"", ""Female"", ""Male"", ""Mice"", ""Ovarian Follicle"", ""Pregnancy"", ""Progesterone"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""Reverse Transcriptase Polymerase Chain Reaction""], ""substances"": [""CRF receptor type 2"", ""Chorionic Gonadotropin, beta Subunit, Human"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""Progesterone"", ""Estradiol"", ""CRF receptor type 1"", ""Corticotropin-Releasing Hormone""]}",False
CAUSES_NO_CHANGE,7981,38122,2016.0,26702100,False,False,False,"TDP-43-depleted cells showed a decrease of raptor, but not mTOR, p18, and RagB, compared with control cells (Fig 2B)",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,41509,21289,2017.0,28760828,False,False,False,"Of note, whereas mimicking acetylation at most non-KXGS sites had minimal impact on tau aggregation, K274Q also significantly decreased tau assembly in vitro, albeit to a lesser extent than K321Q (Fig. 1b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,2017,1650,2012.0,21958873,False,False,False,"Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,14219,32541,2007.0,16820021,False,False,False,"As was the case with BDNF expression, treatment with antalarmin had no impact upon the isolation-induced alterations in TrkB expression.",#69:40,,"{""full_journal_name"": ""The European journal of neuroscience"", ""pub_date"": ""2007-04-03"", ""ref"": ""16820021"", ""pub_year"": 2007, ""last_author"": ""Lawrence AJ"", ""type"": ""PubMed"", ""author_list"": [""Djouma E"", ""Card K"", ""Lodge DJ"", ""Lawrence AJ""], ""title"": ""The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.""}","{""Confidence"": [""Medium""], ""mesh"": [""Amygdala"", ""Animals"", ""Behavior, Animal"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Male"", ""Nucleus Accumbens"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Inbred Strains"", ""Receptor, trkB"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""Social Isolation"", ""Up-Regulation""], ""substances"": [""8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""antalarmin"", ""CRF receptor type 1"", ""Receptor, trkB"", ""NCQ 298""]}",False
CAUSES_NO_CHANGE,14406,25391,2013.0,23383175,False,False,False,"However, anatabine significantly suppressed the production of IL-1b, IL-6 and IL-17A in the serum of EAE mice (Fig. 2B) but did not significantly impact IFN-gamma and TNF-alpha",#68:42,PMC3559544,"{""full_journal_name"": ""PloS one"", ""pub_date"": ""2013-07-22"", ""ref"": ""23383175"", ""pub_year"": 2013, ""last_author"": ""Mullan MJ"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Mullan M"", ""Ait-Ghezala G"", ""Mathura V"", ""Bachmeier C"", ""Crawford F"", ""Mullan MJ""], ""title"": ""Amelioration of experimental autoimmune encephalomyelitis by anatabine."", ""doi"": ""10.1371/journal.pone.0055392""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Serum""], ""MeSHDisease"": [""Encephalomyelitis""], ""Species"": [""10090""], ""mesh"": [""Administration, Oral"", ""Alkaloids"", ""Analysis of Variance"", ""Animals"", ""Blotting, Western"", ""Cytokines"", ""Encephalomyelitis, Autoimmune, Experimental"", ""Immunohistochemistry"", ""Mice"", ""Multiple Sclerosis"", ""Pyridines"", ""Th1 Cells"", ""Th17 Cells""], ""substances"": [""Alkaloids"", ""Cytokines"", ""Pyridines"", ""anatabine""]}",False
CAUSES_NO_CHANGE,32628,1588,2020.0,30837838,False,False,False,"Several mutations in the RRMs are shown to disrupt the RNA binding capability while not significantly interfering with the RNA recognition (Lukavsky et al., 2013).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}",{},False
CAUSES_NO_CHANGE,11931,10729,2009.0,19126755,False,False,False,"In fact, as described above, AChE inhibitors do not affect alpha7 nAChR-mediated synaptic transmission evoked by low-frequency stimulation of cholinergic fibers in chick ciliary ganglia (522).",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,6709,37803,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,14407,14254,2013.0,22530628,False,False,False,"For example, some compounds such as curcumin inhibit oligomerization but not ﬁbrillation [105], and other compounds such as o-vanillin inhibit the formation of both oligomers and ﬁbrils [106]. Other molecules such as the naphthalene sulfonates inhibit ﬁbrillation but not oligomerization [107].",#57:51,PMC6493450,"{""full_journal_name"": ""CNS neuroscience & therapeutics"", ""pub_date"": ""2013-05-20"", ""ref"": ""22530628"", ""pub_year"": 2013, ""last_author"": ""Zeitlin R"", ""type"": ""PubMed"", ""author_list"": [""Echeverria V"", ""Zeitlin R""], ""title"": ""Cotinine: a potential new therapeutic agent against Alzheimer's disease."", ""doi"": ""10.1111/j.1755-5949.2012.00317.x""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cotinine"", ""Drug Delivery Systems"", ""Humans"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic"", ""Cotinine""]}",False
CAUSES_NO_CHANGE,11772,1650,2012.0,21958873,False,False,False,"Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,42998,13972,2014.0,24227736,False,False,False,"Gene transcription of Il-1β and Tnfsf2 (TNF-α) was significantly increased in microglia challenged with neural debris after knockdown of Siglece mRNA, although no effect on Nos2 mRNA was observed (Fig. 3A).",#57:0,PMC3828472,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2014-01-06"", ""ref"": ""24227736"", ""pub_year"": 2014, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Claude J"", ""Linnartz-Gerlach B"", ""Kudin AP"", ""Kunz WS"", ""Neumann H""], ""title"": ""Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst."", ""doi"": ""10.1523/JNEUROSCI.2211-13.2013""}","{""ChallengeType"": [""neural debris""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cells, Cultured"", ""Coculture Techniques"", ""Female"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Microglia"", ""Neurons"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Protein Binding"", ""Respiratory Burst"", ""Sialic Acid Binding Ig-like Lectin 3""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cd33 protein, mouse"", ""Neuroprotective Agents"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Siglece protein, mouse""]}",False
CAUSES_NO_CHANGE,1193,1491,2017.0,27794524,False,False,False,"Notably, follicle- like structures are probably able to sustain a high level of humoral response, as well as other autoimmune mechanisms within the CNS, in a manner independent of peripheral inflammation.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""central nervous system""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,41542,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Dopaminergic subgraph""]}",False
CAUSES_NO_CHANGE,6957,2452,2011.0,20847424,False,False,False,"In a direct investigation of the acute effects of extracellular and intracellular Abeta42 peptides on synaptic transmission, Moreno et al. [194] noticed inhibition of synaptic transmission by nanomolar concentrations of intra-axonal oligomeric Abeta42, but not oligomeric Abeta40 or extracellular oligomeric Abeta42",#63:30,PMC3079354,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2011-06-09"", ""ref"": ""20847424"", ""pub_year"": 2011, ""last_author"": ""Brewer GJ"", ""type"": ""PubMed"", ""author_list"": [""Parihar MS"", ""Brewer GJ""], ""title"": ""Amyloid-\u03b2 as a modulator of synaptic plasticity."", ""doi"": ""10.3233/JAD-2010-101020""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Axons""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Neuronal Plasticity"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,42894,7207,2012.0,22179319,False,False,False,"Using Oxymax metabolic cages to measure energy expenditure continuously for a week and monitoring daily food intake, we found that SIRT1 overexpression mainly counteracted the negative effect of mutant Htt on food intake (Supplementary Fig. 2e) but did not affect energy expenditure (Supplementary Fig. 2f).",#66:20,PMC4551453,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2012-03-14"", ""ref"": ""22179319"", ""pub_year"": 2012, ""last_author"": ""Duan W"", ""type"": ""PubMed"", ""author_list"": [""Jiang M"", ""Wang J"", ""Fu J"", ""Du L"", ""Jeong H"", ""West T"", ""Xiang L"", ""Peng Q"", ""Hou Z"", ""Cai H"", ""Seredenina T"", ""Arbez N"", ""Zhu S"", ""Sommers K"", ""Qian J"", ""Zhang J"", ""Mori S"", ""Yang XW"", ""Tamashiro KL"", ""Aja S"", ""Moran TH"", ""Luthi-Carter R"", ""Martin B"", ""Maudsley S"", ""Mattson MP"", ""Cichewicz RH"", ""Ross CA"", ""Holtzman DM"", ""Krainc D"", ""Duan W""], ""title"": ""Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets."", ""doi"": ""10.1038/nm.2558""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""MeSHDisease"": [""Huntington Disease""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Disease Models, Animal"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""Gene Expression Regulation"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins"", ""Rats"", ""Receptor, trkB"", ""Signal Transduction"", ""Sirtuin 1""], ""substances"": [""Brain-Derived Neurotrophic Factor"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""FoxO3 protein, mouse"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Ppp1r1b protein, mouse"", ""Receptor, trkB"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,14443,4511,2006.0,16816118,False,False,False,"In the present study we injected bilaterally 3-morpholino-sydnonimine (SIN-1), a recognized and widely used peroxynitrite donor (25–30), into rat hippocampus, and investigated whether or not peroxynitrite could induce simultaneously nitration and hyperphosphorylation of tau and the underlying mechanisms in vivo. The level of nitrated and hyperphosphorylated tau was markedly increased in rat hippocampus 24 h, and prevented by preinjection of uric acid, a natural scavenger of peroxynitrite. GSK-3beta and p38 MAPKs, including p38alpha, p38beta, and p38delta activity was increased, but no change in the activity of p38gamma, ERK, and c-Jun amino-terminal kinase (JNK). Both nitrated tau and hyperphosphorylated tau were aggregated in the hippocampus, with activity of 20S proteasome significantly arrested in SIN-1-injected rats. Hyperphosphorylated tau was degraded as efficiently as normal tau by 20S proteasome, but the nitrated tau with an unorderly secondary structure became more resistant to the proteolysis, providing evidence that peroxynitrite simultaneously induces tau hyperphosphorylation, nitration, and accumulation, and that activation of GSK-3beta, p38alpha, p38beta, p38delta isoforms and the inhibition of proteasome activity are respectively responsible for the peroxynitrite-induced tau hyperphosphorylation and accumulation.",#60:23,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2006-07-31"", ""ref"": ""16816118"", ""pub_year"": 2006, ""last_author"": ""Wang JZ"", ""type"": ""PubMed"", ""author_list"": [""Zhang YJ"", ""Xu YF"", ""Liu YH"", ""Yin J"", ""Li HL"", ""Wang Q"", ""Wang JZ""], ""title"": ""Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms.""}","{""Anatomy"": [""hippocampal formation""], ""Confidence"": [""Medium""], ""ExpMethod"": [""in vivo""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Caspase 3"", ""Caspases"", ""Cell Nucleus"", ""Glycogen Synthase Kinase 3"", ""Hippocampus"", ""Male"", ""Maze Learning"", ""Peroxynitrous Acid"", ""Phosphorylation"", ""Rats"", ""Rats, Wistar"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""Peroxynitrous Acid"", ""Glycogen Synthase Kinase 3"", ""Casp3 protein, rat"", ""Caspase 3"", ""Caspases""]}",False
CAUSES_NO_CHANGE,40821,20824,2015.0,21329555,False,False,False,There was no signiﬁcant diﬀerence in APP level between p65 transfected cells and controls (p>0.05).,#64:30,,"{""full_journal_name"": ""The international journal of neuropsychopharmacology"", ""pub_date"": ""2015-01-22"", ""ref"": ""21329555"", ""pub_year"": 2015, ""last_author"": ""Song W"", ""type"": ""PubMed"", ""author_list"": [""Chen CH"", ""Zhou W"", ""Liu S"", ""Deng Y"", ""Cai F"", ""Tone M"", ""Tone Y"", ""Tong Y"", ""Song W""], ""title"": ""Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease."", ""doi"": ""10.1017/S1461145711000149""}","{""Confidence"": [""High""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""Humans"", ""Promoter Regions, Genetic"", ""Signal Transduction"", ""Transcription Factor RelA"", ""Transcription, Genetic"", ""Tumor Necrosis Factor-alpha"", ""Up-Regulation""], ""substances"": [""APP protein, human"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Transcription Factor RelA"", ""Tumor Necrosis Factor-alpha"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,37373,28838,,27299292,,False,,"Interestingly, mTORC1 lysosomal localization was found not to be essential for mTORC1 regulation of lysosomal function.[32]",#69:80,PMC5032832,"{""full_journal_name"": ""Annals of the New York Academy of Sciences"", ""pub_date"": ""2017-07-19"", ""ref"": ""27299292"", ""pub_year"": 2017, ""last_author"": ""Sardiello M"", ""type"": ""PubMed"", ""author_list"": [""Sardiello M""], ""title"": ""Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases."", ""doi"": ""10.1111/nyas.13131""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Humans"", ""Lysosomal Storage Diseases"", ""Lysosomes"", ""Models, Biological"", ""Molecular Targeted Therapy"", ""Signal Transduction""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors""]}",
CAUSES_NO_CHANGE,37057,6901,2020.0,31413141,False,False,False,"Consistent with our previous findings, there was no significant correlation between CSF sTREM2 concentrations and CSF Abeta 42 concentrations (r = 0.074, P = 0.052; fig. S1).",#59:17,PMC6697053,"{""full_journal_name"": ""Science translational medicine"", ""pub_date"": ""2020-07-27"", ""ref"": ""31413141"", ""pub_year"": 2020, ""last_author"": ""Cruchaga C"", ""type"": ""PubMed"", ""author_list"": [""Deming Y"", ""Filipello F"", ""Cignarella F"", ""Cantoni C"", ""Hsu S"", ""Mikesell R"", ""Li Z"", ""Del-Aguila JL"", ""Dube U"", ""Farias FG"", ""Bradley J"", ""Budde J"", ""Ibanez L"", ""Fernandez MV"", ""Blennow K"", ""Zetterberg H"", ""Heslegrave A"", ""Johansson PM"", ""Svensson J"", ""Nellg\u00e5rd B"", ""Lleo A"", ""Alcolea D"", ""Clarimon J"", ""Rami L"", ""Molinuevo JL"", ""Su\u00e1rez-Calvet M"", ""Morenas-Rodr\u00edguez E"", ""Kleinberger G"", ""Ewers M"", ""Harari O"", ""Haass C"", ""Brett TJ"", ""Benitez BA"", ""Karch CM"", ""Piccio L"", ""Cruchaga C""], ""title"": {""#text"": ""The  gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk."", ""i"": ""MS4A""}, ""doi"": ""10.1126/scitranslmed.aau2291""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""mesh"": [""Alzheimer Disease"", ""Female"", ""Genome-Wide Association Study"", ""Humans"", ""Macrophages"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Meta-Analysis as Topic"", ""Multigene Family"", ""Receptors, Immunologic""], ""substances"": [""MS4A4A protein, human"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
CAUSES_NO_CHANGE,35995,2190,2010.0,20203208,False,False,False,This protective function of Siglec-11 on neuronal cell body survival was not observed when PSA was removed from neurons (Fig. 4C).,#57:0,PMC6634112,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2010-05-05"", ""ref"": ""20203208"", ""pub_year"": 2010, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Wang Y"", ""Neumann H""], ""title"": ""Alleviation of neurotoxicity by microglial human Siglec-11."", ""doi"": ""10.1523/JNEUROSCI.3940-09.2010""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Adolescent"", ""Adult"", ""Alternative Splicing"", ""Animals"", ""Apoptosis"", ""Cell Communication"", ""Cells, Cultured"", ""Child"", ""Coculture Techniques"", ""Cytoprotection"", ""Encephalitis"", ""Female"", ""Genetic Vectors"", ""Gliosis"", ""Humans"", ""Inflammation Mediators"", ""Lectins"", ""Lipopolysaccharides"", ""Male"", ""Membrane Proteins"", ""Mice"", ""Mice, Inbred C57BL"", ""Microglia"", ""Nerve Degeneration"", ""Neural Cell Adhesion Molecule L1"", ""Neurons"", ""Phagocytosis"", ""Protein Isoforms"", ""RNA, Messenger"", ""Sialic Acids"", ""Transfection"", ""Young Adult""], ""substances"": [""Inflammation Mediators"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neural Cell Adhesion Molecule L1"", ""Protein Isoforms"", ""RNA, Messenger"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""polysialic acid"", ""polysialyl neural cell adhesion molecule""]}",False
CAUSES_NO_CHANGE,41670,861,2009.0,19277525,False,False,False,"For example, the small tumor antigen derived from the DNA tumor viruses SV40 and polyoma viruses was shown to only interact with the PP2A core enzyme, but not the holoenzyme",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""High""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,1854,26991,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,38594,43653,2019.0,29540553,False,False,False,"Levels of human ac-K174 tau detected with AC312 antibody were significantly elevated by loss of SIRT1 (t(11)    4.69, p 0.0007, unpaired t test), whereas levels of ac-K274 tau remained unaffected (Fig. 2A,B).",#68:33,PMC5895994,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2019-10-03"", ""ref"": ""29540553"", ""pub_year"": 2019, ""last_author"": ""Gan L"", ""type"": ""PubMed"", ""author_list"": [""Min SW"", ""Sohn PD"", ""Li Y"", ""Devidze N"", ""Johnson JR"", ""Krogan NJ"", ""Masliah E"", ""Mok SA"", ""Gestwicki JE"", ""Gan L""], ""title"": ""SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy."", ""doi"": ""10.1523/JNEUROSCI.2369-17.2018""}","{""CellLine"": [""HEK293""], ""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Female"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Male"", ""Maze Learning"", ""Mice"", ""Sirtuin 1"", ""Synaptic Transmission"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mapt protein, mouse"", ""tau Proteins"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,7025,12467,2019.0,29590627,False,False,False,"We confirmed that heparin within the aggregated tau preparations did not contribute to tau entry into neurons, finding that uptake of both monomeric and aggregated tau was unaffected in the presence of heparin (Figures S4C and S4D",#57:66,PMC5896171,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2019-11-05"", ""ref"": ""29590627"", ""pub_year"": 2019, ""last_author"": ""Livesey FJ"", ""type"": ""PubMed"", ""author_list"": [""Evans LD"", ""Wassmer T"", ""Fraser G"", ""Smith J"", ""Perkinton M"", ""Billinton A"", ""Livesey FJ""], ""title"": ""Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways."", ""doi"": ""10.1016/j.celrep.2018.03.021""}","{""mesh"": [""Cerebral Cortex"", ""Dynamins"", ""Endocytosis"", ""Human Embryonic Stem Cells"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregation, Pathological"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,6590,7246,2018.0,30027901,False,False,False,"In a double-blind crossover trial involving four treatments of haloperidol, haloperidol and lithium carbonate, lithium carbonate and placebo carried out for three weeks, none of the treatments provided effective relief from choreiform movements.",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,12015,5198,2017.0,27623715,False,False,False,"Only middle-aged Tet-mev-1 mice showed JNK/MARK activation and Ca2+ overload, particularly in astrocytes with decreased hippocampal GFAP and S100ß, but without pathological features such as apoptosis, amyloidosis, and lactic acidosis in neurons and astrocytes. This led to decreasing levels of glial fibrillary acidic protein and S100β in the hippocampal area.",#60:23,PMC5242301,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2017-06-05"", ""ref"": ""27623715"", ""pub_year"": 2017, ""last_author"": ""Ishii N"", ""type"": ""PubMed"", ""author_list"": [""Ishii T"", ""Takanashi Y"", ""Sugita K"", ""Miyazawa M"", ""Yanagihara R"", ""Yasuda K"", ""Onouchi H"", ""Kawabe N"", ""Nakata M"", ""Yamamoto Y"", ""Hartman PS"", ""Ishii N""], ""title"": ""Endogenous reactive oxygen species cause astrocyte defects and neuronal dysfunctions in the hippocampus: a new model for aging brain."", ""doi"": ""10.1111/acel.12523""}","{""Anatomy"": [""hippocampal formation""], ""Cell"": [""astrocyte"", ""neuron""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""Study_Group"": [""Tet-mev-1 mice""], ""mesh"": [""Aging"", ""Animals"", ""Astrocytes"", ""Biomarkers"", ""Calcium"", ""Cyclic AMP Response Element-Binding Protein"", ""Disease Models, Animal"", ""Glial Fibrillary Acidic Protein"", ""Hippocampus"", ""JNK Mitogen-Activated Protein Kinases"", ""Membrane Proteins"", ""Memory"", ""Mice, Inbred C57BL"", ""Mitochondria"", ""Models, Biological"", ""Mutation"", ""Neurons"", ""Oxidation-Reduction"", ""Phosphorylation"", ""Reactive Oxygen Species"", ""S100 Proteins"", ""Signal Transduction"", ""Superoxide Dismutase""], ""substances"": [""Biomarkers"", ""Cyclic AMP Response Element-Binding Protein"", ""Glial Fibrillary Acidic Protein"", ""Membrane Proteins"", ""Reactive Oxygen Species"", ""S100 Proteins"", ""SDHC protein, mouse"", ""Superoxide Dismutase"", ""JNK Mitogen-Activated Protein Kinases"", ""Calcium""]}",False
CAUSES_NO_CHANGE,6933,2583,2019.0,29196815,False,False,False,"On the contrary, no relationship between total Aβ plaque burden and number of astrocytes or neurons was found (da Rocha-Souto et al. 2011).",#65:51,,"{""full_journal_name"": ""Journal of neural transmission (Vienna, Austria : 1996)"", ""pub_date"": ""2019-09-30"", ""ref"": ""29196815"", ""pub_year"": 2019, ""last_author"": ""Lewczuk P"", ""type"": ""PubMed"", ""author_list"": [""Mroczko B"", ""Groblewska M"", ""Litman-Zawadzka A"", ""Kornhuber J"", ""Lewczuk P""], ""title"": ""Amyloid \u03b2 oligomers (A\u03b2Os) in Alzheimer's disease."", ""doi"": ""10.1007/s00702-017-1820-x""}","{""Cell"": [""neuron""], ""CellStructure"": [""Extracellular Space""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Biomarkers"", ""Humans"", ""Peptide Fragments""], ""substances"": [""Amyloid beta-Peptides"", ""Biomarkers"", ""Peptide Fragments""]}",False
CAUSES_NO_CHANGE,14441,1553,2015.0,25639674,False,False,False,"However other agonists that target α7 nAChRs, such as SSR-180711 and tropisetron, fail to induce analgesia when tested in the formalin model for pain [168], suggesting that targeting α7* nAChRs for pain relief is modality selective.",#60:18,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""MeSHDisease"": [""Pain""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,11786,12841,2020.0,30606258,False,False,False,"Despite the clear reduction in Tau35 phosphorylation, LiCl did not affect the proportion of either microtubule-bound Tau35, or polymerized α-tubulin in CHO-Tau35 cells (Fig. 3c, d).",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,26554,21520,2018.0,27671637,False,False,False,"Having observed that 64627 restores presynaptic functioning (i.e., PPF, Fig. 4F), neuronal activity (induction of Fos, Fig. 4D), and dendritic spine levels in proaggregant Tau transgenic organotypic slices (Fig. 5 A and B), we tested whether we could restore long-term spatial memory in proaggregant Tau transgenic mice as well",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Axons""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,41708,38126,2015.0,25546293,False,False,False,"While HDAC6 inhibitors increased levels of Ac-Lys49 β- catenin, there was no change in overall levels of β-catenin in the NPCs (Figure 2).",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,12759,43753,2011.0,21882945,False,False,False,"This model is consistent with the data that hyperphosphorylated tau appears to be specifically selected for degradation by some chaperone machines, such as the Hsp90–FKBP51 complex, without effects on normal tau [132,136].",#69:73,PMC3190966,"{""full_journal_name"": ""Future medicinal chemistry"", ""pub_date"": ""2011-12-23"", ""ref"": ""21882945"", ""pub_year"": 2011, ""last_author"": ""Gestwicki JE"", ""type"": ""PubMed"", ""author_list"": [""Miyata Y"", ""Koren J"", ""Kiray J"", ""Dickey CA"", ""Gestwicki JE""], ""title"": ""Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies."", ""doi"": ""10.4155/fmc.11.88""}","{""Confidence"": [""Medium""], ""mesh"": [""Drug Evaluation, Preclinical"", ""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Humans"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""Protein Interaction Mapping"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,7786,43753,1971.0,4255369,False,False,False,"We found that DC8E8 therapy significantly reduced the levels of sarcosyl-insoluble tau oligomers (89%) (Figure 3C and D). Strikingly, total tau levels did not differ between the groups (Figure 3A and B).",#63:73,,"{""full_journal_name"": ""Gigiena i sanitariia"", ""pub_date"": ""1971-12-02"", ""ref"": ""4255369"", ""pub_year"": 1971, ""last_author"": ""Kosiachenko EP"", ""type"": ""PubMed"", ""author_list"": [""Kosiachenko EP""], ""title"": ""[Organization and carrying out of sanitary-educational work in the Berezov region of the Brest Oblast].""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Health Education"", ""Republic of Belarus""]}",False
CAUSES_NO_CHANGE,4127,7161,2012.0,22107728,False,False,False,"Several genetic association studies examined IDE gene as a susceptibility gene for Alzheimer's disease (AD), however with controversial results.We examined associations of three IDE polymorphisms (IDE2, rs4646953; IDE7, rs2251101 and IDE9, rs1887922) with AD, Abeta42 plasma level and T2DM risk in the longitudinal Vienna Transdanube Aging (VITA) study cohort.The upstream polymorphism IDE2 was found to influence AD risk and to trigger the Abeta42 plasma level, whereas the downstream polymorphism IDE7 modified the T2DM risk; no associations were found for the intronic variant IDE9.Based on our SNP and haplotype results, we delineate the model that IDE promoter and 3' untranslated region/downstream variation may have different effects on IDE expression, presumably a relevant endophenotype with disorder-specific effects on AD and T2DM susceptibility.",#59:5,PMC3266204,"{""full_journal_name"": ""BMC medical genetics"", ""pub_date"": ""2012-03-12"", ""ref"": ""22107728"", ""pub_year"": 2012, ""last_author"": ""Gr\u00fcnblatt E"", ""type"": ""PubMed"", ""author_list"": [""Bartl J"", ""Scholz CJ"", ""Hinterberger M"", ""Jungwirth S"", ""Wichart I"", ""Rainer MK"", ""Kneitz S"", ""Danielczyk W"", ""Tragl KH"", ""Fischer P"", ""Riederer P"", ""Gr\u00fcnblatt E""], ""title"": ""Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene."", ""doi"": ""10.1186/1471-2350-12-151""}","{""Subgraph"": [""Amyloidogenic subgraph""], ""mesh"": [""3' Untranslated Regions"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Cohort Studies"", ""Diabetes Mellitus, Type 2"", ""Genetic Association Studies"", ""Genotype"", ""Haplotypes"", ""Humans"", ""Insulysin"", ""Longitudinal Studies"", ""Peptide Fragments"", ""Polymorphism, Single Nucleotide"", ""Promoter Regions, Genetic"", ""Risk""], ""substances"": [""3' Untranslated Regions"", ""Amyloid beta-Peptides"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""Insulysin""]}",False
CAUSES_NO_CHANGE,1380,3353,2019.0,30962309,False,False,False,"The three miRNAs miR-223 (100), miR-155-5p (101), and miR-146a (102) are upregulated in synovial tissue from RA patients compared with osteoarthritis synovium, and two of them, miR-155-5p and miR-146a-5p, are elevated in PBMCs of RA patients (103, 104).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Cell"": [""synovial cell""], ""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
CAUSES_NO_CHANGE,6709,43816,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,7260,7765,2009.0,19293145,False,False,False,"Tg2576 mice expressing human Abeta show reduced [3H]cytisine binding (a label of nAChRs) in the cortex at 17 months after birth (Apelt et al., 2002). In contrast, however, levels of alpha7 or alpha4 subunits were unchanged in double-mutant Swedish APP/PS-1 mice as determined by radiolabeled cytosine (alpha4beta2) or alpha-bungarotoxin (alpha7) binding (Marutle et al., 2002).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,2047,12440,2019.0,30664622,False,False,False,"Representative pictures show penetration of the Evans blue dye in the periphery (Fig. 1d), but not in the brain (Fig. 1e), with brain concentration values < 0.03 ng/ml (Supplemental Fig. S1)",#69:15,PMC6341082,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-06-10"", ""ref"": ""30664622"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Sragovich S"", ""Malishkevich A"", ""Piontkewitz Y"", ""Giladi E"", ""Touloumi O"", ""Lagoudaki R"", ""Grigoriadis N"", ""Gozes I""], ""title"": ""The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse."", ""doi"": ""10.1038/s41398-018-0357-6""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Brain"", ""Diffusion Tensor Imaging"", ""Disease Models, Animal"", ""Female"", ""Haploinsufficiency"", ""Homeodomain Proteins"", ""Magnetic Resonance Imaging"", ""Male"", ""Mice"", ""Mice, 129 Strain"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Neuroprotection"", ""Oligopeptides"", ""Synapses"", ""Vesicular Glutamate Transport Protein 1""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Oligopeptides"", ""Slc17a7 protein, mouse"", ""Vesicular Glutamate Transport Protein 1"", ""davunetide""]}",False
CAUSES_NO_CHANGE,14219,7114,2007.0,16820021,False,False,False,"As was the case with BDNF expression, treatment with antalarmin had no impact upon the isolation-induced alterations in TrkB expression.",#69:40,,"{""full_journal_name"": ""The European journal of neuroscience"", ""pub_date"": ""2007-04-03"", ""ref"": ""16820021"", ""pub_year"": 2007, ""last_author"": ""Lawrence AJ"", ""type"": ""PubMed"", ""author_list"": [""Djouma E"", ""Card K"", ""Lodge DJ"", ""Lawrence AJ""], ""title"": ""The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.""}","{""Confidence"": [""Medium""], ""mesh"": [""Amygdala"", ""Animals"", ""Behavior, Animal"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Male"", ""Nucleus Accumbens"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Inbred Strains"", ""Receptor, trkB"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""Social Isolation"", ""Up-Regulation""], ""substances"": [""8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""antalarmin"", ""CRF receptor type 1"", ""Receptor, trkB"", ""NCQ 298""]}",False
CAUSES_NO_CHANGE,34600,12096,2000.0,10656250,False,False,False,"In contrast to the expression of Asp 2, cathepsin D does not cause an increase in the secretion of sAPPb (Fig. 2d).",#64:10,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2000-02-17"", ""ref"": ""10656250"", ""pub_year"": 2000, ""last_author"": ""Christie G"", ""type"": ""PubMed"", ""author_list"": [""Hussain I"", ""Powell D"", ""Howlett DR"", ""Tew DG"", ""Meek TD"", ""Chapman C"", ""Gloger IS"", ""Murphy KE"", ""Southan CD"", ""Ryan DM"", ""Smith TS"", ""Simmons DL"", ""Walsh FS"", ""Dingwall C"", ""Christie G""], ""title"": ""Identification of a novel aspartic protease (Asp 2) as beta-secretase.""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""COS Cells"", ""Cathepsin D"", ""Cell Line"", ""Cell Membrane"", ""Endopeptidases"", ""Female"", ""Hippocampus"", ""Humans"", ""Middle Aged"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Papain"", ""Recombinant Proteins"", ""Sequence Alignment"", ""Sequence Homology, Amino Acid"", ""Transfection""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Recombinant Proteins"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Papain"", ""Aspartic Acid Endopeptidases"", ""BACE2 protein, human"", ""BACE1 protein, human"", ""Cathepsin D""]}",False
CAUSES_NO_CHANGE,7761,1625,2020.0,30837838,False,False,False,"Several of these interactions were unperturbed by the ALS-linked mutations, A315T and M337V (Freibaum et al., 2010; Kim et al., 2010).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""]}",False
CAUSES_NO_CHANGE,35432,6994,2017.0,28148553,False,False,False,Annonacin but not 4R or 3R tau overexpression increased the level of MC1-immunoreactive tau in LUHMES neurons.,#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,11825,8679,2017.0,27594586,False,False,False,"Interestingly, the level and activity of MMP-2 was not affected after the PD98059 treatment in tau-A152T neurons (Figure 4B) and MAPT IVS10+16 neurons (Figure 4C)",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,11664,41708,2019.0,30270813,False,False,False,"As shown in Fig. 3b, cisplatin did not change the protein level of HDAC6 in the brain (two-way ANOVA, F (1, 12) = 0.7129, p = 0.4150).",#63:68,PMC6166273,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2019-06-06"", ""ref"": ""30270813"", ""pub_year"": 2019, ""last_author"": ""Heijnen CJ"", ""type"": ""PubMed"", ""author_list"": [""Ma J"", ""Huo X"", ""Jarpe MB"", ""Kavelaars A"", ""Heijnen CJ""], ""title"": ""Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment."", ""doi"": ""10.1186/s40478-018-0604-3""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""MeSHAnatomy"": [""Brain""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antineoplastic Agents"", ""Cisplatin"", ""Cognitive Dysfunction"", ""Disease Models, Animal"", ""Disks Large Homolog 4 Protein"", ""Dose-Response Relationship, Drug"", ""Enzyme Inhibitors"", ""Green Fluorescent Proteins"", ""Histone Deacetylase 6"", ""Hydroxamic Acids"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Microscopy, Electron, Transmission"", ""Mitochondria"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Synaptosomes"", ""Tauopathies"", ""Time Factors"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Antineoplastic Agents"", ""Disks Large Homolog 4 Protein"", ""Enzyme Inhibitors"", ""Hydroxamic Acids"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Tubulin"", ""synaptopHIuorin"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Cisplatin"", ""ricolinostat""]}",False
CAUSES_NO_CHANGE,3521,4941,2015.0,25374103,False,False,False,Toxicity assays revealed that neither CHIP nor any of the tau constructs caused cell death compared to the control GFP vector (Supplementary Fig. 1).,#63:21,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-10-26"", ""ref"": ""25374103"", ""pub_year"": 2015, ""last_author"": ""Spires-Jones TL"", ""type"": ""PubMed"", ""author_list"": [""Saidi LJ"", ""Polydoro M"", ""Kay KR"", ""Sanchez L"", ""Mandelkow EM"", ""Hyman BT"", ""Spires-Jones TL""], ""title"": ""Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes."", ""doi"": ""10.3233/JAD-142094""}","{""Confidence"": [""High""], ""mesh"": [""Caspase 3"", ""Cell Line, Tumor"", ""Cell Proliferation"", ""Gene Expression Regulation"", ""Green Fluorescent Proteins"", ""HSP70 Heat-Shock Proteins"", ""Humans"", ""Mitochondria"", ""Mutation"", ""Neuroblastoma"", ""Protein Binding"", ""Transfection"", ""Ubiquitin-Protein Ligases"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""STUB1 protein, human"", ""Ubiquitin-Protein Ligases"", ""Caspase 3""]}",False
CAUSES_NO_CHANGE,1411,39301,2016.0,27013968,False,False,False,"In control conditions total Erk1/2 and phospho-Erk1/2 levels were similar in WT and R6/2 cultures (Figures 4A,C). Acute exposure to BDNF increased phospho-Erk1/2 levels over control conditions in both WT and R6/2 cultures (Figures 4A,E).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,11820,14208,2007.0,17082178,False,False,False,Acrolein and methylglyoxal were the most reactive compounds followed by glyoxal and malondialdehyde in terms of formation of Tau dimers and higher molecular weight oligomers. Analysis of the Tau aggregates by electron microscopy study showed that formation of fibrils using wild- type Tau and several Tau mutants could be observed with acrolein and methylglyoxal but not with glyoxal and malondialdehyde.,#60:23,,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2007-04-13"", ""ref"": ""17082178"", ""pub_year"": 2007, ""last_author"": ""M\u00fcnch G"", ""type"": ""PubMed"", ""author_list"": [""Kuhla B"", ""Haase C"", ""Flach K"", ""L\u00fcth HJ"", ""Arendt T"", ""M\u00fcnch G""], ""title"": ""Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation.""}","{""Confidence"": [""Medium""], ""Method"": [""Electron Microscopy"", ""SDS-PAGE"", ""Thioflavin T Assay"", ""Western Blot""], ""mesh"": [""Acrolein"", ""Blotting, Western"", ""Electrophoresis, Polyacrylamide Gel"", ""Fluorescence"", ""Glycation End Products, Advanced"", ""Glyoxal"", ""Humans"", ""Lipid Peroxidation"", ""Malondialdehyde"", ""Microscopy, Electron"", ""Neurofibrillary Tangles"", ""Phosphorylation"", ""Pyruvaldehyde"", ""tau Proteins""], ""substances"": [""Glycation End Products, Advanced"", ""tau Proteins"", ""Malondialdehyde"", ""Glyoxal"", ""Pyruvaldehyde"", ""Acrolein""]}",False
CAUSES_NO_CHANGE,44396,42624,2015.0,25681350,False,False,False,"In these cells, basal expression of YKL-40 is RelB-, p65-, and STAT3-independent, implicating other unknown factors.",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Cell"": [""chondrocyte""], ""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,1854,10854,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,7260,10254,2012.0,22299660,False,False,False,"Decreased mRNA levels of PP2A C have been reported in the CA3 region of AD hippocampus by in situ RNA hybridisation [56]. Moreover, microarray RNA analysis carried out to compare the expression of more than 7,000 gene in the amygdala, cingulate cortex, striatum and cerebellum dis- closed down-regulation of the catalytic subunit PP2A C in AD [57]. This has been further corroborated by quantitative TaqMan PCR showing reduced PP2A C mRNA expression levels in the hippocampus, but not in the frontal cortex, in AD cases with disease progression Fig. (1).",#71:18,,"{""full_journal_name"": ""Current Alzheimer research"", ""pub_date"": ""2012-07-20"", ""ref"": ""22299660"", ""pub_year"": 2012, ""last_author"": ""Ferrer I"", ""type"": ""PubMed"", ""author_list"": [""Torrent L"", ""Ferrer I""], ""title"": ""PP2A and Alzheimer disease.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Frontal Lobe""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Brain"", ""Female"", ""Humans"", ""Individuality"", ""Male"", ""Middle Aged"", ""Postmortem Changes"", ""Protein Phosphatase 2""], ""substances"": [""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,9671,7161,2010.0,19542625,False,False,False,"There has been a lot of disappointment surrounding the recent failure of the largest ever study in patients with Alzheimer's disease (AD) with tarenflurbil. A straightforward explanation of this failure is that the gamma-secretase is not the right target for therapy or that, in general, blocking A beta does not produce clinical benefits in AD",#59:5,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2010-09-22"", ""ref"": ""19542625"", ""pub_year"": 2010, ""last_author"": ""Imbimbo BP"", ""type"": ""PubMed"", ""author_list"": [""Imbimbo BP""], ""title"": ""Why did tarenflurbil fail in Alzheimer's disease?"", ""doi"": ""10.3233/JAD-2009-1092""}","{""DiseaseState"": [""Mild AD""], ""FDASTATUS"": [""Phase 3""], ""Subgraph"": [""Gamma secretase subgraph"", ""Inflammatory response subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Brain"", ""Flurbiprofen"", ""Humans"", ""Treatment Failure""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""tarenflurbil"", ""Flurbiprofen"", ""Amyloid Precursor Protein Secretases""]}",False
CAUSES_NO_CHANGE,30134,32631,2009.0,18986241,False,False,False,"CBF neurons displaying the tau C3 epitope, a marker for early stage NFT formation, were often hyperinnervated by GAL-containing fibers, whereas CBF neurons displaying the tau epitope MN423, an end-stage NFT marker, were not associated with GAL. Single cell gene expression studies have demonstrated that the levels of mRNAs encoding select subclasses of PP1 subunits (e.g., PP1alpha and PP1gamma) are stable in GAL hyperinnervated but downregulated in non-hyperinnervated CBF neurons in AD [149]",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""Disease"": [""Alzheimer's disease""], ""MeSHAnatomy"": [""Cholinergic Neurons""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,44629,12096,2007.0,17293005,False,False,False,"BI-1 treatment dose-dependently inhibited the release of both sAPPa and sAPPb in the conditioned medium (Figs. 2A and 3A). The 50% inhibitory concentrations (IC50) of BI-1 were about 1.5 mM for sAPPa and 0.9 mM for APPb, respectively. But BI-2, which is mainly composed of the core region BACE1 69–73, did not show the inhibitory effects",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,7260,2882,2001.0,11230871,False,False,False,"Examination of the regional expression of mRNA of the nAChR alpha4 and alpha3 subunits has shown no difference in autopsy AD brain tissue in any region analyzed (Hellstro ¨m-Lindahl et al 1999; Terzano et al 1998), whereas the level of the alpha7 mRNA was significantly higher in the hippocampus (Hellstro¨m-Lindahl et al 1999)",#65:45,,"{""full_journal_name"": ""Biological psychiatry"", ""pub_date"": ""2001-06-07"", ""ref"": ""11230871"", ""pub_year"": 2001, ""last_author"": ""Nordberg A"", ""type"": ""PubMed"", ""author_list"": [""Nordberg A""], ""title"": ""Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Hippocampus""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Brain"", ""Cholinergic Agents"", ""Humans"", ""Receptors, Nicotinic"", ""Treatment Outcome""], ""substances"": [""Cholinergic Agents"", ""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,19897,33314,2017.0,28148553,False,False,False,"When overexpressing 4R tau in neurons, PERK activator treatment still increased pNRF2, but not pEIF2A (Fig EV2F and G), while PERK inhibitor treatment decreased pEIF2A but not pNRF2.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,23438,12009,2018.0,27671637,False,False,False,"Indeed, the reduced level of spines seen in proaggregant Tau transgenic slices are normalized when treated with 64627, whereas no significant changes are found in antiaggregant Tau transgenic slices or littermate controls (Fig. 5 A and B)",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,11891,43190,2019.0,30935091,False,False,False,"Class I specific HDACi MS-275 and BG-45 did not increase Ac-K49-beta -catenin, but treatment with HDAC6i ACY- resulted in marked increase in Ac-K49-beta -catenin.",#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,1936,14223,2018.0,28528849,False,False,False,"The fibril-treated cells (cross-linked with GA or not) did not reduce the spine density significantly (Fig 4C, bars 8 and 9).",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,1982,2342,2016.0,23393546,False,False,False,"Addition of pizotifen, cyproheptadine, or loxapine to the ST Hdh Q7/Q7 cells after serum withdrawal had no effect on ATP levels, indicating that the drugs do not have a general effect on viability but rather correct a deficit specific to the ST Hdh Q111/Q111 cells (Figure 2 A ).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,3928,25160,2017.0,27087442,False,False,False,"The levels of CDK5, its regulatory subunits (p35 and p25) and calpain (including calpain1 and calpain2), but not GSK3ß, were significantly increased in E4FAD mice compared to E3FAD mice.",#60:23,,"{""full_journal_name"": ""Current Alzheimer research"", ""pub_date"": ""2017-10-16"", ""ref"": ""27087442"", ""pub_year"": 2017, ""last_author"": ""Chen X"", ""type"": ""PubMed"", ""author_list"": [""Zhou M"", ""Huang T"", ""Collins N"", ""Zhang J"", ""Shen H"", ""Dai X"", ""Xiao N"", ""Wu X"", ""Wei Z"", ""York J"", ""Lin L"", ""Zhu Y"", ""LaDu MJ"", ""Chen X""], ""title"": ""APOE4 Induces Site-Specific Tau Phosphorylation Through Calpain-CDK5 Signaling Pathway in EFAD-Tg Mice.""}","{""Confidence"": [""High""], ""Research_Model"": [""E4FAD mice""], ""Species"": [""10090""], ""mesh"": [""Aging"", ""Amyloid beta-Peptides"", ""Animals"", ""Apolipoprotein E4"", ""Calpain"", ""Cerebral Cortex"", ""Cyclin-Dependent Kinase 5"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Peptide Fragments"", ""Phosphorylation"", ""Signal Transduction"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Apolipoprotein E4"", ""Mapt protein, mouse"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Cyclin-Dependent Kinase 5"", ""Glycogen Synthase Kinase 3 beta"", ""Cdk5 protein, mouse"", ""Calpain""]}",False
CAUSES_NO_CHANGE,39928,5263,2020.0,30515821,False,False,False,"P110, a selective Drp1–FIS1 interaction inhibitor without affecting the basal mitochondrial fission, was found to improve the structure and function and significantly reduce the production of ROS causing increased neuronal cell viability and decreased muscle atrophy in SOD G93A mice suggesting that inhibition of the abnormal mitochondrial fission by the Drp1/FIS1 inhibitor ameliorate the disease progression of ALS.",#65:66,,"{""full_journal_name"": ""Journal of cellular physiology"", ""pub_date"": ""2020-05-04"", ""ref"": ""30515821"", ""pub_year"": 2020, ""last_author"": ""Chen L"", ""type"": ""PubMed"", ""author_list"": [""Qi Z"", ""Huang Z"", ""Xie F"", ""Chen L""], ""title"": ""Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases."", ""doi"": ""10.1002/jcp.27866""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Dynamins"", ""Humans"", ""Huntingtin Protein"", ""Mitochondria"", ""Mitochondrial Dynamics"", ""Nerve Degeneration"", ""Nervous System"", ""Neurodegenerative Diseases"", ""Protein Processing, Post-Translational"", ""Signal Transduction"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Huntingtin Protein"", ""tau Proteins"", ""DNM1L protein, human"", ""Dnm1l protein, mouse"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,29213,5209,2009.0,19885299,False,False,False,"Glucose transport within the brain is mostly insulin independent, suggesting that the primary role of brain insulin might be in signal transduction pathways involved in cognitive processes [Schulingkamp et al., 2000]. Indeed, studies have shown that insulin and insulin receptors are abundantly but selectively distributed in brain areas that are important for learning and memory [Schulingkamp et al., 2000], and treatment of both normal healthy individuals and patients with mild AD with insulin has been shown to improve cognition [Watson and Craft, 2004].",#59:5,PMC2769828,"{""full_journal_name"": ""Journal of diabetes science and technology"", ""pub_date"": ""2009-12-15"", ""ref"": ""19885299"", ""pub_year"": 2009, ""last_author"": ""Wands JR"", ""type"": ""PubMed"", ""author_list"": [""de la Monte SM"", ""Wands JR""], ""title"": ""Alzheimer's disease is type 3 diabetes-evidence reviewed.""}","{""MeSHAnatomy"": [""Brain""], ""Subgraph"": [""Insulin signal transduction""]}",False
CAUSES_NO_CHANGE,7091,7926,2009.0,19293145,False,False,False,"In studies on SH-SY5Y cells and cultured rat hippocampal neurons, nicotine, acting through alpha7 nAChRs, results in the activation of ERK-1/2 pathways dependent upon calcium and protein kinase A (Dajas- Bailador et al., 2002b). In addition, the alpha7-specific agonist GTS-21 promotes ERK-1/2 phosphorylation, but not that of c-jun N-terminal kinase (JNK) or p38 (Ren et al., 2005).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""CellLine"": [""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,21402,41587,2000.0,10887109,False,False,False,"These experiments determined that Lck, but not Syk or Zap70, was capable of mediating phosphorylation of CD33 in vivo (Figure 2A).",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,6582,18840,2019.0,29311797,False,False,False,"The Cdc37/Hsp90 inhibitors, Celasterol and Withaferin A (Zhang et al., 2008; Yu et al., 2010), reduce tau levels and a new compound, platycodin D has just been discovered (Li et al., 2017). Platycodin D does not aﬀect the ATPase activity of Hsp90, but instead disrupts the interaction between Hsp90 and Cdc37 leading to client protein degradation without an increase in Hsp70 (Li et al., 2017).",#63:47,PMC5744016,"{""full_journal_name"": ""Frontiers in neuroscience"", ""pub_date"": ""2020-09-30"", ""ref"": ""29311797"", ""pub_year"": 2020, ""last_author"": ""Blair LJ"", ""type"": ""PubMed"", ""author_list"": [""Shelton LB"", ""Koren J"", ""Blair LJ""], ""title"": ""Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies."", ""doi"": ""10.3389/fnins.2017.00724""}","{""Confidence"": [""Medium""]}",False
CAUSES_NO_CHANGE,36799,24527,2000.0,10887109,False,False,False,These authors found that a change in the amino acid −2 relative to the phosphotyrosine from valine to either isoleucine or leucine did not show significant difference in the phosphatase activity of the peptides.,#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,44220,5350,2004.0,14976144,False,False,False,"Initially, the expression of p35 was believed to be restricted to the central nervous system, the lens (22), and recently in developing muscle, where it forms a p35/CDK5 active complex that regulates the expression of the acetylcholine receptor gene (23). Despite its name CDK5 does not affect the cell division cycle; it is expressed postmitotically, and its function is related to cytoskeletal dynamics, cell migration, cell differentiation, and exocytosis (14) instead of cellular proliferation. Recently, Pho-85, a yeast ortholog of CDK5, was shown to be involved in metabolic control by regulating different steps of glycogen and phosphate metabolism (13). Expression of CDK5 in insulin-producing cells is not surprising because widespread expression of this kinase has been described. CDK5 expression in β-cells has also been reported (24).",#59:5,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""2004-06-24"", ""ref"": ""14976144"", ""pub_year"": 2004, ""last_author"": ""Habener JF"", ""type"": ""PubMed"", ""author_list"": [""Ubeda M"", ""Kemp DM"", ""Habener JF""], ""title"": ""Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.""}","{""Subgraph"": [""Cyclin-CDK subgraph""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cell Line"", ""Culture Techniques"", ""Cyclin-Dependent Kinase 5"", ""Cyclin-Dependent Kinases"", ""Glucose"", ""Humans"", ""Insulin"", ""Islets of Langerhans"", ""Male"", ""Nerve Tissue Proteins"", ""Osmolar Concentration"", ""Precipitin Tests"", ""Protein Kinases"", ""Rats"", ""Rats, Wistar"", ""Signal Transduction"", ""Transcription, Genetic"", ""Transfection""], ""substances"": [""Insulin"", ""Nerve Tissue Proteins"", ""neuronal Cdk5 activator (p25-p35)"", ""Protein Kinases"", ""Cyclin-Dependent Kinase 5"", ""CDK5 protein, human"", ""Cdk5 protein, rat"", ""Cyclin-Dependent Kinases"", ""Glucose""]}",False
CAUSES_NO_CHANGE,11460,35991,2019.0,30108137,False,False,False,"Immunoblotting for total tau and phospho-tau antibodies, PHF1 and CP13, demonstrated no statistical difference in hippocampal brain lysate from TFEB- versus EGFP-injected rTg4510 male or female mice",#64:12,PMC6122971,"{""full_journal_name"": ""The Journal of experimental medicine"", ""pub_date"": ""2019-09-04"", ""ref"": ""30108137"", ""pub_year"": 2019, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Martini-Stoica H"", ""Cole AL"", ""Swartzlander DB"", ""Chen F"", ""Wan YW"", ""Bajaj L"", ""Bader DA"", ""Lee VMY"", ""Trojanowski JQ"", ""Liu Z"", ""Sardiello M"", ""Zheng H""], ""title"": ""TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading."", ""doi"": ""10.1084/jem.20172158""}","{""Cell"": [""astrocyte""], ""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Hippocampus""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Astrocytes"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Disease Models, Animal"", ""Gene Knockdown Techniques"", ""Hippocampus"", ""Lysosomes"", ""Mice"", ""Synapses"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Tcfeb protein, mouse"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11660,39861,2015.0,25546293,False,False,False,"In the presence of the HDAC6 inhibitor ACY-1215, the increased levels of Ac-Lys49 β-catenin had no effect on the levels for β-catenin phosphorylated at Ser33, Ser37, and Thr41 (Figure 3A, B).",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,38540,5120,2017.0,27373205,False,False,False,"In contrast to hT40 monomer, perfusion of S422E monomer selectively inhibited anterograde transport (Fig. 5C; Fig. 6A; p = 0.028), but not retrograde FAT. Surprisingly, aggregated S422E significantly inhibited both anterograde and retrograde FAT rates (Fig. 5D; Fig. 6A, B) compared to S422E monomer (anterograde, p = 0.012; retrograde, p = 0.002) and hT40 aggregates (retrograde only, p = 0.019).",#69:78,PMC4992631,"{""full_journal_name"": ""Experimental neurology"", ""pub_date"": ""2017-05-05"", ""ref"": ""27373205"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Tiernan CT"", ""Combs B"", ""Cox K"", ""Morfini G"", ""Brady ST"", ""Counts SE"", ""Kanaan NM""], ""title"": ""Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport."", ""doi"": ""10.1016/j.expneurol.2016.06.030""}","{""Confidence"": [""High""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Axonal Transport"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Frontal Lobe"", ""Humans"", ""Male"", ""Phosphorylation"", ""Serine"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""Serine""]}",False
CAUSES_NO_CHANGE,6681,7313,2020.0,30988501,False,False,False,"Minocycline also had positive effects as an adjunctive treatment to risperidone in children with ASD 145, although not as a single medication in a small pilot study 146.",#59:65,,"{""full_journal_name"": ""Nature reviews. Neurology"", ""pub_date"": ""2020-01-27"", ""ref"": ""30988501"", ""pub_year"": 2020, ""last_author"": ""Zipp F"", ""type"": ""PubMed"", ""author_list"": [""Pape K"", ""Tamouza R"", ""Leboyer M"", ""Zipp F""], ""title"": ""Immunoneuropsychiatry - novel perspectives on brain disorders."", ""doi"": ""10.1038/s41582-019-0174-4""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Brain Diseases"", ""Encephalitis"", ""Humans"", ""Inflammation"", ""Mental Disorders"", ""Neurology""]}",False
CAUSES_NO_CHANGE,3834,6741,2014.0,23727081,False,False,False,"Although we observed no association between rs3785883 or rs1868402 alone and change in CDR-sb (P > .10), there was a significant association between a combined genotype model and change in CDR-sb: carriers of the high-risk genotypes at both loci progressed >2.9 times faster than noncarriers (P = .015).",#67:28,PMC3809344,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2014-12-10"", ""ref"": ""23727081"", ""pub_year"": 2014, ""last_author"": ""Kauwe JS"", ""type"": ""PubMed"", ""author_list"": [""Peterson D"", ""Munger C"", ""Crowley J"", ""Corcoran C"", ""Cruchaga C"", ""Goate AM"", ""Norton MC"", ""Green RC"", ""Munger RG"", ""Breitner JC"", ""Welsh-Bohmer KA"", ""Lyketsos C"", ""Tschanz J"", ""Kauwe JS""], ""title"": ""Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study."", ""doi"": ""10.1016/j.jalz.2013.02.010""}","{""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Calcineurin"", ""Disease Progression"", ""Female"", ""Follow-Up Studies"", ""Genetic Predisposition to Disease"", ""Genotyping Techniques"", ""Heterozygote"", ""Humans"", ""Linear Models"", ""Male"", ""Models, Genetic"", ""Polymorphism, Single Nucleotide"", ""Risk"", ""Severity of Illness Index"", ""Time Factors"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Calcineurin"", ""PPP3R1 protein, human""]}",False
CAUSES_NO_CHANGE,11825,39080,2017.0,27594586,False,False,False,"Interestingly, the level and activity of MMP-2 was not affected after the PD98059 treatment in tau-A152T neurons (Figure 4B) and MAPT IVS10+16 neurons (Figure 4C)",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,11664,5399,2019.0,30270813,False,False,False,"Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",#63:68,PMC6166273,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2019-06-06"", ""ref"": ""30270813"", ""pub_year"": 2019, ""last_author"": ""Heijnen CJ"", ""type"": ""PubMed"", ""author_list"": [""Ma J"", ""Huo X"", ""Jarpe MB"", ""Kavelaars A"", ""Heijnen CJ""], ""title"": ""Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment."", ""doi"": ""10.1186/s40478-018-0604-3""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antineoplastic Agents"", ""Cisplatin"", ""Cognitive Dysfunction"", ""Disease Models, Animal"", ""Disks Large Homolog 4 Protein"", ""Dose-Response Relationship, Drug"", ""Enzyme Inhibitors"", ""Green Fluorescent Proteins"", ""Histone Deacetylase 6"", ""Hydroxamic Acids"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Microscopy, Electron, Transmission"", ""Mitochondria"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Synaptosomes"", ""Tauopathies"", ""Time Factors"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Antineoplastic Agents"", ""Disks Large Homolog 4 Protein"", ""Enzyme Inhibitors"", ""Hydroxamic Acids"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Tubulin"", ""synaptopHIuorin"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Cisplatin"", ""ricolinostat""]}",False
CAUSES_NO_CHANGE,1650,28824,2020.0,30686764,False,False,False,Efavirenz increased 24-hydroxycholesterol secretion from APP-dp and APP-null neurons in a dose-dependent manner that correlated well with its effect on pThr231Tau/tTau in these neurons (Figures 6D and S6D).,#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Astrocytes""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,7260,33495,2009.0,18986241,False,False,False,"For example, the vesicular ACh transporter (VAChT), which is co- expressed with ChAT in human CBF neurons and participates in loading ACh into synaptic vesicles in cholinergic terminals, is not severely altered in AD [40]. In this regard, pharmacological studies of VAChT in postmortem AD tissue or in vivo imaging studies using vesamicol and its analogs, suggest that VAChT levels remain steady or are minimally decreased coincident with a severe decline in ChAT activity in cortical areas [41].",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,43028,38622,2007.0,17293005,False,False,False,"Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,37552,1486,2014.0,24027553,False,False,False,"In contrast, another study used mass spectroscopy and sequencing to identify the “17 kDa” tau cleavage product and found it did not correspond to the recombinant fragment utilized in the above studies (19). Expression of a recombinant form of the mass spectroscopy- identified fragment in hippocampal neurons was not toxic (19).",#57:4,PMC3759803,"{""full_journal_name"": ""Frontiers in neurology"", ""pub_date"": ""2014-06-24"", ""ref"": ""24027553"", ""pub_year"": 2014, ""last_author"": ""Johnson GV"", ""type"": ""PubMed"", ""author_list"": [""Chesser AS"", ""Pritchard SM"", ""Johnson GV""], ""title"": ""Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease."", ""doi"": ""10.3389/fneur.2013.00122""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""]}",False
CAUSES_NO_CHANGE,24268,7587,2014.0,24027553,False,False,False,"For example, as discussed above, certain modified forms of tau, such as caspase-cleaved tau, have a stronger tendency to aggregate. As tau begins to assemble into oligomers, it may become increasingly undesirable as a proteasomal substrate. These low-order, soluble oligomers may be preferentially degraded by autophagy.",#57:4,PMC3759803,"{""full_journal_name"": ""Frontiers in neurology"", ""pub_date"": ""2014-06-24"", ""ref"": ""24027553"", ""pub_year"": 2014, ""last_author"": ""Johnson GV"", ""type"": ""PubMed"", ""author_list"": [""Chesser AS"", ""Pritchard SM"", ""Johnson GV""], ""title"": ""Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease."", ""doi"": ""10.3389/fneur.2013.00122""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""]}",False
CAUSES_NO_CHANGE,29022,6741,2015.0,25171717,False,False,False,"We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",#67:28,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-08-18"", ""ref"": ""25171717"", ""pub_year"": 2015, ""last_author"": ""Karsdal MA"", ""type"": ""PubMed"", ""author_list"": [""Henriksen K"", ""Byrjalsen I"", ""Christiansen C"", ""Karsdal MA""], ""title"": ""Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease."", ""doi"": ""10.3233/JAD-140984""}","{""mesh"": [""Aged"", ""Alzheimer Disease"", ""Biomarkers"", ""Clinical Trials, Phase III as Topic"", ""Disease Progression"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Humans"", ""Linear Models"", ""Male"", ""Mental Status Schedule"", ""Severity of Illness Index"", ""Time Factors"", ""tau Proteins""], ""substances"": [""Biomarkers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,39699,12009,2018.0,27671637,False,False,False,"Proaggregant Tau transgenic slices showed a significant reduction of spines compared with littermate control slices, whereas spine density of antiaggregant Tau transgenic slices was similar to controls (Fig. 3 A and B)",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,41708,966,2013.0,23356410,False,False,False,Treatment with tubacin or HDAC6 knockdown in vivo did not impair the interaction between HDAC6 and tau but was able to decrease tau phosphorylation [32].,#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,37647,5394,2017.0,27522251,False,False,False,"We did not detect any glia or microglia activation in WT-APP (Fig. 3C and F) compared with WT-GFP (Fig. 3B and E), meaning that the neuroinflammation does not play a role in the memory deficit we observed",#68:77,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-09-28"", ""ref"": ""27522251"", ""pub_year"": 2017, ""last_author"": ""Maskos U"", ""type"": ""PubMed"", ""author_list"": [""Lombardo S"", ""Catteau J"", ""Besson M"", ""Maskos U""], ""title"": ""A role for \u03b22* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus."", ""doi"": ""10.1016/j.neurobiolaging.2016.06.005""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Dentate Gyrus""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Dentate Gyrus"", ""Disease Models, Animal"", ""Hippocampus"", ""Male"", ""Memory Disorders"", ""Mice, Inbred C57BL"", ""Receptors, Nicotinic""], ""substances"": [""Amyloid beta-Peptides"", ""Receptors, Nicotinic"", ""nicotinic receptor beta2""]}",False
CAUSES_NO_CHANGE,11568,36837,2014.0,23871825,False,False,False,"Depending on the treatment received, a distinct inflammatory and oxidative stress profile was observed: in Rivastigmine-treated group, IL6 levels were 47% lower than the average value of the remaining AD patients; homocysteine and glutathione reductase were statistically unchanged in the Rivastigmine and Donepezil-Memantine, respectively Donepezil group.",#59:5,,"{""full_journal_name"": ""Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association"", ""pub_date"": ""2014-10-06"", ""ref"": ""23871825"", ""pub_year"": 2014, ""last_author"": ""Kouretas D"", ""type"": ""PubMed"", ""author_list"": [""Gubandru M"", ""Margina D"", ""Tsitsimpikou C"", ""Goutzourelas N"", ""Tsarouhas K"", ""Ilie M"", ""Tsatsakis AM"", ""Kouretas D""], ""title"": ""Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers."", ""doi"": ""10.1016/j.fct.2013.07.013""}","{""Species"": [""9606""], ""Subgraph"": [""Glutathione reductase subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Antioxidants"", ""Arginine"", ""Biomarkers"", ""Case-Control Studies"", ""Endothelium, Vascular"", ""Female"", ""Glutathione"", ""Homocysteine"", ""Humans"", ""Inflammation"", ""Interleukin-6"", ""Male"", ""Oxidative Stress"", ""Protein Carbonylation"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Antioxidants"", ""Biomarkers"", ""Interleukin-6"", ""Tumor Necrosis Factor-alpha"", ""dimethylarginine"", ""Homocysteine"", ""Arginine"", ""Glutathione""]}",False
CAUSES_NO_CHANGE,1791,1650,2007.0,17640819,False,False,False,The density of this deposition was not affected by 2 weeks of twice per day injections of 1 mg/kg 4OH-GTS-21 (275 deposits/section) or by FFX lesions (37±0.4 deposits/section),#57:56,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,25428,1650,2011.0,21214928,False,False,False,Downregulation of CD147 increases Abeta production but its overexpression has no effect on Abeta generation [113],#68:47,PMC3022812,"{""full_journal_name"": ""Molecular brain"", ""pub_date"": ""2011-04-18"", ""ref"": ""21214928"", ""pub_year"": 2011, ""last_author"": ""Xu H"", ""type"": ""PubMed"", ""author_list"": [""Zhang YW"", ""Thompson R"", ""Zhang H"", ""Xu H""], ""title"": ""APP processing in Alzheimer's disease."", ""doi"": ""10.1186/1756-6606-4-3""}","{""Confidence"": [""Low""], ""PublicationType"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Caspases"", ""Humans"", ""Isoenzymes"", ""Plaque, Amyloid"", ""Signal Transduction""], ""substances"": [""APP protein, human"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Isoenzymes"", ""Amyloid Precursor Protein Secretases"", ""Caspases""]}",False
CAUSES_NO_CHANGE,35506,7335,2020.0,30967783,False,False,False,"However, speciﬁc deletion of MHCII in microglia does not aﬀect disease progression,suggesting that microglia are not important in reactivating eﬃcient T cells in the CNS (Wolf et al., 2018).",#70:13,PMC6438858,"{""full_journal_name"": ""Frontiers in pharmacology"", ""pub_date"": ""2020-09-30"", ""ref"": ""30967783"", ""pub_year"": 2020, ""last_author"": ""He Q"", ""type"": ""PubMed"", ""author_list"": [""Wang J"", ""Wang J"", ""Wang J"", ""Yang B"", ""Weng Q"", ""He Q""], ""title"": ""Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis."", ""doi"": ""10.3389/fphar.2019.00286""}","{""Anatomy"": [""central nervous system""], ""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,11492,2361,2011.0,21745645,False,False,False,"Consistent with the results from electrical SO stimulation, when cholinergic input was activated 100 ms (i.e., light exposure 120 ms to take into account the 20 ms delay) before SC stimulation, LTP was induced, which was blocked by the a7 nAChR antagonist MLA, but not by DHbE or atropine (Figures 5I and 5H)",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""100 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,25424,7353,2003.0,14556719,False,False,False,"Therefore, patients with AR-JP—who cannot degrade it because of the mutation in the Parkin E3 (see above)—develop neurodegeneration",#57:46,,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2003-12-01"", ""ref"": ""14556719"", ""pub_year"": 2003, ""last_author"": ""Brundin P"", ""type"": ""PubMed"", ""author_list"": [""Ciechanover A"", ""Brundin P""], ""title"": ""The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Parkinsonian Disorders""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Humans"", ""Multienzyme Complexes"", ""Neurodegenerative Diseases"", ""Proteasome Endopeptidase Complex"", ""Signal Transduction"", ""Ubiquitin""], ""substances"": [""Multienzyme Complexes"", ""Ubiquitin"", ""Cysteine Endopeptidases"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,1849,33326,2020.0,30686764,False,False,False,"Activation of homologous nuclear receptors such as PPARa (by GW50156) and PPARg (by Rosiglitazone), which regulate fatty acid metabolism but not cholesterol export, did not decrease pThr231Tau/tTau (Figures 2C, S2F, and S2G).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,14219,7114,2007.0,16820021,False,False,False,Treatment with antalarmin had no impact upon the isolation-induced alterations of BDNF expression.,#69:40,,"{""full_journal_name"": ""The European journal of neuroscience"", ""pub_date"": ""2007-04-03"", ""ref"": ""16820021"", ""pub_year"": 2007, ""last_author"": ""Lawrence AJ"", ""type"": ""PubMed"", ""author_list"": [""Djouma E"", ""Card K"", ""Lodge DJ"", ""Lawrence AJ""], ""title"": ""The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.""}","{""Confidence"": [""Medium""], ""mesh"": [""Amygdala"", ""Animals"", ""Behavior, Animal"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Male"", ""Nucleus Accumbens"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Inbred Strains"", ""Receptor, trkB"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""Social Isolation"", ""Up-Regulation""], ""substances"": [""8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""antalarmin"", ""CRF receptor type 1"", ""Receptor, trkB"", ""NCQ 298""]}",False
CAUSES_NO_CHANGE,1609,38244,2019.0,30008470,False,False,False,"In addition, Adnp expression was increased at the 24 h time point in the NAc of female, but not male mouse (one-way ANOVA; females: F(2,9) = 10.87, p < 0.005; post hoc: p < 0.005; males: p > 0.05).",#65:46,PMC6300527,"{""full_journal_name"": ""Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"", ""pub_date"": ""2019-02-11"", ""ref"": ""30008470"", ""pub_year"": 2019, ""last_author"": ""Barak S"", ""type"": ""PubMed"", ""author_list"": [""Ziv Y"", ""Rahamim N"", ""Lezmy N"", ""Even-Chen O"", ""Shaham O"", ""Malishkevich A"", ""Giladi E"", ""Elkon R"", ""Gozes I"", ""Barak S""], ""title"": ""Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice."", ""doi"": ""10.1038/s41386-018-0132-7""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""MeSHAnatomy"": [""Nucleus Accumbens""], ""Species"": [""10090""], ""mesh"": [""Alcohol Drinking"", ""Animals"", ""Disease Models, Animal"", ""Ethanol"", ""Female"", ""Gene Expression"", ""Haploinsufficiency"", ""Hippocampus"", ""Homeodomain Proteins"", ""Male"", ""Mice"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Sex Factors""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Ethanol""]}",False
CAUSES_NO_CHANGE,7981,5742,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,43753,37770,2017.0,28760828,False,False,False,"Whereas mutating Lys-321 to arginine to maintain the charge but prevent acetylation has no significant impact on filament formation compared with wild-type tau (Fig. 2 (a, c, and d–f) and supplemental Fig. S2 (a and b)), K321Q dramatically alters tau filament assembly and aggregation (Fig. 2 (a and b and d–f) and supplemental Fig. S2 (a and b)).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,6673,1484,2020.0,30837838,False,False,False,"Notably, the zinc ions could induce inclusion bodies formation and aggregation in the neuronal cell cultures, and this effect was not observed with copper or iron, indicating zinc-specific effects (Caragounis et al., 2010).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Cell"": [""neuron""]}",False
CAUSES_NO_CHANGE,41708,1349,2012.0,22372633,False,False,False,HDAC6 deficiency in HD mice also does not influence the disease progression at the behavioral level (53).,#57:37,,"{""full_journal_name"": ""Traffic (Copenhagen, Denmark)"", ""pub_date"": ""2012-10-04"", ""ref"": ""22372633"", ""pub_year"": 2012, ""last_author"": ""Van Den Bosch L"", ""type"": ""PubMed"", ""author_list"": [""d'Ydewalle C"", ""Bogaert E"", ""Van Den Bosch L""], ""title"": ""HDAC6 at the Intersection of Neuroprotection and Neurodegeneration."", ""doi"": ""10.1111/j.1600-0854.2012.01347.x""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Huntington Disease""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Autophagy"", ""Cytoskeleton"", ""Gene Expression Regulation, Enzymologic"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Humans"", ""Microtubules"", ""Models, Biological"", ""Models, Genetic"", ""Neurodegenerative Diseases"", ""Neuroprotective Agents"", ""Protein Binding"", ""Protein Conformation"", ""Ubiquitin""], ""substances"": [""Neuroprotective Agents"", ""Ubiquitin"", ""HDAC6 protein, human"", ""Histone Deacetylase 6"", ""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,44197,4941,2015.0,25374103,False,False,False,Toxicity assays revealed that neither CHIP nor any of the tau constructs caused cell death compared to the control GFP vector (Supplementary Fig. 1).,#63:21,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-10-26"", ""ref"": ""25374103"", ""pub_year"": 2015, ""last_author"": ""Spires-Jones TL"", ""type"": ""PubMed"", ""author_list"": [""Saidi LJ"", ""Polydoro M"", ""Kay KR"", ""Sanchez L"", ""Mandelkow EM"", ""Hyman BT"", ""Spires-Jones TL""], ""title"": ""Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes."", ""doi"": ""10.3233/JAD-142094""}","{""Confidence"": [""High""], ""mesh"": [""Caspase 3"", ""Cell Line, Tumor"", ""Cell Proliferation"", ""Gene Expression Regulation"", ""Green Fluorescent Proteins"", ""HSP70 Heat-Shock Proteins"", ""Humans"", ""Mitochondria"", ""Mutation"", ""Neuroblastoma"", ""Protein Binding"", ""Transfection"", ""Ubiquitin-Protein Ligases"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""STUB1 protein, human"", ""Ubiquitin-Protein Ligases"", ""Caspase 3""]}",False
CAUSES_NO_CHANGE,6605,2342,2016.0,23393546,False,False,False,"Cetirizine, diphenhydramine, ketotifen, desloratadine, and chlorphreniramine failed to rescue ST Hdh Q111/Q111 cells (Figure 6). This suggests that the activity of the drugs in the cell-based assay is not related solely to their common ability to block the H1 receptor.",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,32645,36970,2015.0,25069841,False,False,False,"As expected, enhanced TFEB-dependent PTEN upregulation is associated with reduced pAkt (S473), pP70SK6 (T389) and pULK1 (S757), but not their total protein levels (Supplementary Fig S10).",#72:5,PMC4197862,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2015-05-22"", ""ref"": ""25069841"", ""pub_year"": 2015, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Polito VA"", ""Li H"", ""Martini-Stoica H"", ""Wang B"", ""Yang L"", ""Xu Y"", ""Swartzlander DB"", ""Palmieri M"", ""di Ronza A"", ""Lee VM"", ""Sardiello M"", ""Ballabio A"", ""Zheng H""], ""title"": ""Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB."", ""doi"": ""10.15252/emmm.201303671""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyloid Neuropathies""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Gene Expression Regulation"", ""Lysosomes"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""PTEN Phosphohydrolase"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Mapt protein, mouse"", ""Tcfeb protein, mouse"", ""tau Proteins"", ""PTEN Phosphohydrolase"", ""Pten protein, mouse""]}",False
CAUSES_NO_CHANGE,33569,7335,2018.0,28843454,False,False,False,"Children with HLADRB1*15 alleles were more likely to ultimately meet diagnostic criteria for MS (OR=2.7). This effect was greater in children of European ancestry (OR=3.3). No difference in DRB1*15 allele frequency was found between children with monophasic acute demyelinating syndrome and unaffected controls (84), suggesting that the HLA-DRB1*15 allele is a risk factor for pediatric MS but not monophasic demyelinating events (23).",#58:12,,"{""full_journal_name"": ""Pediatric neurology"", ""pub_date"": ""2018-05-17"", ""ref"": ""28843454"", ""pub_year"": 2018, ""last_author"": ""Brenton JN"", ""type"": ""PubMed"", ""author_list"": [""Cappa R"", ""Theroux L"", ""Brenton JN""], ""title"": ""Pediatric Multiple Sclerosis: Genes, Environment, and a Comprehensive Therapeutic Approach."", ""doi"": ""10.1016/j.pediatrneurol.2017.07.005""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Demyelinating Diseases""], ""Species"": [""9606""], ""mesh"": [""Environment"", ""Environmental Exposure"", ""Genome-Wide Association Study"", ""Humans"", ""Multiple Sclerosis"", ""Pediatrics""]}",False
CAUSES_NO_CHANGE,29213,6921,2009.0,19519303,False,False,False,"Clinical tr ials in health y hum ans under hyper insulin emic euglycemic clamp conditions showed a n egative shi ft in transcortica l direct current potentials, indicati ng that circ ulatÂ­ ing insulin can rapidly act on brain activity independent from its systemic effects [91 ]. Longitudinal studies revealed th at insulin resistance with persisting hyperi nsu linem i a comes along w ith an elevated risk for disturbed cognition, impa ired memory and A D (10, 92, 93]. In AD patients as well as i n h ealthy subjects hyperinsulinemic eug lycemic clamp studies revea led an i mproving effect of.insu li n on cognitive functio n (94, 95]. Intranasa l app l ication of insu lin in healthy hum ans directly entered th e CSF and improved memory function and cogn it ive capacity especi a lly in women with out in fluencing per i phera l blood gl ucose levels (96-98]. These gender speÂ­ cific findings suggest an influence of sex hormon es. Accord Â­ ingly, Cl egg el a!. d emonstrated th a t i nsul in sensitiv i ty in ra t brains differ, dependin g on estrogen levels (99].",#59:5,,"{""full_journal_name"": ""Current Alzheimer research"", ""pub_date"": ""2009-08-19"", ""ref"": ""19519303"", ""pub_year"": 2009, ""last_author"": ""Schubert M"", ""type"": ""PubMed"", ""author_list"": [""Freude S"", ""Schilbach K"", ""Schubert M""], ""title"": ""The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.""}","{""Gender"": [""Female""], ""MeSHAnatomy"": [""Blood""], ""Subgraph"": [""Insulin signal transduction""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Disease Models, Animal"", ""Humans"", ""Models, Biological"", ""Receptor, IGF Type 1"", ""Receptor, Insulin"", ""Signal Transduction"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Receptor, IGF Type 1"", ""Receptor, Insulin"", ""Amyloid Precursor Protein Secretases""]}",False
CAUSES_NO_CHANGE,35124,4941,2019.0,30562574,False,False,False,"Moreover, assessment of cell survival by nuclear counts assay carried out at the same time-point, revealed no detectable cytotoxicity stemming from LAMP2A down-regulation (Fig. 1C). To exclude any aberrant effects that might precede cell death per se, but might still confound our analysis, we measured gross levels of two established neuronal markers: the axon-associated tubulin beta-3 chain (TUBB3/TUJ-1) (Fig. 1D), and the dendritic marker microtubule- associated protein 2(MAP2) (Fig. 1E) - both of which showed no significant changes.",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,6709,21227,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,6884,10729,2015.0,26088141,False,False,False,"As shown in Fig. 5, A–C, barium replacement had little to no effect on the peak and total calcium transient observed in α7 (peak: 1474.83% ΔF/Fθ ± 162.00%; AUC: 693.5% ΔF/Fθ2 × s ± 154.15%) and α7345–348A expressing cells (peak: 794% ΔF/Fθ ± 81.36%; AUC: 543.5% ΔF/Fθ2 × s ± 89.59%).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,14265,6707,2020.0,30686764,False,False,False,"24-Hydroxycholesterol (a direct downstream metabolite of cholesterol) was increased in media from efavirenz-treated neurons, was decreased in AY-9944-treated samples, and was unaltered in atorvastatin- and T0901317-treated neurons (Figure S2P).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,7260,646,2001.0,11230871,False,False,False,A decrease in protein levels of the alpha4 nAChR but not of the alpha3 and alpha7 nAChRs was reported by Martin-Ruiz et al (1999),#65:45,,"{""full_journal_name"": ""Biological psychiatry"", ""pub_date"": ""2001-06-07"", ""ref"": ""11230871"", ""pub_year"": 2001, ""last_author"": ""Nordberg A"", ""type"": ""PubMed"", ""author_list"": [""Nordberg A""], ""title"": ""Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.""}","{""Confidence"": [""Medium""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Brain"", ""Cholinergic Agents"", ""Humans"", ""Receptors, Nicotinic"", ""Treatment Outcome""], ""substances"": [""Cholinergic Agents"", ""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,37099,1650,2007.0,17293005,False,False,False,"Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,4380,43249,2014.0,24027553,False,False,False,"Evidence supporting a role for thrombin in tau proteolysis came initially from an in vitro study showing that thrombin degraded recombinant full-length tau from the N-terminus yielding a 25-kDa fragment, while preserving the microtubule binding repeat domain (13).",#57:4,PMC3759803,"{""full_journal_name"": ""Frontiers in neurology"", ""pub_date"": ""2014-06-24"", ""ref"": ""24027553"", ""pub_year"": 2014, ""last_author"": ""Johnson GV"", ""type"": ""PubMed"", ""author_list"": [""Chesser AS"", ""Pritchard SM"", ""Johnson GV""], ""title"": ""Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease."", ""doi"": ""10.3389/fneur.2013.00122""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""]}",False
CAUSES_NO_CHANGE,40529,37163,2012.0,22179319,False,False,False,"Whether SIRT1 has protective role in mammalian HD remains undefined, however, as results from lower organisms such as Caenorhabditis elegans [13] and Drosophila melanogaster [14] are contradictory; for example, overexpression of sir2, an ortholog of human SIRT1, suppressed mutant huntingtin (Htt)-induced neurotoxicity [13], whereas overexpression of sir2 in drosophila showed no significant protection [15].",#66:20,PMC4551453,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2012-03-14"", ""ref"": ""22179319"", ""pub_year"": 2012, ""last_author"": ""Duan W"", ""type"": ""PubMed"", ""author_list"": [""Jiang M"", ""Wang J"", ""Fu J"", ""Du L"", ""Jeong H"", ""West T"", ""Xiang L"", ""Peng Q"", ""Hou Z"", ""Cai H"", ""Seredenina T"", ""Arbez N"", ""Zhu S"", ""Sommers K"", ""Qian J"", ""Zhang J"", ""Mori S"", ""Yang XW"", ""Tamashiro KL"", ""Aja S"", ""Moran TH"", ""Luthi-Carter R"", ""Martin B"", ""Maudsley S"", ""Mattson MP"", ""Cichewicz RH"", ""Ross CA"", ""Holtzman DM"", ""Krainc D"", ""Duan W""], ""title"": ""Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets."", ""doi"": ""10.1038/nm.2558""}","{""Confidence"": [""Low""], ""Species"": [""7227""], ""mesh"": [""Animals"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Disease Models, Animal"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""Gene Expression Regulation"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins"", ""Rats"", ""Receptor, trkB"", ""Signal Transduction"", ""Sirtuin 1""], ""substances"": [""Brain-Derived Neurotrophic Factor"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""FoxO3 protein, mouse"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Ppp1r1b protein, mouse"", ""Receptor, trkB"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,26554,4994,2018.0,27671637,False,False,False,"This result suggests an impaired learning association between the sound and the foot shock in proaggregant mice, which can be rescued by 64627 treatment",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Axons""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,1411,43738,2016.0,27013968,False,False,False,Our assays on presymptomatic R6/2 mice indicated that striatal morphology and protein levels of BDNF and fl-TrkB are normal but levels of activated phospho-TrkB are reduced compared to WT mice.,#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,12015,7186,2017.0,27623715,False,False,False,"Only middle-aged Tet-mev-1 mice showed JNK/MARK activation and Ca2+ overload, particularly in astrocytes with decreased hippocampal GFAP and S100ß, but without pathological features such as apoptosis, amyloidosis, and lactic acidosis in neurons and astrocytes. This led to decreasing levels of glial fibrillary acidic protein and S100β in the hippocampal area.",#60:23,PMC5242301,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2017-06-05"", ""ref"": ""27623715"", ""pub_year"": 2017, ""last_author"": ""Ishii N"", ""type"": ""PubMed"", ""author_list"": [""Ishii T"", ""Takanashi Y"", ""Sugita K"", ""Miyazawa M"", ""Yanagihara R"", ""Yasuda K"", ""Onouchi H"", ""Kawabe N"", ""Nakata M"", ""Yamamoto Y"", ""Hartman PS"", ""Ishii N""], ""title"": ""Endogenous reactive oxygen species cause astrocyte defects and neuronal dysfunctions in the hippocampus: a new model for aging brain."", ""doi"": ""10.1111/acel.12523""}","{""Anatomy"": [""hippocampal formation""], ""Cell"": [""astrocyte"", ""neuron""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""Study_Group"": [""Tet-mev-1 mice""], ""mesh"": [""Aging"", ""Animals"", ""Astrocytes"", ""Biomarkers"", ""Calcium"", ""Cyclic AMP Response Element-Binding Protein"", ""Disease Models, Animal"", ""Glial Fibrillary Acidic Protein"", ""Hippocampus"", ""JNK Mitogen-Activated Protein Kinases"", ""Membrane Proteins"", ""Memory"", ""Mice, Inbred C57BL"", ""Mitochondria"", ""Models, Biological"", ""Mutation"", ""Neurons"", ""Oxidation-Reduction"", ""Phosphorylation"", ""Reactive Oxygen Species"", ""S100 Proteins"", ""Signal Transduction"", ""Superoxide Dismutase""], ""substances"": [""Biomarkers"", ""Cyclic AMP Response Element-Binding Protein"", ""Glial Fibrillary Acidic Protein"", ""Membrane Proteins"", ""Reactive Oxygen Species"", ""S100 Proteins"", ""SDHC protein, mouse"", ""Superoxide Dismutase"", ""JNK Mitogen-Activated Protein Kinases"", ""Calcium""]}",False
CAUSES_NO_CHANGE,2091,7208,2017.0,27794524,False,False,False,"However, clinical trials of lamotrigine in patients with progressive multiple sclerosis did not show advantages over placebo with respect to neuroprotection (Hayton et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,11479,14393,2007.0,17640819,False,False,False,"4OH-GTS-21 had no protective effect on GABAergic neuronal number in this strain, with FFX lesions causing a 34±9% reduction compared with contralateral controls (n=10; P<0.05 compared with unlesioned side, one-way ANOVA)",#65:41,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""Assay"": [""Immunochemistry""], ""MouseStrain"": [""C57BL/6J""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,16858,32750,2017.0,28083634,False,False,False,"AAV-driven expression of Otub1-C91A did not increase AT8-positive Tau, in contrast to expression of wild-type Otub1 and the N-terminally truncated form of Otub1. This was demonstrated by immunofluorescence staining (Fig. 6a) and confirmed by biochemical analysis (Fig. 6b).",#64:64,PMC5390007,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2017-04-20"", ""ref"": ""28083634"", ""pub_year"": 2017, ""last_author"": ""Dewachter I"", ""type"": ""PubMed"", ""author_list"": [""Wang P"", ""Joberty G"", ""Buist A"", ""Vanoosthuyse A"", ""Stancu IC"", ""Vasconcelos B"", ""Pierrot N"", ""Faelth-Savitski M"", ""Kienlen-Campard P"", ""Octave JN"", ""Bantscheff M"", ""Drewes G"", ""Moechars D"", ""Dewachter I""], ""title"": ""Tau interactome mapping\u00a0based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo."", ""doi"": ""10.1007/s00401-016-1663-9""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Deubiquitinating Enzymes"", ""Humans"", ""Mice, Transgenic"", ""Neurofibrillary Tangles"", ""Neurons"", ""Tauopathies"", ""Ubiquitin"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Ubiquitin"", ""tau Proteins"", ""Deubiquitinating Enzymes"", ""Cysteine Endopeptidases"", ""Otub1 protein, mouse""]}",False
CAUSES_NO_CHANGE,1854,158,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,11960,24495,2014.0,24590577,False,False,False,"During the past few years, the M1 mAChR allosteric agonists VU0184670 and VU0357017 have been screened out, and have more exciting properties. Both compounds have high solubility in aqueous solutions as well as good CNS penetration, without any agonist or antagonist activity for the M2 and M5 subtypes",#69:61,PMC5562652,"{""full_journal_name"": ""Neuroscience bulletin"", ""pub_date"": ""2014-12-03"", ""ref"": ""24590577"", ""pub_year"": 2014, ""last_author"": ""Zhang YW"", ""type"": ""PubMed"", ""author_list"": [""Jiang S"", ""Li Y"", ""Zhang C"", ""Zhao Y"", ""Bu G"", ""Xu H"", ""Zhang YW""], ""title"": ""M1 muscarinic acetylcholine receptor in Alzheimer's disease."", ""doi"": ""10.1007/s12264-013-1406-z""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""Receptor, Muscarinic M1""], ""substances"": [""Receptor, Muscarinic M1""]}",False
CAUSES_NO_CHANGE,38407,37995,2009.0,19713215,False,False,False,"Arhgef5 can strongly activate RhoA and RhoB and weakly RhoC and RhoG, but not Rac1, RhoQ, RhoD, or RhoV, in transfected human embryonic kidney 293 cells.",#59:5,PMC2781403,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2009-11-24"", ""ref"": ""19713215"", ""pub_year"": 2009, ""last_author"": ""Wu D"", ""type"": ""PubMed"", ""author_list"": [""Wang Z"", ""Kumamoto Y"", ""Wang P"", ""Gan X"", ""Lehmann D"", ""Smrcka AV"", ""Cohn L"", ""Iwasaki A"", ""Li L"", ""Wu D""], ""title"": ""Regulation of immature dendritic cell migration by RhoA guanine nucleotide exchange factor Arhgef5."", ""doi"": ""10.1074/jbc.M109.047282""}","{""CellLine"": [""HEK293""], ""Subgraph"": [""RhoA subgraph""], ""mesh"": [""Animals"", ""Asthma"", ""Cell Culture Techniques"", ""Cell Movement"", ""Chemotaxis"", ""Dendritic Cells"", ""Gene Expression Regulation"", ""Guanine Nucleotide Exchange Factors"", ""Humans"", ""Luciferases"", ""Mice"", ""Mice, Transgenic"", ""Ovalbumin"", ""Proto-Oncogene Proteins"", ""Rho Guanine Nucleotide Exchange Factors"", ""rhoA GTP-Binding Protein""], ""substances"": [""ARHGEF5 protein, human"", ""Guanine Nucleotide Exchange Factors"", ""Proto-Oncogene Proteins"", ""Rho Guanine Nucleotide Exchange Factors"", ""Ovalbumin"", ""Luciferases"", ""rhoA GTP-Binding Protein""]}",False
CAUSES_NO_CHANGE,11560,1513,2015.0,25639674,False,False,False,"The α4β2 nAChR PAM, NS-9283, administered alone did not affect mechanical allodynia in the spinal nerve ligation test (a model of neuropathic pain), nor on nociception and inflammation in various rodent models of pain [185, 186].",#60:18,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""MeSHAnatomy"": [""Neurons"", ""Spinal Cord""], ""MeSHDisease"": [""Pain""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,1650,27111,2020.0,30686764,False,False,False,"While Ab secretion was no longer regulated by atorvastatin in these neurons, atorvastatin still decreased pT231Tau/tTau ratio (in an identical manner as in their isogenic wild-type controls) (Figure 4F), again confirming that the effect of CE on pTau and the effect of CE on Ab are regulated through two separate pathways.",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,1934,1391,2020.0,30837838,False,False,False,"Notably, the zinc ions could induce inclusion bodies formation and aggregation in the neuronal cell cultures, and this effect was not observed with copper or iron, indicating zinc-specific effects (Caragounis et al., 2010).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}",{},False
CAUSES_NO_CHANGE,38148,21289,2017.0,28760828,False,False,False,"Of note, whereas mimicking acetylation at most non-KXGS sites had minimal impact on tau aggregation, K274Q also significantly decreased tau assembly in vitro, albeit to a lesser extent than K321Q (Fig. 1b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,11898,1650,2015.0,25331948,False,False,False,"We tested a selective BTK inhibitor (BTK inhibitor III, 1-(3-(4-amino-3-(4-phenyloxy phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, N-acryloyl-(3-(4-amino-3-(4-phenyloxyphenyl)- 1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine) on Aβ production, and we found that this compound was unable to significantly inhibit Aβ production (data not shown) suggesting that the Aβ-lowering properties of nilvadipine are not mediated via an inhibition of BTK.",#70:54,PMC4256331,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-03-03"", ""ref"": ""25331948"", ""pub_year"": 2015, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Ait-Ghezala G"", ""Bachmeier C"", ""Laco G"", ""Beaulieu-Abdelahad D"", ""Lin Y"", ""Jin C"", ""Crawford F"", ""Mullan M""], ""title"": ""The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-\u03b2 production and Tau hyperphosphorylation."", ""doi"": ""10.1074/jbc.M114.608091""}","{""Confidence"": [""High""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""CHO Cells"", ""Calcium Channel Blockers"", ""Cell Line, Tumor"", ""Cricetulus"", ""Gene Expression Regulation"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""Neurons"", ""Nifedipine"", ""Phosphorylation"", ""Protein-Tyrosine Kinases"", ""Signal Transduction"", ""Syk Kinase"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Calcium Channel Blockers"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""tau Proteins"", ""nilvadipine"", ""Protein-Tyrosine Kinases"", ""SYK protein, human"", ""Syk Kinase"", ""Syk protein, mouse"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Nifedipine""]}",False
CAUSES_NO_CHANGE,7981,18297,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,2017,12096,2012.0,21958873,False,False,False,Nicotine does not appear to affect sAPPβ and sAPPα secretion in 7W CHO contrary to anatabine (Fig. 4),#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,42014,29331,2016.0,26702100,False,False,False,"In contrast, starvation or depletion of RagB led to an increase of nuclear, but not lysosomal translocation of TFEB, even if the cells were subsequently incubated with Torin-1 (Fig 3F).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""High""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,16795,21289,2017.0,28760828,False,False,False,"Of note, whereas mimicking acetylation at most non-KXGS sites had minimal impact on tau aggregation, K274Q also significantly decreased tau assembly in vitro, albeit to a lesser extent than K321Q (Fig. 1b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,7161,37957,2002.0,12218646,False,False,False,"Sera from patients with Alzheimer disease and non-demented elderly subjects caused an increase in IL-2 and a decrease in IL-10 production by PBMC from middle-aged control subjects but did not affect IL-1beta, IL-6, and TNFalpha secretion, indicating alterations of the immune system related to aging.",#59:5,,"{""full_journal_name"": ""Alzheimer disease and associated disorders"", ""pub_date"": ""2002-12-04"", ""ref"": ""12218646"", ""pub_year"": 2002, ""last_author"": ""Bessler H"", ""type"": ""PubMed"", ""author_list"": [""Bergman M"", ""Salman H"", ""Beloosesky Y"", ""Djaldetti M"", ""Bessler H""], ""title"": ""Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli?""}","{""MeSHAnatomy"": [""Serum""], ""MeSHDisease"": [""Alzheimer Disease""], ""Species"": [""9606""], ""Subgraph"": [""Interleukin signaling subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Apoptosis"", ""Female"", ""Humans"", ""Interleukin-1"", ""Interleukin-10"", ""Interleukin-2"", ""Interleukin-6"", ""Male"", ""Monocytes"", ""Reference Values"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Interleukin-1"", ""Interleukin-2"", ""Interleukin-6"", ""Tumor Necrosis Factor-alpha"", ""Interleukin-10""]}",False
CAUSES_NO_CHANGE,2017,12078,2013.0,22530628,False,False,False,"However, the failure of nicotine to improve memory in AD patients, its inherent toxicity, and the fact that it induces tachyphylaxis and addiction have discouraged its use in the clinical arena [32].",#57:51,PMC6493450,"{""full_journal_name"": ""CNS neuroscience & therapeutics"", ""pub_date"": ""2013-05-20"", ""ref"": ""22530628"", ""pub_year"": 2013, ""last_author"": ""Zeitlin R"", ""type"": ""PubMed"", ""author_list"": [""Echeverria V"", ""Zeitlin R""], ""title"": ""Cotinine: a potential new therapeutic agent against Alzheimer's disease."", ""doi"": ""10.1111/j.1755-5949.2012.00317.x""}","{""Confidence"": [""High""], ""Disease"": [""Alzheimer's disease""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cotinine"", ""Drug Delivery Systems"", ""Humans"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic"", ""Cotinine""]}",False
CAUSES_NO_CHANGE,38768,34846,2000.0,10656250,False,False,False,"However, while there is a significant increase in the production of CTFb in the presence of wild-type Asp 2, there is no increase in the presence of the mutant enzymes (Fig. 4b).",#64:10,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2000-02-17"", ""ref"": ""10656250"", ""pub_year"": 2000, ""last_author"": ""Christie G"", ""type"": ""PubMed"", ""author_list"": [""Hussain I"", ""Powell D"", ""Howlett DR"", ""Tew DG"", ""Meek TD"", ""Chapman C"", ""Gloger IS"", ""Murphy KE"", ""Southan CD"", ""Ryan DM"", ""Smith TS"", ""Simmons DL"", ""Walsh FS"", ""Dingwall C"", ""Christie G""], ""title"": ""Identification of a novel aspartic protease (Asp 2) as beta-secretase.""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""COS Cells"", ""Cathepsin D"", ""Cell Line"", ""Cell Membrane"", ""Endopeptidases"", ""Female"", ""Hippocampus"", ""Humans"", ""Middle Aged"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Papain"", ""Recombinant Proteins"", ""Sequence Alignment"", ""Sequence Homology, Amino Acid"", ""Transfection""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Recombinant Proteins"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Papain"", ""Aspartic Acid Endopeptidases"", ""BACE2 protein, human"", ""BACE1 protein, human"", ""Cathepsin D""]}",False
CAUSES_NO_CHANGE,7981,20543,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,18547,37057,2020.0,31413141,False,False,False,"The SNP commonly used as a proxy for APOE epsilon 4, rs769449, was also not associated with CSF sTREM2 (beta = −106.9, P = 0.308).",#59:17,PMC6697053,"{""full_journal_name"": ""Science translational medicine"", ""pub_date"": ""2020-07-27"", ""ref"": ""31413141"", ""pub_year"": 2020, ""last_author"": ""Cruchaga C"", ""type"": ""PubMed"", ""author_list"": [""Deming Y"", ""Filipello F"", ""Cignarella F"", ""Cantoni C"", ""Hsu S"", ""Mikesell R"", ""Li Z"", ""Del-Aguila JL"", ""Dube U"", ""Farias FG"", ""Bradley J"", ""Budde J"", ""Ibanez L"", ""Fernandez MV"", ""Blennow K"", ""Zetterberg H"", ""Heslegrave A"", ""Johansson PM"", ""Svensson J"", ""Nellg\u00e5rd B"", ""Lleo A"", ""Alcolea D"", ""Clarimon J"", ""Rami L"", ""Molinuevo JL"", ""Su\u00e1rez-Calvet M"", ""Morenas-Rodr\u00edguez E"", ""Kleinberger G"", ""Ewers M"", ""Harari O"", ""Haass C"", ""Brett TJ"", ""Benitez BA"", ""Karch CM"", ""Piccio L"", ""Cruchaga C""], ""title"": {""#text"": ""The  gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk."", ""i"": ""MS4A""}, ""doi"": ""10.1126/scitranslmed.aau2291""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""mesh"": [""Alzheimer Disease"", ""Female"", ""Genome-Wide Association Study"", ""Humans"", ""Macrophages"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Meta-Analysis as Topic"", ""Multigene Family"", ""Receptors, Immunologic""], ""substances"": [""MS4A4A protein, human"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
CAUSES_NO_CHANGE,6709,41993,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,1788,10760,2015.0,26088141,False,False,False,"In α7345–348A nAChR expressing cells, nifedipine had no effect on the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%; AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5, A–C). The findings suggest that choline- induced calcium responses in PC12 cells involve the activity of VGCC (37, 38).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,14472,7115,2017.0,27794524,False,False,False,"However, in EAE, idebenone failed to affect disease incidence or onset when applied preventively, or to reduce disease severity when applied therapeutically.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,26253,5148,2013.0,23531502,False,False,False,"The data (Fig. 8B) shows that no significant difference in the extent of tubulin assembly could be observed with normal tau or tau incubated with CA. These results also indicate that once assembled, the microtubules remained stable to the same extent in the presence or in the absence of CA.",#60:23,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2013-12-09"", ""ref"": ""23531502"", ""pub_year"": 2013, ""last_author"": ""Graves DJ"", ""type"": ""PubMed"", ""author_list"": [""George RC"", ""Lew J"", ""Graves DJ""], ""title"": ""Interaction of cinnamaldehyde and epicatechin with tau: implications of beneficial effects in modulating Alzheimer's disease pathogenesis."", ""doi"": ""10.3233/JAD-122113""}","{""Confidence"": [""Medium""], ""ExpMethod"": [""in vitro""], ""Method"": [""Electron Microscopy, Transmission"", ""Mass Spectrometry""], ""mesh"": [""Acrolein"", ""Alzheimer Disease"", ""Animals"", ""Catechin"", ""Cattle"", ""Cysteine"", ""In Vitro Techniques"", ""Microscopy, Electron, Transmission"", ""Microtubules"", ""Oxidation-Reduction"", ""Spectrometry, Mass, Electrospray Ionization"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Tubulin"", ""tau Proteins"", ""Acrolein"", ""Catechin"", ""Cysteine"", ""cinnamaldehyde""]}",False
CAUSES_NO_CHANGE,3562,20343,2015.0,25681350,False,False,False,"In contrast to astrocytes and U373 cells, we found that basal expression of YKL-40 and RelB mRNA was very high in primary human chondrocytes and not stimulated by IL-1 or OSM (Supplementary Fig 3).",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Cell"": [""chondrocyte""], ""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,6709,25323,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,6709,43315,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,6449,42365,2020.0,31413141,False,False,False,Extracellular sTREM2 concentrations were unchanged with increasing concentrations of the isotype-matched control antibody [mouse immunoglobulin G (IgG); Fig. 5B].,#59:17,PMC6697053,"{""full_journal_name"": ""Science translational medicine"", ""pub_date"": ""2020-07-27"", ""ref"": ""31413141"", ""pub_year"": 2020, ""last_author"": ""Cruchaga C"", ""type"": ""PubMed"", ""author_list"": [""Deming Y"", ""Filipello F"", ""Cignarella F"", ""Cantoni C"", ""Hsu S"", ""Mikesell R"", ""Li Z"", ""Del-Aguila JL"", ""Dube U"", ""Farias FG"", ""Bradley J"", ""Budde J"", ""Ibanez L"", ""Fernandez MV"", ""Blennow K"", ""Zetterberg H"", ""Heslegrave A"", ""Johansson PM"", ""Svensson J"", ""Nellg\u00e5rd B"", ""Lleo A"", ""Alcolea D"", ""Clarimon J"", ""Rami L"", ""Molinuevo JL"", ""Su\u00e1rez-Calvet M"", ""Morenas-Rodr\u00edguez E"", ""Kleinberger G"", ""Ewers M"", ""Harari O"", ""Haass C"", ""Brett TJ"", ""Benitez BA"", ""Karch CM"", ""Piccio L"", ""Cruchaga C""], ""title"": {""#text"": ""The  gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk."", ""i"": ""MS4A""}, ""doi"": ""10.1126/scitranslmed.aau2291""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Female"", ""Genome-Wide Association Study"", ""Humans"", ""Macrophages"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Meta-Analysis as Topic"", ""Multigene Family"", ""Receptors, Immunologic""], ""substances"": [""MS4A4A protein, human"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
CAUSES_NO_CHANGE,32340,7161,2010.0,19542625,False,False,False,"There has been a lot of disappointment surrounding the recent failure of the largest ever study in patients with Alzheimer's disease (AD) with tarenflurbil. A straightforward explanation of this failure is that the gamma-secretase is not the right target for therapy or that, in general, blocking A beta does not produce clinical benefits in AD",#59:5,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2010-09-22"", ""ref"": ""19542625"", ""pub_year"": 2010, ""last_author"": ""Imbimbo BP"", ""type"": ""PubMed"", ""author_list"": [""Imbimbo BP""], ""title"": ""Why did tarenflurbil fail in Alzheimer's disease?"", ""doi"": ""10.3233/JAD-2009-1092""}","{""DiseaseState"": [""Mild AD""], ""FDASTATUS"": [""Phase 3""], ""Subgraph"": [""Gamma secretase subgraph"", ""Inflammatory response subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Brain"", ""Flurbiprofen"", ""Humans"", ""Treatment Failure""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""tarenflurbil"", ""Flurbiprofen"", ""Amyloid Precursor Protein Secretases""]}",False
CAUSES_NO_CHANGE,43348,616,2018.0,28445721,False,False,False,"For alpha7 and alpha3beta2, RIC-3 did not enable detectable [3H]epibatidine binding, yet RIC-3 profoundly augmented the effects of NACHO on [3H]epibatidine binding to either receptor subtype (Figures 3A and S1A)",#64:74,,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2018-01-19"", ""ref"": ""28445721"", ""pub_year"": 2018, ""last_author"": ""Bredt DS"", ""type"": ""PubMed"", ""author_list"": [""Matta JA"", ""Gu S"", ""Davini WB"", ""Lord B"", ""Siuda ER"", ""Harrington AW"", ""Bredt DS""], ""title"": ""NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain."", ""doi"": ""10.1016/j.celrep.2017.04.008""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Binding Sites"", ""Brain"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Cell Line"", ""Cognitive Dysfunction"", ""Conotoxins"", ""Humans"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Mice"", ""Mice, Knockout"", ""Molecular Chaperones"", ""Neurons"", ""Nicotine"", ""Protein Binding"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic""], ""substances"": [""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Conotoxins"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Molecular Chaperones"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic"", ""Ric-3 protein, mouse"", ""Nicotine"", ""Iodine-125"", ""epibatidine""]}",False
CAUSES_NO_CHANGE,20982,11635,2017.0,27209302,False,False,False,The results indicated that microglia with TFEB-K116Q overexpression could neither facilitate fAβ degradation (Fig. S5B) nor upregulate the lysosomal biogenesis and function (Fig. S5C and S5D).,#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,1411,43708,2018.0,30027901,False,False,False,No significant alterations were found in the dopamine synthesizing enzyme tyrosine hydroxylase in post-mortem HD striatum (Bird and Iversen 1977). Deficit in vesicular monoamine transporter type 2 (VMAT2) expression was found in posterior putamen in post-mortem HD brains (Bohnen et al. 2000).,#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Anatomy"": [""corpus striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,11492,2361,2011.0,21745645,False,False,False,"The LTP induced by the preceding SO stimulation (100 ms) was completely blocked by MLA (10 nM), whereas DHβE (1 μM) and atropine (5 μM) were ineffective(Figure 2A).Similarly the induction of STD by SO 10 ms before SC was also blocked by MLA, with DHβE and atropine also having no effect(Figure 2B).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""100 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,11527,21563,2012.0,22020111,False,False,False,"A recent laboratory study of dimethyl fumarate found that the compound activates Nrf2 in primary astrocytes, but not in the C6 glioma-derived cell line (Wilms et al., 2010), demonstrating that different cells may respond quite differently to Nrf2 activators",#69:51,,"{""full_journal_name"": ""Molecular aspects of medicine"", ""pub_date"": ""2012-05-15"", ""ref"": ""22020111"", ""pub_year"": 2012, ""last_author"": ""McCord JM"", ""type"": ""PubMed"", ""author_list"": [""Hybertson BM"", ""Gao B"", ""Bose SK"", ""McCord JM""], ""title"": ""Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation."", ""doi"": ""10.1016/j.mam.2011.10.006""}","{""CellLine"": [""C6 cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Antioxidants"", ""Drugs, Chinese Herbal"", ""Humans"", ""Inflammation"", ""NF-E2-Related Factor 2"", ""Oxidative Stress"", ""Signal Transduction""], ""substances"": [""Antioxidants"", ""Drugs, Chinese Herbal"", ""NF-E2-Related Factor 2"", ""Protandim""]}",False
CAUSES_NO_CHANGE,4177,2380,2017.0,27594586,False,False,False,"Thus, both molecular and electrophysiological analyses suggest MAPT mutations do not affect early neuronal differentiation",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,26417,39135,2017.0,28148553,False,False,False,"Cells transduced with 4R tau-overexpressing lentivirus showed increased levels in CP13-, AD2-, and HT7 tau (but not MC1). CP13- but not AD2- and HT7 tau were normalized by simultaneous PERK activator treatment (Fig 3G and H).",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,34694,42147,2018.0,28528849,False,False,False,"We also checked the phosphorylation of tau at other sites (e.g., using the antibody AT8, reacting only with the endogenous tau) and did not observe an increase in the phosphorylation.",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""High""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,11560,1365,2015.0,25639674,False,False,False,"The α4β2 nAChR PAM, NS-9283, administered alone did not affect mechanical allodynia in the spinal nerve ligation test (a model of neuropathic pain), nor on nociception and inflammation in various rodent models of pain [185, 186].",#59:10,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons"", ""Spinal Cord""], ""MeSHDisease"": [""Pain""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,39524,20593,2018.0,28877763,False,False,False,We analyzed the possible impact of Syk overexpression on Tau mRNA levels by quantitative RT-PCR and found that Syk overexpression does not affect Tau transcription (data not shown) sug- gesting that Syk may regulate tau degradation or tau protein translation.,#62:1,PMC5588676,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2018-05-07"", ""ref"": ""28877763"", ""pub_year"": 2018, ""last_author"": ""Paris D"", ""type"": ""PubMed"", ""author_list"": [""Schweig JE"", ""Yao H"", ""Beaulieu-Abdelahad D"", ""Ait-Ghezala G"", ""Mouzon B"", ""Crawford F"", ""Mullan M"", ""Paris D""], ""title"": ""Alzheimer's disease pathological lesions activate the spleen tyrosine kinase."", ""doi"": ""10.1186/s40478-017-0472-2""}","{""Confidence"": [""Medium""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Aging"", ""Alzheimer Disease"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Brain"", ""Cell Line, Tumor"", ""Disease Models, Animal"", ""Female"", ""Humans"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Microglia"", ""Neurons"", ""Plaque, Amyloid"", ""Presenilin-1"", ""Syk Kinase"", ""tau Proteins""], ""substances"": [""APP protein, human"", ""Amyloid beta-Protein Precursor"", ""MAPT protein, human"", ""Mapt protein, mouse"", ""PSEN1 protein, human"", ""Presenilin-1"", ""tau Proteins"", ""SYK protein, human"", ""Syk Kinase"", ""Syk protein, mouse""]}",False
CAUSES_NO_CHANGE,44172,14307,2014.0,23516100,False,False,False,"Mouse models expressing truncated α-syn showed dopamine depletion, and the dopaminergic cells were more vulnerable to stress [99, 100].Furthermore, cells expressing C-terminally truncated species (aa 1–120) show enhanced susceptibility to oxidative stress and have the tendency to develop aggregates.",#71:22,,"{""full_journal_name"": ""Molecular neurobiology"", ""pub_date"": ""2014-06-18"", ""ref"": ""23516100"", ""pub_year"": 2014, ""last_author"": ""Novak M"", ""type"": ""PubMed"", ""author_list"": [""Jadhav S"", ""Zilka N"", ""Novak M""], ""title"": ""Protein truncation as a common denominator of human neurodegenerative foldopathies."", ""doi"": ""10.1007/s12035-013-8440-8""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Dopaminergic Neurons""], ""Species"": [""10090""], ""mesh"": [""Calpain"", ""Caspases"", ""Humans"", ""Intrinsically Disordered Proteins"", ""Neurodegenerative Diseases"", ""Protein Folding"", ""Proteolysis""], ""substances"": [""Intrinsically Disordered Proteins"", ""Calpain"", ""Caspases""]}",False
CAUSES_NO_CHANGE,11790,2231,2009.0,19237574,False,False,False,"Taken together, these results indicate that metformin likely augments Abeta production through mechanisms independent of insulin signaling and glucose metabolism",#59:5,PMC2656178,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2009-03-26"", ""ref"": ""19237574"", ""pub_year"": 2009, ""last_author"": ""Liao FF"", ""type"": ""PubMed"", ""author_list"": [""Chen Y"", ""Zhou K"", ""Wang R"", ""Liu Y"", ""Kwak YD"", ""Ma T"", ""Thompson RC"", ""Zhao Y"", ""Smith L"", ""Gasparini L"", ""Luo Z"", ""Xu H"", ""Liao FF""], ""title"": ""Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription."", ""doi"": ""10.1073/pnas.0807991106""}","{""Subgraph"": [""Insulin signal transduction""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Base Sequence"", ""Binding Sites"", ""Enzyme Activation"", ""Glucose"", ""Hypoglycemic Agents"", ""Insulin"", ""Metformin"", ""Mice"", ""Molecular Sequence Data"", ""Peptides"", ""Promoter Regions, Genetic"", ""Rats"", ""Signal Transduction"", ""Transcription, Genetic"", ""Up-Regulation""], ""substances"": [""Amyloid beta-Peptides"", ""Hypoglycemic Agents"", ""Insulin"", ""Peptides"", ""Metformin"", ""AMP-Activated Protein Kinases"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Glucose""]}",False
CAUSES_NO_CHANGE,4138,9442,2009.0,19293145,False,False,False,"The APOE-epsilon4 gene-dose effect was also found to correlate with the loss of nAChR binding sites in patients with AD, as well as a reduced respon- siveness to the therapeutic AChE inhibitor tacrine (Poirier et al., 1995). Within an AD cohort, APOE-epsilon4 dose dependently correlates with higher losses of ChAT but not with losses in alpha4beta2 nAChRs (Lai et al., 2006).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,1845,25225,2006.0,16511867,False,False,False,"Cerebrolysin is a peptide mixture with neurotrophic effects that might reduce the neurodegenerative pathology in Alzheimer's disease (AD). Cerebrolysin might reduce amyloid deposition by regulating amyloid- beta (Abeta) degradation or by modulating APP expression, maturation, or processing. To investigate these possibilities, APP tg mice were treated for 6 months with Cerebrolysin and analyzed in the water maze, followed by RNA, immunoblot, and confocal microscopy analysis of full- length (FL) APP and its fragments, beta-secretase (BACE1), and Abeta- degrading enzymes [neprilysin (Nep) and insulin-degrading enzyme (IDE)]. Consistent with previous studies, Cerebrolysin ameliorated the performance deficits in the spatial learning portion of the water maze and reduced the synaptic pathology and amyloid burden in the brains of APP tg mice. These effects were associated with reduced levels of FL APP and APP C-terminal fragments, but levels of BACE1, Notch1, Nep, and IDE were unchanged. In contrast, levels of active cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3beta [GSK-3beta; but not stress-activated protein kinase-1 (SAPK1)], kinases that phosphorylate APP, were reduced. Furthermore, Cerebrolysin reduced the levels of phosphorylated APP and the accumulation of APP in the neuritic processes. Taken together, these results suggest that Cerebrolysin might reduce AD-like pathology in the APP tg mice by regulating APP maturation and transport to sites where Abeta protein is generated.",#59:5,,"{""full_journal_name"": ""Journal of neuroscience research"", ""pub_date"": ""2006-07-25"", ""ref"": ""16511867"", ""pub_year"": 2006, ""last_author"": ""Masliah E"", ""type"": ""PubMed"", ""author_list"": [""Rockenstein E"", ""Torrance M"", ""Mante M"", ""Adame A"", ""Paulino A"", ""Rose JB"", ""Crews L"", ""Moessler H"", ""Masliah E""], ""title"": ""Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.""}","{""Species"": [""10090""], ""Subgraph"": [""Nerve growth factor subgraph"", ""Notch signaling subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amino Acids"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""Cyclin-Dependent Kinase 5"", ""Disease Models, Animal"", ""Down-Regulation"", ""Endopeptidases"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Insulysin"", ""Maze Learning"", ""Mice"", ""Mice, Transgenic"", ""Neprilysin"", ""Neurons"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Protein Transport"", ""RNA, Messenger""], ""substances"": [""Amino Acids"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Neuroprotective Agents"", ""RNA, Messenger"", ""cerebrolysin"", ""Cyclin-Dependent Kinase 5"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Neprilysin"", ""Insulysin""]}",False
CAUSES_NO_CHANGE,1222,3262,2009.0,19293145,False,False,False,"Intracerebral injection of Abeta into rats resulted in a loss of alpha4 and alpha7 subunits as measured by Western blotting but an increase in alpha7 mRNA (Liu et al., 2008), again suggesting that Abeta directly reduces expression of alpha7 nAChRs through mechanisms other than reduced mRNAproduction, although caution should be exercised in interpreting quantitative data from Western blot studies. It is noteworthy that a combined patch-clamp and in situ hybridization study of dissociated human brain tissue (obtained as route-of-access tissue removed during surgery) indicated that neurons near Abeta plaques retained alpha4 and alpha7 mRNA transcripts, whereas these transcripts were absent in neurons burdened with hyperphosphorylated tau protein (Wevers et al., 1999).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,14406,12180,2012.0,21958873,False,False,False,No cytotoxicity was observed (as measured by the release of lactate dehydrogenase in the culture medium of 7W CHO cells) with the dose range of anatabine tested (data not shown).,#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,4946,7407,2017.0,27181519,False,False,False,"Moreover, selective autophagy is particularly well-suited to clearance of large (> 2 um) protein aggregates and RNP granules that need to be disassembled, in part because large protein aggregates and persistent RNP granules are known to be resistant to ubiquitin-proteasome degradation (Venkatraman et al., 2004).",#65:50,PMC5055418,"{""full_journal_name"": ""Brain research"", ""pub_date"": ""2017-05-16"", ""ref"": ""27181519"", ""pub_year"": 2017, ""last_author"": ""Pandey UB"", ""type"": ""PubMed"", ""author_list"": [""Monahan Z"", ""Shewmaker F"", ""Pandey UB""], ""title"": ""Stress granules at the intersection of autophagy and ALS."", ""doi"": ""10.1016/j.brainres.2016.05.022""}","{""Confidence"": [""Medium""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Adenosine Triphosphatases"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Autophagy-Related Proteins"", ""C9orf72 Protein"", ""Cell Cycle Proteins"", ""Cytoplasmic Granules"", ""DNA-Binding Proteins"", ""Disease Models, Animal"", ""Heterogeneous-Nuclear Ribonucleoprotein Group A-B"", ""Humans"", ""Membrane Transport Proteins"", ""Nuclear Matrix-Associated Proteins"", ""Protein Serine-Threonine Kinases"", ""Proteins"", ""RNA-Binding Protein FUS"", ""RNA-Binding Proteins"", ""Transcription Factor TFIIIA"", ""Ubiquitins"", ""Valosin Containing Protein""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Autophagy-Related Proteins"", ""C9orf72 Protein"", ""C9orf72 protein, human"", ""Cell Cycle Proteins"", ""DNA-Binding Proteins"", ""Heterogeneous-Nuclear Ribonucleoprotein Group A-B"", ""MATR3 protein, human"", ""Membrane Transport Proteins"", ""Nuclear Matrix-Associated Proteins"", ""OPTN protein, human"", ""Proteins"", ""RNA-Binding Protein FUS"", ""RNA-Binding Proteins"", ""TARDBP protein, human"", ""Transcription Factor TFIIIA"", ""UBQLN2 protein, human"", ""Ubiquitins"", ""hnRNP A2"", ""Protein Serine-Threonine Kinases"", ""TBK1 protein, human"", ""Adenosine Triphosphatases"", ""Valosin Containing Protein""]}",False
CAUSES_NO_CHANGE,38768,12096,2000.0,10656250,False,False,False,"However, expression of either of the Asp 2 mutants does not produce the increase in the secretion of sAPPb (Fig. 2b) seen for wild-type Asp 2. In contrast to this clear effect on sAPPb, Asp 2 has no effect on the secretion of soluble APPa or on full-length APP in the cell (data not shown).",#64:10,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2000-02-17"", ""ref"": ""10656250"", ""pub_year"": 2000, ""last_author"": ""Christie G"", ""type"": ""PubMed"", ""author_list"": [""Hussain I"", ""Powell D"", ""Howlett DR"", ""Tew DG"", ""Meek TD"", ""Chapman C"", ""Gloger IS"", ""Murphy KE"", ""Southan CD"", ""Ryan DM"", ""Smith TS"", ""Simmons DL"", ""Walsh FS"", ""Dingwall C"", ""Christie G""], ""title"": ""Identification of a novel aspartic protease (Asp 2) as beta-secretase.""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""COS Cells"", ""Cathepsin D"", ""Cell Line"", ""Cell Membrane"", ""Endopeptidases"", ""Female"", ""Hippocampus"", ""Humans"", ""Middle Aged"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Papain"", ""Recombinant Proteins"", ""Sequence Alignment"", ""Sequence Homology, Amino Acid"", ""Transfection""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Recombinant Proteins"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Papain"", ""Aspartic Acid Endopeptidases"", ""BACE2 protein, human"", ""BACE1 protein, human"", ""Cathepsin D""]}",False
CAUSES_NO_CHANGE,8165,11830,2017.0,27594586,False,False,False,The percentages of VGLUT1-positive excitatory and GABA-positive inhibitory neurons were similar in neuronal cultures differentiated from control and patient iPSCs (Figures S2B and S2C),#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,37505,37770,2017.0,28760828,False,False,False,"Whereas mutating Lys-321 to arginine to maintain the charge but prevent acetylation has no significant impact on filament formation compared with wild-type tau (Fig. 2 (a, c, and d–f) and supplemental Fig. S2 (a and b)), K321Q dramatically alters tau filament assembly and aggregation (Fig. 2 (a and b and d–f) and supplemental Fig. S2 (a and b)).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,34694,6912,2018.0,28528849,False,False,False,There was no significant change in the LDH release in oligomer-treated cells compared with controls indicating that TauRDΔK oligomers do not compromise the membrane integrity (Supplementary Fig. 5G-H).,#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""CellLine"": [""SH-SY5Y""], ""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,6947,3798,2019.0,30935091,False,False,False,"The antidepressant-like effects of 5-HT2A receptor antagonist ketanserin and the SSRI fluoxetine in rats were accompanied by increase in the membrane fraction of β-catenin and a parallel increase in N-cadherin, but without any change in levels of nuclear β-catenin [122].",#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""Species"": [""10116""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,1748,20982,2017.0,27209302,False,False,False,"As we expected, in contrast with wildtype TFEB (TFEB-WT), acetylation level of K116R mutant (TFEB-K116R) can no longer be elevated by NAM treatment (Fig. 3E).",#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,3518,1588,2020.0,30837838,False,False,False,"Several mutations in the RRMs are shown to disrupt the RNA binding capability while not significantly interfering with the RNA recognition (Lukavsky et al., 2013).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,35995,2190,2010.0,20203208,False,False,False,"The neuroprotective effect of Siglec-11 was dependent on polysialic acid (PSA) residues on neurons, but independent on PSA on microglia.",#57:0,PMC6634112,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2010-05-05"", ""ref"": ""20203208"", ""pub_year"": 2010, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Wang Y"", ""Neumann H""], ""title"": ""Alleviation of neurotoxicity by microglial human Siglec-11."", ""doi"": ""10.1523/JNEUROSCI.3940-09.2010""}","{""PublicationType"": [""Research""], ""Section"": [""Abstract""], ""mesh"": [""Adolescent"", ""Adult"", ""Alternative Splicing"", ""Animals"", ""Apoptosis"", ""Cell Communication"", ""Cells, Cultured"", ""Child"", ""Coculture Techniques"", ""Cytoprotection"", ""Encephalitis"", ""Female"", ""Genetic Vectors"", ""Gliosis"", ""Humans"", ""Inflammation Mediators"", ""Lectins"", ""Lipopolysaccharides"", ""Male"", ""Membrane Proteins"", ""Mice"", ""Mice, Inbred C57BL"", ""Microglia"", ""Nerve Degeneration"", ""Neural Cell Adhesion Molecule L1"", ""Neurons"", ""Phagocytosis"", ""Protein Isoforms"", ""RNA, Messenger"", ""Sialic Acids"", ""Transfection"", ""Young Adult""], ""substances"": [""Inflammation Mediators"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neural Cell Adhesion Molecule L1"", ""Protein Isoforms"", ""RNA, Messenger"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""polysialic acid"", ""polysialyl neural cell adhesion molecule""]}",False
CAUSES_NO_CHANGE,3562,18455,2015.0,25681350,False,False,False,"In contrast to astrocytes and U373 cells, we found that basal expression of YKL-40 and RelB mRNA was very high in primary human chondrocytes and not stimulated by IL-1 or OSM (Supplementary Fig 3).",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Cell"": [""chondrocyte""], ""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,1854,8664,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,2017,34536,2011.0,21482353,False,False,False,"At the level of whole brain, chronic nicotine causes selective upregulation of nAChRs among major brain regions. Upregulation occurs in cortex, midbrain, and hypothalamus, but not in thalamus or cerebellum (Pauly et al., 1991; Marks et al., 1992; Nguyen et al., 2003; Nashmi et al., 2007; Doura et al., 2008)",#70:39,PMC4418790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-06-07"", ""ref"": ""21482353"", ""pub_year"": 2011, ""last_author"": ""Lester HA"", ""type"": ""PubMed"", ""author_list"": [""Miwa JM"", ""Freedman R"", ""Lester HA""], ""title"": ""Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses."", ""doi"": ""10.1016/j.neuron.2011.03.014""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cerebellum"", ""Thalamus""], ""mesh"": [""Animals"", ""Cholinergic Fibers"", ""Humans"", ""Nervous System Diseases"", ""Neural Pathways"", ""Neurons"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,1854,4564,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,7260,13895,2009.0,18986241,False,False,False,"Single cell gene array studies have shown that synaptic transcripts are selectively downregulated in CBF neurons in AD, with significant reductions in synaptophysin and synaptotagmin but not synaptobrevin or SNAP29 mRNA [134,135]. Intriguingly, synaptotagmin function is related to vesicle-presynaptic membrane fusion and neurotransmitter release, suggesting that perturbations in presynaptic vesicle trafficking comprise a common event in vulnerable neuronal populations in AD. In contrast to synaptic transcripts, mRNAs encoding APP and Notch were unchanged between control and AD subjects, whereas acid hydrolase cathepsin D mRNA was upregulated in AD [134–136].",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,43028,21784,2007.0,17293005,False,False,False,These results suggest that BACE1 derived peptides do not directly inhibit BACE activities in vitro when the fluorogenic peptides are used as a substrate.,#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,11613,1870,2013.0,23484434,False,False,False,"Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",#58:53,,"{""full_journal_name"": ""Journal of medicinal chemistry"", ""pub_date"": ""2013-08-20"", ""ref"": ""23484434"", ""pub_year"": 2013, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Bulic B"", ""Pickhardt M"", ""Mandelkow E""], ""title"": ""Progress and developments in tau aggregation inhibitors for Alzheimer disease."", ""doi"": ""10.1021/jm3017317""}","{""ArticleCompoundNumber"": [""5""], ""Confidence"": [""High""], ""Figure"": [""4""], ""Page"": [""D""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Clinical Trials as Topic"", ""Humans"", ""Hydrogen Bonding"", ""Models, Molecular"", ""Protein Binding"", ""Protein Conformation"", ""Structure-Activity Relationship"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,41007,43310,2017.0,28148553,False,False,False,"None of the lentiviral models significantly increased PERK or pPERK, showing that tau overload per se is not sufficient to activate the UPR.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,14254,43744,2014.0,24760868,False,False,False,"We observed that synaptic activation promoted EGFP-Tau T205A translocation to the spine but FRAP experiments revealed a shorter tau turnover time in the spine (Fig. 9B), whereas Abetao driven translocation to the spine was no longer observable in EGFP-Tau S404A-transfected neurons (Fig. 9F,G). These experiments highlight the pivotal role of these phosphorylations in tau translocation features to the spine.",#62:16,PMC6608293,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2014-06-09"", ""ref"": ""24760868"", ""pub_year"": 2014, ""last_author"": ""Buisson A"", ""type"": ""PubMed"", ""author_list"": [""Frandemiche ML"", ""De Seranno S"", ""Rush T"", ""Borel E"", ""Elie A"", ""Arnal I"", ""Lant\u00e9 F"", ""Buisson A""], ""title"": ""Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers."", ""doi"": ""10.1523/JNEUROSCI.4261-13.2014""}","{""Confidence"": [""High""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Dendrites"", ""Mice"", ""Neurons"", ""Peptide Fragments"", ""Phosphorylation"", ""Protein Transport"", ""Synapses"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,23298,11238,2013.0,23356410,False,False,False,"In a Drosophila model of HD, the co-expression of human chaperones HSP70 and HSP40 acted synergistically to suppress the degenerative phenotype without changing the morphology of cell huntingtin aggregates.",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Huntington Disease""], ""Species"": [""7227""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,35177,43753,2015.0,25069841,False,False,False,"Western blot analysis of detergent soluble protein lysates using these antibodies as well as antibodies against total Tau and unphosphorylated Tau at the S202/ T205 sites (Tau1), allowed us to determine that TFEB had no effect on wild-type Tau proteins (Fig 1C and E, WT vs. WT + TFEB); it, however, drastically reduced the AT8-, PHF1- and MC1-positive Tau species in Tau transgenic mice (Fig 1C and F, Tau vs. Tau + TFEB).",#72:5,PMC4197862,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2015-05-22"", ""ref"": ""25069841"", ""pub_year"": 2015, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Polito VA"", ""Li H"", ""Martini-Stoica H"", ""Wang B"", ""Yang L"", ""Xu Y"", ""Swartzlander DB"", ""Palmieri M"", ""di Ronza A"", ""Lee VM"", ""Sardiello M"", ""Ballabio A"", ""Zheng H""], ""title"": ""Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB."", ""doi"": ""10.15252/emmm.201303671""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyloid Neuropathies""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Gene Expression Regulation"", ""Lysosomes"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""PTEN Phosphohydrolase"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Mapt protein, mouse"", ""Tcfeb protein, mouse"", ""tau Proteins"", ""PTEN Phosphohydrolase"", ""Pten protein, mouse""]}",False
CAUSES_NO_CHANGE,7085,1952,2016.0,23393546,False,False,False,"Addition of pizotifen, cyproheptadine, or loxapine to the ST Hdh Q7/Q7 cells after serum withdrawal had no effect on ATP levels, indicating that the drugs do not have a general effect on viability but rather correct a deficit specific to the ST Hdh Q111/Q111 cells (Figure 2 A ).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,6630,14838,2011.0,21745645,False,False,False,"When cholinergic input was activated 10 ms after SC stimulation, LTP was induced, which was blocked by atropine but not by MLA or DHβE(Figures 5K and 5L).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""after SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,29150,1625,2020.0,30837838,False,False,False,"Several of these interactions were unperturbed by the ALS-linked mutations, A315T and M337V (Freibaum et al., 2010; Kim et al., 2010).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""]}",False
CAUSES_NO_CHANGE,1845,43887,2006.0,16511867,False,False,False,"Cerebrolysin is a peptide mixture with neurotrophic effects that might reduce the neurodegenerative pathology in Alzheimer's disease (AD). Cerebrolysin might reduce amyloid deposition by regulating amyloid- beta (Abeta) degradation or by modulating APP expression, maturation, or processing. To investigate these possibilities, APP tg mice were treated for 6 months with Cerebrolysin and analyzed in the water maze, followed by RNA, immunoblot, and confocal microscopy analysis of full- length (FL) APP and its fragments, beta-secretase (BACE1), and Abeta- degrading enzymes [neprilysin (Nep) and insulin-degrading enzyme (IDE)]. Consistent with previous studies, Cerebrolysin ameliorated the performance deficits in the spatial learning portion of the water maze and reduced the synaptic pathology and amyloid burden in the brains of APP tg mice. These effects were associated with reduced levels of FL APP and APP C-terminal fragments, but levels of BACE1, Notch1, Nep, and IDE were unchanged. In contrast, levels of active cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3beta [GSK-3beta; but not stress-activated protein kinase-1 (SAPK1)], kinases that phosphorylate APP, were reduced. Furthermore, Cerebrolysin reduced the levels of phosphorylated APP and the accumulation of APP in the neuritic processes. Taken together, these results suggest that Cerebrolysin might reduce AD-like pathology in the APP tg mice by regulating APP maturation and transport to sites where Abeta protein is generated.",#59:5,,"{""full_journal_name"": ""Journal of neuroscience research"", ""pub_date"": ""2006-07-25"", ""ref"": ""16511867"", ""pub_year"": 2006, ""last_author"": ""Masliah E"", ""type"": ""PubMed"", ""author_list"": [""Rockenstein E"", ""Torrance M"", ""Mante M"", ""Adame A"", ""Paulino A"", ""Rose JB"", ""Crews L"", ""Moessler H"", ""Masliah E""], ""title"": ""Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.""}","{""Species"": [""10090""], ""Subgraph"": [""Nerve growth factor subgraph"", ""Notch signaling subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amino Acids"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""Cyclin-Dependent Kinase 5"", ""Disease Models, Animal"", ""Down-Regulation"", ""Endopeptidases"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Insulysin"", ""Maze Learning"", ""Mice"", ""Mice, Transgenic"", ""Neprilysin"", ""Neurons"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Protein Transport"", ""RNA, Messenger""], ""substances"": [""Amino Acids"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Neuroprotective Agents"", ""RNA, Messenger"", ""cerebrolysin"", ""Cyclin-Dependent Kinase 5"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Neprilysin"", ""Insulysin""]}",False
CAUSES_NO_CHANGE,2017,7765,2009.0,19126755,False,False,False,"First, age-related nAChR subunit expression decline was observed in both strains, and this was dominated by diminished alpha4 nAChR expression. Second, long-term (12 mo) oral nicotine failed to reduce the age-related decline in the number of neurons expressing alpha4 nAChR subunits, although the neurons that remained exhibited larger processes with more varicosities than age-matched controls (165, 396). Acute nicotine treatment (alpha6 wk of oral nicotine) of aged mice had no measurable influence on nAChR expression, neuronal viability, or dendritic complexity (e.g., Ref. 396)",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,41520,12459,2019.0,30008470,False,False,False,"As shown in Fig. 3e, f, we found no difference between genotypes in saccharin or quinine intake, suggesting that the effect of Adnp deficiency is specific to alcohol, and does not apply to sweet reinforcers or bitter-taste solutions",#65:46,PMC6300527,"{""full_journal_name"": ""Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"", ""pub_date"": ""2019-02-11"", ""ref"": ""30008470"", ""pub_year"": 2019, ""last_author"": ""Barak S"", ""type"": ""PubMed"", ""author_list"": [""Ziv Y"", ""Rahamim N"", ""Lezmy N"", ""Even-Chen O"", ""Shaham O"", ""Malishkevich A"", ""Giladi E"", ""Elkon R"", ""Gozes I"", ""Barak S""], ""title"": ""Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice."", ""doi"": ""10.1038/s41386-018-0132-7""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alcohol Drinking"", ""Animals"", ""Disease Models, Animal"", ""Ethanol"", ""Female"", ""Gene Expression"", ""Haploinsufficiency"", ""Hippocampus"", ""Homeodomain Proteins"", ""Male"", ""Mice"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Sex Factors""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Ethanol""]}",False
CAUSES_NO_CHANGE,14403,2361,2011.0,21745645,False,False,False,"The LTP induced by pairing the SC 10 ms before the SO was blocked by atropine, but not by MLA or DHbE.",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""after SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,4698,42766,2000.0,10887109,False,False,False,"Even though each of the mutant receptors was expressed in 293T cells as detected by flow cytometry (data not shown) and immunoblotting of parallel samples with anti-CD33, we detected significant tyrosine phosphorylation only of wild-type CD33 and CD33 Y358F (Figure 2B, lanes 2 and 4).",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,6709,37359,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,1650,1265,2009.0,19293145,False,False,False,"APP and APP/presenilin-1 (PS-1) mice do not show neurodegeneration (Irizarry et al., 1997) and yet show several features of AD, including accumulation of plaques and defects in learning (Hsiao et al., 1996), suggesting that many features of AD are not the result of neuronal loss. These animals nonetheless have swollen cholinergic nerve terminals at 12 months, suggesting defective nerve sprouting (Hernandez et al., 2001).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,1411,35858,2016.0,27013968,False,False,False,"In control conditions total Erk1/2 and phospho-Erk1/2 levels were similar in WT and R6/2 cultures (Figures 4A,C). Acute exposure to BDNF increased phospho-Erk1/2 levels over control conditions in both WT and R6/2 cultures (Figures 4A,E).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,11577,4941,2016.0,26458742,False,False,False,There was no difference in cell viability between tau-aggregate positive and negative cells for up to 4 days (Supplementary Fig. 10).,#58:63,PMC4608380,"{""full_journal_name"": ""Nature communications"", ""pub_date"": ""2016-05-20"", ""ref"": ""26458742"", ""pub_year"": 2016, ""last_author"": ""Hyman BT"", ""type"": ""PubMed"", ""author_list"": [""Takeda S"", ""Wegmann S"", ""Cho H"", ""DeVos SL"", ""Commins C"", ""Roe AD"", ""Nicholls SB"", ""Carlson GA"", ""Pitstick R"", ""Nobuhara CK"", ""Costantino I"", ""Frosch MP"", ""M\u00fcller DJ"", ""Irimia D"", ""Hyman BT""], ""title"": ""Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain."", ""doi"": ""10.1038/ncomms9490""}","{""Confidence"": [""Medium""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Brain"", ""Cell Survival"", ""Female"", ""HEK293 Cells"", ""Humans"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Microfluidic Analytical Techniques"", ""Neurons"", ""Phosphorylation"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,11773,1287,2017.0,27956442,False,False,False,"There are a large number of phase III trials using agents such azathioprine, ciclosporin, β-interferon, dirucotide (myelin basic protein), immunoglobulins and cladribine, as well as other immunomodulators, in progressive MS that have been reported over the last 25 years. Unfortunately, the results have essentially been negative. [10]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,1650,28824,2020.0,30686764,False,False,False,Efavirenz increased 24-hydroxycholesterol secretion from APP-dp and APP-null neurons in a dose-dependent manner that correlated well with its effect on pThr231Tau/tTau in these neurons (Figures 6D and S6D).,#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Astrocytes""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,25465,2211,2017.0,27574109,False,False,False,"hT40, hT34, hT24, hT37 and hT23 aggregates did not significantly impair retrograde FAT when compared to the respective monomers, but hT39 aggregates elicited a mild inhibitory effect on retrograde FAT (Fig. 4B)",#70:49,PMC5075521,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-10-17"", ""ref"": ""27574109"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Cox K"", ""Combs B"", ""Abdelmesih B"", ""Morfini G"", ""Brady ST"", ""Kanaan NM""], ""title"": ""Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition."", ""doi"": ""10.1016/j.neurobiolaging.2016.07.015""}","{""mesh"": [""Alzheimer Disease"", ""Animals"", ""Axonal Transport"", ""Decapodiformes"", ""Humans"", ""In Vitro Techniques"", ""Polymerization"", ""Protein Aggregates"", ""Protein Domains"", ""Protein Isoforms"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Protein Aggregates"", ""Protein Isoforms"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11660,5073,2019.0,30270813,False,False,False,"However, treatment with ACY-1215 in the same schedule that reversed peripheral neuropathy did not restore cognitive function (Fig. 1c) (two-way ANOVA, F (1, 20) = 0.3809, p = 0.54).",#63:68,PMC6166273,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2019-06-06"", ""ref"": ""30270813"", ""pub_year"": 2019, ""last_author"": ""Heijnen CJ"", ""type"": ""PubMed"", ""author_list"": [""Ma J"", ""Huo X"", ""Jarpe MB"", ""Kavelaars A"", ""Heijnen CJ""], ""title"": ""Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment."", ""doi"": ""10.1186/s40478-018-0604-3""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antineoplastic Agents"", ""Cisplatin"", ""Cognitive Dysfunction"", ""Disease Models, Animal"", ""Disks Large Homolog 4 Protein"", ""Dose-Response Relationship, Drug"", ""Enzyme Inhibitors"", ""Green Fluorescent Proteins"", ""Histone Deacetylase 6"", ""Hydroxamic Acids"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Microscopy, Electron, Transmission"", ""Mitochondria"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Synaptosomes"", ""Tauopathies"", ""Time Factors"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Antineoplastic Agents"", ""Disks Large Homolog 4 Protein"", ""Enzyme Inhibitors"", ""Hydroxamic Acids"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Tubulin"", ""synaptopHIuorin"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Cisplatin"", ""ricolinostat""]}",False
CAUSES_NO_CHANGE,39190,11034,2017.0,27209302,False,False,False,"Furthermore, SIRT6 and SIRT7 could not reduce acetylation levels on TFEB as compared with SIRT1 (Fig. S3D), excluding the possibility that SIRT6 or SIRT7 might involve in deacetylation of TFEB in the nucleus.",#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,1648,1870,2013.0,23484434,False,False,False,"Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",#58:53,,"{""full_journal_name"": ""Journal of medicinal chemistry"", ""pub_date"": ""2013-08-20"", ""ref"": ""23484434"", ""pub_year"": 2013, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Bulic B"", ""Pickhardt M"", ""Mandelkow E""], ""title"": ""Progress and developments in tau aggregation inhibitors for Alzheimer disease."", ""doi"": ""10.1021/jm3017317""}","{""ArticleCompoundNumber"": [""4""], ""Confidence"": [""High""], ""Figure"": [""4""], ""Page"": [""D""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Clinical Trials as Topic"", ""Humans"", ""Hydrogen Bonding"", ""Models, Molecular"", ""Protein Binding"", ""Protein Conformation"", ""Structure-Activity Relationship"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,43028,1650,2007.0,17293005,False,False,False,"Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,37138,39422,2018.0,29202785,False,False,False,"Surprisingly, there was an ~80% increase in the endogenous mouse Tau level in slices obtained from pups expressing anti-aggregant TauRDΔKPP (Fig. 5b lane 2 and 5c bar 2), compared with age matched non- transgenic controls and pro-aggregant TauRDΔK (Fig. 5b lane 1 and 3; and 5c lane 1 and 3)",#59:39,PMC5715613,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2018-10-18"", ""ref"": ""29202785"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Joseph M"", ""Anglada-Huguet M"", ""Paesler K"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Anti-aggregant tau mutant promotes neurogenesis."", ""doi"": ""10.1186/s13024-017-0230-8""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Astrocytes"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutant Proteins"", ""Neural Stem Cells"", ""Neurogenesis"", ""Proline"", ""Protein Aggregation, Pathological"", ""Protein Conformation"", ""Protein Conformation, beta-Strand"", ""Protein Domains"", ""Repetitive Sequences, Amino Acid"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mutant Proteins"", ""tau Proteins"", ""Proline""]}",False
CAUSES_NO_CHANGE,11664,12012,2019.0,30270813,False,False,False,"Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",#63:68,PMC6166273,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2019-06-06"", ""ref"": ""30270813"", ""pub_year"": 2019, ""last_author"": ""Heijnen CJ"", ""type"": ""PubMed"", ""author_list"": [""Ma J"", ""Huo X"", ""Jarpe MB"", ""Kavelaars A"", ""Heijnen CJ""], ""title"": ""Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment."", ""doi"": ""10.1186/s40478-018-0604-3""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antineoplastic Agents"", ""Cisplatin"", ""Cognitive Dysfunction"", ""Disease Models, Animal"", ""Disks Large Homolog 4 Protein"", ""Dose-Response Relationship, Drug"", ""Enzyme Inhibitors"", ""Green Fluorescent Proteins"", ""Histone Deacetylase 6"", ""Hydroxamic Acids"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Microscopy, Electron, Transmission"", ""Mitochondria"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Synaptosomes"", ""Tauopathies"", ""Time Factors"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Antineoplastic Agents"", ""Disks Large Homolog 4 Protein"", ""Enzyme Inhibitors"", ""Hydroxamic Acids"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Tubulin"", ""synaptopHIuorin"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Cisplatin"", ""ricolinostat""]}",False
CAUSES_NO_CHANGE,7038,43190,2019.0,30935091,False,False,False,"Class I specific HDACi MS-275 and BG-45 did not increase Ac-K49-beta -catenin, but treatment with HDAC6i ACY- resulted in marked increase in Ac-K49-beta -catenin.",#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,3772,2211,2017.0,27574109,False,False,False,"hT40, hT34, hT24, hT37 and hT23 aggregates did not significantly impair retrograde FAT when compared to the respective monomers, but hT39 aggregates elicited a mild inhibitory effect on retrograde FAT (Fig. 4B)",#70:49,PMC5075521,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-10-17"", ""ref"": ""27574109"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Cox K"", ""Combs B"", ""Abdelmesih B"", ""Morfini G"", ""Brady ST"", ""Kanaan NM""], ""title"": ""Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition."", ""doi"": ""10.1016/j.neurobiolaging.2016.07.015""}","{""mesh"": [""Alzheimer Disease"", ""Animals"", ""Axonal Transport"", ""Decapodiformes"", ""Humans"", ""In Vitro Techniques"", ""Polymerization"", ""Protein Aggregates"", ""Protein Domains"", ""Protein Isoforms"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Protein Aggregates"", ""Protein Isoforms"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,1411,38804,2016.0,27013968,False,False,False,Our assays on presymptomatic R6/2 mice indicated that striatal morphology and protein levels of BDNF and fl-TrkB are normal but levels of activated phospho-TrkB are reduced compared to WT mice.,#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,41118,16835,2011.0,21367866,False,False,False,Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged,#62:7,PMC3089541,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2011-07-12"", ""ref"": ""21367866"", ""pub_year"": 2011, ""last_author"": ""Dickey CA"", ""type"": ""PubMed"", ""author_list"": [""Jinwal UK"", ""Trotter JH"", ""Abisambra JF"", ""Koren J"", ""Lawson LY"", ""Vestal GD"", ""O'Leary JC"", ""Johnson AG"", ""Jin Y"", ""Jones JR"", ""Li Q"", ""Weeber EJ"", ""Dickey CA""], ""title"": ""The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics."", ""doi"": ""10.1074/jbc.M110.182493""}","{""Confidence"": [""Medium""], ""Method"": [""Immunocytochemistry"", ""RNA Interference, siRNA"", ""Western Blot""], ""mesh"": [""Alzheimer Disease"", ""Brain"", ""Cell Cycle Proteins"", ""Cell Line, Tumor"", ""Chaperonins"", ""HSP90 Heat-Shock Proteins"", ""HeLa Cells"", ""Humans"", ""Immunohistochemistry"", ""Molecular Chaperones"", ""Neurons"", ""Phosphorylation"", ""RNA, Small Interfering"", ""Transfection"", ""tau Proteins""], ""substances"": [""CDC37 protein, human"", ""Cell Cycle Proteins"", ""HSP90 Heat-Shock Proteins"", ""Molecular Chaperones"", ""RNA, Small Interfering"", ""tau Proteins"", ""Chaperonins""]}",False
CAUSES_NO_CHANGE,14219,2068,2018.0,29807032,False,False,False,"The greatest heat shock-induced mortality occurred during the first 1 h of recovery and plateaued after 5 h recovery (main effect of time P<0.001; n=3; Fig. 3B), but the presence of antalarmin did not influence this response.",#64:39,,"{""full_journal_name"": ""General and comparative endocrinology"", ""pub_date"": ""2018-09-10"", ""ref"": ""29807032"", ""pub_year"": 2018, ""last_author"": ""Bernier NJ"", ""type"": ""PubMed"", ""author_list"": [""Alderman SL"", ""Leishman EM"", ""Fuzzen MLM"", ""Bernier NJ""], ""title"": ""Corticotropin-releasing factor regulates caspase-3 and may protect developing zebrafish from stress-induced apoptosis."", ""doi"": ""10.1016/j.ygcen.2018.05.025""}","{""CellLine"": [""embryonic cell line""], ""Confidence"": [""High""], ""Species"": [""7955""], ""mesh"": [""Animals"", ""Apoptosis"", ""Caspase 3"", ""Corticotropin-Releasing Hormone"", ""Gene Expression Regulation, Developmental"", ""Heat-Shock Response"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""Stress, Physiological"", ""Zebrafish""], ""substances"": [""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""CRF receptor type 1"", ""Corticotropin-Releasing Hormone"", ""Caspase 3""]}",False
CAUSES_NO_CHANGE,7260,3262,2001.0,11230871,False,False,False,"Examination of the regional expression of mRNA of the nAChR alpha4 and alpha3 subunits has shown no difference in autopsy AD brain tissue in any region analyzed (Hellstro ¨m-Lindahl et al 1999; Terzano et al 1998), whereas the level of the alpha7 mRNA was significantly higher in the hippocampus (Hellstro¨m-Lindahl et al 1999)",#65:45,,"{""full_journal_name"": ""Biological psychiatry"", ""pub_date"": ""2001-06-07"", ""ref"": ""11230871"", ""pub_year"": 2001, ""last_author"": ""Nordberg A"", ""type"": ""PubMed"", ""author_list"": [""Nordberg A""], ""title"": ""Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Hippocampus""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Brain"", ""Cholinergic Agents"", ""Humans"", ""Receptors, Nicotinic"", ""Treatment Outcome""], ""substances"": [""Cholinergic Agents"", ""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,15684,35112,2017.0,28148553,False,False,False,"When overexpressing 4R tau in neurons, PERK activator treatment still increased pNRF2, but not pEIF2A (Fig EV2F and G), while PERK inhibitor treatment decreased pEIF2A but not pNRF2.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,24268,7519,2014.0,24027553,False,False,False,"Soluble, monomeric tau is an ideal proteasomal substrate. Indeed, it has been clearly demonstrated that tau can be degraded by the proteasome (65–67, 73). It thus can be suggested that under physiologic circumstances much of tau is degraded in this manner, with select modified forms being cleared by autophagy.However, within the context of the AD milieu, additional tau modifications and degradative impairments may cause the balance to shift away from proteasomal degradation toward autophagy.",#57:4,PMC3759803,"{""full_journal_name"": ""Frontiers in neurology"", ""pub_date"": ""2014-06-24"", ""ref"": ""24027553"", ""pub_year"": 2014, ""last_author"": ""Johnson GV"", ""type"": ""PubMed"", ""author_list"": [""Chesser AS"", ""Pritchard SM"", ""Johnson GV""], ""title"": ""Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease."", ""doi"": ""10.3389/fneur.2013.00122""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""TextLocation"": [""Review""]}",False
CAUSES_NO_CHANGE,1845,39315,2006.0,16511867,False,False,False,"Cerebrolysin is a peptide mixture with neurotrophic effects that might reduce the neurodegenerative pathology in Alzheimer's disease (AD). Cerebrolysin might reduce amyloid deposition by regulating amyloid- beta (Abeta) degradation or by modulating APP expression, maturation, or processing. To investigate these possibilities, APP tg mice were treated for 6 months with Cerebrolysin and analyzed in the water maze, followed by RNA, immunoblot, and confocal microscopy analysis of full- length (FL) APP and its fragments, beta-secretase (BACE1), and Abeta- degrading enzymes [neprilysin (Nep) and insulin-degrading enzyme (IDE)]. Consistent with previous studies, Cerebrolysin ameliorated the performance deficits in the spatial learning portion of the water maze and reduced the synaptic pathology and amyloid burden in the brains of APP tg mice. These effects were associated with reduced levels of FL APP and APP C-terminal fragments, but levels of BACE1, Notch1, Nep, and IDE were unchanged. In contrast, levels of active cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3beta [GSK-3beta; but not stress-activated protein kinase-1 (SAPK1)], kinases that phosphorylate APP, were reduced. Furthermore, Cerebrolysin reduced the levels of phosphorylated APP and the accumulation of APP in the neuritic processes. Taken together, these results suggest that Cerebrolysin might reduce AD-like pathology in the APP tg mice by regulating APP maturation and transport to sites where Abeta protein is generated.",#59:5,,"{""full_journal_name"": ""Journal of neuroscience research"", ""pub_date"": ""2006-07-25"", ""ref"": ""16511867"", ""pub_year"": 2006, ""last_author"": ""Masliah E"", ""type"": ""PubMed"", ""author_list"": [""Rockenstein E"", ""Torrance M"", ""Mante M"", ""Adame A"", ""Paulino A"", ""Rose JB"", ""Crews L"", ""Moessler H"", ""Masliah E""], ""title"": ""Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.""}","{""Species"": [""10090""], ""Subgraph"": [""Beta secretase subgraph"", ""Nerve growth factor subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amino Acids"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""Cyclin-Dependent Kinase 5"", ""Disease Models, Animal"", ""Down-Regulation"", ""Endopeptidases"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Insulysin"", ""Maze Learning"", ""Mice"", ""Mice, Transgenic"", ""Neprilysin"", ""Neurons"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Protein Transport"", ""RNA, Messenger""], ""substances"": [""Amino Acids"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Neuroprotective Agents"", ""RNA, Messenger"", ""cerebrolysin"", ""Cyclin-Dependent Kinase 5"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Neprilysin"", ""Insulysin""]}",False
CAUSES_NO_CHANGE,35124,21246,2019.0,30562574,False,False,False,"Indeed, DIV0 LAMP2A downregulation evoked a significant, 38±13% reduction of MAP2 protein levels (Fig. 4E) which coincided with a significant reduction of CRMP-2 protein levels (32±14%), comparable to what we had already seen in mature cultures. No change in TUJ-1 abundance was detected (Fig. 4F), suggesting that there was a specific effect on dendritic, and not axonal, projections.",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,6894,25138,2019.0,30106381,False,False,False,"Importantly, in males, NAP treatment did not affect PSD95 shaft synapse density in either tested region (Supplemental Figures 3 and 4, insets).",#63:5,PMC6205398,"{""full_journal_name"": ""The Journal of clinical investigation"", ""pub_date"": ""2019-09-11"", ""ref"": ""30106381"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Hacohen-Kleiman G"", ""Sragovich S"", ""Karmon G"", ""Gao AYL"", ""Grigg I"", ""Pasmanik-Chor M"", ""Le A"", ""Korenkov\u00e1 V"", ""McKinney RA"", ""Gozes I""], ""title"": ""Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome."", ""doi"": ""10.1172/JCI98199""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Autistic Disorder"", ""Behavior, Animal"", ""Biomarkers"", ""Cell Membrane"", ""Dendritic Spines"", ""Gene Expression Regulation"", ""Homeodomain Proteins"", ""Humans"", ""Mice"", ""Mice, Knockout"", ""Microtubules"", ""Models, Neurological"", ""Mutation"", ""Naphthoquinones"", ""Nerve Tissue Proteins"", ""Synapses"", ""Syndrome""], ""substances"": [""2-(3,5-di-tert-butyl-4-hydroxyl)-3-chloro-1,4-naphthoquinone"", ""Adnp protein, mouse"", ""Biomarkers"", ""Homeodomain Proteins"", ""Naphthoquinones"", ""Nerve Tissue Proteins""]}",False
CAUSES_NO_CHANGE,1193,1491,2017.0,27794524,False,False,False,"Notably, follicle- like structures are probably able to sustain a high level of humoral response, as well as other autoimmune mechanisms within the CNS, in a manner independent of peripheral inflammation.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""central nervous system""], ""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,14406,12153,2012.0,21958873,False,False,False,We then tested the impact of anatabine on sAPPα and sAPPβ production using 7W CHO cells and observed that anatabine inhibits sAPPβ secretion without impacting sAPPα suggesting that anatabine is preventing the β-cleavage of APP (Fig. 4).,#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,7981,25530,2016.0,26702100,False,False,False,"TDP-43-depleted cells showed a decrease of raptor, but not mTOR, p18, and RagB, compared with control cells (Fig 2B)",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,38234,21289,2017.0,28760828,False,False,False,"Of note, whereas mimicking acetylation at most non-KXGS sites had minimal impact on tau aggregation, K274Q also significantly decreased tau assembly in vitro, albeit to a lesser extent than K321Q (Fig. 1b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,6901,8384,2012.0,22419736,False,False,False,"Among AK isoforms, AK2 was not detected in the primary neurons and HT22 cells, whereas AK3 expression was observed in the neurons but not regulated by Ab42",#72:19,,"{""full_journal_name"": ""Human molecular genetics"", ""pub_date"": ""2012-10-09"", ""ref"": ""22419736"", ""pub_year"": 2012, ""last_author"": ""Jung YK"", ""type"": ""PubMed"", ""author_list"": [""Park H"", ""Kam TI"", ""Kim Y"", ""Choi H"", ""Gwon Y"", ""Kim C"", ""Koh JY"", ""Jung YK""], ""title"": ""Neuropathogenic role of adenylate kinase-1 in A\u03b2-mediated tau phosphorylation via AMPK and GSK3\u03b2."", ""doi"": ""10.1093/hmg/dds100""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Neurons""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Genetically Modified"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Drosophila"", ""Drosophila Proteins"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Green Fluorescent Proteins"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microscopy, Fluorescence"", ""Neurodegenerative Diseases"", ""Neurons"", ""Peptide Fragments"", ""Phosphorylation"", ""RNA Interference"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Drosophila Proteins"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""adenylate kinase 1""]}",False
CAUSES_NO_CHANGE,41708,2342,2012.0,22372633,False,False,False,Genetic ablation of HDAC6 leads to hyperacetylation of microtubules and HSP90 without any obvious abnormal effects on development and survival of these mice (33).,#57:37,,"{""full_journal_name"": ""Traffic (Copenhagen, Denmark)"", ""pub_date"": ""2012-10-04"", ""ref"": ""22372633"", ""pub_year"": 2012, ""last_author"": ""Van Den Bosch L"", ""type"": ""PubMed"", ""author_list"": [""d'Ydewalle C"", ""Bogaert E"", ""Van Den Bosch L""], ""title"": ""HDAC6 at the Intersection of Neuroprotection and Neurodegeneration."", ""doi"": ""10.1111/j.1600-0854.2012.01347.x""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Autophagy"", ""Cytoskeleton"", ""Gene Expression Regulation, Enzymologic"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Humans"", ""Microtubules"", ""Models, Biological"", ""Models, Genetic"", ""Neurodegenerative Diseases"", ""Neuroprotective Agents"", ""Protein Binding"", ""Protein Conformation"", ""Ubiquitin""], ""substances"": [""Neuroprotective Agents"", ""Ubiquitin"", ""HDAC6 protein, human"", ""Histone Deacetylase 6"", ""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,40615,7522,2020.0,30985105,False,False,False,"Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",#70:0,,"{""full_journal_name"": ""ACS chemical neuroscience"", ""pub_date"": ""2020-05-21"", ""ref"": ""30985105"", ""pub_year"": 2020, ""last_author"": ""Rudrawar S"", ""type"": ""PubMed"", ""author_list"": [""Ryan P"", ""Xu M"", ""Davey AK"", ""Danon JJ"", ""Mellick GD"", ""Kassiou M"", ""Rudrawar S""], ""title"": ""O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease."", ""doi"": ""10.1021/acschemneuro.9b00143""}","{""Confidence"": [""High""], ""mesh"": [""Acetylglucosamine"", ""Animals"", ""Brain"", ""Humans"", ""Neurodegenerative Diseases"", ""Protein Aggregation, Pathological"", ""Protein Folding"", ""Protein Processing, Post-Translational""], ""substances"": [""Acetylglucosamine""]}",False
CAUSES_NO_CHANGE,1152,1471,2020.0,30988501,False,False,False,"Another example of the intricate relationship between cognition and chronic infection is HIV-associated neurocognitive disorder, which emerges in patients with HIV infection despite highly active antiretroviral therapy 51.",#59:65,,"{""full_journal_name"": ""Nature reviews. Neurology"", ""pub_date"": ""2020-01-27"", ""ref"": ""30988501"", ""pub_year"": 2020, ""last_author"": ""Zipp F"", ""type"": ""PubMed"", ""author_list"": [""Pape K"", ""Tamouza R"", ""Leboyer M"", ""Zipp F""], ""title"": ""Immunoneuropsychiatry - novel perspectives on brain disorders."", ""doi"": ""10.1038/s41582-019-0174-4""}","{""Confidence"": [""High""], ""MeSHDisease"": [""HIV Infections""], ""mesh"": [""Animals"", ""Brain"", ""Brain Diseases"", ""Encephalitis"", ""Humans"", ""Inflammation"", ""Mental Disorders"", ""Neurology""]}",False
CAUSES_NO_CHANGE,6846,2666,2010.0,20392114,False,False,False,"Finally,to evaluate possible major toxicities associated with the ATPZs, all test compounds were evaluated in a cytotoxicity assay that employs rapidly dividing HEK293. All compounds were found to be nontoxic at 100 microM.",#61:0,PMC2872922,"{""full_journal_name"": ""Journal of medicinal chemistry"", ""pub_date"": ""2010-06-11"", ""ref"": ""20392114"", ""pub_year"": 2010, ""last_author"": ""Smith AB"", ""type"": ""PubMed"", ""author_list"": [""Ballatore C"", ""Brunden KR"", ""Piscitelli F"", ""James MJ"", ""Crowe A"", ""Yao Y"", ""Hyde E"", ""Trojanowski JQ"", ""Lee VM"", ""Smith AB""], ""title"": ""Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation."", ""doi"": ""10.1021/jm100138f""}","{""Assay"": [""cytotoxicity assay""], ""CellLine"": [""HEK293""], ""TextLocation"": [""Results""], ""mesh"": [""Administration, Oral"", ""Animals"", ""Biological Availability"", ""Blood-Brain Barrier"", ""Drug Discovery"", ""Mice"", ""Protein Multimerization"", ""Pyridazines"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Pyridazines"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,1380,3356,2019.0,30962309,False,False,False,"The three miRNAs miR-223 (100), miR-155-5p (101), and miR-146a (102) are upregulated in synovial tissue from RA patients compared with osteoarthritis synovium, and two of them, miR-155-5p and miR-146a-5p, are elevated in PBMCs of RA patients (103, 104).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Cell"": [""synovial cell""], ""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
CAUSES_NO_CHANGE,6709,39893,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,42746,1265,2009.0,19293145,False,False,False,"APP and APP/presenilin-1 (PS-1) mice do not show neurodegeneration (Irizarry et al., 1997) and yet show several features of AD, including accumulation of plaques and defects in learning (Hsiao et al., 1996), suggesting that many features of AD are not the result of neuronal loss. These animals nonetheless have swollen cholinergic nerve terminals at 12 months, suggesting defective nerve sprouting (Hernandez et al., 2001).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,1854,8512,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,11999,11938,2015.0,26088141,False,False,False,"SP pretreatment did not significantly alter calcium peaks in α7345–348A nAChR expressing cells, showing a small (−31.24%) reduction in calcium responses relative to the α7345–348A baseline measure (p > 0.05).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,14265,12198,2020.0,30686764,False,False,False,"More importantly, atorvastatin treatment (Figure 4E) did not affect Ab42 secretion in these neurons indicating that the effect of lowering CE on Ab42 is mediated by the cholesterol-binding domain in APP.",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,1491,7106,2017.0,27794524,False,False,False,"In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""cortex""], ""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,4191,6741,2014.0,23727081,False,False,False,"Although we observed no association between rs3785883 or rs1868402 alone and change in CDR-sb (P > .10), there was a significant association between a combined genotype model and change in CDR-sb: carriers of the high-risk genotypes at both loci progressed >2.9 times faster than noncarriers (P = .015).",#67:28,PMC3809344,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2014-12-10"", ""ref"": ""23727081"", ""pub_year"": 2014, ""last_author"": ""Kauwe JS"", ""type"": ""PubMed"", ""author_list"": [""Peterson D"", ""Munger C"", ""Crowley J"", ""Corcoran C"", ""Cruchaga C"", ""Goate AM"", ""Norton MC"", ""Green RC"", ""Munger RG"", ""Breitner JC"", ""Welsh-Bohmer KA"", ""Lyketsos C"", ""Tschanz J"", ""Kauwe JS""], ""title"": ""Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study."", ""doi"": ""10.1016/j.jalz.2013.02.010""}","{""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Calcineurin"", ""Disease Progression"", ""Female"", ""Follow-Up Studies"", ""Genetic Predisposition to Disease"", ""Genotyping Techniques"", ""Heterozygote"", ""Humans"", ""Linear Models"", ""Male"", ""Models, Genetic"", ""Polymorphism, Single Nucleotide"", ""Risk"", ""Severity of Illness Index"", ""Time Factors"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Calcineurin"", ""PPP3R1 protein, human""]}",False
CAUSES_NO_CHANGE,39699,1513,2018.0,29202785,False,False,False,"The antiaggregant TauRDΔKPP slices had ramified form of microglia with 6-7 branches on an average indicating that the microglial cells were in their normal physiologically active form and there is no sign of inflammation (Fig 3d, bars 1 and 2).",#59:39,PMC5715613,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2018-10-18"", ""ref"": ""29202785"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Joseph M"", ""Anglada-Huguet M"", ""Paesler K"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Anti-aggregant tau mutant promotes neurogenesis."", ""doi"": ""10.1186/s13024-017-0230-8""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Astrocytes"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutant Proteins"", ""Neural Stem Cells"", ""Neurogenesis"", ""Proline"", ""Protein Aggregation, Pathological"", ""Protein Conformation"", ""Protein Conformation, beta-Strand"", ""Protein Domains"", ""Repetitive Sequences, Amino Acid"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mutant Proteins"", ""tau Proteins"", ""Proline""]}",False
CAUSES_NO_CHANGE,6782,966,2013.0,23356410,False,False,False,Treatment with tubacin or HDAC6 knockdown in vivo did not impair the interaction between HDAC6 and tau but was able to decrease tau phosphorylation [32].,#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,43753,16892,2011.0,21339331,False,False,False,"The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",#62:7,PMC3044115,"{""full_journal_name"": ""The Journal of cell biology"", ""pub_date"": ""2011-04-25"", ""ref"": ""21339331"", ""pub_year"": 2011, ""last_author"": ""Brandt R"", ""type"": ""PubMed"", ""author_list"": [""Gauthier-Kemper A"", ""Weissmann C"", ""Golovyashkina N"", ""Seb\u00f6-Lemke Z"", ""Drewes G"", ""Gerke V"", ""Heinisch JJ"", ""Brandt R""], ""title"": ""The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner."", ""doi"": ""10.1083/jcb.201007161""}","{""Confidence"": [""Medium""], ""Method"": [""Confocal Microscopy, Laser Scanning"", ""Immunocytochemistry"", ""Mass Spectrometry"", ""Pull-down Assay, GFP"", ""RNA Interference, shRNA"", ""Tandem Affinity Purification, TAP""], ""mesh"": [""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Animals"", ""Annexin A2"", ""Binding Sites"", ""Cell Membrane"", ""Humans"", ""Microtubules"", ""Molecular Sequence Data"", ""Neurites"", ""PC12 Cells"", ""Phosphorylation"", ""Rats"", ""tau Proteins""], ""substances"": [""Annexin A2"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,42894,1534,2012.0,22179319,False,False,False,"Intriguingly, SIRT1 overexpression did not extend the life span in N171-82Q HD mice.",#66:20,PMC4551453,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2012-03-14"", ""ref"": ""22179319"", ""pub_year"": 2012, ""last_author"": ""Duan W"", ""type"": ""PubMed"", ""author_list"": [""Jiang M"", ""Wang J"", ""Fu J"", ""Du L"", ""Jeong H"", ""West T"", ""Xiang L"", ""Peng Q"", ""Hou Z"", ""Cai H"", ""Seredenina T"", ""Arbez N"", ""Zhu S"", ""Sommers K"", ""Qian J"", ""Zhang J"", ""Mori S"", ""Yang XW"", ""Tamashiro KL"", ""Aja S"", ""Moran TH"", ""Luthi-Carter R"", ""Martin B"", ""Maudsley S"", ""Mattson MP"", ""Cichewicz RH"", ""Ross CA"", ""Holtzman DM"", ""Krainc D"", ""Duan W""], ""title"": ""Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets."", ""doi"": ""10.1038/nm.2558""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""MeSHDisease"": [""Huntington Disease""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Disease Models, Animal"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""Gene Expression Regulation"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins"", ""Rats"", ""Receptor, trkB"", ""Signal Transduction"", ""Sirtuin 1""], ""substances"": [""Brain-Derived Neurotrophic Factor"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""FoxO3 protein, mouse"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Ppp1r1b protein, mouse"", ""Receptor, trkB"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,20746,44235,2005.0,15597323,False,False,False,"Cognate siRNA duplex did not affect the expression of other monocyte surface markers including CD11b and CD14, thus proving specificity (Fig. 2A).",#57:0,,"{""full_journal_name"": ""European journal of immunology"", ""pub_date"": ""2005-02-23"", ""ref"": ""15597323"", ""pub_year"": 2005, ""last_author"": ""Chizzolini C"", ""type"": ""PubMed"", ""author_list"": [""Lajaunias F"", ""Dayer JM"", ""Chizzolini C""], ""title"": ""Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Gene Silencing"", ""Humans"", ""Immunity, Innate"", ""In Vitro Techniques"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-8"", ""Monocytes"", ""N-Acetylneuraminic Acid"", ""Phosphatidylinositol 3-Kinases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Signal Transduction"", ""Tumor Necrosis Factor-alpha"", ""p38 Mitogen-Activated Protein Kinases""], ""substances"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Interleukin-1"", ""Interleukin-8"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Tumor Necrosis Factor-alpha"", ""Phosphatidylinositol 3-Kinases"", ""p38 Mitogen-Activated Protein Kinases"", ""N-Acetylneuraminic Acid""]}",False
CAUSES_NO_CHANGE,37876,5615,2017.0,27288790,False,False,False,"Stimulation of GSK3β but not GSK3α promoted BACE1 gene expression and BACE1-mediated APP processing in vitro by regulating BACE1 gene promoter activity, which was dependent on NF-κB p65-binding elements in the BACE1 pro- moter [51].",#61:51,,"{""full_journal_name"": ""Journal of the neurological sciences"", ""pub_date"": ""2017-04-25"", ""ref"": ""27288790"", ""pub_year"": 2017, ""last_author"": ""Hong W"", ""type"": ""PubMed"", ""author_list"": [""Shi ZM"", ""Han YW"", ""Han XH"", ""Zhang K"", ""Chang YN"", ""Hu ZM"", ""Qi HX"", ""Ting C"", ""Zhen Z"", ""Hong W""], ""title"": ""Upstream regulators and downstream effectors of NF-\u03baB in Alzheimer's disease."", ""doi"": ""10.1016/j.jns.2016.05.022""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""NF-kappa B""], ""substances"": [""NF-kappa B""]}",False
CAUSES_NO_CHANGE,6709,38093,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,37074,11577,2017.0,28083634,False,False,False,"Expression of the candidate deubiquitinases Otub1, USP5, and USP9x in this assay demonstrated significantly increased Tau aggregation following expression of Otub1 (Fig. 2a; Fig. S3), not observed following expression of USP5 or USP9x (Fig. S3).",#64:64,PMC5390007,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2017-04-20"", ""ref"": ""28083634"", ""pub_year"": 2017, ""last_author"": ""Dewachter I"", ""type"": ""PubMed"", ""author_list"": [""Wang P"", ""Joberty G"", ""Buist A"", ""Vanoosthuyse A"", ""Stancu IC"", ""Vasconcelos B"", ""Pierrot N"", ""Faelth-Savitski M"", ""Kienlen-Campard P"", ""Octave JN"", ""Bantscheff M"", ""Drewes G"", ""Moechars D"", ""Dewachter I""], ""title"": ""Tau interactome mapping\u00a0based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo."", ""doi"": ""10.1007/s00401-016-1663-9""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Deubiquitinating Enzymes"", ""Humans"", ""Mice, Transgenic"", ""Neurofibrillary Tangles"", ""Neurons"", ""Tauopathies"", ""Ubiquitin"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Ubiquitin"", ""tau Proteins"", ""Deubiquitinating Enzymes"", ""Cysteine Endopeptidases"", ""Otub1 protein, mouse""]}",False
CAUSES_NO_CHANGE,34970,12680,2004.0,14657037,False,False,False,"Caspase-9 activation is mainly triggered by cytochrome c release from the mitochondria, which occurs at the asymptomatic stage prior to disease onset (Gueï¿½gan et al., 2001). Cytochrome c, together with ATP/ADP, Apaf-1 and procaspase-9, forms a complex termed `apoptosome', in which caspase-9 is activated. Caspase-9 then cleaves procaspase-3 to generate active caspase-3. Both caspase-9 and caspase-3 cleave procaspase-9 to form an `amplication loop' of caspase-9 activation. XIAP does not inhibit `apoptosome' formation and its upstream events, but suppresses the downstream `ampliï¿½cation loop' by inhibition of caspase-9 and -3. Therefore, the activation of caspase-9 preceded by cytochrome c release can occur in the presence of a potent caspase-9 inhibitor XIAP and be considered an indicator of disease onset, regardless of the level of caspase-9.",#59:5,PMC291829,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2004-03-02"", ""ref"": ""14657037"", ""pub_year"": 2004, ""last_author"": ""Takahashi R"", ""type"": ""PubMed"", ""author_list"": [""Inoue H"", ""Tsukita K"", ""Iwasato T"", ""Suzuki Y"", ""Tomioka M"", ""Tateno M"", ""Nagao M"", ""Kawata A"", ""Saido TC"", ""Miura M"", ""Misawa H"", ""Itohara S"", ""Takahashi R""], ""title"": ""The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.""}","{""Species"": [""10090""], ""Subgraph"": [""Caspase subgraph"", ""Electron transport chain"", ""XIAP subgraph""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Base Sequence"", ""Cysteine Proteinase Inhibitors"", ""DNA Primers"", ""Disease Models, Animal"", ""Genotype"", ""Immunohistochemistry"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Proteins"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""Spinal Cord"", ""Superoxide Dismutase"", ""Superoxide Dismutase-1"", ""X-Linked Inhibitor of Apoptosis Protein""], ""substances"": [""Cysteine Proteinase Inhibitors"", ""DNA Primers"", ""Proteins"", ""SOD1 protein, human"", ""X-Linked Inhibitor of Apoptosis Protein"", ""Sod1 protein, mouse"", ""Superoxide Dismutase"", ""Superoxide Dismutase-1""]}",False
CAUSES_NO_CHANGE,43348,9452,2018.0,28445721,False,False,False,"For alpha7 and alpha3beta2, RIC-3 did not enable detectable [3H]epibatidine binding, yet RIC-3 profoundly augmented the effects of NACHO on [3H]epibatidine binding to either receptor subtype (Figures 3A and S1A)",#64:74,,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2018-01-19"", ""ref"": ""28445721"", ""pub_year"": 2018, ""last_author"": ""Bredt DS"", ""type"": ""PubMed"", ""author_list"": [""Matta JA"", ""Gu S"", ""Davini WB"", ""Lord B"", ""Siuda ER"", ""Harrington AW"", ""Bredt DS""], ""title"": ""NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain."", ""doi"": ""10.1016/j.celrep.2017.04.008""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Binding Sites"", ""Brain"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Cell Line"", ""Cognitive Dysfunction"", ""Conotoxins"", ""Humans"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Mice"", ""Mice, Knockout"", ""Molecular Chaperones"", ""Neurons"", ""Nicotine"", ""Protein Binding"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic""], ""substances"": [""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Conotoxins"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Molecular Chaperones"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic"", ""Ric-3 protein, mouse"", ""Nicotine"", ""Iodine-125"", ""epibatidine""]}",False
CAUSES_NO_CHANGE,11533,1650,2012.0,21958873,False,False,False,"Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,14465,1365,2015.0,25639674,False,False,False,"In a chronic constriction injury model for neuropathic pain, an anti- hyperalgesic and anti-allodynic effect of PNU-120596 was observed, however NS-1738 did not have any effect in the same study [184].One possible mechanism for this may be the ability of PNU-120596 to enhance α7 nAChR activation over a certain threshold, which would indirectly stimulate inhibitory neurons located in the neural circuits for neuropathic pain.",#60:18,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""MeSHDisease"": [""Neuralgia""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,11786,5224,2020.0,30606258,False,False,False,"Despite the clear reduction in Tau35 phosphorylation, LiCl did not affect the proportion of either microtubule-bound Tau35, or polymerized α-tubulin in CHO-Tau35 cells (Fig. 3c, d).",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,11809,1513,2017.0,27794524,False,False,False,"Because levels of inflammation were not affected by MitoQ, it is conceivable that increased mitochondrial protection against ROS is sufficient to reduce axonal damage.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,3987,1222,2014.0,25031639,False,False,False,"For instance, in a mouse model of AD, genetic ablation of HDAC6 alleviated cognitive impairment without impacting plaque burden, which may suggest that beneficial consequences of loss of HDAC6 expression are due to effects on endogenous tau, though this has not yet been assessed in this model [47].",#69:36,PMC4075151,"{""full_journal_name"": ""Alzheimer's research & therapy"", ""pub_date"": ""2014-07-17"", ""ref"": ""25031639"", ""pub_year"": 2014, ""last_author"": ""Petrucelli L"", ""type"": ""PubMed"", ""author_list"": [""Cook C"", ""Stankowski JN"", ""Carlomagno Y"", ""Stetler C"", ""Petrucelli L""], ""title"": ""Acetylation: a new key to unlock tau's role in neurodegeneration."", ""doi"": ""10.1186/alzrt259""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,1650,28988,2019.0,30126037,False,False,False,"In 15-month-old mice with heavy Abeta deposition and phosphorylated tau, but lacking NFT pathology (Orr et al., 2014), Cdkn2a expression was not elevated (Figure 4e). These data indicate that Cdkn2a expression was neither a response to general protein accumulation, nor to pre-NFT tau pathology, but instead required the presence of NFTs",#59:44,PMC6260915,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2019-10-21"", ""ref"": ""30126037"", ""pub_year"": 2019, ""last_author"": ""Orr ME"", ""type"": ""PubMed"", ""author_list"": [""Musi N"", ""Valentine JM"", ""Sickora KR"", ""Baeuerle E"", ""Thompson CS"", ""Shen Q"", ""Orr ME""], ""title"": ""Tau protein aggregation is associated with cellular senescence in the brain."", ""doi"": ""10.1111/acel.12840""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Hippocampus""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Aged, 80 and over"", ""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Antioxidants"", ""Atrophy"", ""Brain"", ""Cellular Senescence"", ""Cyclin-Dependent Kinase Inhibitor p16"", ""Dasatinib"", ""Disease Models, Animal"", ""Female"", ""Gene Expression"", ""Humans"", ""Male"", ""Mice"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Protein Kinase Inhibitors"", ""Quercetin"", ""Supranuclear Palsy, Progressive"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""Antioxidants"", ""CDKN2A protein, human"", ""Cdkn2a protein, mouse"", ""Cyclin-Dependent Kinase Inhibitor p16"", ""MAPT protein, human"", ""Protein Aggregates"", ""Protein Kinase Inhibitors"", ""tau Proteins"", ""Quercetin"", ""Dasatinib""]}",False
CAUSES_NO_CHANGE,6637,12078,2020.0,30988501,False,False,False,The complex and diverse roles of adaptive immune cells are further underlined by the finding that a lack of B cells does not impair learning behaviour in mice 20.,#59:65,,"{""full_journal_name"": ""Nature reviews. Neurology"", ""pub_date"": ""2020-01-27"", ""ref"": ""30988501"", ""pub_year"": 2020, ""last_author"": ""Zipp F"", ""type"": ""PubMed"", ""author_list"": [""Pape K"", ""Tamouza R"", ""Leboyer M"", ""Zipp F""], ""title"": ""Immunoneuropsychiatry - novel perspectives on brain disorders."", ""doi"": ""10.1038/s41582-019-0174-4""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Brain"", ""Brain Diseases"", ""Encephalitis"", ""Humans"", ""Inflammation"", ""Mental Disorders"", ""Neurology""]}",False
CAUSES_NO_CHANGE,34646,6994,2017.0,28148553,False,False,False,Annonacin but not 4R or 3R tau overexpression increased the level of MC1-immunoreactive tau in LUHMES neurons.,#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,7981,40146,2016.0,26702100,False,False,False,"The enrichment of the active Rag GTPases (RagAGTP/RagCGDP) (Martina & Puertollano, 2013) on lysosomes was not disturbed after knockdown of TDP-43, but was strongly abolished after knockdown of p18, which anchors Rag GTPases to lysosomes (Fig 3D), indicating that loss of TDP-43 does not affect the localization of the Rag GTPases.",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,11655,44621,2019.0,29844403,False,False,False,"In addition, MPT0G211 concentration-dependently increased the acetylation of α-tubulin in SH-SY5Y and Neuro-2a cells, the common used neuronal cell lines in the study of AD, at concentrations ranging from 0.1 to 1 μM without affecting the acetylation of histones, which is consistent with the selective inhibition of HDAC6 (Fig. 1b, c).",#71:1,PMC5974403,"{""full_journal_name"": ""Cell death & disease"", ""pub_date"": ""2019-12-10"", ""ref"": ""29844403"", ""pub_year"": 2019, ""last_author"": ""Yang CR"", ""type"": ""PubMed"", ""author_list"": [""Fan SJ"", ""Huang FI"", ""Liou JP"", ""Yang CR""], ""title"": ""The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model."", ""doi"": ""10.1038/s41419-018-0688-5""}","{""CellLine"": [""Neuro-2a cell"", ""SH-SY5Y""], ""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Benzamides"", ""Cell Line, Tumor"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3 beta"", ""Histone Deacetylase Inhibitors"", ""Memory Disorders"", ""Models, Biological"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Aggregates"", ""Proteolysis"", ""Quinolines"", ""Rats, Sprague-Dawley"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Benzamides"", ""Histone Deacetylase Inhibitors"", ""MPT0G211"", ""Neuroprotective Agents"", ""Protein Aggregates"", ""Quinolines"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,6789,43910,2015.0,25331948,False,False,False,"We further confirmed that possibility by showing that Tau phosphorylation at the typical GSK3β sites (PHF-1 and CP13) is reduced following treatment of SH-SY5Y cells with BAY61-3606, whereas Tau phosphorylation at the RZ3 site was not significantly impacted in SH- SY5Y cells (Fig. 9C).",#70:54,PMC4256331,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-03-03"", ""ref"": ""25331948"", ""pub_year"": 2015, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Ait-Ghezala G"", ""Bachmeier C"", ""Laco G"", ""Beaulieu-Abdelahad D"", ""Lin Y"", ""Jin C"", ""Crawford F"", ""Mullan M""], ""title"": ""The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-\u03b2 production and Tau hyperphosphorylation."", ""doi"": ""10.1074/jbc.M114.608091""}","{""Confidence"": [""High""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""CHO Cells"", ""Calcium Channel Blockers"", ""Cell Line, Tumor"", ""Cricetulus"", ""Gene Expression Regulation"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""Neurons"", ""Nifedipine"", ""Phosphorylation"", ""Protein-Tyrosine Kinases"", ""Signal Transduction"", ""Syk Kinase"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Calcium Channel Blockers"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""tau Proteins"", ""nilvadipine"", ""Protein-Tyrosine Kinases"", ""SYK protein, human"", ""Syk Kinase"", ""Syk protein, mouse"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Nifedipine""]}",False
CAUSES_NO_CHANGE,7260,43505,2001.0,11230871,False,False,False,A decrease in protein levels of the alpha4 nAChR but not of the alpha3 and alpha7 nAChRs was reported by Martin-Ruiz et al (1999),#65:45,,"{""full_journal_name"": ""Biological psychiatry"", ""pub_date"": ""2001-06-07"", ""ref"": ""11230871"", ""pub_year"": 2001, ""last_author"": ""Nordberg A"", ""type"": ""PubMed"", ""author_list"": [""Nordberg A""], ""title"": ""Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.""}","{""Confidence"": [""Medium""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Brain"", ""Cholinergic Agents"", ""Humans"", ""Receptors, Nicotinic"", ""Treatment Outcome""], ""substances"": [""Cholinergic Agents"", ""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,29278,12096,2000.0,10656250,False,False,False,"However, expression of either of the Asp 2 mutants does not produce the increase in the secretion of sAPPb (Fig. 2b) seen for wild-type Asp 2. In contrast to this clear effect on sAPPb, Asp 2 has no effect on the secretion of soluble APPa or on full-length APP in the cell (data not shown).",#64:10,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2000-02-17"", ""ref"": ""10656250"", ""pub_year"": 2000, ""last_author"": ""Christie G"", ""type"": ""PubMed"", ""author_list"": [""Hussain I"", ""Powell D"", ""Howlett DR"", ""Tew DG"", ""Meek TD"", ""Chapman C"", ""Gloger IS"", ""Murphy KE"", ""Southan CD"", ""Ryan DM"", ""Smith TS"", ""Simmons DL"", ""Walsh FS"", ""Dingwall C"", ""Christie G""], ""title"": ""Identification of a novel aspartic protease (Asp 2) as beta-secretase.""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""COS Cells"", ""Cathepsin D"", ""Cell Line"", ""Cell Membrane"", ""Endopeptidases"", ""Female"", ""Hippocampus"", ""Humans"", ""Middle Aged"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Papain"", ""Recombinant Proteins"", ""Sequence Alignment"", ""Sequence Homology, Amino Acid"", ""Transfection""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Recombinant Proteins"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Papain"", ""Aspartic Acid Endopeptidases"", ""BACE2 protein, human"", ""BACE1 protein, human"", ""Cathepsin D""]}",False
CAUSES_NO_CHANGE,8165,30968,2017.0,27594586,False,False,False,The percentages of VGLUT1-positive excitatory and GABA-positive inhibitory neurons were similar in neuronal cultures differentiated from control and patient iPSCs (Figures S2B and S2C),#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,1934,1705,2020.0,30837838,False,False,False,"Notably, the zinc ions could induce inclusion bodies formation and aggregation in the neuronal cell cultures, and this effect was not observed with copper or iron, indicating zinc-specific effects (Caragounis et al., 2010).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,6709,34974,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,11999,10760,2015.0,26088141,False,False,False,"SP pretreatment did not significantly alter calcium peaks in α7345–348A nAChR expressing cells, showing a small (−31.24%) reduction in calcium responses relative to the α7345–348A baseline measure (p > 0.05).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,1650,27111,2020.0,30686764,False,False,False,"While Ab secretion was no longer regulated by atorvastatin in these neurons, atorvastatin still decreased pT231Tau/tTau ratio (in an identical manner as in their isogenic wild-type controls) (Figure 4F), again confirming that the effect of CE on pTau and the effect of CE on Ab are regulated through two separate pathways.",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,6709,42594,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,34440,20838,2015.0,25681350,False,False,False,"Knockdown of either RelB or p50 significantly diminished cytokine- induced YKL-40 mRNA expression, whereas knockdown of p65, cRel and p52 had no effect (Fig. 4A). This finding implicates both RelB and p50 in YKL-40 regulation.",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,1854,2200,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,1791,2425,2016.0,25514383,False,False,False,"Whilst the spatial memory deficit was restored by 4OH-GTS-21 treatment, this molecule had no effect on neuronal density (Ren et al., 2007)",#61:27,,"{""full_journal_name"": ""Neuropharmacology"", ""pub_date"": ""2016-03-22"", ""ref"": ""25514383"", ""pub_year"": 2016, ""last_author"": ""Maskos U"", ""type"": ""PubMed"", ""author_list"": [""Lombardo S"", ""Maskos U""], ""title"": ""Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment."", ""doi"": ""10.1016/j.neuropharm.2014.11.018""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Humans"", ""Mice, Transgenic"", ""Neurons"", ""Nicotine"", ""Nicotinic Agonists"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic""], ""substances"": [""Amyloid beta-Peptides"", ""Nicotinic Agonists"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Nicotine""]}",False
CAUSES_NO_CHANGE,2036,24495,2014.0,24590577,False,False,False,"During the past few years, the M1 mAChR allosteric agonists VU0184670 and VU0357017 have been screened out, and have more exciting properties. Both compounds have high solubility in aqueous solutions as well as good CNS penetration, without any agonist or antagonist activity for the M2 and M5 subtypes",#69:61,PMC5562652,"{""full_journal_name"": ""Neuroscience bulletin"", ""pub_date"": ""2014-12-03"", ""ref"": ""24590577"", ""pub_year"": 2014, ""last_author"": ""Zhang YW"", ""type"": ""PubMed"", ""author_list"": [""Jiang S"", ""Li Y"", ""Zhang C"", ""Zhao Y"", ""Bu G"", ""Xu H"", ""Zhang YW""], ""title"": ""M1 muscarinic acetylcholine receptor in Alzheimer's disease."", ""doi"": ""10.1007/s12264-013-1406-z""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""Receptor, Muscarinic M1""], ""substances"": [""Receptor, Muscarinic M1""]}",False
CAUSES_NO_CHANGE,14488,5455,2008.0,18450518,False,False,False,"Flurbiprofen, the NSAID of which tarenflurbil is the R-enantiomer, has substantial amyloid-reducing activity. Because the R-enantiomer retains this anti-amyloid effect but does not have the cyclo-oxygenase inhibitory effect of flurbiprofen, it can be given at relatively high doses to elderly patients. It is thus a promising candidate for treatment of AD.",#59:5,,"{""full_journal_name"": ""The Lancet. Neurology"", ""pub_date"": ""2008-07-25"", ""ref"": ""18450518"", ""pub_year"": 2008, ""last_author"": ""Aisen PS"", ""type"": ""PubMed"", ""author_list"": [""Aisen PS""], ""title"": ""Tarenflurbil: a shot on goal."", ""doi"": ""10.1016/S1474-4422(08)70091-7""}","{""DiseaseState"": [""Mild AD""], ""FDASTATUS"": [""Phase 2""], ""Subgraph"": [""Inflammatory response subgraph"", ""Prostaglandin subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Brain"", ""Clinical Trials, Phase II as Topic"", ""Clinical Trials, Phase III as Topic"", ""Enzyme Inhibitors"", ""Flurbiprofen"", ""Humans"", ""Plaque, Amyloid"", ""Treatment Outcome""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Enzyme Inhibitors"", ""Flurbiprofen"", ""Amyloid Precursor Protein Secretases""]}",False
CAUSES_NO_CHANGE,7260,20341,2009.0,18986241,False,False,False,"Single cell gene array studies have shown that synaptic transcripts are selectively downregulated in CBF neurons in AD, with significant reductions in synaptophysin and synaptotagmin but not synaptobrevin or SNAP29 mRNA [134,135]. Intriguingly, synaptotagmin function is related to vesicle-presynaptic membrane fusion and neurotransmitter release, suggesting that perturbations in presynaptic vesicle trafficking comprise a common event in vulnerable neuronal populations in AD. In contrast to synaptic transcripts, mRNAs encoding APP and Notch were unchanged between control and AD subjects, whereas acid hydrolase cathepsin D mRNA was upregulated in AD [134–136].",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,11572,13478,2020.0,30686764,False,False,False,"The reduction of both pTau as well as tTau could indicate a proteostatic regulatory event, rather than altered Tau phosphorylation and dephosphorylation events. This was further substantiated by the finding that activity of GSK3b (a major Tau kinase) was not affected by statin-mediated CE reduction (Figure S5E).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,42558,21754,2020.0,30515821,False,False,False,"Interestingly, the E193K does not affect the kinase activity of LRRK2 compared with the G2019S, suggesting that E193K does not affect the activity of Drp1 but affects LRRK2 phosphorylation at Ser‐935 and increases the mitochondrial response to MPP+ (a mitochondrial toxin can induce PD) in the patients’ fibroblast.",#65:66,,"{""full_journal_name"": ""Journal of cellular physiology"", ""pub_date"": ""2020-05-04"", ""ref"": ""30515821"", ""pub_year"": 2020, ""last_author"": ""Chen L"", ""type"": ""PubMed"", ""author_list"": [""Qi Z"", ""Huang Z"", ""Xie F"", ""Chen L""], ""title"": ""Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases."", ""doi"": ""10.1002/jcp.27866""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Fibroblasts""], ""MeSHDisease"": [""Parkinson Disease""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Dynamins"", ""Humans"", ""Huntingtin Protein"", ""Mitochondria"", ""Mitochondrial Dynamics"", ""Nerve Degeneration"", ""Nervous System"", ""Neurodegenerative Diseases"", ""Protein Processing, Post-Translational"", ""Signal Transduction"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Huntingtin Protein"", ""tau Proteins"", ""DNM1L protein, human"", ""Dnm1l protein, mouse"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,11479,1650,2007.0,17640819,False,False,False,Nine-month-old APP/PS1 mice had significant 6E10-staining amyloid deposition (325 deposits/section). The density of this deposition was not affected by 2 weeks of twice per day injections of 1 mg/kg 4OH-GTS-21 (275 deposits/section) or by FFX lesions,#65:41,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""Assay"": [""Immunochemistry""], ""Dosage"": [""1 mg/kg""], ""MouseStrain"": [""K670N/M671L/PS1M146L""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,33361,25540,2017.0,28083634,False,False,False,"Immunostaining and biochemical analysis, 2 months postinjection, unambiguously revealed that the catalytically dead mutant C91A did not affect AT8-stained Tau in vivo, while N-terminal truncated mutant of Otub1 increased AT8-positive Tau in vivo, similarly as wild-type Otub1 (Fig. 8).",#64:64,PMC5390007,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2017-04-20"", ""ref"": ""28083634"", ""pub_year"": 2017, ""last_author"": ""Dewachter I"", ""type"": ""PubMed"", ""author_list"": [""Wang P"", ""Joberty G"", ""Buist A"", ""Vanoosthuyse A"", ""Stancu IC"", ""Vasconcelos B"", ""Pierrot N"", ""Faelth-Savitski M"", ""Kienlen-Campard P"", ""Octave JN"", ""Bantscheff M"", ""Drewes G"", ""Moechars D"", ""Dewachter I""], ""title"": ""Tau interactome mapping\u00a0based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo."", ""doi"": ""10.1007/s00401-016-1663-9""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Deubiquitinating Enzymes"", ""Humans"", ""Mice, Transgenic"", ""Neurofibrillary Tangles"", ""Neurons"", ""Tauopathies"", ""Ubiquitin"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Ubiquitin"", ""tau Proteins"", ""Deubiquitinating Enzymes"", ""Cysteine Endopeptidases"", ""Otub1 protein, mouse""]}",False
CAUSES_NO_CHANGE,11566,43753,2020.0,30686764,False,False,False,"Inhibition of the respective non-sterol isoprenoid pathways (by geranyl- or farnesyl- transferase inhibitors GGTI-298 and FTI-227, respectively) did not significantly reduce pThr231Tau/ tTau (Figures 2C, S2F, and S2G).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,35432,11318,2011.0,21427723,False,False,False,"Thus, K280 acetylation is a feature found in a variety of human 4R or 3R/4R tauopathies including AD, but not 3R tauopathies such as PiD.",#65:56,PMC3120096,"{""full_journal_name"": ""Nature communications"", ""pub_date"": ""2011-08-01"", ""ref"": ""21427723"", ""pub_year"": 2011, ""last_author"": ""Lee VM"", ""type"": ""PubMed"", ""author_list"": [""Cohen TJ"", ""Guo JL"", ""Hurtado DE"", ""Kwong LK"", ""Mills IP"", ""Trojanowski JQ"", ""Lee VM""], ""title"": ""The acetylation of tau inhibits its function and promotes pathological tau aggregation."", ""doi"": ""10.1038/ncomms1255""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Brain"", ""Female"", ""HEK293 Cells"", ""Humans"", ""Immunohistochemistry"", ""Lysine"", ""Male"", ""Mass Spectrometry"", ""Membrane Proteins"", ""Mice"", ""Mice, Transgenic"", ""Microtomy"", ""Microtubules"", ""Middle Aged"", ""Neurons"", ""Phosphorylation"", ""Protein Binding"", ""Protein Processing, Post-Translational"", ""Recombinant Proteins"", ""Transfection""], ""substances"": [""Membrane Proteins"", ""Recombinant Proteins"", ""tau 40 protein, human"", ""Lysine""]}",False
CAUSES_NO_CHANGE,37138,2132,2018.0,28528849,False,False,False,"By contrast, monomers of TauRDΔK even at 10 mM concentration did not cause any significant ROS increase (Fig. 5B).",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""High""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,11942,2342,2016.0,23393546,False,False,False,"Addition of pizotifen, cyproheptadine, or loxapine to the ST Hdh Q7/Q7 cells after serum withdrawal had no effect on ATP levels, indicating that the drugs do not have a general effect on viability but rather correct a deficit specific to the ST Hdh Q111/Q111 cells (Figure 2 A ).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,1650,28785,2011.0,21745645,False,False,False,"Here we show that the α7 nAChR-dependent LTP and STD were largely blocked in slices preexposed to 10 nM Aβ for 2 hr (Figures 6A, 6B, and 6D); our Aβ preparation contains oligomeric, as well as monomeric, Aβ (Lambert et al., 1998). The mAChR-mediated LTP is relatively resistant to 0.1 μM Aβ, but was blocked by higher concentrations of Aβ pre-exposure (partial blockade by 0.3 and complete blockade by 1 μM) (Figures 6C and 6D).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Dosage"": [""0.1 microMolar""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,31959,41587,2000.0,10887109,False,False,False,"These experiments determined that Lck, but not Syk or Zap70, was capable of mediating phosphorylation of CD33 in vivo (Figure 2A).",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,11790,7370,2009.0,19237574,False,False,False,"Furthermore, the effect of metformin on Abeta generation is mediated by transcriptional up-regulation of β-secretase (BACE1), which results in an elevated protein level and increased enzymatic activity. Unlike insulin, metformin exerts no effect on Abeta degradation. In addition, we found that glucose deprivation and various tyrphostins, known inhibitors of insulin-like growth factors/insulin receptor tyrosine kinases, do not modulate the effect of metformin on Abeta. Finally, inhibition of AMP-activated protein kinase (AMPK) by the pharmacological inhibitor Compound C largely suppresses metformin's effect on Abeta generation and BACE1 transcription, suggesting an AMPK-dependent mechanism. Although insulin and metformin display opposing effects on Abeta generation, in combined use, metformin enhances insulin's effect in reducing Abeta levels",#59:5,PMC2656178,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2009-03-26"", ""ref"": ""19237574"", ""pub_year"": 2009, ""last_author"": ""Liao FF"", ""type"": ""PubMed"", ""author_list"": [""Chen Y"", ""Zhou K"", ""Wang R"", ""Liu Y"", ""Kwak YD"", ""Ma T"", ""Thompson RC"", ""Zhao Y"", ""Smith L"", ""Gasparini L"", ""Luo Z"", ""Xu H"", ""Liao FF""], ""title"": ""Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription."", ""doi"": ""10.1073/pnas.0807991106""}","{""Subgraph"": [""Amyloidogenic subgraph"", ""Beta secretase subgraph"", ""Insulin signal transduction""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Base Sequence"", ""Binding Sites"", ""Enzyme Activation"", ""Glucose"", ""Hypoglycemic Agents"", ""Insulin"", ""Metformin"", ""Mice"", ""Molecular Sequence Data"", ""Peptides"", ""Promoter Regions, Genetic"", ""Rats"", ""Signal Transduction"", ""Transcription, Genetic"", ""Up-Regulation""], ""substances"": [""Amyloid beta-Peptides"", ""Hypoglycemic Agents"", ""Insulin"", ""Peptides"", ""Metformin"", ""AMP-Activated Protein Kinases"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Glucose""]}",False
CAUSES_NO_CHANGE,7091,36068,2009.0,19293145,False,False,False,"In studies on SH-SY5Y cells and cultured rat hippocampal neurons, nicotine, acting through alpha7 nAChRs, results in the activation of ERK-1/2 pathways dependent upon calcium and protein kinase A (Dajas- Bailador et al., 2002b). In addition, the alpha7-specific agonist GTS-21 promotes ERK-1/2 phosphorylation, but not that of c-jun N-terminal kinase (JNK) or p38 (Ren et al., 2005).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""CellLine"": [""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,39747,32340,2014.0,24189376,False,False,False,"Eleven AD patients and 7 healthy volunteers (HV) underwent combined [Â¹â�¸F]MK-9470 PET and [Â¹Â¹C]PIB PET scans to assess CBâ‚�R availability and amyloid deposition, respectively, and T1 volumetric MRI for partial volume correction. We found no difference in CBâ‚�R availability between AD and HV, VOI-based fractional uptake values (FUR) were 0.043Â±0.01 for AD and 0.045Â±0.01 for controls (p=0.9). CBâ‚�R availability did not correlate with neuropsychological test scores and was not modulated by ApoE genotype. As expected, global [Â¹Â¹C]PIB SUVR (standardized uptake value ratio) was increased in AD (SUVR 1.9Â±0.3) compared to HV (1.2Â±0.1) with p<0.001, but no correlation was found between amyloid β (Abeta) deposition and CBâ‚�R availability.",#59:5,,"{""full_journal_name"": ""European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology"", ""pub_date"": ""2014-10-21"", ""ref"": ""24189376"", ""pub_year"": 2014, ""last_author"": ""Vandenbulcke M"", ""type"": ""PubMed"", ""author_list"": [""Ahmad R"", ""Goffin K"", ""Van den Stock J"", ""De Winter FL"", ""Cleeren E"", ""Bormans G"", ""Tournoy J"", ""Persoons P"", ""Van Laere K"", ""Vandenbulcke M""], ""title"": ""In vivo type 1 cannabinoid receptor availability in Alzheimer's disease."", ""doi"": ""10.1016/j.euroneuro.2013.10.002""}","{""NIFT"": [""Volumetric MRI""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Aniline Compounds"", ""Apolipoproteins E"", ""Benzothiazoles"", ""Brain"", ""Cognition"", ""Female"", ""Humans"", ""Magnetic Resonance Imaging"", ""Male"", ""Middle Aged"", ""Neuropsychological Tests"", ""Positron-Emission Tomography"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptor, Cannabinoid, CB1"", ""Thiazoles""], ""substances"": [""2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole"", ""Amyloid beta-Peptides"", ""Aniline Compounds"", ""Apolipoproteins E"", ""Benzothiazoles"", ""CNR1 protein, human"", ""MK-9470"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptor, Cannabinoid, CB1"", ""Thiazoles""]}",False
CAUSES_NO_CHANGE,1783,5218,2009.0,19293145,False,False,False,"The loss of nAChR subunits, as determined by [3H]- epibatidine binding, seems to take place after the transition from mild cognitive impairment (MCI) to AD (Sabbagh et al., 2006), although the loss of epibatidine binding did not correlate with decline in memory, cognitive performance, or with the development of neurofibrillary tangles or plaques (Sabbagh et al., 2001).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,14406,30716,2013.0,23383175,False,False,False,"However, anatabine significantly suppressed the production of IL-1b, IL-6 and IL-17A in the serum of EAE mice (Fig. 2B) but did not significantly impact IFN-gamma and TNF-alpha",#68:42,PMC3559544,"{""full_journal_name"": ""PloS one"", ""pub_date"": ""2013-07-22"", ""ref"": ""23383175"", ""pub_year"": 2013, ""last_author"": ""Mullan MJ"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Mullan M"", ""Ait-Ghezala G"", ""Mathura V"", ""Bachmeier C"", ""Crawford F"", ""Mullan MJ""], ""title"": ""Amelioration of experimental autoimmune encephalomyelitis by anatabine."", ""doi"": ""10.1371/journal.pone.0055392""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Serum""], ""MeSHDisease"": [""Encephalomyelitis""], ""Species"": [""10090""], ""mesh"": [""Administration, Oral"", ""Alkaloids"", ""Analysis of Variance"", ""Animals"", ""Blotting, Western"", ""Cytokines"", ""Encephalomyelitis, Autoimmune, Experimental"", ""Immunohistochemistry"", ""Mice"", ""Multiple Sclerosis"", ""Pyridines"", ""Th1 Cells"", ""Th17 Cells""], ""substances"": [""Alkaloids"", ""Cytokines"", ""Pyridines"", ""anatabine""]}",False
CAUSES_NO_CHANGE,7981,2747,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,3473,43310,2017.0,28148553,False,False,False,"None of the lentiviral models significantly increased PERK or pPERK, showing that tau overload per se is not sufficient to activate the UPR.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,1679,32750,2019.0,30145931,False,False,False,"Missorted dendritic MAPT showed phosphorylation mainly at the 12E8 sites upon treatment with either the autophagy inhibitor wortmannin (Fig. 4B; 57.2±9.4% dendrites) or the proteasomal inhibitor epoxomicin (Fig. 4C, 62.9±7.4% dendrites) (Fig. 4A-C, quantification in Fig. 4D), but not at the AT8 and the PHF1 (p-S396/p-S404) sites (Fig. S5, Fig 4D).",#69:71,PMC6984766,"{""full_journal_name"": ""Autophagy"", ""pub_date"": ""2019-10-22"", ""ref"": ""30145931"", ""pub_year"": 2019, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Balaji V"", ""Kaniyappan S"", ""Mandelkow E"", ""Wang Y"", ""Mandelkow EM""], ""title"": ""Pathological missorting of endogenous MAPT/Tau in neurons caused by failure of protein degradation systems."", ""doi"": ""10.1080/15548627.2018.1509607""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Dendrites""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Embryo, Mammalian"", ""Mice"", ""Mice, Knockout"", ""Neurites"", ""Neurons"", ""Protein Transport"", ""Proteolysis"", ""Rats"", ""Rats, Sprague-Dawley"", ""Synapses"", ""tau Proteins""], ""substances"": [""Mapt protein, mouse"", ""Mapt protein, rat"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11660,8596,2015.0,25546293,False,False,False,"While overall levels of β- catenin bound to N-cadherin did not appear to change in NPCs treated with ACY-1215, the pool of β-catenin bound to Ncadherin was enriched for Lys49 acetylation (Figure 5D).",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,7260,43753,2012.0,22419736,False,False,False,"Interestingly, the phosphorylated form of tau at Ser 396/404 (PHF-1) was detected exclusively in AD patients, although total amounts of tau protein (TG5) were not changed",#72:19,,"{""full_journal_name"": ""Human molecular genetics"", ""pub_date"": ""2012-10-09"", ""ref"": ""22419736"", ""pub_year"": 2012, ""last_author"": ""Jung YK"", ""type"": ""PubMed"", ""author_list"": [""Park H"", ""Kam TI"", ""Kim Y"", ""Choi H"", ""Gwon Y"", ""Kim C"", ""Koh JY"", ""Jung YK""], ""title"": ""Neuropathogenic role of adenylate kinase-1 in A\u03b2-mediated tau phosphorylation via AMPK and GSK3\u03b2."", ""doi"": ""10.1093/hmg/dds100""}","{""Confidence"": [""Medium""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Genetically Modified"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Drosophila"", ""Drosophila Proteins"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Green Fluorescent Proteins"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microscopy, Fluorescence"", ""Neurodegenerative Diseases"", ""Neurons"", ""Peptide Fragments"", ""Phosphorylation"", ""RNA Interference"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Drosophila Proteins"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""adenylate kinase 1""]}",False
CAUSES_NO_CHANGE,42894,37163,2012.0,22179319,False,False,False,"Overexpression of SIRT1 did not decrease mutant Htt expression in BACHD mice (Supplementary Fig. 1b), but significantly attenuated motor deficits, as indicated in both accelerating rotarod tests and open field assays. (Fig. 1g-h).",#66:20,PMC4551453,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2012-03-14"", ""ref"": ""22179319"", ""pub_year"": 2012, ""last_author"": ""Duan W"", ""type"": ""PubMed"", ""author_list"": [""Jiang M"", ""Wang J"", ""Fu J"", ""Du L"", ""Jeong H"", ""West T"", ""Xiang L"", ""Peng Q"", ""Hou Z"", ""Cai H"", ""Seredenina T"", ""Arbez N"", ""Zhu S"", ""Sommers K"", ""Qian J"", ""Zhang J"", ""Mori S"", ""Yang XW"", ""Tamashiro KL"", ""Aja S"", ""Moran TH"", ""Luthi-Carter R"", ""Martin B"", ""Maudsley S"", ""Mattson MP"", ""Cichewicz RH"", ""Ross CA"", ""Holtzman DM"", ""Krainc D"", ""Duan W""], ""title"": ""Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets."", ""doi"": ""10.1038/nm.2558""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Huntington Disease""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Disease Models, Animal"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""Gene Expression Regulation"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins"", ""Rats"", ""Receptor, trkB"", ""Signal Transduction"", ""Sirtuin 1""], ""substances"": [""Brain-Derived Neurotrophic Factor"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""FoxO3 protein, mouse"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Ppp1r1b protein, mouse"", ""Receptor, trkB"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,32645,42354,2015.0,25069841,False,False,False,"As expected, enhanced TFEB-dependent PTEN upregulation is associated with reduced pAkt (S473), pP70SK6 (T389) and pULK1 (S757), but not their total protein levels (Supplementary Fig S10).",#72:5,PMC4197862,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2015-05-22"", ""ref"": ""25069841"", ""pub_year"": 2015, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Polito VA"", ""Li H"", ""Martini-Stoica H"", ""Wang B"", ""Yang L"", ""Xu Y"", ""Swartzlander DB"", ""Palmieri M"", ""di Ronza A"", ""Lee VM"", ""Sardiello M"", ""Ballabio A"", ""Zheng H""], ""title"": ""Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB."", ""doi"": ""10.15252/emmm.201303671""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyloid Neuropathies""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Gene Expression Regulation"", ""Lysosomes"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""PTEN Phosphohydrolase"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Mapt protein, mouse"", ""Tcfeb protein, mouse"", ""tau Proteins"", ""PTEN Phosphohydrolase"", ""Pten protein, mouse""]}",False
CAUSES_NO_CHANGE,14467,12108,2017.0,27794524,False,False,False,"It reduces both pro- and anti-inflammatory cytokine levels, while growth factor secretion remains high.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,28968,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,34425,37057,2020.0,31413141,False,False,False,"The SNP commonly used as a proxy for APOE epsilon 4, rs769449, was also not associated with CSF sTREM2 (beta = −106.9, P = 0.308).",#59:17,PMC6697053,"{""full_journal_name"": ""Science translational medicine"", ""pub_date"": ""2020-07-27"", ""ref"": ""31413141"", ""pub_year"": 2020, ""last_author"": ""Cruchaga C"", ""type"": ""PubMed"", ""author_list"": [""Deming Y"", ""Filipello F"", ""Cignarella F"", ""Cantoni C"", ""Hsu S"", ""Mikesell R"", ""Li Z"", ""Del-Aguila JL"", ""Dube U"", ""Farias FG"", ""Bradley J"", ""Budde J"", ""Ibanez L"", ""Fernandez MV"", ""Blennow K"", ""Zetterberg H"", ""Heslegrave A"", ""Johansson PM"", ""Svensson J"", ""Nellg\u00e5rd B"", ""Lleo A"", ""Alcolea D"", ""Clarimon J"", ""Rami L"", ""Molinuevo JL"", ""Su\u00e1rez-Calvet M"", ""Morenas-Rodr\u00edguez E"", ""Kleinberger G"", ""Ewers M"", ""Harari O"", ""Haass C"", ""Brett TJ"", ""Benitez BA"", ""Karch CM"", ""Piccio L"", ""Cruchaga C""], ""title"": {""#text"": ""The  gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk."", ""i"": ""MS4A""}, ""doi"": ""10.1126/scitranslmed.aau2291""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""mesh"": [""Alzheimer Disease"", ""Female"", ""Genome-Wide Association Study"", ""Humans"", ""Macrophages"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Meta-Analysis as Topic"", ""Multigene Family"", ""Receptors, Immunologic""], ""substances"": [""MS4A4A protein, human"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
CAUSES_NO_CHANGE,1854,2709,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,38127,13640,2018.0,28445721,False,False,False,"NACHO does not affect function of ion channels gated by numerous other ligands including glutamate, GABA, serotonin, and capsaicin, suggesting that NACHO represents the only essential client-specific chaperone yet identified for any mammalian neurotransmitter receptor (Gu et al., 2016)",#64:74,,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2018-01-19"", ""ref"": ""28445721"", ""pub_year"": 2018, ""last_author"": ""Bredt DS"", ""type"": ""PubMed"", ""author_list"": [""Matta JA"", ""Gu S"", ""Davini WB"", ""Lord B"", ""Siuda ER"", ""Harrington AW"", ""Bredt DS""], ""title"": ""NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain."", ""doi"": ""10.1016/j.celrep.2017.04.008""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Binding Sites"", ""Brain"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Cell Line"", ""Cognitive Dysfunction"", ""Conotoxins"", ""Humans"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Mice"", ""Mice, Knockout"", ""Molecular Chaperones"", ""Neurons"", ""Nicotine"", ""Protein Binding"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic""], ""substances"": [""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Conotoxins"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Molecular Chaperones"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic"", ""Ric-3 protein, mouse"", ""Nicotine"", ""Iodine-125"", ""epibatidine""]}",False
CAUSES_NO_CHANGE,6933,5108,2019.0,29196815,False,False,False,"On the contrary, no relationship between total Aβ plaque burden and number of astrocytes or neurons was found (da Rocha-Souto et al. 2011).",#65:51,,"{""full_journal_name"": ""Journal of neural transmission (Vienna, Austria : 1996)"", ""pub_date"": ""2019-09-30"", ""ref"": ""29196815"", ""pub_year"": 2019, ""last_author"": ""Lewczuk P"", ""type"": ""PubMed"", ""author_list"": [""Mroczko B"", ""Groblewska M"", ""Litman-Zawadzka A"", ""Kornhuber J"", ""Lewczuk P""], ""title"": ""Amyloid \u03b2 oligomers (A\u03b2Os) in Alzheimer's disease."", ""doi"": ""10.1007/s00702-017-1820-x""}","{""Cell"": [""neuron""], ""CellStructure"": [""Extracellular Space""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Biomarkers"", ""Humans"", ""Peptide Fragments""], ""substances"": [""Amyloid beta-Peptides"", ""Biomarkers"", ""Peptide Fragments""]}",False
CAUSES_NO_CHANGE,7260,20387,2009.0,18986241,False,False,False,"Single cell expression via microarray analysis was used to determine whether expression levels for nAChR and mAChR receptors, as well as ChAT, were differentially regulated within individual CBF neurons harvested from NCI, MCI and AD cases. ChAT mRNA expression levels did not differ across clinical conditions (Table 1). However, there was a significant upregulation of alpha7 nAChR subunit expression in AD compared with NCI and MCI.",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cholinergic Neurons""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,40458,2136,2015.0,25171717,False,False,False,"We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",#67:28,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-08-18"", ""ref"": ""25171717"", ""pub_year"": 2015, ""last_author"": ""Karsdal MA"", ""type"": ""PubMed"", ""author_list"": [""Henriksen K"", ""Byrjalsen I"", ""Christiansen C"", ""Karsdal MA""], ""title"": ""Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease."", ""doi"": ""10.3233/JAD-140984""}","{""mesh"": [""Aged"", ""Alzheimer Disease"", ""Biomarkers"", ""Clinical Trials, Phase III as Topic"", ""Disease Progression"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Humans"", ""Linear Models"", ""Male"", ""Mental Status Schedule"", ""Severity of Illness Index"", ""Time Factors"", ""tau Proteins""], ""substances"": [""Biomarkers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,2664,43753,2014.0,24027553,False,False,False,"Additionally, in a hippocampal slice preparation, induction of autophagy by treatment with methylene blue led to a decrease in phosphorylated tau and insoluble tau without an effect on total tau (95).",#57:4,PMC3759803,"{""full_journal_name"": ""Frontiers in neurology"", ""pub_date"": ""2014-06-24"", ""ref"": ""24027553"", ""pub_year"": 2014, ""last_author"": ""Johnson GV"", ""type"": ""PubMed"", ""author_list"": [""Chesser AS"", ""Pritchard SM"", ""Johnson GV""], ""title"": ""Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease."", ""doi"": ""10.3389/fneur.2013.00122""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Hippocampus""], ""TextLocation"": [""Review""]}",False
CAUSES_NO_CHANGE,11891,35264,2015.0,25546293,False,False,False,"However, inhibitors specific for class I HDACs, such as CI-994, which inhibits HDACs 1, 2, and 3, Cpd-60, which inhibits HDACs 1 and 2, and BG-45, which preferentially inhibits HDAC3, did not increase levels of Ac-Lys49 β-catenin.",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,7025,12491,2019.0,29590627,False,False,False,"We confirmed that heparin within the aggregated tau preparations did not contribute to tau entry into neurons, finding that uptake of both monomeric and aggregated tau was unaffected in the presence of heparin (Figures S4C and S4D",#57:66,PMC5896171,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2019-11-05"", ""ref"": ""29590627"", ""pub_year"": 2019, ""last_author"": ""Livesey FJ"", ""type"": ""PubMed"", ""author_list"": [""Evans LD"", ""Wassmer T"", ""Fraser G"", ""Smith J"", ""Perkinton M"", ""Billinton A"", ""Livesey FJ""], ""title"": ""Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways."", ""doi"": ""10.1016/j.celrep.2018.03.021""}","{""mesh"": [""Cerebral Cortex"", ""Dynamins"", ""Endocytosis"", ""Human Embryonic Stem Cells"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregation, Pathological"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,14368,7246,2018.0,30027901,False,False,False,"In a double-blind crossover trial involving four treatments of haloperidol, haloperidol and lithium carbonate, lithium carbonate and placebo carried out for three weeks, none of the treatments provided effective relief from choreiform movements.",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,41118,38913,2011.0,21367866,False,False,False,Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged,#62:7,PMC3089541,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2011-07-12"", ""ref"": ""21367866"", ""pub_year"": 2011, ""last_author"": ""Dickey CA"", ""type"": ""PubMed"", ""author_list"": [""Jinwal UK"", ""Trotter JH"", ""Abisambra JF"", ""Koren J"", ""Lawson LY"", ""Vestal GD"", ""O'Leary JC"", ""Johnson AG"", ""Jin Y"", ""Jones JR"", ""Li Q"", ""Weeber EJ"", ""Dickey CA""], ""title"": ""The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics."", ""doi"": ""10.1074/jbc.M110.182493""}","{""Confidence"": [""Medium""], ""Method"": [""Immunocytochemistry"", ""RNA Interference, siRNA"", ""Western Blot""], ""mesh"": [""Alzheimer Disease"", ""Brain"", ""Cell Cycle Proteins"", ""Cell Line, Tumor"", ""Chaperonins"", ""HSP90 Heat-Shock Proteins"", ""HeLa Cells"", ""Humans"", ""Immunohistochemistry"", ""Molecular Chaperones"", ""Neurons"", ""Phosphorylation"", ""RNA, Small Interfering"", ""Transfection"", ""tau Proteins""], ""substances"": [""CDC37 protein, human"", ""Cell Cycle Proteins"", ""HSP90 Heat-Shock Proteins"", ""Molecular Chaperones"", ""RNA, Small Interfering"", ""tau Proteins"", ""Chaperonins""]}",False
CAUSES_NO_CHANGE,4839,41587,2000.0,10887109,False,False,False,"These experiments determined that Lck, but not Syk or Zap70, was capable of mediating phosphorylation of CD33 in vivo (Figure 2A).",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,14403,21816,2011.0,21745645,False,False,False,"When cholinergic input was activated 10 ms before SC stimulation, STD was induced, which was also sensitive to MLA but not to DHβE or atropine (Figures 5J and 5H).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,43753,30393,2013.0,22908190,False,False,False,In vitro experiments further showed that aggregated (recombinant) tau—but not nonaggregated (monomeric) tau—can inhibit the proteasome activity.,#61:56,PMC3405832,"{""full_journal_name"": ""Cold Spring Harbor perspectives in medicine"", ""pub_date"": ""2013-06-26"", ""ref"": ""22908190"", ""pub_year"": 2013, ""last_author"": ""Nixon R"", ""type"": ""PubMed"", ""author_list"": [""Ihara Y"", ""Morishima-Kawashima M"", ""Nixon R""], ""title"": ""The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease."", ""doi"": ""10.1101/cshperspect.a006361""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Amyloid beta-Peptides"", ""Animals"", ""Autophagy"", ""Cellular Senescence"", ""Disease Models, Animal"", ""Disease Progression"", ""Endosomes"", ""Humans"", ""Lysosomes"", ""Mice"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""Neurons"", ""Proteasome Endopeptidase Complex"", ""Proteolysis"", ""Ubiquitin"", ""tau Proteins""], ""substances"": [""Amyloid"", ""Amyloid beta-Peptides"", ""Ubiquitin"", ""tau Proteins"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,2047,12440,2019.0,30664622,False,False,False,"Further results showed no significant brain penetration of Evans blue ( < 0.1 ng/ml, which was the limit of detection), and no difference between chlorobutanol and saline.",#69:15,PMC6341082,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-06-10"", ""ref"": ""30664622"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Sragovich S"", ""Malishkevich A"", ""Piontkewitz Y"", ""Giladi E"", ""Touloumi O"", ""Lagoudaki R"", ""Grigoriadis N"", ""Gozes I""], ""title"": ""The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse."", ""doi"": ""10.1038/s41398-018-0357-6""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Brain"", ""Diffusion Tensor Imaging"", ""Disease Models, Animal"", ""Female"", ""Haploinsufficiency"", ""Homeodomain Proteins"", ""Magnetic Resonance Imaging"", ""Male"", ""Mice"", ""Mice, 129 Strain"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Neuroprotection"", ""Oligopeptides"", ""Synapses"", ""Vesicular Glutamate Transport Protein 1""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Oligopeptides"", ""Slc17a7 protein, mouse"", ""Vesicular Glutamate Transport Protein 1"", ""davunetide""]}",False
CAUSES_NO_CHANGE,1650,10729,2009.0,19293145,False,False,False,"It has also been observed that although Abeta inhibits recombinant human and mouse alpha7 nAChRs, transgenic mice overexpressing human Abeta express functional alpha7 nAChRs, and the amplitude of alpha7- mediated currents is no different from that of wild-type mice (Spencer et al., 2006).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,1609,38244,2019.0,30008470,False,False,False,We found no changes in the expression of Adnp in the VTA (p’s > 0.05).,#65:46,PMC6300527,"{""full_journal_name"": ""Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"", ""pub_date"": ""2019-02-11"", ""ref"": ""30008470"", ""pub_year"": 2019, ""last_author"": ""Barak S"", ""type"": ""PubMed"", ""author_list"": [""Ziv Y"", ""Rahamim N"", ""Lezmy N"", ""Even-Chen O"", ""Shaham O"", ""Malishkevich A"", ""Giladi E"", ""Elkon R"", ""Gozes I"", ""Barak S""], ""title"": ""Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice."", ""doi"": ""10.1038/s41386-018-0132-7""}","{""Confidence"": [""High""], ""Gender"": [""Female"", ""Male""], ""MeSHAnatomy"": [""Ventral Tegmental Area""], ""Species"": [""10090""], ""mesh"": [""Alcohol Drinking"", ""Animals"", ""Disease Models, Animal"", ""Ethanol"", ""Female"", ""Gene Expression"", ""Haploinsufficiency"", ""Hippocampus"", ""Homeodomain Proteins"", ""Male"", ""Mice"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Sex Factors""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Ethanol""]}",False
CAUSES_NO_CHANGE,7981,23653,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,35124,7247,2019.0,30562574,False,False,False,"Moreover, assessment of cell survival by nuclear counts assay carried out at the same time-point, revealed no detectable cytotoxicity stemming from LAMP2A down-regulation (Fig. 1C). To exclude any aberrant effects that might precede cell death per se, but might still confound our analysis, we measured gross levels of two established neuronal markers: the axon-associated tubulin beta-3 chain (TUBB3/TUJ-1) (Fig. 1D), and the dendritic marker microtubule- associated protein 2(MAP2) (Fig. 1E) - both of which showed no significant changes.",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,1845,7649,2006.0,16511867,False,False,False,"Cerebrolysin is a peptide mixture with neurotrophic effects that might reduce the neurodegenerative pathology in Alzheimer's disease (AD). Cerebrolysin might reduce amyloid deposition by regulating amyloid- beta (Abeta) degradation or by modulating APP expression, maturation, or processing. To investigate these possibilities, APP tg mice were treated for 6 months with Cerebrolysin and analyzed in the water maze, followed by RNA, immunoblot, and confocal microscopy analysis of full- length (FL) APP and its fragments, beta-secretase (BACE1), and Abeta- degrading enzymes [neprilysin (Nep) and insulin-degrading enzyme (IDE)]. Consistent with previous studies, Cerebrolysin ameliorated the performance deficits in the spatial learning portion of the water maze and reduced the synaptic pathology and amyloid burden in the brains of APP tg mice. These effects were associated with reduced levels of FL APP and APP C-terminal fragments, but levels of BACE1, Notch1, Nep, and IDE were unchanged. In contrast, levels of active cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3beta [GSK-3beta; but not stress-activated protein kinase-1 (SAPK1)], kinases that phosphorylate APP, were reduced. Furthermore, Cerebrolysin reduced the levels of phosphorylated APP and the accumulation of APP in the neuritic processes. Taken together, these results suggest that Cerebrolysin might reduce AD-like pathology in the APP tg mice by regulating APP maturation and transport to sites where Abeta protein is generated.",#59:5,,"{""full_journal_name"": ""Journal of neuroscience research"", ""pub_date"": ""2006-07-25"", ""ref"": ""16511867"", ""pub_year"": 2006, ""last_author"": ""Masliah E"", ""type"": ""PubMed"", ""author_list"": [""Rockenstein E"", ""Torrance M"", ""Mante M"", ""Adame A"", ""Paulino A"", ""Rose JB"", ""Crews L"", ""Moessler H"", ""Masliah E""], ""title"": ""Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.""}","{""Species"": [""10090""], ""Subgraph"": [""Nerve growth factor subgraph"", ""Notch signaling subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amino Acids"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""Cyclin-Dependent Kinase 5"", ""Disease Models, Animal"", ""Down-Regulation"", ""Endopeptidases"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Insulysin"", ""Maze Learning"", ""Mice"", ""Mice, Transgenic"", ""Neprilysin"", ""Neurons"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Protein Transport"", ""RNA, Messenger""], ""substances"": [""Amino Acids"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Neuroprotective Agents"", ""RNA, Messenger"", ""cerebrolysin"", ""Cyclin-Dependent Kinase 5"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Neprilysin"", ""Insulysin""]}",False
CAUSES_NO_CHANGE,1222,2970,2009.0,19293145,False,False,False,"Intracerebral injection of Abeta into rats resulted in a loss of alpha4 and alpha7 subunits as measured by Western blotting but an increase in alpha7 mRNA (Liu et al., 2008), again suggesting that Abeta directly reduces expression of alpha7 nAChRs through mechanisms other than reduced mRNAproduction, although caution should be exercised in interpreting quantitative data from Western blot studies. It is noteworthy that a combined patch-clamp and in situ hybridization study of dissociated human brain tissue (obtained as route-of-access tissue removed during surgery) indicated that neurons near Abeta plaques retained alpha4 and alpha7 mRNA transcripts, whereas these transcripts were absent in neurons burdened with hyperphosphorylated tau protein (Wevers et al., 1999).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,41520,7139,2019.0,30106381,False,False,False,"This was coupled with deficits in olfactory function in the Adnp+/– females, but not males, with the female mice exhibiting impaired odor discrimination that was also restored by NAP treatment (Figure 7E; for more detail, see Supplemental Figure 14).",#63:5,PMC6205398,"{""full_journal_name"": ""The Journal of clinical investigation"", ""pub_date"": ""2019-09-11"", ""ref"": ""30106381"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Hacohen-Kleiman G"", ""Sragovich S"", ""Karmon G"", ""Gao AYL"", ""Grigg I"", ""Pasmanik-Chor M"", ""Le A"", ""Korenkov\u00e1 V"", ""McKinney RA"", ""Gozes I""], ""title"": ""Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome."", ""doi"": ""10.1172/JCI98199""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""9606""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Autistic Disorder"", ""Behavior, Animal"", ""Biomarkers"", ""Cell Membrane"", ""Dendritic Spines"", ""Gene Expression Regulation"", ""Homeodomain Proteins"", ""Humans"", ""Mice"", ""Mice, Knockout"", ""Microtubules"", ""Models, Neurological"", ""Mutation"", ""Naphthoquinones"", ""Nerve Tissue Proteins"", ""Synapses"", ""Syndrome""], ""substances"": [""2-(3,5-di-tert-butyl-4-hydroxyl)-3-chloro-1,4-naphthoquinone"", ""Adnp protein, mouse"", ""Biomarkers"", ""Homeodomain Proteins"", ""Naphthoquinones"", ""Nerve Tissue Proteins""]}",False
CAUSES_NO_CHANGE,11128,37478,2013.0,22926167,False,False,False,"In fact, phosphorylation of Pin1 at Ser16 inhibits its nuclear localization possibly through inhibition of Pin1 substrate-binding property (Lu et al., 2002) while phosphorylation at Ser65 does not change activity of localization but stabilizes Pin1 by preventing its ubiquitination",#60:23,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2013-05-24"", ""ref"": ""22926167"", ""pub_year"": 2013, ""last_author"": ""Bu\u00e9e L"", ""type"": ""PubMed"", ""author_list"": [""Ando K"", ""Dourlen P"", ""Sambo AV"", ""Bretteville A"", ""B\u00e9larbi K"", ""Vingtdeux V"", ""Eddarkaoui S"", ""Drobecq H"", ""Ghestem A"", ""B\u00e9gard S"", ""Demey-Thomas E"", ""Melnyk P"", ""Smet C"", ""Lippens G"", ""Maurage CA"", ""Caillet-Boudin ML"", ""Verdier Y"", ""Vinh J"", ""Landrieu I"", ""Galas MC"", ""Blum D"", ""Hamdane M"", ""Sergeant N"", ""Bu\u00e9e L""], ""title"": ""Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker."", ""doi"": ""10.1016/j.neurobiolaging.2012.08.004""}","{""Confidence"": [""Medium""], ""mesh"": [""Acetylation"", ""Adult"", ""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Biomarkers"", ""Brain"", ""Cell Line, Tumor"", ""Disease Models, Animal"", ""Female"", ""Humans"", ""Male"", ""Mice"", ""Mice, Transgenic"", ""Middle Aged"", ""NIMA-Interacting Peptidylprolyl Isomerase"", ""Oxidation-Reduction"", ""Peptidylprolyl Isomerase"", ""Phosphorylation"", ""Proline"", ""Protein Processing, Post-Translational"", ""Proteome"", ""Serine"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Biomarkers"", ""MAPT protein, human"", ""Mapt protein, mouse"", ""NIMA-Interacting Peptidylprolyl Isomerase"", ""Proteome"", ""tau Proteins"", ""Serine"", ""Proline"", ""PIN1 protein, human"", ""Peptidylprolyl Isomerase"", ""Pin1 protein, mouse""]}",False
CAUSES_NO_CHANGE,7296,3334,2019.0,30962309,False,False,False,"Furthermore, miR-146a expression is increased in colonic mucosa of Crohn disease patients compared with ulcerative colitis and healthy controls, and it is increased in colonic tissue in both Crohn disease and ulcerative colitis (121).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
CAUSES_NO_CHANGE,6709,7908,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,1808,27049,2011.0,20847424,False,False,False,"Abeta40 inhibits cultured neuron death caused by Cu2+, Fe2+, and Fe3+ but does not protect neurons against H2O2-induced damage [94].",#63:30,PMC3079354,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2011-06-09"", ""ref"": ""20847424"", ""pub_year"": 2011, ""last_author"": ""Brewer GJ"", ""type"": ""PubMed"", ""author_list"": [""Parihar MS"", ""Brewer GJ""], ""title"": ""Amyloid-\u03b2 as a modulator of synaptic plasticity."", ""doi"": ""10.3233/JAD-2010-101020""}","{""Confidence"": [""High""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Neuronal Plasticity"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,38594,39470,2019.0,29540553,False,False,False,"Interestingly, deletion of SIRT1 did not affect the number of neurofibrillary tangles significantly, as measured with Gallyas silver staining (Fig. 3D).",#68:33,PMC5895994,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2019-10-03"", ""ref"": ""29540553"", ""pub_year"": 2019, ""last_author"": ""Gan L"", ""type"": ""PubMed"", ""author_list"": [""Min SW"", ""Sohn PD"", ""Li Y"", ""Devidze N"", ""Johnson JR"", ""Krogan NJ"", ""Masliah E"", ""Mok SA"", ""Gestwicki JE"", ""Gan L""], ""title"": ""SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy."", ""doi"": ""10.1523/JNEUROSCI.2369-17.2018""}","{""CellLine"": [""HEK293""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Female"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Male"", ""Maze Learning"", ""Mice"", ""Sirtuin 1"", ""Synaptic Transmission"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mapt protein, mouse"", ""tau Proteins"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,35177,43753,2017.0,27257626,False,False,False,These results clearly suggest that TFEB overexpression selectively clears hyperphosphorylated tau species but not the nonphosphorylated forms of tau.,#64:26,PMC4876487,"{""full_journal_name"": ""eNeuro"", ""pub_date"": ""2017-10-20"", ""ref"": ""27257626"", ""pub_year"": 2017, ""last_author"": ""Lakshmana MK"", ""type"": ""PubMed"", ""author_list"": [""Wang H"", ""Wang R"", ""Carrera I"", ""Xu S"", ""Lakshmana MK""], ""title"": ""TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits."", ""doi"": ""10.1523/ENEURO.0042-16.2016""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Tauopathies""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""DNA-Binding Proteins"", ""Disease Models, Animal"", ""Lipofuscin"", ""Male"", ""Maze Learning"", ""Memory Disorders"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Neurons"", ""Polycomb-Group Proteins"", ""Tauopathies"", ""Transcription Factors"", ""beta-Galactosidase"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Lipofuscin"", ""Phf1 protein, mouse"", ""Polycomb-Group Proteins"", ""TFEB protein, human"", ""Transcription Factors"", ""tau Proteins"", ""beta-Galactosidase""]}",False
CAUSES_NO_CHANGE,6938,1543,2017.0,27794524,False,False,False,"In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,1928,35264,2015.0,25546293,False,False,False,"However, inhibitors specific for class I HDACs, such as CI-994, which inhibits HDACs 1, 2, and 3, Cpd-60, which inhibits HDACs 1 and 2, and BG-45, which preferentially inhibits HDAC3, did not increase levels of Ac-Lys49 β-catenin.",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,12060,7350,2019.0,29024336,False,False,False,The most notable difference between the two tau mutants was the inability of P301L to undergo degradation by CMA or by macroautophagy,#61:23,PMC5770880,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2019-07-30"", ""ref"": ""29024336"", ""pub_year"": 2019, ""last_author"": ""Cuervo AM"", ""type"": ""PubMed"", ""author_list"": [""Caballero B"", ""Wang Y"", ""Diaz A"", ""Tasset I"", ""Juste YR"", ""Stiller B"", ""Mandelkow EM"", ""Mandelkow E"", ""Cuervo AM""], ""title"": ""Interplay of pathogenic forms of human tau with different autophagic pathways."", ""doi"": ""10.1111/acel.12692""}","{""CellStructure"": [""Multivesicular Bodies""], ""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Brain""], ""mesh"": [""Animals"", ""Autophagy"", ""Brain"", ""Humans"", ""Male"", ""Mutation"", ""Neurodegenerative Diseases"", ""Neurons"", ""Phosphorylation"", ""Proteolysis"", ""Rats, Wistar"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,42797,7247,2013.0,23356410,False,False,False,"In addition to this, the overexpression of HDAC3 resulted in cytotoxicity in cortical neurons and in hippocampally derived HT22 cells, but not in primary kidney fibroblasts, HEK293 and HeLa cell lines [55].",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Fibroblasts"", ""Kidney""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,1748,5394,2017.0,27209302,False,False,False,"Meanwhile, we found that TSA could not affect microglial degradative capability on fAβ (Fig. S4E), indicating that it is SIRT1, but not other HDACs, that is responsible for fAβ degradation in microglia.",#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,35177,21112,2015.0,25069841,False,False,False,Immunohistochemical staining and quantification of Ab pathology also showed that TFEB had no appreciable effect on amyloid deposition (Supplementary Fig S2C–F).,#72:5,PMC4197862,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2015-05-22"", ""ref"": ""25069841"", ""pub_year"": 2015, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Polito VA"", ""Li H"", ""Martini-Stoica H"", ""Wang B"", ""Yang L"", ""Xu Y"", ""Swartzlander DB"", ""Palmieri M"", ""di Ronza A"", ""Lee VM"", ""Sardiello M"", ""Ballabio A"", ""Zheng H""], ""title"": ""Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB."", ""doi"": ""10.15252/emmm.201303671""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyloid Neuropathies""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Gene Expression Regulation"", ""Lysosomes"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""PTEN Phosphohydrolase"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Mapt protein, mouse"", ""Tcfeb protein, mouse"", ""tau Proteins"", ""PTEN Phosphohydrolase"", ""Pten protein, mouse""]}",False
CAUSES_NO_CHANGE,42894,6573,2012.0,22179319,False,False,False,"In addition, SIRT1 overexpression did not alter aggregation of mutant Htt (Supplementary Fig. 4), suggesting that aggregation does not play a major role in neuroprotective effects of SIRT1 in our models.",#66:20,PMC4551453,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2012-03-14"", ""ref"": ""22179319"", ""pub_year"": 2012, ""last_author"": ""Duan W"", ""type"": ""PubMed"", ""author_list"": [""Jiang M"", ""Wang J"", ""Fu J"", ""Du L"", ""Jeong H"", ""West T"", ""Xiang L"", ""Peng Q"", ""Hou Z"", ""Cai H"", ""Seredenina T"", ""Arbez N"", ""Zhu S"", ""Sommers K"", ""Qian J"", ""Zhang J"", ""Mori S"", ""Yang XW"", ""Tamashiro KL"", ""Aja S"", ""Moran TH"", ""Luthi-Carter R"", ""Martin B"", ""Maudsley S"", ""Mattson MP"", ""Cichewicz RH"", ""Ross CA"", ""Holtzman DM"", ""Krainc D"", ""Duan W""], ""title"": ""Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets."", ""doi"": ""10.1038/nm.2558""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Huntington Disease""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Disease Models, Animal"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""Gene Expression Regulation"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins"", ""Rats"", ""Receptor, trkB"", ""Signal Transduction"", ""Sirtuin 1""], ""substances"": [""Brain-Derived Neurotrophic Factor"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""FoxO3 protein, mouse"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Ppp1r1b protein, mouse"", ""Receptor, trkB"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,11645,7926,2005.0,15597323,False,False,False,"Interestingly, we could not observe an increase in p38 phosphorylation when monocytes were preincubated with LY294002, thus indicating that IL‐1β enhancement induced by PI3K was not operating directly on p38 MAPK.",#57:0,,"{""full_journal_name"": ""European journal of immunology"", ""pub_date"": ""2005-02-23"", ""ref"": ""15597323"", ""pub_year"": 2005, ""last_author"": ""Chizzolini C"", ""type"": ""PubMed"", ""author_list"": [""Lajaunias F"", ""Dayer JM"", ""Chizzolini C""], ""title"": ""Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Gene Silencing"", ""Humans"", ""Immunity, Innate"", ""In Vitro Techniques"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-8"", ""Monocytes"", ""N-Acetylneuraminic Acid"", ""Phosphatidylinositol 3-Kinases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Signal Transduction"", ""Tumor Necrosis Factor-alpha"", ""p38 Mitogen-Activated Protein Kinases""], ""substances"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Interleukin-1"", ""Interleukin-8"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Tumor Necrosis Factor-alpha"", ""Phosphatidylinositol 3-Kinases"", ""p38 Mitogen-Activated Protein Kinases"", ""N-Acetylneuraminic Acid""]}",False
CAUSES_NO_CHANGE,11809,1513,2017.0,27794524,False,False,False,"Because levels of inflammation were not affected by MitoQ, it is conceivable that increased mitochondrial protection against ROS is sufficient to reduce axonal damage.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6673,1391,2020.0,30837838,False,False,False,"Notably, the zinc ions could induce inclusion bodies formation and aggregation in the neuronal cell cultures, and this effect was not observed with copper or iron, indicating zinc-specific effects (Caragounis et al., 2010).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}",{},False
CAUSES_NO_CHANGE,41600,33753,2017.0,28148553,False,False,False,"However, similar to the situation in PSP, 4R tau (but not 3R tau or mCherry) suppressed EIF2A at the protein level. pEIF2A was reduced by both 4R and 3R tau.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,43753,2245,2011.0,21734277,False,False,False,"perfusion of full-length WT tau monomers (2 􏰊M) (Fig. 1 A) had no effect on FAT in squid axoplasm (Fig. 2 A), while 6D and 6P tau monomers (2 􏰊M) significantly inhibited anterograde FAT when compared with WT tau monomer (Fig. 2 B, C) or buffer controls (data not shown).",#69:76,PMC3391724,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2011-09-09"", ""ref"": ""21734277"", ""pub_year"": 2011, ""last_author"": ""Binder LI"", ""type"": ""PubMed"", ""author_list"": [""Kanaan NM"", ""Morfini GA"", ""LaPointe NE"", ""Pigino GF"", ""Patterson KR"", ""Song Y"", ""Andreadis A"", ""Fu Y"", ""Brady ST"", ""Binder LI""], ""title"": ""Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases."", ""doi"": ""10.1523/JNEUROSCI.0560-11.2011""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cytoplasm"", ""Neurons""], ""mesh"": [""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Axonal Transport"", ""Axons"", ""Brain"", ""Decapodiformes"", ""Enzyme Inhibitors"", ""Enzyme-Linked Immunosorbent Assay"", ""Glycogen Synthase Kinase 3"", ""Humans"", ""In Vitro Techniques"", ""Kinesins"", ""Models, Biological"", ""Mutagenesis"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Phosphotransferases"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Enzyme Inhibitors"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""tau Proteins"", ""neuropeptide Y4 receptor"", ""Phosphotransferases"", ""Glycogen Synthase Kinase 3"", ""Kinesins""]}",False
CAUSES_NO_CHANGE,14465,1365,2015.0,25639674,False,False,False,"In a chronic constriction injury model for neuropathic pain, an anti- hyperalgesic and anti-allodynic effect of PNU-120596 was observed, however NS-1738 did not have any effect in the same study [184].One possible mechanism for this may be the ability of PNU-120596 to enhance α7 nAChR activation over a certain threshold, which would indirectly stimulate inhibitory neurons located in the neural circuits for neuropathic pain.",#59:10,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Neuralgia""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,1650,39329,2009.0,19293145,False,False,False,"Again, despite numerous reports of a block of alpha7, one study indicated that Abeta failed to block alpha7, even though it blocked alpha4beta2, alpha2beta2 and alpha4alpha5beta2 receptors (Lamb et al., 2005).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,38407,44542,2009.0,19713215,False,False,False,"Arhgef5 can strongly activate RhoA and RhoB and weakly RhoC and RhoG, but not Rac1, RhoQ, RhoD, or RhoV, in transfected human embryonic kidney 293 cells.",#59:5,PMC2781403,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2009-11-24"", ""ref"": ""19713215"", ""pub_year"": 2009, ""last_author"": ""Wu D"", ""type"": ""PubMed"", ""author_list"": [""Wang Z"", ""Kumamoto Y"", ""Wang P"", ""Gan X"", ""Lehmann D"", ""Smrcka AV"", ""Cohn L"", ""Iwasaki A"", ""Li L"", ""Wu D""], ""title"": ""Regulation of immature dendritic cell migration by RhoA guanine nucleotide exchange factor Arhgef5."", ""doi"": ""10.1074/jbc.M109.047282""}","{""CellLine"": [""HEK293""], ""Subgraph"": [""RhoA subgraph""], ""mesh"": [""Animals"", ""Asthma"", ""Cell Culture Techniques"", ""Cell Movement"", ""Chemotaxis"", ""Dendritic Cells"", ""Gene Expression Regulation"", ""Guanine Nucleotide Exchange Factors"", ""Humans"", ""Luciferases"", ""Mice"", ""Mice, Transgenic"", ""Ovalbumin"", ""Proto-Oncogene Proteins"", ""Rho Guanine Nucleotide Exchange Factors"", ""rhoA GTP-Binding Protein""], ""substances"": [""ARHGEF5 protein, human"", ""Guanine Nucleotide Exchange Factors"", ""Proto-Oncogene Proteins"", ""Rho Guanine Nucleotide Exchange Factors"", ""Ovalbumin"", ""Luciferases"", ""rhoA GTP-Binding Protein""]}",False
CAUSES_NO_CHANGE,1846,1396,2017.0,26979166,False,False,False,"Remarkably, α7 nAChR-positive allosteric modulators (galantamine, galantamine plus choline, and JNJ39393406) were completely inactive [100].",#58:34,PMC4894934,"{""full_journal_name"": ""Cellular and molecular life sciences : CMLS"", ""pub_date"": ""2017-02-15"", ""ref"": ""26979166"", ""pub_year"": 2017, ""last_author"": ""Feuerbach D"", ""type"": ""PubMed"", ""author_list"": [""Kalkman HO"", ""Feuerbach D""], ""title"": ""Modulatory effects of \u03b17 nAChRs on the immune system and its relevance for CNS disorders."", ""doi"": ""10.1007/s00018-016-2175-4""}","{""Confidence"": [""High""], ""Disease"": [""schizophrenia""], ""mesh"": [""Animals"", ""Central Nervous System Diseases"", ""Drug Discovery"", ""Humans"", ""Immune System"", ""Signal Transduction"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor""]}",False
CAUSES_NO_CHANGE,3728,35208,2020.0,30606258,False,False,False,"We were unable to detect phosphorylation (activation) of inositol- requiring enzyme 1α (IRE1α) in any of the three cell lines and there were no differences in the total amount of IRE1α present (Fig. 6c, d), suggesting that this branch of the UPR is not activated by either Tau35 or FL-tau.",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,7981,10238,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,42691,21289,2017.0,28760828,False,False,False,"Of note, whereas mimicking acetylation at most non-KXGS sites had minimal impact on tau aggregation, K274Q also significantly decreased tau assembly in vitro, albeit to a lesser extent than K321Q (Fig. 1b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,6789,34512,2015.0,25331948,False,False,False,"Interestingly, we also detected a reduction in Tau phosphorylation at PHF-1 (Ser(P)- 396/Ser(P)-404) and CP13 (Ser(P)-202) in epitopes following treatment of Tg Tau P301S mice with BAY61-3606, whereas the RZ3 (Thr(P)-231) Tau epitope was not significantly impacted (Fig. 8) suggesting that Syk inhibition may also control the activity of other downstream kinases involved in Tau hyperphosphorylation",#70:54,PMC4256331,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-03-03"", ""ref"": ""25331948"", ""pub_year"": 2015, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Ait-Ghezala G"", ""Bachmeier C"", ""Laco G"", ""Beaulieu-Abdelahad D"", ""Lin Y"", ""Jin C"", ""Crawford F"", ""Mullan M""], ""title"": ""The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-\u03b2 production and Tau hyperphosphorylation."", ""doi"": ""10.1074/jbc.M114.608091""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""CHO Cells"", ""Calcium Channel Blockers"", ""Cell Line, Tumor"", ""Cricetulus"", ""Gene Expression Regulation"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""Neurons"", ""Nifedipine"", ""Phosphorylation"", ""Protein-Tyrosine Kinases"", ""Signal Transduction"", ""Syk Kinase"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Calcium Channel Blockers"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""tau Proteins"", ""nilvadipine"", ""Protein-Tyrosine Kinases"", ""SYK protein, human"", ""Syk Kinase"", ""Syk protein, mouse"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Nifedipine""]}",False
CAUSES_NO_CHANGE,6824,7262,2018.0,30027901,False,False,False,"GABAergic strategies have included muscimol, a potent GABA mimetic agonist (Shoulson et al. 1978). In this double-blind study,muscimol treatment did not lead to any improvement in motor and cognitive deficits in 10 HD patients. However, administration of muscimol ameliorated chorea in the most severely affected hyperkinetic patients. It also heightened dystonia, particularly in the early onset patients who had predominant parkinsonism and dystonic features.",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,29628,7122,2017.0,29191965,False,False,False,"Loss of function in other genes (cat-2, cat-4, tph-1) that also regulate the dopamine or serotonin levels (130–132),did not affect the tau-induced toxicity in TauV337M; however, their activity is essential for bas-1-mediated suppression of tau-induced toxicity in TauV337M (105)",#69:60,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2017-12-11"", ""ref"": ""29191965"", ""pub_year"": 2017, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Pir GJ"", ""Choudhary B"", ""Mandelkow E""], ""title"": {""#text"": ""models of tauopathy."", ""i"": ""Caenorhabditis elegans""}, ""doi"": ""10.1096/fj.201701007""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Caenorhabditis elegans"", ""Disease Models, Animal"", ""Neurodegenerative Diseases"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,41242,11938,2000.0,10887109,False,False,False,"Cross-linking of control antibody or CD33 alone resulted in no increase in [Ca++]i. In contrast, cross-linking of CD64 resulted in robust mobilization of intracellular calcium as demonstrated by the increase in [Ca++]i (Figure 7).Co-cross-linking of CD64 with CD33, however, resulted in diminished calcium mobilization as compared with cross-linking of CD64 alone.",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""CellLine"": [""U937""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,14403,2361,2011.0,21745645,False,False,False,"When cholinergic input was activated 10 ms after SC stimulation, LTP was induced, which was blocked by atropine but not by MLA or DHβE(Figures 5K and 5L).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""after SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,3452,6064,2009.0,19277525,False,False,False,Neither mutation of the carboxy-terminal Leu residue nor removal of the carboxy-terminal 14 amino acids of the catalytic subunit prevented formation of heterotrimeric holoenzymes involving the B or B′ subunits,#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""Medium""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,6709,36474,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,1299,37306,2006.0,16273023,False,False,False,"Despite the various cholinergic abnormalities seen in Alzheimer's disease, ACh receptor systems remain relatively unaltered in affected patients.8",#58:1,,"{""full_journal_name"": ""CNS spectrums"", ""pub_date"": ""2006-02-24"", ""ref"": ""16273023"", ""pub_year"": 2006, ""last_author"": ""Francis PT"", ""type"": ""PubMed"", ""author_list"": [""Francis PT""], ""title"": ""The interplay of neurotransmitters in Alzheimer's disease.""}","{""Confidence"": [""High""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Cholinergic Fibers"", ""Glutamate Plasma Membrane Transport Proteins"", ""Humans"", ""Neural Pathways"", ""Neurotransmitter Agents"", ""Receptors, Glutamate"", ""Receptors, N-Methyl-D-Aspartate""], ""substances"": [""Glutamate Plasma Membrane Transport Proteins"", ""Neurotransmitter Agents"", ""Receptors, Glutamate"", ""Receptors, N-Methyl-D-Aspartate""]}",False
CAUSES_NO_CHANGE,14217,43753,2020.0,30686764,False,False,False,"Activation of homologous nuclear receptors such as PPARa (by GW50156) and PPARg (by Rosiglitazone), which regulate fatty acid metabolism but not cholesterol export, did not decrease pThr231Tau/tTau (Figures 2C, S2F, and S2G).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,7260,31845,2009.0,18986241,False,False,False,"Butyrylcholinesterase (BChE) is a serine hydrolase similar to AChE that is widely distributed throughout the CNS and also catalyzes the hydrolysis of ACh. BChE is localized to neurons and glia, and is associated with NFTs and senile plaques (SPs) in AD brain [32]. Interestingly, population-based genetic studies of AD have identified a point mutation that changes Ala539 to threonine in the K variant of BChE, which effectively reduces serum BChE concentrations, and may be associated with cognitive decline [33]. BChE activity also increases in AD brain whereas AChE activity remains unchanged or declines [34,35].",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""Medium""], ""Disease"": [""Alzheimer's disease""], ""MeSHAnatomy"": [""Neuroglia"", ""Neurons""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,14217,43753,2020.0,30686764,False,False,False,"Activation of homologous nuclear receptors such as PPARa (by GW50156) and PPARg (by Rosiglitazone), which regulate fatty acid metabolism but not cholesterol export, did not decrease pThr231Tau/tTau (Figures 2C, S2F, and S2G).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,2721,7416,2019.0,30116051,False,False,False,"Htt is not efficiently cleared by CMA, and the same appears to hold for its fragments and mutant and post- translationally modified forms, although the precise role of CMA in Htt elimination remains to be more fully defined 2,45–47 .",#63:7,PMC6456907,"{""full_journal_name"": ""Nature reviews. Drug discovery"", ""pub_date"": ""2019-07-08"", ""ref"": ""30116051"", ""pub_year"": 2019, ""last_author"": ""Millan MJ"", ""type"": ""PubMed"", ""author_list"": [""Boland B"", ""Yu WH"", ""Corti O"", ""Mollereau B"", ""Henriques A"", ""Bezard E"", ""Pastores GM"", ""Rubinsztein DC"", ""Nixon RA"", ""Duchen MR"", ""Mallucci GR"", ""Kroemer G"", ""Levine B"", ""Eskelinen EL"", ""Mochel F"", ""Spedding M"", ""Louis C"", ""Martin OR"", ""Millan MJ""], ""title"": ""Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing."", ""doi"": ""10.1038/nrd.2018.109""}","{""Confidence"": [""Medium""], ""mesh"": [""Aging"", ""Animals"", ""Autophagy"", ""Humans"", ""Neurodegenerative Diseases"", ""Neurotoxins"", ""Proteasome Endopeptidase Complex"", ""Ubiquitin""], ""substances"": [""Neurotoxins"", ""Ubiquitin"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,38594,44178,2019.0,29540553,False,False,False,2A). Levels of total human tau or mouse tau were not significantly affected by SIRT1 deletion.,#68:33,PMC5895994,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2019-10-03"", ""ref"": ""29540553"", ""pub_year"": 2019, ""last_author"": ""Gan L"", ""type"": ""PubMed"", ""author_list"": [""Min SW"", ""Sohn PD"", ""Li Y"", ""Devidze N"", ""Johnson JR"", ""Krogan NJ"", ""Masliah E"", ""Mok SA"", ""Gestwicki JE"", ""Gan L""], ""title"": ""SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy."", ""doi"": ""10.1523/JNEUROSCI.2369-17.2018""}","{""CellLine"": [""HEK293""], ""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Female"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Male"", ""Maze Learning"", ""Mice"", ""Sirtuin 1"", ""Synaptic Transmission"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mapt protein, mouse"", ""tau Proteins"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,37870,2211,2017.0,27574109,False,False,False,"hT40, hT34, hT24, hT37 and hT23 aggregates did not significantly impair retrograde FAT when compared to the respective monomers, but hT39 aggregates elicited a mild inhibitory effect on retrograde FAT (Fig. 4B)",#70:49,PMC5075521,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-10-17"", ""ref"": ""27574109"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Cox K"", ""Combs B"", ""Abdelmesih B"", ""Morfini G"", ""Brady ST"", ""Kanaan NM""], ""title"": ""Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition."", ""doi"": ""10.1016/j.neurobiolaging.2016.07.015""}","{""mesh"": [""Alzheimer Disease"", ""Animals"", ""Axonal Transport"", ""Decapodiformes"", ""Humans"", ""In Vitro Techniques"", ""Polymerization"", ""Protein Aggregates"", ""Protein Domains"", ""Protein Isoforms"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Protein Aggregates"", ""Protein Isoforms"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,42797,7247,2013.0,23356410,False,False,False,"In addition to this, the overexpression of HDAC3 resulted in cytotoxicity in cortical neurons and in hippocampally derived HT22 cells, but not in primary kidney fibroblasts, HEK293 and HeLa cell lines [55].",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""CellLine"": [""HEK293"", ""HeLa cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,33520,39369,2008.0,17954934,False,False,False,We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.,#62:7,,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2008-02-20"", ""ref"": ""17954934"", ""pub_year"": 2008, ""last_author"": ""Ginzburg I"", ""type"": ""PubMed"", ""author_list"": [""Elliott E"", ""Tsvetkov P"", ""Ginzburg I""], ""title"": ""BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.""}","{""CellLine"": [""HEK293""], ""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Hippocampus""], ""Method"": [""Degradation Assay, 20S Proteasomal"", ""Immunohistochemistry"", ""Immunoprecipitation"", ""Pull-down Assay, GST"", ""SDS-PAGE"", ""Western Blot""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Disease Models, Animal"", ""HSC70 Heat-Shock Proteins"", ""Humans"", ""Mice"", ""Multiprotein Complexes"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Binding"", ""Transcription Factors"", ""tau Proteins""], ""substances"": [""BCL2-associated athanogene 1 protein"", ""DNA-Binding Proteins"", ""HSC70 Heat-Shock Proteins"", ""HSPA8 protein, human"", ""Hspa8 protein, mouse"", ""MAPT protein, human"", ""Multiprotein Complexes"", ""Transcription Factors"", ""tau Proteins"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,14206,1287,2017.0,27956442,False,False,False,"There are a large number of phase III trials using agents such azathioprine, ciclosporin, β-interferon, dirucotide (myelin basic protein), immunoglobulins and cladribine, as well as other immunomodulators, in progressive MS that have been reported over the last 25 years. Unfortunately, the results have essentially been negative. [10]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,1963,5734,2016.0,26582367,False,False,False,"Results showed that polySia avDP20 prevented the LPS-induced gene transcription of TNFSF2 at the concentration of 1.5 μM, while Sia as monomer or oligoSia with a DP of 6 had no effect (Fig. 2c).",#57:0,PMC4652165,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2016-09-12"", ""ref"": ""26582367"", ""pub_year"": 2016, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Shahraz A"", ""Kopatz J"", ""Mathy R"", ""Kappler J"", ""Winter D"", ""Kapoor S"", ""Sch\u00fctza V"", ""Scheper T"", ""Gieselmann V"", ""Neumann H""], ""title"": ""Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages."", ""doi"": ""10.1038/srep16800""}","{""CellLine"": [""THP-1""], ""ChallengeType"": [""lipopolysaccharide stimulation""], ""LPSDosage"": [""1 \u03bcg/ml""], ""NumberOfResidues"": [""6""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Cell Line"", ""Chromatography, High Pressure Liquid"", ""Homeostasis"", ""Humans"", ""Lectins"", ""Lipopolysaccharides"", ""Macrophages"", ""Membrane Proteins"", ""Microspheres"", ""Molecular Weight"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Polymerization"", ""Respiratory Burst"", ""Sialic Acids"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neuroprotective Agents"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""TNF protein, human"", ""Tumor Necrosis Factor-alpha"", ""polysialic acid""]}",False
CAUSES_NO_CHANGE,41670,9801,2009.0,19277525,False,False,False,"For example, the small tumor antigen derived from the DNA tumor viruses SV40 and polyoma viruses was shown to only interact with the PP2A core enzyme, but not the holoenzyme",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""High""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,6709,41363,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,14219,10065,2007.0,16820021,False,False,False,Treatment with antalarmin had no impact upon the isolation-induced alterations of BDNF expression.,#69:40,,"{""full_journal_name"": ""The European journal of neuroscience"", ""pub_date"": ""2007-04-03"", ""ref"": ""16820021"", ""pub_year"": 2007, ""last_author"": ""Lawrence AJ"", ""type"": ""PubMed"", ""author_list"": [""Djouma E"", ""Card K"", ""Lodge DJ"", ""Lawrence AJ""], ""title"": ""The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.""}","{""Confidence"": [""Medium""], ""mesh"": [""Amygdala"", ""Animals"", ""Behavior, Animal"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Male"", ""Nucleus Accumbens"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Inbred Strains"", ""Receptor, trkB"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""Social Isolation"", ""Up-Regulation""], ""substances"": [""8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""antalarmin"", ""CRF receptor type 1"", ""Receptor, trkB"", ""NCQ 298""]}",False
CAUSES_NO_CHANGE,6992,7291,2005.0,16179266,False,False,False,Therapeutic trials with melatonin have been effective in slowing the progression of Alzheimer's disease but not of Parkinson's disease.,#59:5,,"{""full_journal_name"": ""Neurotoxicity research"", ""pub_date"": ""2005-11-15"", ""ref"": ""16179266"", ""pub_year"": 2005, ""last_author"": ""Cardinali DP"", ""type"": ""PubMed"", ""author_list"": [""Srinivasan V"", ""Pandi-Perumal SR"", ""Maestroni GJ"", ""Esquifino AI"", ""Hardeland R"", ""Cardinali DP""], ""title"": ""Role of melatonin in neurodegenerative diseases.""}","{""MeSHDisease"": [""Parkinson Disease""], ""Species"": [""9606""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Animals"", ""Antioxidants"", ""Brain Chemistry"", ""Brain Injuries"", ""Free Radical Scavengers"", ""Free Radicals"", ""Humans"", ""Huntington Disease"", ""Melatonin"", ""Mitochondria"", ""Nerve Regeneration"", ""Neurodegenerative Diseases"", ""Parkinson Disease"", ""Reperfusion Injury""], ""substances"": [""Antioxidants"", ""Free Radical Scavengers"", ""Free Radicals"", ""Melatonin""]}",False
CAUSES_NO_CHANGE,32274,23589,2016.0,25881725,False,False,False,mRNA levels of a7 nAChR subunit. Relative quantification by using a real-time RT-PCR did not reveal any significant differences in the levels of mRNA for the a7 nAChR subunits either in the hippocampus or in the cortex of various groups (p>0.05). The groups showed results in the cortex (data not shown) similar to those observed in the hippocampus (Fig. 6).,#61:66,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2016-03-21"", ""ref"": ""25881725"", ""pub_year"": 2016, ""last_author"": ""Shanehbandi D"", ""type"": ""PubMed"", ""author_list"": [""Sadigh-Eteghad S"", ""Talebi M"", ""Mahmoudi J"", ""Babri S"", ""Shanehbandi D""], ""title"": ""Selective activation of \u03b17 nicotinic acetylcholine receptor by PHA-543613 improves A\u03b225-35-mediated cognitive deficits in mice."", ""doi"": ""10.1016/j.neuroscience.2015.04.017""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Hippocampus""], ""Species"": [""10090""], ""mesh"": [""Aconitine"", ""Amyloid beta-Peptides"", ""Animals"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Cholinesterase Inhibitors"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Galantamine"", ""Gene Expression Regulation"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred BALB C"", ""Nicotinic Agonists"", ""Nicotinic Antagonists"", ""Peptide Fragments"", ""Psychomotor Performance"", ""Quinuclidines"", ""RNA, Messenger"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Cholinesterase Inhibitors"", ""N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide"", ""Nicotinic Agonists"", ""Nicotinic Antagonists"", ""Peptide Fragments"", ""Quinuclidines"", ""RNA, Messenger"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""amyloid beta-protein (25-35)"", ""Galantamine"", ""methyllycaconitine"", ""Aconitine""]}",False
CAUSES_NO_CHANGE,14265,12198,2020.0,30686764,False,False,False,"More importantly, atorvastatin treatment (Figure 4E) did not affect Ab42 secretion in these neurons indicating that the effect of lowering CE on Ab42 is mediated by the cholesterol-binding domain in APP.",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,7981,20224,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,26417,1897,2017.0,28148553,False,False,False,"Cells transduced with 4R tau-overexpressing lentivirus showed increased levels in CP13-, AD2-, and HT7 tau (but not MC1). CP13- but not AD2- and HT7 tau were normalized by simultaneous PERK activator treatment (Fig 3G and H).",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,34694,16892,2018.0,28528849,False,False,False,"We also checked the phosphorylation of tau at other sites (e.g., using the antibody AT8, reacting only with the endogenous tau) and did not observe an increase in the phosphorylation.",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""High""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,11708,2342,2016.0,23393546,False,False,False,"Cetirizine, diphenhydramine, ketotifen, desloratadine, and chlorphreniramine failed to rescue ST Hdh Q111/Q111 cells (Figure 6). This suggests that the activity of the drugs in the cell-based assay is not related solely to their common ability to block the H1 receptor.",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,30003,7122,2017.0,29191965,False,False,False,"Loss of function in other genes (cat-2, cat-4, tph-1) that also regulate the dopamine or serotonin levels (130–132),did not affect the tau-induced toxicity in TauV337M; however, their activity is essential for bas-1-mediated suppression of tau-induced toxicity in TauV337M (105)",#69:60,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2017-12-11"", ""ref"": ""29191965"", ""pub_year"": 2017, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Pir GJ"", ""Choudhary B"", ""Mandelkow E""], ""title"": {""#text"": ""models of tauopathy."", ""i"": ""Caenorhabditis elegans""}, ""doi"": ""10.1096/fj.201701007""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Caenorhabditis elegans"", ""Disease Models, Animal"", ""Neurodegenerative Diseases"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,18879,34730,2014.0,23516100,False,False,False,"PHFs are more resistant to cleavage by calpain, suggesting that either the cleavage sites are incorporated into the filament core, or abnormal phosphorylation can protect tau from calpain cleavage [9, 107, 121, 131].",#71:22,,"{""full_journal_name"": ""Molecular neurobiology"", ""pub_date"": ""2014-06-18"", ""ref"": ""23516100"", ""pub_year"": 2014, ""last_author"": ""Novak M"", ""type"": ""PubMed"", ""author_list"": [""Jadhav S"", ""Zilka N"", ""Novak M""], ""title"": ""Protein truncation as a common denominator of human neurodegenerative foldopathies."", ""doi"": ""10.1007/s12035-013-8440-8""}","{""Confidence"": [""High""], ""mesh"": [""Calpain"", ""Caspases"", ""Humans"", ""Intrinsically Disordered Proteins"", ""Neurodegenerative Diseases"", ""Protein Folding"", ""Proteolysis""], ""substances"": [""Intrinsically Disordered Proteins"", ""Calpain"", ""Caspases""]}",False
CAUSES_NO_CHANGE,14403,14838,2011.0,21745645,False,False,False,"When cholinergic input was activated 10 ms after SC stimulation, LTP was induced, which was blocked by atropine but not by MLA or DHβE(Figures 5K and 5L).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""after SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,40844,43069,2011.0,21734277,False,False,False,"Together, these data suggest that increased PAD exposure represents an early event in AD pathogenesis and that AT8 may not be required for PAD exposure in situ.",#69:76,PMC3391724,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2011-09-09"", ""ref"": ""21734277"", ""pub_year"": 2011, ""last_author"": ""Binder LI"", ""type"": ""PubMed"", ""author_list"": [""Kanaan NM"", ""Morfini GA"", ""LaPointe NE"", ""Pigino GF"", ""Patterson KR"", ""Song Y"", ""Andreadis A"", ""Fu Y"", ""Brady ST"", ""Binder LI""], ""title"": ""Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases."", ""doi"": ""10.1523/JNEUROSCI.0560-11.2011""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Axonal Transport"", ""Axons"", ""Brain"", ""Decapodiformes"", ""Enzyme Inhibitors"", ""Enzyme-Linked Immunosorbent Assay"", ""Glycogen Synthase Kinase 3"", ""Humans"", ""In Vitro Techniques"", ""Kinesins"", ""Models, Biological"", ""Mutagenesis"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Phosphotransferases"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Enzyme Inhibitors"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""tau Proteins"", ""neuropeptide Y4 receptor"", ""Phosphotransferases"", ""Glycogen Synthase Kinase 3"", ""Kinesins""]}",False
CAUSES_NO_CHANGE,41708,2415,2012.0,22372633,False,False,False,Genetic ablation of HDAC6 leads to hyperacetylation of microtubules and HSP90 without any obvious abnormal effects on development and survival of these mice (33).,#57:37,,"{""full_journal_name"": ""Traffic (Copenhagen, Denmark)"", ""pub_date"": ""2012-10-04"", ""ref"": ""22372633"", ""pub_year"": 2012, ""last_author"": ""Van Den Bosch L"", ""type"": ""PubMed"", ""author_list"": [""d'Ydewalle C"", ""Bogaert E"", ""Van Den Bosch L""], ""title"": ""HDAC6 at the Intersection of Neuroprotection and Neurodegeneration."", ""doi"": ""10.1111/j.1600-0854.2012.01347.x""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Autophagy"", ""Cytoskeleton"", ""Gene Expression Regulation, Enzymologic"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Humans"", ""Microtubules"", ""Models, Biological"", ""Models, Genetic"", ""Neurodegenerative Diseases"", ""Neuroprotective Agents"", ""Protein Binding"", ""Protein Conformation"", ""Ubiquitin""], ""substances"": [""Neuroprotective Agents"", ""Ubiquitin"", ""HDAC6 protein, human"", ""Histone Deacetylase 6"", ""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,40615,7376,2020.0,30985105,False,False,False,"Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",#70:0,,"{""full_journal_name"": ""ACS chemical neuroscience"", ""pub_date"": ""2020-05-21"", ""ref"": ""30985105"", ""pub_year"": 2020, ""last_author"": ""Rudrawar S"", ""type"": ""PubMed"", ""author_list"": [""Ryan P"", ""Xu M"", ""Davey AK"", ""Danon JJ"", ""Mellick GD"", ""Kassiou M"", ""Rudrawar S""], ""title"": ""O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease."", ""doi"": ""10.1021/acschemneuro.9b00143""}","{""Confidence"": [""High""], ""mesh"": [""Acetylglucosamine"", ""Animals"", ""Brain"", ""Humans"", ""Neurodegenerative Diseases"", ""Protein Aggregation, Pathological"", ""Protein Folding"", ""Protein Processing, Post-Translational""], ""substances"": [""Acetylglucosamine""]}",False
CAUSES_NO_CHANGE,1741,2342,2016.0,23393546,False,False,False,"Cetirizine, diphenhydramine, ketotifen, desloratadine, and chlorphreniramine failed to rescue ST Hdh Q111/Q111 cells (Figure 6). This suggests that the activity of the drugs in the cell-based assay is not related solely to their common ability to block the H1 receptor.",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,37099,12096,2007.0,17293005,False,False,False,"BI-3 also potentially inhibited the release of sAPPb (IC50 = 0.5 mM) and sAPPa (IC50 = 3.4 mM, Figs. 2B and 3B). BI- 4, which is short peptide of BI-3, showed no effects on sAPP secretion.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,6964,32750,2019.0,30145931,False,False,False,"Missorted dendritic MAPT showed phosphorylation mainly at the 12E8 sites upon treatment with either the autophagy inhibitor wortmannin (Fig. 4B; 57.2±9.4% dendrites) or the proteasomal inhibitor epoxomicin (Fig. 4C, 62.9±7.4% dendrites) (Fig. 4A-C, quantification in Fig. 4D), but not at the AT8 and the PHF1 (p-S396/p-S404) sites (Fig. S5, Fig 4D).",#69:71,PMC6984766,"{""full_journal_name"": ""Autophagy"", ""pub_date"": ""2019-10-22"", ""ref"": ""30145931"", ""pub_year"": 2019, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Balaji V"", ""Kaniyappan S"", ""Mandelkow E"", ""Wang Y"", ""Mandelkow EM""], ""title"": ""Pathological missorting of endogenous MAPT/Tau in neurons caused by failure of protein degradation systems."", ""doi"": ""10.1080/15548627.2018.1509607""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Dendrites""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Embryo, Mammalian"", ""Mice"", ""Mice, Knockout"", ""Neurites"", ""Neurons"", ""Protein Transport"", ""Proteolysis"", ""Rats"", ""Rats, Sprague-Dawley"", ""Synapses"", ""tau Proteins""], ""substances"": [""Mapt protein, mouse"", ""Mapt protein, rat"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,32311,21292,2015.0,25546293,False,False,False,"Our results in the human NPCs are supportive of this latter model as HDAC6 inhibition-induced increase in Lys49 acetylation was accompanied by increase in Ser45 phosphorylation but increased Ser45 phosphorylation was not accompanied by increased phosphorylation of Ser33, Ser37, and Thr41.",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,6566,5218,2019.0,29196815,False,False,False,"It was also demonstrated that fibril-free AβO solutions are essential for memory loss (Brito-Moreira et al. 2017), while the fibrillar Aβ in amyloid deposits is not the active factor affecting the cognition (Martins et al. 2008).",#65:51,,"{""full_journal_name"": ""Journal of neural transmission (Vienna, Austria : 1996)"", ""pub_date"": ""2019-09-30"", ""ref"": ""29196815"", ""pub_year"": 2019, ""last_author"": ""Lewczuk P"", ""type"": ""PubMed"", ""author_list"": [""Mroczko B"", ""Groblewska M"", ""Litman-Zawadzka A"", ""Kornhuber J"", ""Lewczuk P""], ""title"": ""Amyloid \u03b2 oligomers (A\u03b2Os) in Alzheimer's disease."", ""doi"": ""10.1007/s00702-017-1820-x""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Biomarkers"", ""Humans"", ""Peptide Fragments""], ""substances"": [""Amyloid beta-Peptides"", ""Biomarkers"", ""Peptide Fragments""]}",False
CAUSES_NO_CHANGE,14453,7102,2020.0,30697142,False,False,False,"The biotransformed metabolite cotinine long has been held to be responsible for memory supportive eﬀects of nicotine, without the adverse eﬀects (Green et al., 2000; Echeverria et al., 2011; Patel et al., 2014).",#59:13,PMC6341027,"{""full_journal_name"": ""Frontiers in neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30697142"", ""pub_year"": 2020, ""last_author"": ""Gjedde A"", ""type"": ""PubMed"", ""author_list"": [""Majdi A"", ""Kamari F"", ""Sadigh-Eteghad S"", ""Gjedde A""], ""title"": ""Molecular Insights Into Memory-Enhancing Metabolites of Nicotine in Brain: A Systematic Review."", ""doi"": ""10.3389/fnins.2018.01002""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,14265,6707,2020.0,30686764,False,False,False,"24-Hydroxycholesterol (a direct downstream metabolite of cholesterol) was increased in media from efavirenz-treated neurons, was decreased in AY-9944-treated samples, and was unaltered in atorvastatin- and T0901317-treated neurons (Figure S2P).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,2721,7567,2019.0,30116051,False,False,False,"Htt is not efficiently cleared by CMA, and the same appears to hold for its fragments and mutant and post- translationally modified forms, although the precise role of CMA in Htt elimination remains to be more fully defined 2,45–47 .",#63:7,PMC6456907,"{""full_journal_name"": ""Nature reviews. Drug discovery"", ""pub_date"": ""2019-07-08"", ""ref"": ""30116051"", ""pub_year"": 2019, ""last_author"": ""Millan MJ"", ""type"": ""PubMed"", ""author_list"": [""Boland B"", ""Yu WH"", ""Corti O"", ""Mollereau B"", ""Henriques A"", ""Bezard E"", ""Pastores GM"", ""Rubinsztein DC"", ""Nixon RA"", ""Duchen MR"", ""Mallucci GR"", ""Kroemer G"", ""Levine B"", ""Eskelinen EL"", ""Mochel F"", ""Spedding M"", ""Louis C"", ""Martin OR"", ""Millan MJ""], ""title"": ""Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing."", ""doi"": ""10.1038/nrd.2018.109""}","{""Confidence"": [""Medium""], ""mesh"": [""Aging"", ""Animals"", ""Autophagy"", ""Humans"", ""Neurodegenerative Diseases"", ""Neurotoxins"", ""Proteasome Endopeptidase Complex"", ""Ubiquitin""], ""substances"": [""Neurotoxins"", ""Ubiquitin"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,14219,27082,2007.0,16820021,False,False,False,"Overall, no changes were observed in dopamine D1 receptor binding in the brain regions examined following social isolation and ⁄ or antalarmin treatment under these conditions",#69:40,,"{""full_journal_name"": ""The European journal of neuroscience"", ""pub_date"": ""2007-04-03"", ""ref"": ""16820021"", ""pub_year"": 2007, ""last_author"": ""Lawrence AJ"", ""type"": ""PubMed"", ""author_list"": [""Djouma E"", ""Card K"", ""Lodge DJ"", ""Lawrence AJ""], ""title"": ""The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.""}","{""Confidence"": [""High""], ""mesh"": [""Amygdala"", ""Animals"", ""Behavior, Animal"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Male"", ""Nucleus Accumbens"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Inbred Strains"", ""Receptor, trkB"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""Social Isolation"", ""Up-Regulation""], ""substances"": [""8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol"", ""Benzazepines"", ""Brain-Derived Neurotrophic Factor"", ""Dopamine Agonists"", ""Dopamine Antagonists"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""Receptors, Dopamine D1"", ""Receptors, Dopamine D2"", ""Salicylamides"", ""antalarmin"", ""CRF receptor type 1"", ""Receptor, trkB"", ""NCQ 298""]}",False
CAUSES_NO_CHANGE,6709,44121,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,38127,18713,2018.0,28445721,False,False,False,"NACHO does not affect function of ion channels gated by numerous other ligands including glutamate, GABA, serotonin, and capsaicin, suggesting that NACHO represents the only essential client-specific chaperone yet identified for any mammalian neurotransmitter receptor (Gu et al., 2016)",#64:74,,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2018-01-19"", ""ref"": ""28445721"", ""pub_year"": 2018, ""last_author"": ""Bredt DS"", ""type"": ""PubMed"", ""author_list"": [""Matta JA"", ""Gu S"", ""Davini WB"", ""Lord B"", ""Siuda ER"", ""Harrington AW"", ""Bredt DS""], ""title"": ""NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain."", ""doi"": ""10.1016/j.celrep.2017.04.008""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Binding Sites"", ""Brain"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Cell Line"", ""Cognitive Dysfunction"", ""Conotoxins"", ""Humans"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Mice"", ""Mice, Knockout"", ""Molecular Chaperones"", ""Neurons"", ""Nicotine"", ""Protein Binding"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic""], ""substances"": [""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Conotoxins"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Molecular Chaperones"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic"", ""Ric-3 protein, mouse"", ""Nicotine"", ""Iodine-125"", ""epibatidine""]}",False
CAUSES_NO_CHANGE,1832,44482,2012.0,22791904,False,False,False,"and the complement control protein, factor H, were unaffected by Posiphen (26.1% and +23.7%, respectively).",#70:20,PMC3415310,"{""full_journal_name"": ""Journal of neurology, neurosurgery, and psychiatry"", ""pub_date"": ""2012-10-29"", ""ref"": ""22791904"", ""pub_year"": 2012, ""last_author"": ""Greig NH"", ""type"": ""PubMed"", ""author_list"": [""Maccecchini ML"", ""Chang MY"", ""Pan C"", ""John V"", ""Zetterberg H"", ""Greig NH""], ""title"": ""Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-\u03b2 peptide and \u03c4 levels: target engagement, tolerability and pharmacokinetics in humans."", ""doi"": ""10.1136/jnnp-2012-302589""}","{""ArticleCompoundNumber"": [""1""], ""Confidence"": [""High""], ""Page"": [""899""], ""mesh"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Cognitive Dysfunction"", ""Dose-Response Relationship, Drug"", ""Double-Blind Method"", ""Female"", ""Humans"", ""Inflammation Mediators"", ""Male"", ""Peptide Fragments"", ""Physostigmine"", ""Rats"", ""Rats, Inbred F344"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Inflammation Mediators"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Physostigmine"", ""phenserine""]}",False
CAUSES_NO_CHANGE,16585,1650,2012.0,21958873,False,False,False,"Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,1325,20387,2009.0,18986241,False,False,False,"Single cell expression via microarray analysis was used to determine whether expression levels for nAChR and mAChR receptors, as well as ChAT, were differentially regulated within individual CBF neurons harvested from NCI, MCI and AD cases. ChAT mRNA expression levels did not differ across clinical conditions (Table 1). However, there was a significant upregulation of alpha7 nAChR subunit expression in AD compared with NCI and MCI.",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cholinergic Neurons""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,36931,14394,2015.0,25116835,False,False,False,"In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",#67:28,PMC4150238,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2015-08-19"", ""ref"": ""25116835"", ""pub_year"": 2015, ""last_author"": ""Delabar JM"", ""type"": ""PubMed"", ""author_list"": [""Janel N"", ""Sarazin M"", ""Corlier F"", ""Corne H"", ""de Souza LC"", ""Hamelin L"", ""Aka A"", ""Lagarde J"", ""Blehaut H"", ""Hindi\u00e9 V"", ""Rain JC"", ""Arbones ML"", ""Dubois B"", ""Potier MC"", ""Bottlaender M"", ""Delabar JM""], ""title"": ""Plasma DYRK1A as a novel risk factor for Alzheimer's disease."", ""doi"": ""10.1038/tp.2014.61""}","{""Subgraph"": [""DYRK1A subgraph""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Animals"", ""Biomarkers"", ""Brain"", ""Disease Models, Animal"", ""Female"", ""Genetic Association Studies"", ""Genetic Markers"", ""Humans"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Middle Aged"", ""Positron-Emission Tomography"", ""Predictive Value of Tests"", ""Protein Serine-Threonine Kinases"", ""Protein-Tyrosine Kinases""], ""substances"": [""Biomarkers"", ""Genetic Markers"", ""Dyrk kinase"", ""Protein-Tyrosine Kinases"", ""Protein Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,6746,1870,2013.0,23484434,False,False,False,"Redox cycling of methylene blue and TAGI potencies. Upper panel (black): Reduced leuco form 2 and structural overlap with inactive phenothiazines 3, 4, and 5. Lower panel (blue): Structural overlap between oxidized form 1 and azure A (6), reduced anthraquinone, 8, and 9, showing the extended π-conjugated system (ND: not determined).",#58:53,,"{""full_journal_name"": ""Journal of medicinal chemistry"", ""pub_date"": ""2013-08-20"", ""ref"": ""23484434"", ""pub_year"": 2013, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Bulic B"", ""Pickhardt M"", ""Mandelkow E""], ""title"": ""Progress and developments in tau aggregation inhibitors for Alzheimer disease."", ""doi"": ""10.1021/jm3017317""}","{""ArticleCompoundNumber"": [""3""], ""Confidence"": [""High""], ""Figure"": [""4""], ""Page"": [""D""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Clinical Trials as Topic"", ""Humans"", ""Hydrogen Bonding"", ""Models, Molecular"", ""Protein Binding"", ""Protein Conformation"", ""Structure-Activity Relationship"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,27981,40982,2013.0,23178521,False,False,False,"A significant reduction in TNF-a(Mann–Whitney U=12, Z=-2.309, P=0.021) but no significant reduction in IL-6 levels (Mann–Whitney U=25,Z=-1.223,P=0.221) or IL-1b (Mann–Whitney U=8, Z=-1.857,P=0.063) were observed in the kidney of LPS and anatabine cotreated animals(data not shown).",#70:21,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2013-06-10"", ""ref"": ""23178521"", ""pub_year"": 2013, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Abdullah L"", ""Bachmeier C"", ""Ait-Ghezala G"", ""Reed J"", ""Verma M"", ""Crawford F"", ""Mullan M""], ""title"": ""Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation."", ""doi"": ""10.1016/j.ejphar.2012.11.017""}","{""Assay"": [""ELISA""], ""MeSHAnatomy"": [""Kidney""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Animals"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Brain"", ""Cytokines"", ""HEK293 Cells"", ""Humans"", ""Inflammation"", ""Mice"", ""Mice, Inbred C57BL"", ""Phosphorylation"", ""Pyridines"", ""STAT3 Transcription Factor""], ""substances"": [""Alkaloids"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Cytokines"", ""Pyridines"", ""STAT3 Transcription Factor"", ""anatabine""]}",False
CAUSES_NO_CHANGE,38654,38294,2017.0,28083634,False,False,False,"Otub1 displayed strong preference for disassembling Lys48-linked polyubiquitin chains, while leaving Lys63-linked polyubiquitin chains unaffected (Fig. 5a).",#64:64,PMC5390007,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2017-04-20"", ""ref"": ""28083634"", ""pub_year"": 2017, ""last_author"": ""Dewachter I"", ""type"": ""PubMed"", ""author_list"": [""Wang P"", ""Joberty G"", ""Buist A"", ""Vanoosthuyse A"", ""Stancu IC"", ""Vasconcelos B"", ""Pierrot N"", ""Faelth-Savitski M"", ""Kienlen-Campard P"", ""Octave JN"", ""Bantscheff M"", ""Drewes G"", ""Moechars D"", ""Dewachter I""], ""title"": ""Tau interactome mapping\u00a0based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo."", ""doi"": ""10.1007/s00401-016-1663-9""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Deubiquitinating Enzymes"", ""Humans"", ""Mice, Transgenic"", ""Neurofibrillary Tangles"", ""Neurons"", ""Tauopathies"", ""Ubiquitin"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Ubiquitin"", ""tau Proteins"", ""Deubiquitinating Enzymes"", ""Cysteine Endopeptidases"", ""Otub1 protein, mouse""]}",False
CAUSES_NO_CHANGE,11568,43070,2009.0,18692909,False,False,False,"Rivastigmine decreased the reactivity of encephalitogenic T-cells and the production of pro-inflammatory cytokines (TNF-Î±, IFN-γ and IL-17) without affecting IL-10 production.",#59:5,,"{""full_journal_name"": ""Journal of neuroimmunology"", ""pub_date"": ""2009-02-02"", ""ref"": ""18692909"", ""pub_year"": 2009, ""last_author"": ""Brenner T"", ""type"": ""PubMed"", ""author_list"": [""Nizri E"", ""Irony-Tur-Sinai M"", ""Faranesh N"", ""Lavon I"", ""Lavi E"", ""Weinstock M"", ""Brenner T""], ""title"": ""Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine."", ""doi"": ""10.1016/j.jneuroim.2008.06.018""}","{""Subgraph"": [""Interleukin signaling subgraph""], ""mesh"": [""Animals"", ""Antigen Presentation"", ""Cell Division"", ""Cholinesterase Inhibitors"", ""Cognition Disorders"", ""Cytokines"", ""Demyelinating Diseases"", ""Encephalomyelitis, Autoimmune, Experimental"", ""Female"", ""Immunosuppressive Agents"", ""Maze Learning"", ""Memory"", ""Mice"", ""Mice, Inbred C57BL"", ""Myelin Proteins"", ""Myelin-Associated Glycoprotein"", ""Myelin-Oligodendrocyte Glycoprotein"", ""Phenylcarbamates"", ""Receptors, Nicotinic"", ""Rivastigmine"", ""Space Perception"", ""T-Lymphocytes"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Cholinesterase Inhibitors"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Cytokines"", ""Immunosuppressive Agents"", ""MOG protein, human"", ""Mog protein, mouse"", ""Myelin Proteins"", ""Myelin-Associated Glycoprotein"", ""Myelin-Oligodendrocyte Glycoprotein"", ""Phenylcarbamates"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Rivastigmine""]}",False
CAUSES_NO_CHANGE,1458,1491,2017.0,27794524,False,False,False,"Notably, follicle- like structures are probably able to sustain a high level of humoral response, as well as other autoimmune mechanisms within the CNS, in a manner independent of peripheral inflammation.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,32618,38130,2012.0,22419736,False,False,False,"In addition, we found that transient expression of AK1 (but not AK1 R132A mutant) markedly reduced the inhibitory phosphorylation of GSK3b at Ser9 (Fig. 4D and Supplemen- tary Material, S6A), indicating that AK1 may regulate GSK3b activity.",#72:19,,"{""full_journal_name"": ""Human molecular genetics"", ""pub_date"": ""2012-10-09"", ""ref"": ""22419736"", ""pub_year"": 2012, ""last_author"": ""Jung YK"", ""type"": ""PubMed"", ""author_list"": [""Park H"", ""Kam TI"", ""Kim Y"", ""Choi H"", ""Gwon Y"", ""Kim C"", ""Koh JY"", ""Jung YK""], ""title"": ""Neuropathogenic role of adenylate kinase-1 in A\u03b2-mediated tau phosphorylation via AMPK and GSK3\u03b2."", ""doi"": ""10.1093/hmg/dds100""}","{""Confidence"": [""Medium""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Genetically Modified"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Drosophila"", ""Drosophila Proteins"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Green Fluorescent Proteins"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microscopy, Fluorescence"", ""Neurodegenerative Diseases"", ""Neurons"", ""Peptide Fragments"", ""Phosphorylation"", ""RNA Interference"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Drosophila Proteins"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""adenylate kinase 1""]}",False
CAUSES_NO_CHANGE,1982,1952,2016.0,23393546,False,False,False,"Addition of pizotifen, cyproheptadine, or loxapine to the ST Hdh Q7/Q7 cells after serum withdrawal had no effect on ATP levels, indicating that the drugs do not have a general effect on viability but rather correct a deficit specific to the ST Hdh Q111/Q111 cells (Figure 2 A ).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,6630,2361,2011.0,21745645,False,False,False,"When cholinergic input was activated 10 ms after SC stimulation, LTP was induced, which was blocked by atropine but not by MLA or DHβE(Figures 5K and 5L).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""after SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,2017,11685,2009.0,19126755,False,False,False,"One insect has escaped the ill effects of nicotine, Manduca sextans or the tobacco horn worm. While nicotine binds the nAChR to activate and subsequently desensitize it, this insect eats the tobacco plant without ill effects. Manduca exhibits two adaptations to tolerate the effects of nicotine. The first is altered nAChR amino acid sequences that limit the affinity of nicotine for the nAChR (136). The second is the development of the functional equivalent to a blood-brain barrier.",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""Medium""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,28239,1780,2017.0,27167578,False,False,False,"Treatment with 0.1 or 1 mM choline was found unable to modulate neurite elongation in a7345–348A expressing cells (control: 21.24 ± 2.29 μm; 0.1 mM choline 18.94 ±  1.57 μm; 1 mM choline 20.61 ± 2.54 μm; ANOVA:F(2,51) = 0.295, p = 0.746).",#65:18,,"{""full_journal_name"": ""Journal of neurochemistry"", ""pub_date"": ""2017-06-20"", ""ref"": ""27167578"", ""pub_year"": 2017, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Kabbani N""], ""title"": ""Alpha 7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth."", ""doi"": ""10.1111/jnc.13660""}","{""Assay"": [""fluorescence microscopy""], ""CellLine"": [""PC12""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Animals"", ""Benzamides"", ""Bridged Bicyclo Compounds"", ""Calcium Signaling"", ""Cytoskeleton"", ""Enzyme Activation"", ""Female"", ""Growth Cones"", ""Heterotrimeric GTP-Binding Proteins"", ""Male"", ""Mice, Inbred C57BL"", ""Microtubules"", ""Neurogenesis"", ""Neurons"", ""Nicotinic Agonists"", ""PC12 Cells"", ""Rats"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""rhoA GTP-Binding Protein""], ""substances"": [""Benzamides"", ""Bridged Bicyclo Compounds"", ""Nicotinic Agonists"", ""PNU-282987"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Heterotrimeric GTP-Binding Proteins"", ""rhoA GTP-Binding Protein""]}",False
CAUSES_NO_CHANGE,2017,38980,2009.0,19126755,False,False,False,"First, age-related nAChR subunit expression decline was observed in both strains, and this was dominated by diminished alpha4 nAChR expression. Second, long-term (12 mo) oral nicotine failed to reduce the age-related decline in the number of neurons expressing alpha4 nAChR subunits, although the neurons that remained exhibited larger processes with more varicosities than age-matched controls (165, 396). Acute nicotine treatment (alpha6 wk of oral nicotine) of aged mice had no measurable influence on nAChR expression, neuronal viability, or dendritic complexity (e.g., Ref. 396)",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,41520,5008,2019.0,30106381,False,False,False,"Likewise, Adnp+/– males, but not females, showed significantly reduced grip strength that was completely reversed by NAP treatment (Figure 7B).",#63:5,PMC6205398,"{""full_journal_name"": ""The Journal of clinical investigation"", ""pub_date"": ""2019-09-11"", ""ref"": ""30106381"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Hacohen-Kleiman G"", ""Sragovich S"", ""Karmon G"", ""Gao AYL"", ""Grigg I"", ""Pasmanik-Chor M"", ""Le A"", ""Korenkov\u00e1 V"", ""McKinney RA"", ""Gozes I""], ""title"": ""Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome."", ""doi"": ""10.1172/JCI98199""}","{""Confidence"": [""High""], ""Gender"": [""Female""], ""Species"": [""9606""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Autistic Disorder"", ""Behavior, Animal"", ""Biomarkers"", ""Cell Membrane"", ""Dendritic Spines"", ""Gene Expression Regulation"", ""Homeodomain Proteins"", ""Humans"", ""Mice"", ""Mice, Knockout"", ""Microtubules"", ""Models, Neurological"", ""Mutation"", ""Naphthoquinones"", ""Nerve Tissue Proteins"", ""Synapses"", ""Syndrome""], ""substances"": [""2-(3,5-di-tert-butyl-4-hydroxyl)-3-chloro-1,4-naphthoquinone"", ""Adnp protein, mouse"", ""Biomarkers"", ""Homeodomain Proteins"", ""Naphthoquinones"", ""Nerve Tissue Proteins""]}",False
CAUSES_NO_CHANGE,14214,27284,2018.0,28901280,False,False,False,α9 and α9-α10 nAChRs have a number of interesting characteristics: they are acti- vated by ACh but not by the classical agonist nicotine. Cho- line is also a potent selective agonist of the α9 subtype,#61:2,PMC6018187,"{""full_journal_name"": ""Current neuropharmacology"", ""pub_date"": ""2018-09-13"", ""ref"": ""28901280"", ""pub_year"": 2018, ""last_author"": ""Gotti C"", ""type"": ""PubMed"", ""author_list"": [""Zoli M"", ""Pucci S"", ""Vilella A"", ""Gotti C""], ""title"": ""Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors."", ""doi"": ""10.2174/1570159X15666170912110450""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Binding Sites"", ""Humans"", ""Neurons"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,2017,12153,2012.0,21958873,False,False,False,Nicotine does not appear to affect sAPPβ and sAPPα secretion in 7W CHO contrary to anatabine (Fig. 4),#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,7981,6777,2016.0,26702100,False,False,False,"Furthermore, protein expression level of dynactin 1, but not dynein heavy and intermediate chains (DHC and DIC), was decreased in those cells (Fig 7A).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""High""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,3473,35208,2020.0,30606258,False,False,False,"We were unable to detect phosphorylation (activation) of inositol- requiring enzyme 1α (IRE1α) in any of the three cell lines and there were no differences in the total amount of IRE1α present (Fig. 6c, d), suggesting that this branch of the UPR is not activated by either Tau35 or FL-tau.",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,26554,12009,2018.0,27671637,False,False,False,"Having observed that 64627 restores presynaptic functioning (i.e., PPF, Fig. 4F), neuronal activity (induction of Fos, Fig. 4D), and dendritic spine levels in proaggregant Tau transgenic organotypic slices (Fig. 5 A and B), we tested whether we could restore long-term spatial memory in proaggregant Tau transgenic mice as well",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Axons""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,4481,21292,2015.0,25546293,False,False,False,"In the presence of the HDAC6 inhibitor ACY-1215, the increased levels of Ac-Lys49 β-catenin had no effect on the levels for β-catenin phosphorylated at Ser33, Ser37, and Thr41 (Figure 3A, B).",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,11782,6901,2018.0,29626319,False,False,False,"By measuring Aβ levels in superior vena cava and inferior vena cava, it is clear that Aβ levels are getting lower and lower along the direction of the vein blood flow, and the contents of Aβ40 and total Aβ in artery are significantly less than those in vein, suggesting a part of Aβ40 and total Aβ can be cleared by peripheral organs and tissues, such as the liver, kidney, skin, and the gastrointestinal tract, although there is no change in Aβ42 concentrations (Xiang et al. 2015)",#70:59,,"{""full_journal_name"": ""Neurotoxicity research"", ""pub_date"": ""2018-11-06"", ""ref"": ""29626319"", ""pub_year"": 2018, ""last_author"": ""Tan L"", ""type"": ""PubMed"", ""author_list"": [""Xin SH"", ""Tan L"", ""Cao X"", ""Yu JT"", ""Tan L""], ""title"": ""Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy."", ""doi"": ""10.1007/s12640-018-9895-1""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Arteries""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11560,1513,2015.0,25639674,False,False,False,"The α4β2 nAChR PAM, NS-9283, administered alone did not affect mechanical allodynia in the spinal nerve ligation test (a model of neuropathic pain), nor on nociception and inflammation in various rodent models of pain [185, 186].",#59:10,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons"", ""Spinal Cord""], ""MeSHDisease"": [""Pain""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,43753,38845,2011.0,21339331,False,False,False,"The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",#62:7,PMC3044115,"{""full_journal_name"": ""The Journal of cell biology"", ""pub_date"": ""2011-04-25"", ""ref"": ""21339331"", ""pub_year"": 2011, ""last_author"": ""Brandt R"", ""type"": ""PubMed"", ""author_list"": [""Gauthier-Kemper A"", ""Weissmann C"", ""Golovyashkina N"", ""Seb\u00f6-Lemke Z"", ""Drewes G"", ""Gerke V"", ""Heinisch JJ"", ""Brandt R""], ""title"": ""The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner."", ""doi"": ""10.1083/jcb.201007161""}","{""Confidence"": [""Medium""], ""Method"": [""Confocal Microscopy, Laser Scanning"", ""Immunocytochemistry"", ""Mass Spectrometry"", ""Pull-down Assay, GFP"", ""RNA Interference, shRNA"", ""Tandem Affinity Purification, TAP""], ""mesh"": [""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Animals"", ""Annexin A2"", ""Binding Sites"", ""Cell Membrane"", ""Humans"", ""Microtubules"", ""Molecular Sequence Data"", ""Neurites"", ""PC12 Cells"", ""Phosphorylation"", ""Rats"", ""tau Proteins""], ""substances"": [""Annexin A2"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,7180,1604,2017.0,27794524,False,False,False,"In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,40563,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Dopaminergic subgraph""]}",False
CAUSES_NO_CHANGE,2206,1293,2017.0,27522251,False,False,False,"We did not detect any glia or microglia activation in WT-APP (Fig. 3C and F) compared with WT-GFP (Fig. 3B and E), meaning that the neuroinflammation does not play a role in the memory deficit we observed",#68:77,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-09-28"", ""ref"": ""27522251"", ""pub_year"": 2017, ""last_author"": ""Maskos U"", ""type"": ""PubMed"", ""author_list"": [""Lombardo S"", ""Catteau J"", ""Besson M"", ""Maskos U""], ""title"": ""A role for \u03b22* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus."", ""doi"": ""10.1016/j.neurobiolaging.2016.06.005""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Dentate Gyrus""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Dentate Gyrus"", ""Disease Models, Animal"", ""Hippocampus"", ""Male"", ""Memory Disorders"", ""Mice, Inbred C57BL"", ""Receptors, Nicotinic""], ""substances"": [""Amyloid beta-Peptides"", ""Receptors, Nicotinic"", ""nicotinic receptor beta2""]}",False
CAUSES_NO_CHANGE,6709,35634,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,14217,6933,2011.0,21718217,False,False,False,"Pedersen and Flynn examined the effects of rosiglitazone and found that activation of PPAR-g ameliorated behavioral deficits in the Tg2576 AD mouse model. However, these animals displayed no changes in plaque pathology, but had reduced brain Ab42 levels.",#57:29,PMC3156324,"{""full_journal_name"": ""Expert opinion on therapeutic targets"", ""pub_date"": ""2011-12-12"", ""ref"": ""21718217"", ""pub_year"": 2011, ""last_author"": ""Landreth GE"", ""type"": ""PubMed"", ""author_list"": [""Mandrekar-Colucci S"", ""Landreth GE""], ""title"": ""Nuclear receptors as therapeutic targets for Alzheimer's disease."", ""doi"": ""10.1517/14728222.2011.594043""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Brain"", ""Drug Delivery Systems"", ""Drug Design"", ""Energy Metabolism"", ""Humans"", ""Inflammation"", ""Microglia"", ""Receptors, Cytoplasmic and Nuclear""], ""substances"": [""Amyloid beta-Peptides"", ""Receptors, Cytoplasmic and Nuclear""]}",False
CAUSES_NO_CHANGE,14226,13478,2020.0,30686764,False,False,False,"The reduction of both pTau as well as tTau could indicate a proteostatic regulatory event, rather than altered Tau phosphorylation and dephosphorylation events. This was further substantiated by the finding that activity of GSK3b (a major Tau kinase) was not affected by statin-mediated CE reduction (Figure S5E).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,8165,2498,2017.0,27594586,False,False,False,The resting membrane potential did not differ among neurons differentiated from all iPSC lines (Figure S2D),#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,40458,6741,2015.0,25171717,False,False,False,"We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",#67:28,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-08-18"", ""ref"": ""25171717"", ""pub_year"": 2015, ""last_author"": ""Karsdal MA"", ""type"": ""PubMed"", ""author_list"": [""Henriksen K"", ""Byrjalsen I"", ""Christiansen C"", ""Karsdal MA""], ""title"": ""Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease."", ""doi"": ""10.3233/JAD-140984""}","{""mesh"": [""Aged"", ""Alzheimer Disease"", ""Biomarkers"", ""Clinical Trials, Phase III as Topic"", ""Disease Progression"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Humans"", ""Linear Models"", ""Male"", ""Mental Status Schedule"", ""Severity of Illness Index"", ""Time Factors"", ""tau Proteins""], ""substances"": [""Biomarkers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,39699,1690,2018.0,27671637,False,False,False,This suggests that the energy status of the neurons is compromised by proaggregant but not by antiaggregant Tau,#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,6558,12012,2019.0,30270813,False,False,False,"Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",#63:68,PMC6166273,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2019-06-06"", ""ref"": ""30270813"", ""pub_year"": 2019, ""last_author"": ""Heijnen CJ"", ""type"": ""PubMed"", ""author_list"": [""Ma J"", ""Huo X"", ""Jarpe MB"", ""Kavelaars A"", ""Heijnen CJ""], ""title"": ""Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment."", ""doi"": ""10.1186/s40478-018-0604-3""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antineoplastic Agents"", ""Cisplatin"", ""Cognitive Dysfunction"", ""Disease Models, Animal"", ""Disks Large Homolog 4 Protein"", ""Dose-Response Relationship, Drug"", ""Enzyme Inhibitors"", ""Green Fluorescent Proteins"", ""Histone Deacetylase 6"", ""Hydroxamic Acids"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Microscopy, Electron, Transmission"", ""Mitochondria"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Synaptosomes"", ""Tauopathies"", ""Time Factors"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Antineoplastic Agents"", ""Disks Large Homolog 4 Protein"", ""Enzyme Inhibitors"", ""Hydroxamic Acids"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Tubulin"", ""synaptopHIuorin"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Cisplatin"", ""ricolinostat""]}",False
CAUSES_NO_CHANGE,23189,11509,2015.0,25374103,False,False,False,"Co-transfection of CHIP with 4R-tau leads to a significant increase in Hsp70 levels, however this is not the case with wither tauC3 or K18DK280 constructs (Supplementary Fig. 2) suggesting that increased HSP70 protein levels are not necessary for the observed reduction in tau levels.",#63:21,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-10-26"", ""ref"": ""25374103"", ""pub_year"": 2015, ""last_author"": ""Spires-Jones TL"", ""type"": ""PubMed"", ""author_list"": [""Saidi LJ"", ""Polydoro M"", ""Kay KR"", ""Sanchez L"", ""Mandelkow EM"", ""Hyman BT"", ""Spires-Jones TL""], ""title"": ""Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes."", ""doi"": ""10.3233/JAD-142094""}","{""Confidence"": [""Medium""], ""mesh"": [""Caspase 3"", ""Cell Line, Tumor"", ""Cell Proliferation"", ""Gene Expression Regulation"", ""Green Fluorescent Proteins"", ""HSP70 Heat-Shock Proteins"", ""Humans"", ""Mitochondria"", ""Mutation"", ""Neuroblastoma"", ""Protein Binding"", ""Transfection"", ""Ubiquitin-Protein Ligases"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""STUB1 protein, human"", ""Ubiquitin-Protein Ligases"", ""Caspase 3""]}",False
CAUSES_NO_CHANGE,37163,35515,2018.0,30027901,False,False,False,"Cerebellar neurons have been observed to induce Hsp70 expression upon mutant htt expression. However, striatal neurons cannot upregulate their chaperone expression to overcome this proteostasis stress (Tagawa et al. 2007).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Anatomy"": [""corpus striatum""], ""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""MeSHAnatomy"": [""Neurons""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,14403,28785,2011.0,21745645,False,False,False,"The LTP induced by the preceding SO stimulation (100 ms) was completely blocked by MLA (10 nM), whereas DHβE (1 μM) and atropine (5 μM) were ineffective(Figure 2A).Similarly the induction of STD by SO 10 ms before SC was also blocked by MLA, with DHβE and atropine also having no effect(Figure 2B).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,7761,1314,2020.0,30837838,False,False,False,"Several of these interactions were unperturbed by the ALS-linked mutations, A315T and M337V (Freibaum et al., 2010; Kim et al., 2010).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""]}",False
CAUSES_NO_CHANGE,27981,21169,2013.0,23178521,False,False,False,"A significant reduction in TNF-a(Mann–Whitney U=12, Z=-2.309, P=0.021) but no significant reduction in IL-6 levels (Mann–Whitney U=25,Z=-1.223,P=0.221) or IL-1b (Mann–Whitney U=8, Z=-1.857,P=0.063) were observed in the kidney of LPS and anatabine cotreated animals(data not shown).",#70:21,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2013-06-10"", ""ref"": ""23178521"", ""pub_year"": 2013, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Abdullah L"", ""Bachmeier C"", ""Ait-Ghezala G"", ""Reed J"", ""Verma M"", ""Crawford F"", ""Mullan M""], ""title"": ""Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation."", ""doi"": ""10.1016/j.ejphar.2012.11.017""}","{""Assay"": [""ELISA""], ""MeSHAnatomy"": [""Kidney""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Animals"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Brain"", ""Cytokines"", ""HEK293 Cells"", ""Humans"", ""Inflammation"", ""Mice"", ""Mice, Inbred C57BL"", ""Phosphorylation"", ""Pyridines"", ""STAT3 Transcription Factor""], ""substances"": [""Alkaloids"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Cytokines"", ""Pyridines"", ""STAT3 Transcription Factor"", ""anatabine""]}",False
CAUSES_NO_CHANGE,13388,2679,2019.0,30562574,False,False,False,"Indeed, DIV0 LAMP2A downregulation evoked a significant, 38±13% reduction of MAP2 protein levels (Fig. 4E) which coincided with a significant reduction of CRMP-2 protein levels (32±14%), comparable to what we had already seen in mature cultures. No change in TUJ-1 abundance was detected (Fig. 4F), suggesting that there was a specific effect on dendritic, and not axonal, projections.",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""CellStructure"": [""Axons""], ""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,41520,1183,2019.0,30106381,False,False,False,"We then measured the latency to fall off an inverted cage lid (hanging wire) and found a highly significant impairment (decreased latency) in male Adnp+/– mice and a complete reversal with NAP treatment (Figure 7A). The females were not affected in this behavior, indicating sex differences in motor behavior and development in the haploinsufficient mice",#63:5,PMC6205398,"{""full_journal_name"": ""The Journal of clinical investigation"", ""pub_date"": ""2019-09-11"", ""ref"": ""30106381"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Hacohen-Kleiman G"", ""Sragovich S"", ""Karmon G"", ""Gao AYL"", ""Grigg I"", ""Pasmanik-Chor M"", ""Le A"", ""Korenkov\u00e1 V"", ""McKinney RA"", ""Gozes I""], ""title"": ""Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome."", ""doi"": ""10.1172/JCI98199""}","{""Confidence"": [""High""], ""Gender"": [""Female""], ""Species"": [""9606""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Autistic Disorder"", ""Behavior, Animal"", ""Biomarkers"", ""Cell Membrane"", ""Dendritic Spines"", ""Gene Expression Regulation"", ""Homeodomain Proteins"", ""Humans"", ""Mice"", ""Mice, Knockout"", ""Microtubules"", ""Models, Neurological"", ""Mutation"", ""Naphthoquinones"", ""Nerve Tissue Proteins"", ""Synapses"", ""Syndrome""], ""substances"": [""2-(3,5-di-tert-butyl-4-hydroxyl)-3-chloro-1,4-naphthoquinone"", ""Adnp protein, mouse"", ""Biomarkers"", ""Homeodomain Proteins"", ""Naphthoquinones"", ""Nerve Tissue Proteins""]}",False
CAUSES_NO_CHANGE,1852,41416,2013.0,23384725,False,False,False,"Lower amount (1 mM) of H2O2 also induced RRM1 aggregation at a slower rate (Supplemental Figure S1), indicating that the aggregation process is not due to an extraneous amount of oxidant",#70:9,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2013-04-30"", ""ref"": ""23384725"", ""pub_year"": 2013, ""last_author"": ""Huang TH"", ""type"": ""PubMed"", ""author_list"": [""Chang CK"", ""Chiang MH"", ""Toh EK"", ""Chang CF"", ""Huang TH""], ""title"": ""Molecular mechanism of oxidation-induced TDP-43 RRM1 aggregation and loss of function."", ""doi"": ""10.1016/j.febslet.2013.01.038""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Conserved Sequence"", ""Cysteine"", ""DNA-Binding Proteins"", ""Humans"", ""Models, Molecular"", ""Molecular Sequence Data"", ""Neurodegenerative Diseases"", ""Oxidation-Reduction"", ""Protein Denaturation"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Recombinant Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Recombinant Proteins"", ""Cysteine""]}",False
CAUSES_NO_CHANGE,6894,30968,2019.0,30664622,False,False,False,"In females, hippocampal VGLUT1 was not affected by the Adnp genotype or NAP treatment (Supplemental Fig. S4A)",#69:15,PMC6341082,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-06-10"", ""ref"": ""30664622"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Sragovich S"", ""Malishkevich A"", ""Piontkewitz Y"", ""Giladi E"", ""Touloumi O"", ""Lagoudaki R"", ""Grigoriadis N"", ""Gozes I""], ""title"": ""The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse."", ""doi"": ""10.1038/s41398-018-0357-6""}","{""Confidence"": [""High""], ""Gender"": [""Female""], ""MeSHAnatomy"": [""Hippocampus""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Brain"", ""Diffusion Tensor Imaging"", ""Disease Models, Animal"", ""Female"", ""Haploinsufficiency"", ""Homeodomain Proteins"", ""Magnetic Resonance Imaging"", ""Male"", ""Mice"", ""Mice, 129 Strain"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Neuroprotection"", ""Oligopeptides"", ""Synapses"", ""Vesicular Glutamate Transport Protein 1""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Oligopeptides"", ""Slc17a7 protein, mouse"", ""Vesicular Glutamate Transport Protein 1"", ""davunetide""]}",False
CAUSES_NO_CHANGE,7981,42014,2016.0,26702100,False,False,False,"TDP-43-depleted cells showed a decrease of raptor, but not mTOR, p18, and RagB, compared with control cells (Fig 2B)",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,37679,35208,2020.0,30606258,False,False,False,"We were unable to detect phosphorylation (activation) of inositol- requiring enzyme 1α (IRE1α) in any of the three cell lines and there were no differences in the total amount of IRE1α present (Fig. 6c, d), suggesting that this branch of the UPR is not activated by either Tau35 or FL-tau.",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,1854,14977,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""G-protein-mediated signaling""]}",False
CAUSES_NO_CHANGE,1783,5073,2009.0,19293145,False,False,False,"The loss of nAChR subunits, as determined by [3H]- epibatidine binding, seems to take place after the transition from mild cognitive impairment (MCI) to AD (Sabbagh et al., 2006), although the loss of epibatidine binding did not correlate with decline in memory, cognitive performance, or with the development of neurofibrillary tangles or plaques (Sabbagh et al., 2001).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,14406,5323,2013.0,23383175,False,False,False,"Overall, anatabine did not significantly impact EAE induced astrogliosis for the different areas of the brain examined (Fig. 7)",#68:42,PMC3559544,"{""full_journal_name"": ""PloS one"", ""pub_date"": ""2013-07-22"", ""ref"": ""23383175"", ""pub_year"": 2013, ""last_author"": ""Mullan MJ"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Mullan M"", ""Ait-Ghezala G"", ""Mathura V"", ""Bachmeier C"", ""Crawford F"", ""Mullan MJ""], ""title"": ""Amelioration of experimental autoimmune encephalomyelitis by anatabine."", ""doi"": ""10.1371/journal.pone.0055392""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Hippocampus""], ""MeSHDisease"": [""Encephalomyelitis""], ""Species"": [""10090""], ""mesh"": [""Administration, Oral"", ""Alkaloids"", ""Analysis of Variance"", ""Animals"", ""Blotting, Western"", ""Cytokines"", ""Encephalomyelitis, Autoimmune, Experimental"", ""Immunohistochemistry"", ""Mice"", ""Multiple Sclerosis"", ""Pyridines"", ""Th1 Cells"", ""Th17 Cells""], ""substances"": [""Alkaloids"", ""Cytokines"", ""Pyridines"", ""anatabine""]}",False
CAUSES_NO_CHANGE,6944,5253,2018.0,28803412,False,False,False,"In contrast, a-syn 30–110 that forms fibrils at a fast rate, did not display toxicity, indicating that oligomers are indeed the toxic species leading to TH-neuron loss in vivo [162].",#64:79,PMC5663814,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2018-06-13"", ""ref"": ""28803412"", ""pub_year"": 2018, ""last_author"": ""Alegre-Abarrategui J"", ""type"": ""PubMed"", ""author_list"": [""Bengoa-Vergniory N"", ""Roberts RF"", ""Wade-Martins R"", ""Alegre-Abarrategui J""], ""title"": ""Alpha-synuclein oligomers: a new hope."", ""doi"": ""10.1007/s00401-017-1755-1""}","{""Cell"": [""neuron""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Antiparkinson Agents"", ""Biomarkers"", ""Humans"", ""Parkinson Disease"", ""Protein Aggregation, Pathological"", ""alpha-Synuclein""], ""substances"": [""Antiparkinson Agents"", ""Biomarkers"", ""alpha-Synuclein""]}",False
CAUSES_NO_CHANGE,41324,20838,2015.0,25681350,False,False,False,"Knockdown of either RelB or p50 significantly diminished cytokine- induced YKL-40 mRNA expression, whereas knockdown of p65, cRel and p52 had no effect (Fig. 4A). This finding implicates both RelB and p50 in YKL-40 regulation.",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,6709,11103,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,6943,5301,2006.0,16273023,False,False,False,"According to the proposed hypothesis, memantine has the ability to block the passage of Ca2+ through the calcium channel even when, as in Alzheimer's disease, resting synaptic glutamate levels are abnormally high, but it is still readily displaced at peak synaptic glutamate concentrations.13 In other words, the clinical efficacy of memantine appears to stem from its ability to prevent neuronal overactivity without also hindering normal neurotransmission.",#58:1,,"{""full_journal_name"": ""CNS spectrums"", ""pub_date"": ""2006-02-24"", ""ref"": ""16273023"", ""pub_year"": 2006, ""last_author"": ""Francis PT"", ""type"": ""PubMed"", ""author_list"": [""Francis PT""], ""title"": ""The interplay of neurotransmitters in Alzheimer's disease.""}","{""Confidence"": [""High""], ""Disease"": [""Alzheimer's disease""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Cholinergic Fibers"", ""Glutamate Plasma Membrane Transport Proteins"", ""Humans"", ""Neural Pathways"", ""Neurotransmitter Agents"", ""Receptors, Glutamate"", ""Receptors, N-Methyl-D-Aspartate""], ""substances"": [""Glutamate Plasma Membrane Transport Proteins"", ""Neurotransmitter Agents"", ""Receptors, Glutamate"", ""Receptors, N-Methyl-D-Aspartate""]}",False
CAUSES_NO_CHANGE,2055,1287,2017.0,27956442,False,False,False,"There are a large number of phase III trials using agents such azathioprine, ciclosporin, β-interferon, dirucotide (myelin basic protein), immunoglobulins and cladribine, as well as other immunomodulators, in progressive MS that have been reported over the last 25 years. Unfortunately, the results have essentially been negative. [10]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,37373,28838,2017.0,27299292,False,False,False,"Interestingly, mTORC1 lysosomal localization was found not to be essential for mTORC1 regulation of lysosomal function.[32]",#63:52,PMC5032832,"{""full_journal_name"": ""Annals of the New York Academy of Sciences"", ""pub_date"": ""2017-07-19"", ""ref"": ""27299292"", ""pub_year"": 2017, ""last_author"": ""Sardiello M"", ""type"": ""PubMed"", ""author_list"": [""Sardiello M""], ""title"": ""Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases."", ""doi"": ""10.1111/nyas.13131""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Humans"", ""Lysosomal Storage Diseases"", ""Lysosomes"", ""Models, Biological"", ""Molecular Targeted Therapy"", ""Signal Transduction""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors""]}",False
CAUSES_NO_CHANGE,1491,1604,2017.0,27794524,False,False,False,"In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,11438,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,26690,11509,2015.0,25374103,False,False,False,"Co-transfection of CHIP with 4R-tau leads to a significant increase in Hsp70 levels, however this is not the case with wither tauC3 or K18DK280 constructs (Supplementary Fig. 2) suggesting that increased HSP70 protein levels are not necessary for the observed reduction in tau levels.",#63:21,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-10-26"", ""ref"": ""25374103"", ""pub_year"": 2015, ""last_author"": ""Spires-Jones TL"", ""type"": ""PubMed"", ""author_list"": [""Saidi LJ"", ""Polydoro M"", ""Kay KR"", ""Sanchez L"", ""Mandelkow EM"", ""Hyman BT"", ""Spires-Jones TL""], ""title"": ""Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes."", ""doi"": ""10.3233/JAD-142094""}","{""Confidence"": [""Medium""], ""mesh"": [""Caspase 3"", ""Cell Line, Tumor"", ""Cell Proliferation"", ""Gene Expression Regulation"", ""Green Fluorescent Proteins"", ""HSP70 Heat-Shock Proteins"", ""Humans"", ""Mitochondria"", ""Mutation"", ""Neuroblastoma"", ""Protein Binding"", ""Transfection"", ""Ubiquitin-Protein Ligases"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""STUB1 protein, human"", ""Ubiquitin-Protein Ligases"", ""Caspase 3""]}",False
CAUSES_NO_CHANGE,44545,2457,2013.0,23356410,False,False,False,"The deletion of both HDAC1 and 2 during early synaptic development caused a facilitation of excitatory synapse maturation and a modest increase in synapse numbers, which were not observed in the specific deletion of HDAC1 or 2 alone.",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Hippocampus""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,14443,21731,2006.0,16816118,False,False,False,"In the present study we injected bilaterally 3-morpholino-sydnonimine (SIN-1), a recognized and widely used peroxynitrite donor (25–30), into rat hippocampus, and investigated whether or not peroxynitrite could induce simultaneously nitration and hyperphosphorylation of tau and the underlying mechanisms in vivo. The level of nitrated and hyperphosphorylated tau was markedly increased in rat hippocampus 24 h, and prevented by preinjection of uric acid, a natural scavenger of peroxynitrite. GSK-3beta and p38 MAPKs, including p38alpha, p38beta, and p38delta activity was increased, but no change in the activity of p38gamma, ERK, and c-Jun amino-terminal kinase (JNK). Both nitrated tau and hyperphosphorylated tau were aggregated in the hippocampus, with activity of 20S proteasome significantly arrested in SIN-1-injected rats. Hyperphosphorylated tau was degraded as efficiently as normal tau by 20S proteasome, but the nitrated tau with an unorderly secondary structure became more resistant to the proteolysis, providing evidence that peroxynitrite simultaneously induces tau hyperphosphorylation, nitration, and accumulation, and that activation of GSK-3beta, p38alpha, p38beta, p38delta isoforms and the inhibition of proteasome activity are respectively responsible for the peroxynitrite-induced tau hyperphosphorylation and accumulation.",#60:23,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2006-07-31"", ""ref"": ""16816118"", ""pub_year"": 2006, ""last_author"": ""Wang JZ"", ""type"": ""PubMed"", ""author_list"": [""Zhang YJ"", ""Xu YF"", ""Liu YH"", ""Yin J"", ""Li HL"", ""Wang Q"", ""Wang JZ""], ""title"": ""Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms.""}","{""Anatomy"": [""hippocampal formation""], ""Confidence"": [""Medium""], ""ExpMethod"": [""in vivo""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Caspase 3"", ""Caspases"", ""Cell Nucleus"", ""Glycogen Synthase Kinase 3"", ""Hippocampus"", ""Male"", ""Maze Learning"", ""Peroxynitrous Acid"", ""Phosphorylation"", ""Rats"", ""Rats, Wistar"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""Peroxynitrous Acid"", ""Glycogen Synthase Kinase 3"", ""Casp3 protein, rat"", ""Caspase 3"", ""Caspases""]}",False
CAUSES_NO_CHANGE,11534,1287,2017.0,27956442,False,False,False,"There are a large number of phase III trials using agents such azathioprine, ciclosporin, β-interferon, dirucotide (myelin basic protein), immunoglobulins and cladribine, as well as other immunomodulators, in progressive MS that have been reported over the last 25 years. Unfortunately, the results have essentially been negative. [10]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,10861,41587,2000.0,10887109,False,False,False,"These experiments determined that Lck, but not Syk or Zap70, was capable of mediating phosphorylation of CD33 in vivo (Figure 2A).",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,1963,5275,2016.0,26582367,False,False,False,"Next, we analyzed the effect of polySia avDP20 on endocytosis. Basal endocytosis of nanobeads was unchanged after treatment with polySia avDP20.",#57:0,PMC4652165,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2016-09-12"", ""ref"": ""26582367"", ""pub_year"": 2016, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Shahraz A"", ""Kopatz J"", ""Mathy R"", ""Kappler J"", ""Winter D"", ""Kapoor S"", ""Sch\u00fctza V"", ""Scheper T"", ""Gieselmann V"", ""Neumann H""], ""title"": ""Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages."", ""doi"": ""10.1038/srep16800""}","{""CellLine"": [""THP-1""], ""ChallengeType"": [""lipopolysaccharide stimulation""], ""ChemicalDosage"": [""1.5 \u03bcM""], ""LPSDosage"": [""1 \u03bcg/ml""], ""NumberOfResidues"": [""20""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Cell Line"", ""Chromatography, High Pressure Liquid"", ""Homeostasis"", ""Humans"", ""Lectins"", ""Lipopolysaccharides"", ""Macrophages"", ""Membrane Proteins"", ""Microspheres"", ""Molecular Weight"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Polymerization"", ""Respiratory Burst"", ""Sialic Acids"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neuroprotective Agents"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""TNF protein, human"", ""Tumor Necrosis Factor-alpha"", ""polysialic acid""]}",False
CAUSES_NO_CHANGE,35413,863,2009.0,19277525,False,False,False,"Unlike the PP2A holoenzyme involving the B′ subunit, B makes few interactions with the catalytic subunit",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""Medium""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,11566,33326,2020.0,30686764,False,False,False,"Inhibition of the respective non-sterol isoprenoid pathways (by geranyl- or farnesyl- transferase inhibitors GGTI-298 and FTI-227, respectively) did not significantly reduce pThr231Tau/ tTau (Figures 2C, S2F, and S2G).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,3728,12053,2020.0,30606258,False,False,False,"We were unable to detect phosphorylation (activation) of inositol- requiring enzyme 1α (IRE1α) in any of the three cell lines and there were no differences in the total amount of IRE1α present (Fig. 6c, d), suggesting that this branch of the UPR is not activated by either Tau35 or FL-tau.",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,11615,12491,2019.0,29590627,False,False,False,"In contrast, disruption of actin polymerization with Cytochalasin D had little effect on the entry of aggregated tau (total fluorescent intensity and number of objects; Figures 5D–5F; Figure S5)",#57:66,PMC5896171,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2019-11-05"", ""ref"": ""29590627"", ""pub_year"": 2019, ""last_author"": ""Livesey FJ"", ""type"": ""PubMed"", ""author_list"": [""Evans LD"", ""Wassmer T"", ""Fraser G"", ""Smith J"", ""Perkinton M"", ""Billinton A"", ""Livesey FJ""], ""title"": ""Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways."", ""doi"": ""10.1016/j.celrep.2018.03.021""}","{""mesh"": [""Cerebral Cortex"", ""Dynamins"", ""Endocytosis"", ""Human Embryonic Stem Cells"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregation, Pathological"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,7081,7229,2018.0,30027901,False,False,False,"In another study, 18 patients with Huntington’s chorea were examined before and after treatment with three neuroleptic drugs, pimozide, haloperidol and tiapride. Pimozide and haloperidol gave relief from hyperkinesias but none of the drug improved motor performance significantly (Girotti et al. 1984).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,15419,1650,2019.0,30232325,False,False,False,"Notably, in parallel with the protective effect of fasudil on synapses (Fig. 3e, f), treatment with fasudil reversed the stimulatory effects of Dkk1 on Aβ production (Fig. 3g).",#64:35,PMC6145937,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-03-14"", ""ref"": ""30232325"", ""pub_year"": 2019, ""last_author"": ""Killick R"", ""type"": ""PubMed"", ""author_list"": [""Elliott C"", ""Rojo AI"", ""Ribe E"", ""Broadstock M"", ""Xia W"", ""Morin P"", ""Semenov M"", ""Baillie G"", ""Cuadrado A"", ""Al-Shawi R"", ""Ballard CG"", ""Simons P"", ""Killick R""], ""title"": ""A role for APP in Wnt signalling links synapse loss with \u03b2-amyloid production."", ""doi"": ""10.1038/s41398-018-0231-6""}","{""Confidence"": [""Medium""], ""mesh"": [""1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"", ""Alzheimer Disease"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Cells, Cultured"", ""Disease Models, Animal"", ""Female"", ""HEK293 Cells"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Intracellular Signaling Peptides and Proteins"", ""Low Density Lipoprotein Receptor-Related Protein-6"", ""Male"", ""Membrane Proteins"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Neurons"", ""Protein Kinase Inhibitors"", ""Rats"", ""Rats, Sprague-Dawley"", ""Synapses"", ""Wnt Signaling Pathway""], ""substances"": [""Amyloid beta-Protein Precursor"", ""DKK1 protein, human"", ""Intercellular Signaling Peptides and Proteins"", ""Intracellular Signaling Peptides and Proteins"", ""LRP6 protein, human"", ""Low Density Lipoprotein Receptor-Related Protein-6"", ""Membrane Proteins"", ""Protein Kinase Inhibitors"", ""VANGL2 protein, human"", ""1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"", ""fasudil""]}",False
CAUSES_NO_CHANGE,11526,7139,2019.0,30664622,False,False,False,"As social behavior depends on olfaction, this was also measured showing intact odor discrimination ability in CB-treated males (Fig. 2e) and a sex difference, with no preference for a specific olfactory cue in CB-treated females (Supplemental Fig. S2E), thus corroborating previous findings observed for DD-treated mice",#69:15,PMC6341082,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-06-10"", ""ref"": ""30664622"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Sragovich S"", ""Malishkevich A"", ""Piontkewitz Y"", ""Giladi E"", ""Touloumi O"", ""Lagoudaki R"", ""Grigoriadis N"", ""Gozes I""], ""title"": ""The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse."", ""doi"": ""10.1038/s41398-018-0357-6""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Brain"", ""Diffusion Tensor Imaging"", ""Disease Models, Animal"", ""Female"", ""Haploinsufficiency"", ""Homeodomain Proteins"", ""Magnetic Resonance Imaging"", ""Male"", ""Mice"", ""Mice, 129 Strain"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Neuroprotection"", ""Oligopeptides"", ""Synapses"", ""Vesicular Glutamate Transport Protein 1""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Oligopeptides"", ""Slc17a7 protein, mouse"", ""Vesicular Glutamate Transport Protein 1"", ""davunetide""]}",False
CAUSES_NO_CHANGE,11560,1365,2015.0,25639674,False,False,False,"The α4β2 nAChR PAM, NS-9283, administered alone did not affect mechanical allodynia in the spinal nerve ligation test (a model of neuropathic pain), nor on nociception and inflammation in various rodent models of pain [185, 186].",#60:18,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""MeSHAnatomy"": [""Neurons"", ""Spinal Cord""], ""MeSHDisease"": [""Pain""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,15422,44535,2020.0,30606258,False,False,False,"When assessed on western blots, S6K1 phosphorylation in CHO-Tau35 cells was approximately 3-fold higher than that in CHO cells, whereas it was unchanged in CHO-FL cells (Fig. 5a, b), indicating a selective upregulation of S6K1 activity by Tau35.",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,11460,43156,2019.0,30108137,False,False,False,"Immunoblotting for total tau and phospho-tau antibodies, PHF1 and CP13, demonstrated no statistical difference in hippocampal brain lysate from TFEB- versus EGFP-injected rTg4510 male or female mice",#64:12,PMC6122971,"{""full_journal_name"": ""The Journal of experimental medicine"", ""pub_date"": ""2019-09-04"", ""ref"": ""30108137"", ""pub_year"": 2019, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Martini-Stoica H"", ""Cole AL"", ""Swartzlander DB"", ""Chen F"", ""Wan YW"", ""Bajaj L"", ""Bader DA"", ""Lee VMY"", ""Trojanowski JQ"", ""Liu Z"", ""Sardiello M"", ""Zheng H""], ""title"": ""TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading."", ""doi"": ""10.1084/jem.20172158""}","{""Cell"": [""astrocyte""], ""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Hippocampus""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Astrocytes"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Disease Models, Animal"", ""Gene Knockdown Techniques"", ""Hippocampus"", ""Lysosomes"", ""Mice"", ""Synapses"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Tcfeb protein, mouse"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,41708,39647,2017.0,28760828,False,False,False,"Of note, all of tau’s KXGS motifs were responsive to HDAC6 in vitro with the exception of Lys-290 in the second microtubule binding repeat domain, which could not be determined, given that p300 did not acetylate this site under the current conditions.",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,20908,28988,2019.0,30126037,False,False,False,"In 15-month-old mice with heavy Abeta deposition and phosphorylated tau, but lacking NFT pathology (Orr et al., 2014), Cdkn2a expression was not elevated (Figure 4e). These data indicate that Cdkn2a expression was neither a response to general protein accumulation, nor to pre-NFT tau pathology, but instead required the presence of NFTs",#59:44,PMC6260915,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2019-10-21"", ""ref"": ""30126037"", ""pub_year"": 2019, ""last_author"": ""Orr ME"", ""type"": ""PubMed"", ""author_list"": [""Musi N"", ""Valentine JM"", ""Sickora KR"", ""Baeuerle E"", ""Thompson CS"", ""Shen Q"", ""Orr ME""], ""title"": ""Tau protein aggregation is associated with cellular senescence in the brain."", ""doi"": ""10.1111/acel.12840""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Hippocampus""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Aged, 80 and over"", ""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Antioxidants"", ""Atrophy"", ""Brain"", ""Cellular Senescence"", ""Cyclin-Dependent Kinase Inhibitor p16"", ""Dasatinib"", ""Disease Models, Animal"", ""Female"", ""Gene Expression"", ""Humans"", ""Male"", ""Mice"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Protein Kinase Inhibitors"", ""Quercetin"", ""Supranuclear Palsy, Progressive"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""Antioxidants"", ""CDKN2A protein, human"", ""Cdkn2a protein, mouse"", ""Cyclin-Dependent Kinase Inhibitor p16"", ""MAPT protein, human"", ""Protein Aggregates"", ""Protein Kinase Inhibitors"", ""tau Proteins"", ""Quercetin"", ""Dasatinib""]}",False
CAUSES_NO_CHANGE,6833,2342,2016.0,23393546,False,False,False,"Cetirizine, diphenhydramine, ketotifen, desloratadine, and chlorphreniramine failed to rescue ST Hdh Q111/Q111 cells (Figure 6). This suggests that the activity of the drugs in the cell-based assay is not related solely to their common ability to block the H1 receptor.",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,32540,3242,2014.0,24227736,False,False,False,Treatment with interferons (IFN-γ or IFN-α) did not change Siglece transcription as determined by qRT-PCR (data not shown) but slightly increased the cell-surface expression of Siglec-E (Fig. 1B).,#57:0,PMC3828472,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2014-01-06"", ""ref"": ""24227736"", ""pub_year"": 2014, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Claude J"", ""Linnartz-Gerlach B"", ""Kudin AP"", ""Kunz WS"", ""Neumann H""], ""title"": ""Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst."", ""doi"": ""10.1523/JNEUROSCI.2211-13.2013""}","{""Assay"": [""qRT-PCR""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cells, Cultured"", ""Coculture Techniques"", ""Female"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Microglia"", ""Neurons"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Protein Binding"", ""Respiratory Burst"", ""Sialic Acid Binding Ig-like Lectin 3""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cd33 protein, mouse"", ""Neuroprotective Agents"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Siglece protein, mouse""]}",False
CAUSES_NO_CHANGE,4698,43461,2000.0,10887109,False,False,False,"Even though each of the mutant receptors was expressed in 293T cells as detected by flow cytometry (data not shown) and immunoblotting of parallel samples with anti-CD33, we detected significant tyrosine phosphorylation only of wild-type CD33 and CD33 Y358F (Figure 2B, lanes 2 and 4).",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,6709,41910,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,1950,32300,2015.0,25784053,False,False,False,"Treatment with IU1 reduced the levels of Tau, TDP-43, and ataxin-3 in MEFs in a USP14-dependent manner and independently of changes in proteasome levels or composition (147).",#57:57,PMC4539002,"{""full_journal_name"": ""Annual review of biochemistry"", ""pub_date"": ""2015-12-17"", ""ref"": ""25784053"", ""pub_year"": 2015, ""last_author"": ""Morimoto RI"", ""type"": ""PubMed"", ""author_list"": [""Labbadia J"", ""Morimoto RI""], ""title"": ""The biology of proteostasis in aging and disease."", ""doi"": ""10.1146/annurev-biochem-060614-033955""}","{""Cell"": [""motor neuron""], ""CellLine"": [""MEF cell line""], ""Confidence"": [""High""], ""mesh"": [""Aging"", ""Animals"", ""Endoplasmic Reticulum Stress"", ""Humans"", ""Metabolic Networks and Pathways"", ""Neurodegenerative Diseases"", ""Proteins"", ""Proteolysis""], ""substances"": [""Proteins""]}",False
CAUSES_NO_CHANGE,6709,11261,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,7,11795,2013.0,22530628,False,False,False,"For instance, cotinine induced the activation of the pro-survival protein kinase B (Akt)/glycogen synthase kinase 3beta (GSK3beta) pathway in the brains of both Tg6799 and wild type control mice, suggesting that the activation of these factors is independent from its effect on Aβ aggregation [33].",#57:51,PMC6493450,"{""full_journal_name"": ""CNS neuroscience & therapeutics"", ""pub_date"": ""2013-05-20"", ""ref"": ""22530628"", ""pub_year"": 2013, ""last_author"": ""Zeitlin R"", ""type"": ""PubMed"", ""author_list"": [""Echeverria V"", ""Zeitlin R""], ""title"": ""Cotinine: a potential new therapeutic agent against Alzheimer's disease."", ""doi"": ""10.1111/j.1755-5949.2012.00317.x""}","{""Anatomy"": [""brain""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cotinine"", ""Drug Delivery Systems"", ""Humans"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic"", ""Cotinine""]}",False
CAUSES_NO_CHANGE,29278,34846,2000.0,10656250,False,False,False,"However, while there is a significant increase in the production of CTFb in the presence of wild-type Asp 2, there is no increase in the presence of the mutant enzymes (Fig. 4b).",#64:10,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2000-02-17"", ""ref"": ""10656250"", ""pub_year"": 2000, ""last_author"": ""Christie G"", ""type"": ""PubMed"", ""author_list"": [""Hussain I"", ""Powell D"", ""Howlett DR"", ""Tew DG"", ""Meek TD"", ""Chapman C"", ""Gloger IS"", ""Murphy KE"", ""Southan CD"", ""Ryan DM"", ""Smith TS"", ""Simmons DL"", ""Walsh FS"", ""Dingwall C"", ""Christie G""], ""title"": ""Identification of a novel aspartic protease (Asp 2) as beta-secretase.""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""COS Cells"", ""Cathepsin D"", ""Cell Line"", ""Cell Membrane"", ""Endopeptidases"", ""Female"", ""Hippocampus"", ""Humans"", ""Middle Aged"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Papain"", ""Recombinant Proteins"", ""Sequence Alignment"", ""Sequence Homology, Amino Acid"", ""Transfection""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Recombinant Proteins"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Papain"", ""Aspartic Acid Endopeptidases"", ""BACE2 protein, human"", ""BACE1 protein, human"", ""Cathepsin D""]}",False
CAUSES_NO_CHANGE,7180,7106,2017.0,27794524,False,False,False,"In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""cortex""], ""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,37099,12153,2007.0,17293005,False,False,False,"BI-3 also potentially inhibited the release of sAPPb (IC50 = 0.5 mM) and sAPPa (IC50 = 3.4 mM, Figs. 2B and 3B). BI- 4, which is short peptide of BI-3, showed no effects on sAPP secretion.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,11205,12097,2017.0,27594586,False,False,False,"Interestingly, the level and activity of secreted MMP-9 in HEK293 cells expressing WT 3R tau and 3R tau-A152T are similar (Figures S4B and S4C)",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""CellLine"": [""HEK293""], ""Confidence"": [""High""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,6558,5399,2019.0,30270813,False,False,False,"Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",#63:68,PMC6166273,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2019-06-06"", ""ref"": ""30270813"", ""pub_year"": 2019, ""last_author"": ""Heijnen CJ"", ""type"": ""PubMed"", ""author_list"": [""Ma J"", ""Huo X"", ""Jarpe MB"", ""Kavelaars A"", ""Heijnen CJ""], ""title"": ""Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment."", ""doi"": ""10.1186/s40478-018-0604-3""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antineoplastic Agents"", ""Cisplatin"", ""Cognitive Dysfunction"", ""Disease Models, Animal"", ""Disks Large Homolog 4 Protein"", ""Dose-Response Relationship, Drug"", ""Enzyme Inhibitors"", ""Green Fluorescent Proteins"", ""Histone Deacetylase 6"", ""Hydroxamic Acids"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Microscopy, Electron, Transmission"", ""Mitochondria"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Synaptosomes"", ""Tauopathies"", ""Time Factors"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Antineoplastic Agents"", ""Disks Large Homolog 4 Protein"", ""Enzyme Inhibitors"", ""Hydroxamic Acids"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Tubulin"", ""synaptopHIuorin"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Cisplatin"", ""ricolinostat""]}",False
CAUSES_NO_CHANGE,20982,7474,2017.0,27209302,False,False,False,The results indicated that microglia with TFEB-K116Q overexpression could neither facilitate fAβ degradation (Fig. S5B) nor upregulate the lysosomal biogenesis and function (Fig. S5C and S5D).,#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,41743,28886,2013.0,23356410,False,False,False,"Interestingly, the overexpression of HDAC1, but not HDAC2, in cells and in an in vivo model of stroke was able to protect neurons from p25 toxicity [51].",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Stroke""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,14443,27074,2006.0,16816118,False,False,False,"In the present study we injected bilaterally 3-morpholino-sydnonimine (SIN-1), a recognized and widely used peroxynitrite donor (25–30), into rat hippocampus, and investigated whether or not peroxynitrite could induce simultaneously nitration and hyperphosphorylation of tau and the underlying mechanisms in vivo. The level of nitrated and hyperphosphorylated tau was markedly increased in rat hippocampus 24 h, and prevented by preinjection of uric acid, a natural scavenger of peroxynitrite. GSK-3beta and p38 MAPKs, including p38alpha, p38beta, and p38delta activity was increased, but no change in the activity of p38gamma, ERK, and c-Jun amino-terminal kinase (JNK). Both nitrated tau and hyperphosphorylated tau were aggregated in the hippocampus, with activity of 20S proteasome significantly arrested in SIN-1-injected rats. Hyperphosphorylated tau was degraded as efficiently as normal tau by 20S proteasome, but the nitrated tau with an unorderly secondary structure became more resistant to the proteolysis, providing evidence that peroxynitrite simultaneously induces tau hyperphosphorylation, nitration, and accumulation, and that activation of GSK-3beta, p38alpha, p38beta, p38delta isoforms and the inhibition of proteasome activity are respectively responsible for the peroxynitrite-induced tau hyperphosphorylation and accumulation.",#60:23,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2006-07-31"", ""ref"": ""16816118"", ""pub_year"": 2006, ""last_author"": ""Wang JZ"", ""type"": ""PubMed"", ""author_list"": [""Zhang YJ"", ""Xu YF"", ""Liu YH"", ""Yin J"", ""Li HL"", ""Wang Q"", ""Wang JZ""], ""title"": ""Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms.""}","{""Anatomy"": [""hippocampal formation""], ""Confidence"": [""Medium""], ""ExpMethod"": [""in vivo""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Caspase 3"", ""Caspases"", ""Cell Nucleus"", ""Glycogen Synthase Kinase 3"", ""Hippocampus"", ""Male"", ""Maze Learning"", ""Peroxynitrous Acid"", ""Phosphorylation"", ""Rats"", ""Rats, Wistar"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""Peroxynitrous Acid"", ""Glycogen Synthase Kinase 3"", ""Casp3 protein, rat"", ""Caspase 3"", ""Caspases""]}",False
CAUSES_NO_CHANGE,2041,1363,2017.0,27794524,False,False,False,"Natalizumab did show some positive effects on upper limb function, but did not slow down disability accumulation compared to rates observed in the placebo group (NCT01416181).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,1842,7161,,0,False,False,False,"Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB01049"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""MeSHAnatomy"": [""Cerebrum""], ""Subgraph"": [""Dopaminergic subgraph"", ""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,41670,6064,2009.0,19277525,False,False,False,"For example, the small tumor antigen derived from the DNA tumor viruses SV40 and polyoma viruses was shown to only interact with the PP2A core enzyme, but not the holoenzyme",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""High""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,14488,7161,2010.0,20009055,False,False,False,"Tarenflurbil had no beneficial effect on the co-primary outcomes using an intent-to-treat analysis. No significant differences occurred in the secondary outcomes. The ADAS-Cog score decreased by 7.1 points over 18 months. The tarenflurbil group had a small increase in frequency of dizziness, anemia, and infections.",#59:5,PMC2902875,"{""full_journal_name"": ""JAMA"", ""pub_date"": ""2010-01-05"", ""ref"": ""20009055"", ""pub_year"": 2010, ""last_author"": ""Zavitz KH"", ""type"": ""PubMed"", ""author_list"": [""Green RC"", ""Schneider LS"", ""Amato DA"", ""Beelen AP"", ""Wilcock G"", ""Swabb EA"", ""Zavitz KH""], ""title"": ""Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial."", ""doi"": ""10.1001/jama.2009.1866""}","{""DiseaseState"": [""Mild AD""], ""FDASTATUS"": [""Phase 2""], ""Subgraph"": [""Inflammatory response subgraph""], ""mesh"": [""Activities of Daily Living"", ""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Cognition"", ""Cognition Disorders"", ""Double-Blind Method"", ""Enzyme Inhibitors"", ""Female"", ""Flurbiprofen"", ""Humans"", ""Male"", ""Middle Aged"", ""Peptide Fragments""], ""substances"": [""Amyloid beta-Peptides"", ""Enzyme Inhibitors"", ""Peptide Fragments"", ""tarenflurbil"", ""Flurbiprofen"", ""Amyloid Precursor Protein Secretases""]}",False
CAUSES_NO_CHANGE,37647,1237,2017.0,27522251,False,False,False,We finally measured anxiety levels using the LDB paradigm. No differences were observed between both groups for the index of time spent in the lit compartment (p = 0.7) as well as for the number of transitions (p = 0.2; Fig. 2GeH),#68:77,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-09-28"", ""ref"": ""27522251"", ""pub_year"": 2017, ""last_author"": ""Maskos U"", ""type"": ""PubMed"", ""author_list"": [""Lombardo S"", ""Catteau J"", ""Besson M"", ""Maskos U""], ""title"": ""A role for \u03b22* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus."", ""doi"": ""10.1016/j.neurobiolaging.2016.06.005""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Dentate Gyrus""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Dentate Gyrus"", ""Disease Models, Animal"", ""Hippocampus"", ""Male"", ""Memory Disorders"", ""Mice, Inbred C57BL"", ""Receptors, Nicotinic""], ""substances"": [""Amyloid beta-Peptides"", ""Receptors, Nicotinic"", ""nicotinic receptor beta2""]}",False
CAUSES_NO_CHANGE,6894,2306,2019.0,30664622,False,False,False,We have previously shown essentially no significant NAP effects on behavior in the Adnp+/+ mice,#69:15,PMC6341082,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-06-10"", ""ref"": ""30664622"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Sragovich S"", ""Malishkevich A"", ""Piontkewitz Y"", ""Giladi E"", ""Touloumi O"", ""Lagoudaki R"", ""Grigoriadis N"", ""Gozes I""], ""title"": ""The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse."", ""doi"": ""10.1038/s41398-018-0357-6""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Brain"", ""Diffusion Tensor Imaging"", ""Disease Models, Animal"", ""Female"", ""Haploinsufficiency"", ""Homeodomain Proteins"", ""Magnetic Resonance Imaging"", ""Male"", ""Mice"", ""Mice, 129 Strain"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Neuroprotection"", ""Oligopeptides"", ""Synapses"", ""Vesicular Glutamate Transport Protein 1""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Oligopeptides"", ""Slc17a7 protein, mouse"", ""Vesicular Glutamate Transport Protein 1"", ""davunetide""]}",False
CAUSES_NO_CHANGE,1791,2377,2007.0,17640819,False,False,False,"4OH-GTS-21 had no effect on the latency to enter the dark chamber during avoidance training (Fig. 1 ) or on swim speed in the Morris water task (data not shown), indicating that it had no discernible effect on locomotor function",#57:56,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,7642,33314,2017.0,28148553,False,False,False,"Upon 3R tau overexpression, PERK modulation showed no significant changes",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,2041,1363,2017.0,27794524,False,False,False,"Natalizumab did show some positive effects on upper limb function, but did not slow down disability accumulation compared to rates observed in the placebo group (NCT01416181).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,3473,30656,2020.0,30606258,False,False,False,"Western blots of CHOP showed a corresponding increase in CHO-Tau35 cells, whereas the amount of CHOP in CHO-FL cells was unchanged (Fig.6c, d).",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,34694,35851,2018.0,28528849,False,False,False,"However, we did not find significant changes in the expression level of Nox2 protein (another component of NADPH oxidase complex) (Fig. 5C).",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""High""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,11948,2342,2016.0,23393546,False,False,False,"Cetirizine, diphenhydramine, ketotifen, desloratadine, and chlorphreniramine failed to rescue ST Hdh Q111/Q111 cells (Figure 6). This suggests that the activity of the drugs in the cell-based assay is not related solely to their common ability to block the H1 receptor.",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,2002,2666,2010.0,20392114,False,False,False,"Finally,to evaluate possible major toxicities associated with the ATPZs, all test compounds were evaluated in a cytotoxicity assay that employs rapidly dividing HEK293. All compounds were found to be nontoxic at 100 microM.",#61:0,PMC2872922,"{""full_journal_name"": ""Journal of medicinal chemistry"", ""pub_date"": ""2010-06-11"", ""ref"": ""20392114"", ""pub_year"": 2010, ""last_author"": ""Smith AB"", ""type"": ""PubMed"", ""author_list"": [""Ballatore C"", ""Brunden KR"", ""Piscitelli F"", ""James MJ"", ""Crowe A"", ""Yao Y"", ""Hyde E"", ""Trojanowski JQ"", ""Lee VM"", ""Smith AB""], ""title"": ""Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation."", ""doi"": ""10.1021/jm100138f""}","{""Assay"": [""cytotoxicity assay""], ""CellLine"": [""HEK293""], ""TextLocation"": [""Results""], ""mesh"": [""Administration, Oral"", ""Animals"", ""Biological Availability"", ""Blood-Brain Barrier"", ""Drug Discovery"", ""Mice"", ""Protein Multimerization"", ""Pyridazines"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Pyridazines"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,7085,11261,2016.0,23393546,False,False,False,"D2DR, GAD65/67 and 5HT1B levels are also altered in the HD transgenic R6/2 mice, but pizotifen treatment did not normalize the levels (data not shown).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,11790,42812,2009.0,19237574,False,False,False,"We next studied the potential effect of metformin on the levels of 2 enzymes known to degrade Abeta, neprilysin and insulin-degrading enzyme (IDE). Metformin had no effect on both enzymes, including protein levels and their activities (Fig. S2 A and B). Moreover, metformin had no effect on Abeta degradation as measured by pulseâ€“chase assay (Fig. S2C). We also found that the increased Abeta production caused by metformin was not due to increased APP expression, because the total APP level was unaltered (Fig. 1D).",#59:5,PMC2656178,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2009-03-26"", ""ref"": ""19237574"", ""pub_year"": 2009, ""last_author"": ""Liao FF"", ""type"": ""PubMed"", ""author_list"": [""Chen Y"", ""Zhou K"", ""Wang R"", ""Liu Y"", ""Kwak YD"", ""Ma T"", ""Thompson RC"", ""Zhao Y"", ""Smith L"", ""Gasparini L"", ""Luo Z"", ""Xu H"", ""Liao FF""], ""title"": ""Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription."", ""doi"": ""10.1073/pnas.0807991106""}","{""Subgraph"": [""Insulin signal transduction""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Base Sequence"", ""Binding Sites"", ""Enzyme Activation"", ""Glucose"", ""Hypoglycemic Agents"", ""Insulin"", ""Metformin"", ""Mice"", ""Molecular Sequence Data"", ""Peptides"", ""Promoter Regions, Genetic"", ""Rats"", ""Signal Transduction"", ""Transcription, Genetic"", ""Up-Regulation""], ""substances"": [""Amyloid beta-Peptides"", ""Hypoglycemic Agents"", ""Insulin"", ""Peptides"", ""Metformin"", ""AMP-Activated Protein Kinases"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Glucose""]}",False
CAUSES_NO_CHANGE,41949,29084,2015.0,25784053,False,False,False,Cerebellar granular neurons were found to express high levels of HSP70 in response to mHTT expression but not mAtaxin-1.,#57:57,PMC4539002,"{""full_journal_name"": ""Annual review of biochemistry"", ""pub_date"": ""2015-12-17"", ""ref"": ""25784053"", ""pub_year"": 2015, ""last_author"": ""Morimoto RI"", ""type"": ""PubMed"", ""author_list"": [""Labbadia J"", ""Morimoto RI""], ""title"": ""The biology of proteostasis in aging and disease."", ""doi"": ""10.1146/annurev-biochem-060614-033955""}","{""Cell"": [""cerebellar granule cell""], ""Confidence"": [""High""], ""mesh"": [""Aging"", ""Animals"", ""Endoplasmic Reticulum Stress"", ""Humans"", ""Metabolic Networks and Pathways"", ""Neurodegenerative Diseases"", ""Proteins"", ""Proteolysis""], ""substances"": [""Proteins""]}",False
CAUSES_NO_CHANGE,42894,37163,2012.0,22179319,False,False,False,"SIRT1 overexpression did not decrease mutant Htt levels (Supplementary Fig. 1a), but significantly delayed the onset and slowed the progression of motor deficits in HD mice (Fig. 1c).",#66:20,PMC4551453,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2012-03-14"", ""ref"": ""22179319"", ""pub_year"": 2012, ""last_author"": ""Duan W"", ""type"": ""PubMed"", ""author_list"": [""Jiang M"", ""Wang J"", ""Fu J"", ""Du L"", ""Jeong H"", ""West T"", ""Xiang L"", ""Peng Q"", ""Hou Z"", ""Cai H"", ""Seredenina T"", ""Arbez N"", ""Zhu S"", ""Sommers K"", ""Qian J"", ""Zhang J"", ""Mori S"", ""Yang XW"", ""Tamashiro KL"", ""Aja S"", ""Moran TH"", ""Luthi-Carter R"", ""Martin B"", ""Maudsley S"", ""Mattson MP"", ""Cichewicz RH"", ""Ross CA"", ""Holtzman DM"", ""Krainc D"", ""Duan W""], ""title"": ""Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets."", ""doi"": ""10.1038/nm.2558""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Corpus Striatum"", ""Hippocampus"", ""Hypothalamus""], ""MeSHDisease"": [""Huntington Disease""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Disease Models, Animal"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""Gene Expression Regulation"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins"", ""Rats"", ""Receptor, trkB"", ""Signal Transduction"", ""Sirtuin 1""], ""substances"": [""Brain-Derived Neurotrophic Factor"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""FoxO3 protein, mouse"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Ppp1r1b protein, mouse"", ""Receptor, trkB"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,28145,7122,2017.0,29191965,False,False,False,"Loss of function in other genes (cat-2, cat-4, tph-1) that also regulate the dopamine or serotonin levels (130–132),did not affect the tau-induced toxicity in TauV337M; however, their activity is essential for bas-1-mediated suppression of tau-induced toxicity in TauV337M (105)",#69:60,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2017-12-11"", ""ref"": ""29191965"", ""pub_year"": 2017, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Pir GJ"", ""Choudhary B"", ""Mandelkow E""], ""title"": {""#text"": ""models of tauopathy."", ""i"": ""Caenorhabditis elegans""}, ""doi"": ""10.1096/fj.201701007""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Caenorhabditis elegans"", ""Disease Models, Animal"", ""Neurodegenerative Diseases"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,3459,14420,2019.0,30046111,False,False,False,"Moreover, viral expression of mVEGF-C did not significantly affect the diameter of meningeal lymphatic vessels, the level of amyloid-β in the CSF, or amyloid-β deposition in the hippocampus (Extended Data Fig. 8g–n)",#67:25,PMC6085146,"{""full_journal_name"": ""Nature"", ""pub_date"": ""2019-02-08"", ""ref"": ""30046111"", ""pub_year"": 2019, ""last_author"": ""Kipnis J"", ""type"": ""PubMed"", ""author_list"": [""Da Mesquita S"", ""Louveau A"", ""Vaccari A"", ""Smirnov I"", ""Cornelison RC"", ""Kingsmore KM"", ""Contarino C"", ""Onengut-Gumuscu S"", ""Farber E"", ""Raper D"", ""Viar KE"", ""Powell RD"", ""Baker W"", ""Dabhi N"", ""Bai R"", ""Cao R"", ""Hu S"", ""Rich SS"", ""Munson JM"", ""Lopes MB"", ""Overall CC"", ""Acton ST"", ""Kipnis J""], ""title"": ""Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease."", ""doi"": ""10.1038/s41586-018-0368-8""}","{""Confidence"": [""Low""], ""MeSHAnatomy"": [""Meninges""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid"", ""Amyloid beta-Peptides"", ""Animals"", ""Brain"", ""Cognition"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Extracellular Fluid"", ""Female"", ""Homeostasis"", ""Humans"", ""Lymph Nodes"", ""Lymphatic Vessels"", ""Male"", ""Meninges"", ""Mice"", ""Mice, Transgenic"", ""Perfusion""], ""substances"": [""Amyloid"", ""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,11572,13478,2020.0,30686764,False,False,False,"The reduction of both pTau as well as tTau could indicate a proteostatic regulatory event, rather than altered Tau phosphorylation and dephosphorylation events. This was further substantiated by the finding that activity of GSK3b (a major Tau kinase) was not affected by statin-mediated CE reduction (Figure S5E).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,19673,2721,2019.0,29024336,False,False,False,"However, cells expressing the mutant tau proteins failed to further upregulate CMA and even a decrease was noticeable in cells expressing tau-P301L (Fig. 3f,g)",#61:23,PMC5770880,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2019-07-30"", ""ref"": ""29024336"", ""pub_year"": 2019, ""last_author"": ""Cuervo AM"", ""type"": ""PubMed"", ""author_list"": [""Caballero B"", ""Wang Y"", ""Diaz A"", ""Tasset I"", ""Juste YR"", ""Stiller B"", ""Mandelkow EM"", ""Mandelkow E"", ""Cuervo AM""], ""title"": ""Interplay of pathogenic forms of human tau with different autophagic pathways."", ""doi"": ""10.1111/acel.12692""}","{""CellStructure"": [""Intracellular Space""], ""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain""], ""mesh"": [""Animals"", ""Autophagy"", ""Brain"", ""Humans"", ""Male"", ""Mutation"", ""Neurodegenerative Diseases"", ""Neurons"", ""Phosphorylation"", ""Proteolysis"", ""Rats, Wistar"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,4481,41815,2015.0,25546293,False,False,False,"In the presence of the HDAC6 inhibitor ACY-1215, the increased levels of Ac-Lys49 β-catenin had no effect on the levels for β-catenin phosphorylated at Ser33, Ser37, and Thr41 (Figure 3A, B).",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,6878,6901,2018.0,29626319,False,False,False,"By measuring Aβ levels in superior vena cava and inferior vena cava, it is clear that Aβ levels are getting lower and lower along the direction of the vein blood flow, and the contents of Aβ40 and total Aβ in artery are significantly less than those in vein, suggesting a part of Aβ40 and total Aβ can be cleared by peripheral organs and tissues, such as the liver, kidney, skin, and the gastrointestinal tract, although there is no change in Aβ42 concentrations (Xiang et al. 2015)",#70:59,,"{""full_journal_name"": ""Neurotoxicity research"", ""pub_date"": ""2018-11-06"", ""ref"": ""29626319"", ""pub_year"": 2018, ""last_author"": ""Tan L"", ""type"": ""PubMed"", ""author_list"": [""Xin SH"", ""Tan L"", ""Cao X"", ""Yu JT"", ""Tan L""], ""title"": ""Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy."", ""doi"": ""10.1007/s12640-018-9895-1""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Arteries""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,4177,2498,2017.0,27594586,False,False,False,The resting membrane potential did not differ among neurons differentiated from all iPSC lines (Figure S2D),#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,1849,33326,2020.0,30686764,False,False,False,"Activation of homologous nuclear receptors such as PPARa (by GW50156) and PPARg (by Rosiglitazone), which regulate fatty acid metabolism but not cholesterol export, did not decrease pThr231Tau/tTau (Figures 2C, S2F, and S2G).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,11205,24473,2017.0,27594586,False,False,False,"Interestingly, the level and activity of secreted MMP-9 in HEK293 cells expressing WT 3R tau and 3R tau-A152T are similar (Figures S4B and S4C)",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""CellLine"": [""HEK293""], ""Confidence"": [""High""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,32311,39861,2015.0,25546293,False,False,False,"Our results in the human NPCs are supportive of this latter model as HDAC6 inhibition-induced increase in Lys49 acetylation was accompanied by increase in Ser45 phosphorylation but increased Ser45 phosphorylation was not accompanied by increased phosphorylation of Ser33, Ser37, and Thr41.",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,11526,14197,2019.0,30664622,False,False,False,These findings provide clear evidence that the blood brain barrier remained intact in the presence of chlorobutanol,#69:15,PMC6341082,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-06-10"", ""ref"": ""30664622"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Sragovich S"", ""Malishkevich A"", ""Piontkewitz Y"", ""Giladi E"", ""Touloumi O"", ""Lagoudaki R"", ""Grigoriadis N"", ""Gozes I""], ""title"": ""The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse."", ""doi"": ""10.1038/s41398-018-0357-6""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Brain"", ""Diffusion Tensor Imaging"", ""Disease Models, Animal"", ""Female"", ""Haploinsufficiency"", ""Homeodomain Proteins"", ""Magnetic Resonance Imaging"", ""Male"", ""Mice"", ""Mice, 129 Strain"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Neuroprotection"", ""Oligopeptides"", ""Synapses"", ""Vesicular Glutamate Transport Protein 1""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Oligopeptides"", ""Slc17a7 protein, mouse"", ""Vesicular Glutamate Transport Protein 1"", ""davunetide""]}",False
CAUSES_NO_CHANGE,14453,7102,2020.0,30697142,False,False,False,"Cotinine does not cause tachyphylaxis, addiction, or nicotine like withdrawal symptoms, and it has no negative cardiovascular eﬀects as opposed to nicotine (Terry et al., 2005; Benowitz et al., 2009; Zeitlin et al., 2012).",#59:13,PMC6341027,"{""full_journal_name"": ""Frontiers in neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30697142"", ""pub_year"": 2020, ""last_author"": ""Gjedde A"", ""type"": ""PubMed"", ""author_list"": [""Majdi A"", ""Kamari F"", ""Sadigh-Eteghad S"", ""Gjedde A""], ""title"": ""Molecular Insights Into Memory-Enhancing Metabolites of Nicotine in Brain: A Systematic Review."", ""doi"": ""10.3389/fnins.2018.01002""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,43292,38622,2007.0,17293005,False,False,False,"Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,8165,42256,2017.0,27594586,False,False,False,"Moreover, the total expression levels of tau and PSD-95 were the same in 1-month-old neurons derived from control and patient iPSCs (Figure 1B)",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,7981,5479,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,29022,11963,2015.0,25171717,False,False,False,"We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",#67:28,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-08-18"", ""ref"": ""25171717"", ""pub_year"": 2015, ""last_author"": ""Karsdal MA"", ""type"": ""PubMed"", ""author_list"": [""Henriksen K"", ""Byrjalsen I"", ""Christiansen C"", ""Karsdal MA""], ""title"": ""Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease."", ""doi"": ""10.3233/JAD-140984""}","{""mesh"": [""Aged"", ""Alzheimer Disease"", ""Biomarkers"", ""Clinical Trials, Phase III as Topic"", ""Disease Progression"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Humans"", ""Linear Models"", ""Male"", ""Mental Status Schedule"", ""Severity of Illness Index"", ""Time Factors"", ""tau Proteins""], ""substances"": [""Biomarkers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,39699,21520,2018.0,27671637,False,False,False,"We observed a typical paired-pulse facilitation (PPF) response in littermate controls and antiaggregant Tau transgenic slices, whereas in proaggregant Tau transgenic slices, the same stimulus paradigm resulted in a paired-pulse depression (Fig. 4B)",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,14441,1553,2015.0,25639674,False,False,False,"However other agonists that target α7 nAChRs, such as SSR-180711 and tropisetron, fail to induce analgesia when tested in the formalin model for pain [168], suggesting that targeting α7* nAChRs for pain relief is modality selective.",#59:10,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Pain""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,2104,4411,2009.0,19126755,False,False,False,"Surprisingly, however, activation of nAChRs by galantamine or physostigmine was insensitive to blockade by competitive nAChR antagonists, was detected even when the receptors were desensitized by high agonist concentrations, and was inhibited by the monoclonal antibody FK1 (350, 370, 372, 413, 428, 429).",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,7161,11098,2002.0,11814408,False,False,False,Increased uPAR expression was not demonstrated in AD cerebellum.,#59:5,,"{""full_journal_name"": ""Brain research"", ""pub_date"": ""2002-04-04"", ""ref"": ""11814408"", ""pub_year"": 2002, ""last_author"": ""Beach TG"", ""type"": ""PubMed"", ""author_list"": [""Walker DG"", ""Lue LF"", ""Beach TG""], ""title"": ""Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains.""}","{""MeSHAnatomy"": [""Cerebellum""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""Plasminogen activator subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Brain"", ""Cells, Cultured"", ""Female"", ""Free Radicals"", ""Gene Expression"", ""Humans"", ""Male"", ""Microglia"", ""Oxidative Stress"", ""Receptors, Cell Surface"", ""Receptors, Urokinase Plasminogen Activator"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Free Radicals"", ""PLAUR protein, human"", ""Receptors, Cell Surface"", ""Receptors, Urokinase Plasminogen Activator""]}",False
CAUSES_NO_CHANGE,11688,23589,2016.0,25881725,False,False,False,"Also, no alterations in the expression of a7 nAChR mRNA were observed in pretreatment with normal saline or MLA in PHA- or Gal-treated groups (p>0.05). In the same way, the pattern of mRNA expression in the cortex (data not shown) was similar to the hippocampus (Fig. 7).",#61:66,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2016-03-21"", ""ref"": ""25881725"", ""pub_year"": 2016, ""last_author"": ""Shanehbandi D"", ""type"": ""PubMed"", ""author_list"": [""Sadigh-Eteghad S"", ""Talebi M"", ""Mahmoudi J"", ""Babri S"", ""Shanehbandi D""], ""title"": ""Selective activation of \u03b17 nicotinic acetylcholine receptor by PHA-543613 improves A\u03b225-35-mediated cognitive deficits in mice."", ""doi"": ""10.1016/j.neuroscience.2015.04.017""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Hippocampus""], ""Species"": [""10090""], ""mesh"": [""Aconitine"", ""Amyloid beta-Peptides"", ""Animals"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Cholinesterase Inhibitors"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Galantamine"", ""Gene Expression Regulation"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred BALB C"", ""Nicotinic Agonists"", ""Nicotinic Antagonists"", ""Peptide Fragments"", ""Psychomotor Performance"", ""Quinuclidines"", ""RNA, Messenger"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Cholinesterase Inhibitors"", ""N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide"", ""Nicotinic Agonists"", ""Nicotinic Antagonists"", ""Peptide Fragments"", ""Quinuclidines"", ""RNA, Messenger"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""amyloid beta-protein (25-35)"", ""Galantamine"", ""methyllycaconitine"", ""Aconitine""]}",False
CAUSES_NO_CHANGE,14403,14838,2011.0,21745645,False,False,False,"The LTP induced by pairing the SC 10 ms before the SO was blocked by atropine, but not by MLA or DHbE.",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""after SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,7085,40449,2016.0,23393546,False,False,False,"D2DR, GAD65/67 and 5HT1B levels are also altered in the HD transgenic R6/2 mice, but pizotifen treatment did not normalize the levels (data not shown).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,14403,5277,2011.0,21745645,False,False,False,"When cholinergic input was activated 10 ms before SC stimulation, STD was induced, which was also sensitive to MLA but not to DHβE or atropine (Figures 5J and 5H).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,1690,30408,2013.0,23746257,False,False,False,"ATP-independent chaperones, such as the small Hsps, may function as additional holdases that buffer aggregation.",#65:76,,"{""full_journal_name"": ""Annual review of biochemistry"", ""pub_date"": ""2013-11-18"", ""ref"": ""23746257"", ""pub_year"": 2013, ""last_author"": ""Hartl FU"", ""type"": ""PubMed"", ""author_list"": [""Kim YE"", ""Hipp MS"", ""Bracher A"", ""Hayer-Hartl M"", ""Hartl FU""], ""title"": ""Molecular chaperone functions in protein folding and proteostasis."", ""doi"": ""10.1146/annurev-biochem-060208-092442""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Molecular Chaperones"", ""Protein Folding"", ""Proteins"", ""Proteome"", ""Proteostasis Deficiencies""], ""substances"": [""Molecular Chaperones"", ""Proteins"", ""Proteome""]}",False
CAUSES_NO_CHANGE,7161,3524,2002.0,12218646,False,False,False,"Sera from patients with Alzheimer disease and non-demented elderly subjects caused an increase in IL-2 and a decrease in IL-10 production by PBMC from middle-aged control subjects but did not affect IL-1beta, IL-6, and TNFalpha secretion, indicating alterations of the immune system related to aging.",#59:5,,"{""full_journal_name"": ""Alzheimer disease and associated disorders"", ""pub_date"": ""2002-12-04"", ""ref"": ""12218646"", ""pub_year"": 2002, ""last_author"": ""Bessler H"", ""type"": ""PubMed"", ""author_list"": [""Bergman M"", ""Salman H"", ""Beloosesky Y"", ""Djaldetti M"", ""Bessler H""], ""title"": ""Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli?""}","{""MeSHAnatomy"": [""Serum""], ""MeSHDisease"": [""Alzheimer Disease""], ""Species"": [""9606""], ""Subgraph"": [""Interleukin signaling subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Apoptosis"", ""Female"", ""Humans"", ""Interleukin-1"", ""Interleukin-10"", ""Interleukin-2"", ""Interleukin-6"", ""Male"", ""Monocytes"", ""Reference Values"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Interleukin-1"", ""Interleukin-2"", ""Interleukin-6"", ""Tumor Necrosis Factor-alpha"", ""Interleukin-10""]}",False
CAUSES_NO_CHANGE,2104,1729,2009.0,19126755,False,False,False,"For instance, studies carried out in PC12 cells demonstrated that codeine, a drug with no significant effect on ChE, can activate nicotinic single-channel currents and that this nicotinic agonist effect is sensitive to inhibition by FK1 while unaffected by classical nAChR antagonists (450).",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""PC12 Cells""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,1609,38244,2019.0,30008470,False,False,False,No changes in Adnp levels were detected in the VTA or NAc (p’s > 0.05).,#65:46,PMC6300527,"{""full_journal_name"": ""Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"", ""pub_date"": ""2019-02-11"", ""ref"": ""30008470"", ""pub_year"": 2019, ""last_author"": ""Barak S"", ""type"": ""PubMed"", ""author_list"": [""Ziv Y"", ""Rahamim N"", ""Lezmy N"", ""Even-Chen O"", ""Shaham O"", ""Malishkevich A"", ""Giladi E"", ""Elkon R"", ""Gozes I"", ""Barak S""], ""title"": ""Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice."", ""doi"": ""10.1038/s41386-018-0132-7""}","{""Confidence"": [""High""], ""Gender"": [""Female"", ""Male""], ""MeSHAnatomy"": [""Nucleus Accumbens"", ""Ventral Tegmental Area""], ""Species"": [""10090""], ""mesh"": [""Alcohol Drinking"", ""Animals"", ""Disease Models, Animal"", ""Ethanol"", ""Female"", ""Gene Expression"", ""Haploinsufficiency"", ""Hippocampus"", ""Homeodomain Proteins"", ""Male"", ""Mice"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Sex Factors""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Ethanol""]}",False
CAUSES_NO_CHANGE,11807,1396,2017.0,26979166,False,False,False,"Remarkably, α7 nAChR-positive allosteric modulators (galantamine, galantamine plus choline, and JNJ39393406) were completely inactive [100].",#58:34,PMC4894934,"{""full_journal_name"": ""Cellular and molecular life sciences : CMLS"", ""pub_date"": ""2017-02-15"", ""ref"": ""26979166"", ""pub_year"": 2017, ""last_author"": ""Feuerbach D"", ""type"": ""PubMed"", ""author_list"": [""Kalkman HO"", ""Feuerbach D""], ""title"": ""Modulatory effects of \u03b17 nAChRs on the immune system and its relevance for CNS disorders."", ""doi"": ""10.1007/s00018-016-2175-4""}","{""Confidence"": [""High""], ""Disease"": [""schizophrenia""], ""mesh"": [""Animals"", ""Central Nervous System Diseases"", ""Drug Discovery"", ""Humans"", ""Immune System"", ""Signal Transduction"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor""]}",False
CAUSES_NO_CHANGE,11589,2452,2011.0,20847424,False,False,False,"In a direct investigation of the acute effects of extracellular and intracellular Aβ42 peptides on synaptic transmission, Moreno et al. [194] noticed inhibition of synaptic transmission by nanomolar concentrations of intra-axonal oligomeric Aβ42, but not oligomeric Aβ40 or extracellular oligomeric Aβ42",#63:63,PMC3079354,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2011-06-09"", ""ref"": ""20847424"", ""pub_year"": 2011, ""last_author"": ""Brewer GJ"", ""type"": ""PubMed"", ""author_list"": [""Parihar MS"", ""Brewer GJ""], ""title"": ""Amyloid-\u03b2 as a modulator of synaptic plasticity."", ""doi"": ""10.3233/JAD-2010-101020""}","{""MeSHAnatomy"": [""Axons""], ""MeSHDisease"": [""Hippocampus""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Neuronal Plasticity"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,7981,3436,2016.0,26702100,False,False,False,"The enrichment of the active Rag GTPases (RagAGTP/RagCGDP) (Martina & Puertollano, 2013) on lysosomes was not disturbed after knockdown of TDP-43, but was strongly abolished after knockdown of p18, which anchors Rag GTPases to lysosomes (Fig 3D), indicating that loss of TDP-43 does not affect the localization of the Rag GTPases.",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,3634,36139,2019.0,29844403,False,False,False,"As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",#71:1,PMC5974403,"{""full_journal_name"": ""Cell death & disease"", ""pub_date"": ""2019-12-10"", ""ref"": ""29844403"", ""pub_year"": 2019, ""last_author"": ""Yang CR"", ""type"": ""PubMed"", ""author_list"": [""Fan SJ"", ""Huang FI"", ""Liou JP"", ""Yang CR""], ""title"": ""The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model."", ""doi"": ""10.1038/s41419-018-0688-5""}","{""CellLine"": [""Neuro-2a cell"", ""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Benzamides"", ""Cell Line, Tumor"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3 beta"", ""Histone Deacetylase Inhibitors"", ""Memory Disorders"", ""Models, Biological"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Aggregates"", ""Proteolysis"", ""Quinolines"", ""Rats, Sprague-Dawley"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Benzamides"", ""Histone Deacetylase Inhibitors"", ""MPT0G211"", ""Neuroprotective Agents"", ""Protein Aggregates"", ""Quinolines"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,43753,6665,2018.0,28528849,False,False,False,"Tau oligomers from TauRDΔK and TauFLΔK mice reduced the density of the synapses by w50%, whereas tau from wild-type mice had no effect on the density (Fig. 7G).",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,38594,7850,2019.0,29540553,False,False,False,"No significant synaptophysin loss was detected in tauP301S mice or in mice lacking SIRT1 alone in the frontal cortex and hippocampus (Fig. 3B,C).",#68:33,PMC5895994,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2019-10-03"", ""ref"": ""29540553"", ""pub_year"": 2019, ""last_author"": ""Gan L"", ""type"": ""PubMed"", ""author_list"": [""Min SW"", ""Sohn PD"", ""Li Y"", ""Devidze N"", ""Johnson JR"", ""Krogan NJ"", ""Masliah E"", ""Mok SA"", ""Gestwicki JE"", ""Gan L""], ""title"": ""SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy."", ""doi"": ""10.1523/JNEUROSCI.2369-17.2018""}","{""Anatomy"": [""frontal cortex"", ""hippocampal field""], ""CellLine"": [""HEK293""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Female"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Male"", ""Maze Learning"", ""Mice"", ""Sirtuin 1"", ""Synaptic Transmission"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mapt protein, mouse"", ""tau Proteins"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,43753,2517,2017.0,27373205,False,False,False,"As previously reported, perfusion of hT40 monomer had no effect on the rate of anterograde FAT in the squid axoplasm (Fig. 5A), whereas perfusion of hT40 aggregates significantly inhibited anterograde FAT as compared to hT40 monomer (Fig. 5B; Fig. 6A; p = 0.003) (LaPointe et al., 2009b). Neither hT40 monomers nor hT40 aggregates altered the rate of retrograde FAT (Fig. 5A, B; Fig. 6B).",#69:78,PMC4992631,"{""full_journal_name"": ""Experimental neurology"", ""pub_date"": ""2017-05-05"", ""ref"": ""27373205"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Tiernan CT"", ""Combs B"", ""Cox K"", ""Morfini G"", ""Brady ST"", ""Counts SE"", ""Kanaan NM""], ""title"": ""Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport."", ""doi"": ""10.1016/j.expneurol.2016.06.030""}","{""Confidence"": [""Medium""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Axonal Transport"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Frontal Lobe"", ""Humans"", ""Male"", ""Phosphorylation"", ""Serine"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""Serine""]}",False
CAUSES_NO_CHANGE,6672,1287,2017.0,27956442,False,False,False,"There are a large number of phase III trials using agents such azathioprine, ciclosporin, β-interferon, dirucotide (myelin basic protein), immunoglobulins and cladribine, as well as other immunomodulators, in progressive MS that have been reported over the last 25 years. Unfortunately, the results have essentially been negative. [10]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,33319,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,35780,20838,2015.0,25681350,False,False,False,"Knockdown of either RelB or p50 significantly diminished cytokine- induced YKL-40 mRNA expression, whereas knockdown of p65, cRel and p52 had no effect (Fig. 4A). This finding implicates both RelB and p50 in YKL-40 regulation.",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,6709,44560,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Dopaminergic subgraph""]}",False
CAUSES_NO_CHANGE,1788,4980,2015.0,26088141,False,False,False,"In α7345–348A nAChR expressing cells, nifedipine had no effect on the peak or the duration of the calcium transient (peak: 957.00% ΔF/Fθ ± 252.2%; AUC: 333.33% ΔF/Fθ2 × s ± 91.53%) relative to choline treatment alone (Fig. 5, A–C). The findings suggest that choline- induced calcium responses in PC12 cells involve the activity of VGCC (37, 38).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,14219,2068,2018.0,29807032,False,False,False,"Final cumulative mortality (at 10 h recovery) in non-heat shocked embryos was low in both the 0 nM and 10 nM antalarmin groups (4.7% and 8.3%, respectively), and heat shock increased mortality in both groups",#64:39,,"{""full_journal_name"": ""General and comparative endocrinology"", ""pub_date"": ""2018-09-10"", ""ref"": ""29807032"", ""pub_year"": 2018, ""last_author"": ""Bernier NJ"", ""type"": ""PubMed"", ""author_list"": [""Alderman SL"", ""Leishman EM"", ""Fuzzen MLM"", ""Bernier NJ""], ""title"": ""Corticotropin-releasing factor regulates caspase-3 and may protect developing zebrafish from stress-induced apoptosis."", ""doi"": ""10.1016/j.ygcen.2018.05.025""}","{""Cell"": [""embryonic cell""], ""CellLine"": [""embryonic cell line""], ""Confidence"": [""Medium""], ""Species"": [""7955""], ""mesh"": [""Animals"", ""Apoptosis"", ""Caspase 3"", ""Corticotropin-Releasing Hormone"", ""Gene Expression Regulation, Developmental"", ""Heat-Shock Response"", ""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""Stress, Physiological"", ""Zebrafish""], ""substances"": [""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""CRF receptor type 1"", ""Corticotropin-Releasing Hormone"", ""Caspase 3""]}",False
CAUSES_NO_CHANGE,14453,1613,2020.0,30697142,False,False,False,"Cotinine does not cause tachyphylaxis, addiction, or nicotine like withdrawal symptoms, and it has no negative cardiovascular eﬀects as opposed to nicotine (Terry et al., 2005; Benowitz et al., 2009; Zeitlin et al., 2012).",#59:13,PMC6341027,"{""full_journal_name"": ""Frontiers in neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30697142"", ""pub_year"": 2020, ""last_author"": ""Gjedde A"", ""type"": ""PubMed"", ""author_list"": [""Majdi A"", ""Kamari F"", ""Sadigh-Eteghad S"", ""Gjedde A""], ""title"": ""Molecular Insights Into Memory-Enhancing Metabolites of Nicotine in Brain: A Systematic Review."", ""doi"": ""10.3389/fnins.2018.01002""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,44629,38622,2007.0,17293005,False,False,False,"Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,2721,7456,2019.0,30116051,False,False,False,"Htt is not efficiently cleared by CMA, and the same appears to hold for its fragments and mutant and post- translationally modified forms, although the precise role of CMA in Htt elimination remains to be more fully defined 2,45–47 .",#63:7,PMC6456907,"{""full_journal_name"": ""Nature reviews. Drug discovery"", ""pub_date"": ""2019-07-08"", ""ref"": ""30116051"", ""pub_year"": 2019, ""last_author"": ""Millan MJ"", ""type"": ""PubMed"", ""author_list"": [""Boland B"", ""Yu WH"", ""Corti O"", ""Mollereau B"", ""Henriques A"", ""Bezard E"", ""Pastores GM"", ""Rubinsztein DC"", ""Nixon RA"", ""Duchen MR"", ""Mallucci GR"", ""Kroemer G"", ""Levine B"", ""Eskelinen EL"", ""Mochel F"", ""Spedding M"", ""Louis C"", ""Martin OR"", ""Millan MJ""], ""title"": ""Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing."", ""doi"": ""10.1038/nrd.2018.109""}","{""Confidence"": [""Medium""], ""mesh"": [""Aging"", ""Animals"", ""Autophagy"", ""Humans"", ""Neurodegenerative Diseases"", ""Neurotoxins"", ""Proteasome Endopeptidase Complex"", ""Ubiquitin""], ""substances"": [""Neurotoxins"", ""Ubiquitin"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,23027,39549,2011.0,21427723,False,False,False,"Notably, acetylated tau can be modified by HDAC activity as co- expression of CBP with wild-type (WT) HDAC6, but not a catalytically dead HDAC6 mutant, resulted in tau deacetylation (Fig. 2c).",#65:56,PMC3120096,"{""full_journal_name"": ""Nature communications"", ""pub_date"": ""2011-08-01"", ""ref"": ""21427723"", ""pub_year"": 2011, ""last_author"": ""Lee VM"", ""type"": ""PubMed"", ""author_list"": [""Cohen TJ"", ""Guo JL"", ""Hurtado DE"", ""Kwong LK"", ""Mills IP"", ""Trojanowski JQ"", ""Lee VM""], ""title"": ""The acetylation of tau inhibits its function and promotes pathological tau aggregation."", ""doi"": ""10.1038/ncomms1255""}","{""CellLine"": [""HEK293""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Brain"", ""Female"", ""HEK293 Cells"", ""Humans"", ""Immunohistochemistry"", ""Lysine"", ""Male"", ""Mass Spectrometry"", ""Membrane Proteins"", ""Mice"", ""Mice, Transgenic"", ""Microtomy"", ""Microtubules"", ""Middle Aged"", ""Neurons"", ""Phosphorylation"", ""Protein Binding"", ""Protein Processing, Post-Translational"", ""Recombinant Proteins"", ""Transfection""], ""substances"": [""Membrane Proteins"", ""Recombinant Proteins"", ""tau 40 protein, human"", ""Lysine""]}",False
CAUSES_NO_CHANGE,6916,37138,2018.0,27671637,False,False,False,"The axons of transfected neurons (Fig. 1 G and I) clearly reveal small inclusions of Tau (∼1 μm in size, arrowheads), although presynaptic boutons (e.g., giant mossy fiber boutons) are only marginally stained for Tau (Fig. 1I and Fig. S2 A and B; arrow), indicating that Tau does not accumulate at presynaptic boutons in these slices",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,1411,14482,2016.0,27013968,False,False,False,"The estimated total number of neurons in the striatum was similar in WT and R6/2 mice (1,144,207 ± 55,809 vs. 1,333,955 ± 55,522 cells, respectively; p > 0.05).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,44016,7467,2017.0,27209302,False,False,False,"Meanwhile, we found that TSA could not affect microglial degradative capability on fAβ (Fig. S4E), indicating that it is SIRT1, but not other HDACs, that is responsible for fAβ degradation in microglia.",#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,7085,43105,2016.0,23393546,False,False,False,"D2DR, GAD65/67 and 5HT1B levels are also altered in the HD transgenic R6/2 mice, but pizotifen treatment did not normalize the levels (data not shown).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,14403,28785,2011.0,21745645,False,False,False,"The LTP induced by the preceding SO stimulation (100 ms) was completely blocked by MLA (10 nM), whereas DHβE (1 μM) and atropine (5 μM) were ineffective(Figure 2A).Similarly the induction of STD by SO 10 ms before SC was also blocked by MLA, with DHβE and atropine also having no effect(Figure 2B).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""100 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,33361,6908,2017.0,28083634,False,False,False,"This revealed significantly increased oligomeric Tau forms, following expression of wild-type Otub1, but not following expression of GFP or of the catalytically inactive form of Otub1 (C91A) (Fig. 8c).",#64:64,PMC5390007,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2017-04-20"", ""ref"": ""28083634"", ""pub_year"": 2017, ""last_author"": ""Dewachter I"", ""type"": ""PubMed"", ""author_list"": [""Wang P"", ""Joberty G"", ""Buist A"", ""Vanoosthuyse A"", ""Stancu IC"", ""Vasconcelos B"", ""Pierrot N"", ""Faelth-Savitski M"", ""Kienlen-Campard P"", ""Octave JN"", ""Bantscheff M"", ""Drewes G"", ""Moechars D"", ""Dewachter I""], ""title"": ""Tau interactome mapping\u00a0based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo."", ""doi"": ""10.1007/s00401-016-1663-9""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Deubiquitinating Enzymes"", ""Humans"", ""Mice, Transgenic"", ""Neurofibrillary Tangles"", ""Neurons"", ""Tauopathies"", ""Ubiquitin"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Ubiquitin"", ""tau Proteins"", ""Deubiquitinating Enzymes"", ""Cysteine Endopeptidases"", ""Otub1 protein, mouse""]}",False
CAUSES_NO_CHANGE,3964,7161,2014.0,24164934,False,False,False,We did not find differences in LINE-1 methylation levels between patients with Alzheimer's disease and control participants,#59:5,,"{""full_journal_name"": ""American journal of Alzheimer's disease and other dementias"", ""pub_date"": ""2014-10-22"", ""ref"": ""24164934"", ""pub_year"": 2014, ""last_author"": ""Forero DA"", ""type"": ""PubMed"", ""author_list"": [""Hern\u00e1ndez HG"", ""Mahecha MF"", ""Mej\u00eda A"", ""Arboleda H"", ""Forero DA""], ""title"": ""Global long interspersed nuclear element 1 DNA methylation in a Colombian sample of patients with late-onset Alzheimer's disease."", ""doi"": ""10.1177/1533317513505132""}","{""DiseaseState"": [""Late-onset AD""], ""MeSHAnatomy"": [""Blood Cells""], ""Race"": [""Colombian""], ""Subgraph"": [""Epigenetic modification subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Case-Control Studies"", ""Colombia"", ""DNA Methylation"", ""Female"", ""Humans"", ""Linear Models"", ""Long Interspersed Nucleotide Elements"", ""Male""]}",False
CAUSES_NO_CHANGE,1729,11694,2009.0,19126755,False,False,False,"For instance, studies carried out in PC12 cells demonstrated that codeine, a drug with no significant effect on ChE, can activate nicotinic single-channel currents and that this nicotinic agonist effect is sensitive to inhibition by FK1 while unaffected by classical nAChR antagonists (450).",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""PC12 Cells""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,38407,42485,2009.0,19713215,False,False,False,"Arhgef5 can strongly activate RhoA and RhoB and weakly RhoC and RhoG, but not Rac1, RhoQ, RhoD, or RhoV, in transfected human embryonic kidney 293 cells.",#59:5,PMC2781403,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2009-11-24"", ""ref"": ""19713215"", ""pub_year"": 2009, ""last_author"": ""Wu D"", ""type"": ""PubMed"", ""author_list"": [""Wang Z"", ""Kumamoto Y"", ""Wang P"", ""Gan X"", ""Lehmann D"", ""Smrcka AV"", ""Cohn L"", ""Iwasaki A"", ""Li L"", ""Wu D""], ""title"": ""Regulation of immature dendritic cell migration by RhoA guanine nucleotide exchange factor Arhgef5."", ""doi"": ""10.1074/jbc.M109.047282""}","{""CellLine"": [""HEK293""], ""Subgraph"": [""RhoA subgraph""], ""mesh"": [""Animals"", ""Asthma"", ""Cell Culture Techniques"", ""Cell Movement"", ""Chemotaxis"", ""Dendritic Cells"", ""Gene Expression Regulation"", ""Guanine Nucleotide Exchange Factors"", ""Humans"", ""Luciferases"", ""Mice"", ""Mice, Transgenic"", ""Ovalbumin"", ""Proto-Oncogene Proteins"", ""Rho Guanine Nucleotide Exchange Factors"", ""rhoA GTP-Binding Protein""], ""substances"": [""ARHGEF5 protein, human"", ""Guanine Nucleotide Exchange Factors"", ""Proto-Oncogene Proteins"", ""Rho Guanine Nucleotide Exchange Factors"", ""Ovalbumin"", ""Luciferases"", ""rhoA GTP-Binding Protein""]}",False
CAUSES_NO_CHANGE,15307,1396,2017.0,26979166,False,False,False,"Remarkably, α7 nAChR-positive allosteric modulators (galantamine, galantamine plus choline, and JNJ39393406) were completely inactive [100].",#58:34,PMC4894934,"{""full_journal_name"": ""Cellular and molecular life sciences : CMLS"", ""pub_date"": ""2017-02-15"", ""ref"": ""26979166"", ""pub_year"": 2017, ""last_author"": ""Feuerbach D"", ""type"": ""PubMed"", ""author_list"": [""Kalkman HO"", ""Feuerbach D""], ""title"": ""Modulatory effects of \u03b17 nAChRs on the immune system and its relevance for CNS disorders."", ""doi"": ""10.1007/s00018-016-2175-4""}","{""Confidence"": [""High""], ""Disease"": [""schizophrenia""], ""mesh"": [""Animals"", ""Central Nervous System Diseases"", ""Drug Discovery"", ""Humans"", ""Immune System"", ""Signal Transduction"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor""]}",False
CAUSES_NO_CHANGE,3473,25454,2017.0,28148553,False,False,False,"None of the lentiviral models significantly increased PERK or pPERK, showing that tau overload per se is not sufficient to activate the UPR.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,7540,30983,2017.0,28669544,False,False,False,"Specifically, PSD95, a scaffold protein located in dendritic spines, was significantly reduced (Figure 3F), while levels of MAP2, a dendritic structural protein, were comparable between WT and cKO mice",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""CellStructure"": [""Dendrites""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
CAUSES_NO_CHANGE,44350,21289,2017.0,28760828,False,False,False,"Of note, whereas mimicking acetylation at most non-KXGS sites had minimal impact on tau aggregation, K274Q also significantly decreased tau assembly in vitro, albeit to a lesser extent than K321Q (Fig. 1b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,34694,12358,2018.0,28528849,False,False,False,"Endogenous tau protein retained its normal axonal localization and did not missort into the cell body and dendrites (Fig. 6A8), although there was a reduction in the spine density (Fig. 6B6) in the TauRDΔK oligomer-treated neurons.",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,1325,19047,2009.0,18986241,False,False,False,"Notably, reports that physostigmine and oral anticholinesterases have beneficial effects for patients with AD suggest that the CBF system is somewhat preserved during the progression of dementia, despite well- documented loss of cholinergic biosynthetic machinery (including ChAT and AChE enzyme deficits) in patients with this disease. Interestingly, recent studies have shown that ChAT activity, which results in acetylcholine (ACh) synthesis, is preserved in the neocortex of people with MCI [18,19].",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neocortex""], ""MeSHDisease"": [""Cognitive Dysfunction""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,2017,14831,2012.0,21958873,False,False,False,We observed that anatabine dose dependently inhibited NFκB activation by TNFα in HEK293 NFκB luciferase reporter cells (Fig. 5) whereas nicotine was ineffective,#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""HEK293""], ""Confidence"": [""Medium""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,7981,18243,2016.0,26702100,False,False,False,"In TBPH-/- larvae, compared with W1118 control larvae, the phosphorylation levels of S6K and 4E-BP1, but not expression of S6K mRNA, were decreased (Fig 8A and D, and Appendix Fig S6A). Furthermore, the level of phosphorylated S6K and 4E-BP1 was consistently decreased in the first-, second-, and third-instar TBPH -/- larvae (Fig 8E).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""Species"": [""7227""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,6673,1705,2020.0,30837838,False,False,False,"Notably, the zinc ions could induce inclusion bodies formation and aggregation in the neuronal cell cultures, and this effect was not observed with copper or iron, indicating zinc-specific effects (Caragounis et al., 2010).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,6709,40482,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,18802,11795,2013.0,22530628,False,False,False,"For instance, cotinine induced the activation of the pro-survival protein kinase B (Akt)/glycogen synthase kinase 3beta (GSK3beta) pathway in the brains of both Tg6799 and wild type control mice, suggesting that the activation of these factors is independent from its effect on Aβ aggregation [33].",#57:51,PMC6493450,"{""full_journal_name"": ""CNS neuroscience & therapeutics"", ""pub_date"": ""2013-05-20"", ""ref"": ""22530628"", ""pub_year"": 2013, ""last_author"": ""Zeitlin R"", ""type"": ""PubMed"", ""author_list"": [""Echeverria V"", ""Zeitlin R""], ""title"": ""Cotinine: a potential new therapeutic agent against Alzheimer's disease."", ""doi"": ""10.1111/j.1755-5949.2012.00317.x""}","{""Anatomy"": [""brain""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cotinine"", ""Drug Delivery Systems"", ""Humans"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic"", ""Cotinine""]}",False
CAUSES_NO_CHANGE,1832,1182,2012.0,22791904,False,False,False,Posiphen 80 mg was determined as the no observed adverse effect level (table 1).,#70:20,PMC3415310,"{""full_journal_name"": ""Journal of neurology, neurosurgery, and psychiatry"", ""pub_date"": ""2012-10-29"", ""ref"": ""22791904"", ""pub_year"": 2012, ""last_author"": ""Greig NH"", ""type"": ""PubMed"", ""author_list"": [""Maccecchini ML"", ""Chang MY"", ""Pan C"", ""John V"", ""Zetterberg H"", ""Greig NH""], ""title"": ""Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-\u03b2 peptide and \u03c4 levels: target engagement, tolerability and pharmacokinetics in humans."", ""doi"": ""10.1136/jnnp-2012-302589""}","{""ArticleCompoundNumber"": [""1""], ""Confidence"": [""High""], ""MeasurementType"": [""dose""], ""MeasurementUnits"": [""mg""], ""MeasurementValue"": [""80""], ""Page"": [""896""], ""mesh"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Cognitive Dysfunction"", ""Dose-Response Relationship, Drug"", ""Double-Blind Method"", ""Female"", ""Humans"", ""Inflammation Mediators"", ""Male"", ""Peptide Fragments"", ""Physostigmine"", ""Rats"", ""Rats, Inbred F344"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Inflammation Mediators"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Physostigmine"", ""phenserine""]}",False
CAUSES_NO_CHANGE,4127,7219,2012.0,22107728,False,False,False,"Several genetic association studies examined IDE gene as a susceptibility gene for Alzheimer's disease (AD), however with controversial results.We examined associations of three IDE polymorphisms (IDE2, rs4646953; IDE7, rs2251101 and IDE9, rs1887922) with AD, Abeta42 plasma level and T2DM risk in the longitudinal Vienna Transdanube Aging (VITA) study cohort.The upstream polymorphism IDE2 was found to influence AD risk and to trigger the Abeta42 plasma level, whereas the downstream polymorphism IDE7 modified the T2DM risk; no associations were found for the intronic variant IDE9.Based on our SNP and haplotype results, we delineate the model that IDE promoter and 3' untranslated region/downstream variation may have different effects on IDE expression, presumably a relevant endophenotype with disorder-specific effects on AD and T2DM susceptibility.",#59:5,PMC3266204,"{""full_journal_name"": ""BMC medical genetics"", ""pub_date"": ""2012-03-12"", ""ref"": ""22107728"", ""pub_year"": 2012, ""last_author"": ""Gr\u00fcnblatt E"", ""type"": ""PubMed"", ""author_list"": [""Bartl J"", ""Scholz CJ"", ""Hinterberger M"", ""Jungwirth S"", ""Wichart I"", ""Rainer MK"", ""Kneitz S"", ""Danielczyk W"", ""Tragl KH"", ""Fischer P"", ""Riederer P"", ""Gr\u00fcnblatt E""], ""title"": ""Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene."", ""doi"": ""10.1186/1471-2350-12-151""}","{""Subgraph"": [""Amyloidogenic subgraph""], ""mesh"": [""3' Untranslated Regions"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Cohort Studies"", ""Diabetes Mellitus, Type 2"", ""Genetic Association Studies"", ""Genotype"", ""Haplotypes"", ""Humans"", ""Insulysin"", ""Longitudinal Studies"", ""Peptide Fragments"", ""Polymorphism, Single Nucleotide"", ""Promoter Regions, Genetic"", ""Risk""], ""substances"": [""3' Untranslated Regions"", ""Amyloid beta-Peptides"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""Insulysin""]}",False
CAUSES_NO_CHANGE,1543,30038,2017.0,27794524,False,False,False,"Thus, this compartmental CNS B cell immune response may be able to drive CNS injury independent of peripheral immune activity (Lovato et al., 2011).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""central nervous system""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,43228,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Dopaminergic subgraph""]}",False
CAUSES_NO_CHANGE,6880,20824,2014.0,24590577,False,False,False,"Administration of AF267B and AF102B (Cevimeline, EVOXACTM), an M1 mAChRselective agonist once prescribed for the treatment of Sjogren’s syndrome, decreases Abeta42 levels in the cerebral spinal fluid (CSF) of rabbits without affecting APP",#69:61,PMC5562652,"{""full_journal_name"": ""Neuroscience bulletin"", ""pub_date"": ""2014-12-03"", ""ref"": ""24590577"", ""pub_year"": 2014, ""last_author"": ""Zhang YW"", ""type"": ""PubMed"", ""author_list"": [""Jiang S"", ""Li Y"", ""Zhang C"", ""Zhao Y"", ""Bu G"", ""Xu H"", ""Zhang YW""], ""title"": ""M1 muscarinic acetylcholine receptor in Alzheimer's disease."", ""doi"": ""10.1007/s12264-013-1406-z""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""Receptor, Muscarinic M1""], ""substances"": [""Receptor, Muscarinic M1""]}",False
CAUSES_NO_CHANGE,7085,43228,2016.0,23393546,False,False,False,"D2DR, GAD65/67 and 5HT1B levels are also altered in the HD transgenic R6/2 mice, but pizotifen treatment did not normalize the levels (data not shown).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,6797,14208,2007.0,17082178,False,False,False,Acrolein and methylglyoxal were the most reactive compounds followed by glyoxal and malondialdehyde in terms of formation of Tau dimers and higher molecular weight oligomers. Analysis of the Tau aggregates by electron microscopy study showed that formation of fibrils using wild- type Tau and several Tau mutants could be observed with acrolein and methylglyoxal but not with glyoxal and malondialdehyde.,#60:23,,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2007-04-13"", ""ref"": ""17082178"", ""pub_year"": 2007, ""last_author"": ""M\u00fcnch G"", ""type"": ""PubMed"", ""author_list"": [""Kuhla B"", ""Haase C"", ""Flach K"", ""L\u00fcth HJ"", ""Arendt T"", ""M\u00fcnch G""], ""title"": ""Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation.""}","{""Confidence"": [""Medium""], ""Method"": [""Electron Microscopy"", ""SDS-PAGE"", ""Thioflavin T Assay"", ""Western Blot""], ""mesh"": [""Acrolein"", ""Blotting, Western"", ""Electrophoresis, Polyacrylamide Gel"", ""Fluorescence"", ""Glycation End Products, Advanced"", ""Glyoxal"", ""Humans"", ""Lipid Peroxidation"", ""Malondialdehyde"", ""Microscopy, Electron"", ""Neurofibrillary Tangles"", ""Phosphorylation"", ""Pyruvaldehyde"", ""tau Proteins""], ""substances"": [""Glycation End Products, Advanced"", ""tau Proteins"", ""Malondialdehyde"", ""Glyoxal"", ""Pyruvaldehyde"", ""Acrolein""]}",False
CAUSES_NO_CHANGE,40821,42624,2015.0,25681350,False,False,False,"In these cells, basal expression of YKL-40 is RelB-, p65-, and STAT3-independent, implicating other unknown factors.",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Cell"": [""chondrocyte""], ""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,14462,1553,2015.0,25639674,False,False,False,"However other agonists that target α7 nAChRs, such as SSR-180711 and tropisetron, fail to induce analgesia when tested in the formalin model for pain [168], suggesting that targeting α7* nAChRs for pain relief is modality selective.",#59:10,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Pain""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,6630,2361,2011.0,21745645,False,False,False,"The LTP induced by pairing the SC 10 ms before the SO was blocked by atropine, but not by MLA or DHbE.",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""after SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,41670,6401,2009.0,19277525,False,False,False,"For example, the small tumor antigen derived from the DNA tumor viruses SV40 and polyoma viruses was shown to only interact with the PP2A core enzyme, but not the holoenzyme",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""High""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,14488,7161,2008.0,18450517,False,False,False,"In patients with moderate AD, 800 mg tarenflurbil twice per day had no significant effects on ADCS-ADL and ADAS-cog and had a negative effect on CDR-sb (-52%, Cohen's d -1.08; p=0.003).The most common adverse events were diarrhoea (in seven, nine, and five patients in the 800 mg, 400 mg, and placebo groups, respectively), nausea (in seven, seven, and four patients), and dizziness (in five, nine, and four patients).",#59:5,,"{""full_journal_name"": ""The Lancet. Neurology"", ""pub_date"": ""2008-07-25"", ""ref"": ""18450517"", ""pub_year"": 2008, ""last_author"": ""Laughlin MA"", ""type"": ""PubMed"", ""author_list"": [""Wilcock GK"", ""Black SE"", ""Hendrix SB"", ""Zavitz KH"", ""Swabb EA"", ""Laughlin MA""], ""title"": ""Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial."", ""doi"": ""10.1016/S1474-4422(08)70090-5""}","{""DiseaseState"": [""Mild AD""], ""FDASTATUS"": [""Phase 2""], ""Subgraph"": [""Inflammatory response subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Brain"", ""Canada"", ""Diarrhea"", ""Disease Progression"", ""Dose-Response Relationship, Drug"", ""Drug Administration Schedule"", ""Enzyme Inhibitors"", ""Female"", ""Flurbiprofen"", ""Humans"", ""Male"", ""Middle Aged"", ""Nausea"", ""Placebo Effect"", ""Treatment Outcome"", ""United Kingdom""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Enzyme Inhibitors"", ""Flurbiprofen"", ""Amyloid Precursor Protein Secretases""]}",False
CAUSES_NO_CHANGE,1543,30038,2017.0,27794524,False,False,False,"Thus, this compartmental CNS B cell immune response may be able to drive CNS injury independent of peripheral immune activity (Lovato et al., 2011).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""central nervous system""], ""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,43753,12401,2015.0,25887395,False,False,False,"Within the limits of our detection, neither monomer nor dimer was internalized (Fig. 5, A and B). By contrast, trimers and larger species were readily internalized, with trimer uptake being slightly less efficient (Fig. 5, A and B). We did not observe an upper limit of size in terms of uptake.",#58:58,PMC4463437,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-09-10"", ""ref"": ""25887395"", ""pub_year"": 2015, ""last_author"": ""Diamond MI"", ""type"": ""PubMed"", ""author_list"": [""Mirbaha H"", ""Holmes BB"", ""Sanders DW"", ""Bieschke J"", ""Diamond MI""], ""title"": ""Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation."", ""doi"": ""10.1074/jbc.M115.652693""}","{""Confidence"": [""Medium""], ""mesh"": [""Biopolymers"", ""Chromatography, Gel"", ""HEK293 Cells"", ""Humans"", ""Spectrometry, Fluorescence"", ""tau Proteins""], ""substances"": [""Biopolymers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11813,7246,2018.0,30027901,False,False,False,"In a double-blind crossover trial involving four treatments of haloperidol, haloperidol and lithium carbonate, lithium carbonate and placebo carried out for three weeks, none of the treatments provided effective relief from choreiform movements.",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,14403,5277,2011.0,21745645,False,False,False,"The LTP induced by the preceding SO stimulation (100 ms) was completely blocked by MLA (10 nM), whereas DHβE (1 μM) and atropine (5 μM) were ineffective(Figure 2A).Similarly the induction of STD by SO 10 ms before SC was also blocked by MLA, with DHβE and atropine also having no effect(Figure 2B).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,23024,2148,2017.0,28148553,False,False,False,Co-treatment with the PERK inhibitor did not improve the cell metabolic activity (MTT signal). Only ATP concentrations improved at the lowest annonacin concentration (12.5 nM).,#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,7981,20824,2017.0,28669544,False,False,False,"These results definitely show that TDP-43 depletion in microglia promotes Abeta clearance, rather than affecting production.",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""Cell"": [""microglial cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
CAUSES_NO_CHANGE,19779,5145,2017.0,28148553,False,False,False,Wild-type mice showed a typical mushroom type of dentritic spines. Their density was reduced in P301S mice. PERK activator treatment restored this deficit partially.,#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,34694,12291,2018.0,28528849,False,False,False,"Endogenous tau protein retained its normal axonal localization and did not missort into the cell body and dendrites (Fig. 6A8), although there was a reduction in the spine density (Fig. 6B6) in the TauRDΔK oligomer-treated neurons.",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,1411,33715,2016.0,27013968,False,False,False,"In control conditions total Erk1/2 and phospho-Erk1/2 levels were similar in WT and R6/2 cultures (Figures 4A,C). Acute exposure to BDNF increased phospho-Erk1/2 levels over control conditions in both WT and R6/2 cultures (Figures 4A,E).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,43753,11577,2015.0,25887395,False,False,False,"Next we analyzed fractions for seeding activity in the P301S- Nluc/Cluc HEK293 cell lines by a split-luciferase complemen- tation assay, comparing AD and control brains. Trimers and larger BD Tau assemblies induced intracellular aggregation, but not monomer or dimer.",#58:58,PMC4463437,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-09-10"", ""ref"": ""25887395"", ""pub_year"": 2015, ""last_author"": ""Diamond MI"", ""type"": ""PubMed"", ""author_list"": [""Mirbaha H"", ""Holmes BB"", ""Sanders DW"", ""Bieschke J"", ""Diamond MI""], ""title"": ""Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation."", ""doi"": ""10.1074/jbc.M115.652693""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Brain""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Biopolymers"", ""Chromatography, Gel"", ""HEK293 Cells"", ""Humans"", ""Spectrometry, Fluorescence"", ""tau Proteins""], ""substances"": [""Biopolymers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,18879,40328,2014.0,23516100,False,False,False,"PHFs are more resistant to cleavage by calpain, suggesting that either the cleavage sites are incorporated into the filament core, or abnormal phosphorylation can protect tau from calpain cleavage [9, 107, 121, 131].",#71:22,,"{""full_journal_name"": ""Molecular neurobiology"", ""pub_date"": ""2014-06-18"", ""ref"": ""23516100"", ""pub_year"": 2014, ""last_author"": ""Novak M"", ""type"": ""PubMed"", ""author_list"": [""Jadhav S"", ""Zilka N"", ""Novak M""], ""title"": ""Protein truncation as a common denominator of human neurodegenerative foldopathies."", ""doi"": ""10.1007/s12035-013-8440-8""}","{""Confidence"": [""High""], ""mesh"": [""Calpain"", ""Caspases"", ""Humans"", ""Intrinsically Disordered Proteins"", ""Neurodegenerative Diseases"", ""Protein Folding"", ""Proteolysis""], ""substances"": [""Intrinsically Disordered Proteins"", ""Calpain"", ""Caspases""]}",False
CAUSES_NO_CHANGE,11492,5277,2011.0,21745645,False,False,False,"The LTP induced by the preceding SO stimulation (100 ms) was completely blocked by MLA (10 nM), whereas DHβE (1 μM) and atropine (5 μM) were ineffective(Figure 2A).Similarly the induction of STD by SO 10 ms before SC was also blocked by MLA, with DHβE and atropine also having no effect(Figure 2B).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,42838,37057,2020.0,31413141,False,False,False,"CSF sTREM2 concentrations were significantly lower in p.L211P carriers (2578 ± 1444 pg/ml) compared to noncarriers (3903 ± 1919 pg/ml; P = 0.026; fig. S2). CSF sTREM2 concentrations were significantly elevated in p.R47H carriers (4852 ± 1172 pg/ml) compared to p.L211P carriers (P = 0.029) and p.D87N carriers (2082 ± 239 pg/ml; P = 0.041), but were not significantly different from noncarriers (P = 0.223; fig. S2).",#59:17,PMC6697053,"{""full_journal_name"": ""Science translational medicine"", ""pub_date"": ""2020-07-27"", ""ref"": ""31413141"", ""pub_year"": 2020, ""last_author"": ""Cruchaga C"", ""type"": ""PubMed"", ""author_list"": [""Deming Y"", ""Filipello F"", ""Cignarella F"", ""Cantoni C"", ""Hsu S"", ""Mikesell R"", ""Li Z"", ""Del-Aguila JL"", ""Dube U"", ""Farias FG"", ""Bradley J"", ""Budde J"", ""Ibanez L"", ""Fernandez MV"", ""Blennow K"", ""Zetterberg H"", ""Heslegrave A"", ""Johansson PM"", ""Svensson J"", ""Nellg\u00e5rd B"", ""Lleo A"", ""Alcolea D"", ""Clarimon J"", ""Rami L"", ""Molinuevo JL"", ""Su\u00e1rez-Calvet M"", ""Morenas-Rodr\u00edguez E"", ""Kleinberger G"", ""Ewers M"", ""Harari O"", ""Haass C"", ""Brett TJ"", ""Benitez BA"", ""Karch CM"", ""Piccio L"", ""Cruchaga C""], ""title"": {""#text"": ""The  gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk."", ""i"": ""MS4A""}, ""doi"": ""10.1126/scitranslmed.aau2291""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""mesh"": [""Alzheimer Disease"", ""Female"", ""Genome-Wide Association Study"", ""Humans"", ""Macrophages"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Meta-Analysis as Topic"", ""Multigene Family"", ""Receptors, Immunologic""], ""substances"": [""MS4A4A protein, human"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
CAUSES_NO_CHANGE,6709,43806,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,7260,18100,2009.0,19293145,False,False,False,"More recent approaches have confirmed this: RNA profiling of isolated neurons from control brains or brains from patients with AD show no evidence for changes in nAChR RNA (Chow et al., 1998; Ginsberg et al., 2000).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,1849,43753,2020.0,30686764,False,False,False,"Activation of homologous nuclear receptors such as PPARa (by GW50156) and PPARg (by Rosiglitazone), which regulate fatty acid metabolism but not cholesterol export, did not decrease pThr231Tau/tTau (Figures 2C, S2F, and S2G).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,37647,2206,2017.0,27522251,False,False,False,"In addition, viral transduction did not induce any neuroinflammation, as shown in WT noninjected mice (Fig. 3A and D)",#68:77,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-09-28"", ""ref"": ""27522251"", ""pub_year"": 2017, ""last_author"": ""Maskos U"", ""type"": ""PubMed"", ""author_list"": [""Lombardo S"", ""Catteau J"", ""Besson M"", ""Maskos U""], ""title"": ""A role for \u03b22* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus."", ""doi"": ""10.1016/j.neurobiolaging.2016.06.005""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Dentate Gyrus""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Dentate Gyrus"", ""Disease Models, Animal"", ""Hippocampus"", ""Male"", ""Memory Disorders"", ""Mice, Inbred C57BL"", ""Receptors, Nicotinic""], ""substances"": [""Amyloid beta-Peptides"", ""Receptors, Nicotinic"", ""nicotinic receptor beta2""]}",False
CAUSES_NO_CHANGE,38200,12153,2000.0,10656250,False,False,False,"However, expression of either of the Asp 2 mutants does not produce the increase in the secretion of sAPPb (Fig. 2b) seen for wild-type Asp 2. In contrast to this clear effect on sAPPb, Asp 2 has no effect on the secretion of soluble APPa or on full-length APP in the cell (data not shown).",#64:10,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2000-02-17"", ""ref"": ""10656250"", ""pub_year"": 2000, ""last_author"": ""Christie G"", ""type"": ""PubMed"", ""author_list"": [""Hussain I"", ""Powell D"", ""Howlett DR"", ""Tew DG"", ""Meek TD"", ""Chapman C"", ""Gloger IS"", ""Murphy KE"", ""Southan CD"", ""Ryan DM"", ""Smith TS"", ""Simmons DL"", ""Walsh FS"", ""Dingwall C"", ""Christie G""], ""title"": ""Identification of a novel aspartic protease (Asp 2) as beta-secretase.""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""COS Cells"", ""Cathepsin D"", ""Cell Line"", ""Cell Membrane"", ""Endopeptidases"", ""Female"", ""Hippocampus"", ""Humans"", ""Middle Aged"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Papain"", ""Recombinant Proteins"", ""Sequence Alignment"", ""Sequence Homology, Amino Acid"", ""Transfection""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Recombinant Proteins"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Papain"", ""Aspartic Acid Endopeptidases"", ""BACE2 protein, human"", ""BACE1 protein, human"", ""Cathepsin D""]}",False
CAUSES_NO_CHANGE,4177,43753,2017.0,27594586,False,False,False,"Moreover, the total expression levels of tau and PSD-95 were the same in 1-month-old neurons derived from control and patient iPSCs (Figure 1B)",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,7033,16749,2019.0,30935091,False,False,False,"While human NPCs had minimal Ac-K49- beta-catenin at baseline, treatment with the pan-HDACi SAHA and another broadly selective HDACi crebinostat led to a marked increase in Ac-K49-beta -catenin levels, without affecting overall beta-catenin levels [103].",#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,15445,2721,2019.0,29024336,False,False,False,"However, cells expressing the mutant tau proteins failed to further upregulate CMA and even a decrease was noticeable in cells expressing tau-P301L (Fig. 3f,g)",#61:23,PMC5770880,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2019-07-30"", ""ref"": ""29024336"", ""pub_year"": 2019, ""last_author"": ""Cuervo AM"", ""type"": ""PubMed"", ""author_list"": [""Caballero B"", ""Wang Y"", ""Diaz A"", ""Tasset I"", ""Juste YR"", ""Stiller B"", ""Mandelkow EM"", ""Mandelkow E"", ""Cuervo AM""], ""title"": ""Interplay of pathogenic forms of human tau with different autophagic pathways."", ""doi"": ""10.1111/acel.12692""}","{""CellStructure"": [""Intracellular Space""], ""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain""], ""mesh"": [""Animals"", ""Autophagy"", ""Brain"", ""Humans"", ""Male"", ""Mutation"", ""Neurodegenerative Diseases"", ""Neurons"", ""Phosphorylation"", ""Proteolysis"", ""Rats, Wistar"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,11664,2423,2019.0,30270813,False,False,False,"No differences were detected in the total interaction time with objects (two-way ANOVA, F (1, 31) = 0.6425, p = 0.4289) (Fig. 2b), indicating that cisplatin and ACY-1083 had no effect on locomotor activity or interest in the objects..",#63:68,PMC6166273,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2019-06-06"", ""ref"": ""30270813"", ""pub_year"": 2019, ""last_author"": ""Heijnen CJ"", ""type"": ""PubMed"", ""author_list"": [""Ma J"", ""Huo X"", ""Jarpe MB"", ""Kavelaars A"", ""Heijnen CJ""], ""title"": ""Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment."", ""doi"": ""10.1186/s40478-018-0604-3""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antineoplastic Agents"", ""Cisplatin"", ""Cognitive Dysfunction"", ""Disease Models, Animal"", ""Disks Large Homolog 4 Protein"", ""Dose-Response Relationship, Drug"", ""Enzyme Inhibitors"", ""Green Fluorescent Proteins"", ""Histone Deacetylase 6"", ""Hydroxamic Acids"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Microscopy, Electron, Transmission"", ""Mitochondria"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Synaptosomes"", ""Tauopathies"", ""Time Factors"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Antineoplastic Agents"", ""Disks Large Homolog 4 Protein"", ""Enzyme Inhibitors"", ""Hydroxamic Acids"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Tubulin"", ""synaptopHIuorin"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Cisplatin"", ""ricolinostat""]}",False
CAUSES_NO_CHANGE,16448,11034,2017.0,27209302,False,False,False,"Furthermore, SIRT6 and SIRT7 could not reduce acetylation levels on TFEB as compared with SIRT1 (Fig. S3D), excluding the possibility that SIRT6 or SIRT7 might involve in deacetylation of TFEB in the nucleus.",#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,42558,24480,2020.0,30515821,False,False,False,"Interestingly, the E193K does not affect the kinase activity of LRRK2 compared with the G2019S, suggesting that E193K does not affect the activity of Drp1 but affects LRRK2 phosphorylation at Ser‐935 and increases the mitochondrial response to MPP+ (a mitochondrial toxin can induce PD) in the patients’ fibroblast.",#65:66,,"{""full_journal_name"": ""Journal of cellular physiology"", ""pub_date"": ""2020-05-04"", ""ref"": ""30515821"", ""pub_year"": 2020, ""last_author"": ""Chen L"", ""type"": ""PubMed"", ""author_list"": [""Qi Z"", ""Huang Z"", ""Xie F"", ""Chen L""], ""title"": ""Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases."", ""doi"": ""10.1002/jcp.27866""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Fibroblasts""], ""MeSHDisease"": [""Parkinson Disease""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Dynamins"", ""Humans"", ""Huntingtin Protein"", ""Mitochondria"", ""Mitochondrial Dynamics"", ""Nerve Degeneration"", ""Nervous System"", ""Neurodegenerative Diseases"", ""Protein Processing, Post-Translational"", ""Signal Transduction"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Huntingtin Protein"", ""tau Proteins"", ""DNM1L protein, human"", ""Dnm1l protein, mouse"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,35432,11577,2019.0,26655600,False,False,False,"However, granule cells of the dentate gyrus mainly express 3R isoforms, which resist Tau aggregation in AD, but accumulate 3R aggregates in Pick's disease [14]. 3R Tau is a major Tau isoform in laser microdissected Pick bodies [15].",#60:23,,"{""full_journal_name"": ""Biochimica et biophysica acta"", ""pub_date"": ""2019-05-03"", ""ref"": ""26655600"", ""pub_year"": 2019, ""last_author"": ""Qing H"", ""type"": ""PubMed"", ""author_list"": [""Liu K"", ""Liu Y"", ""Li L"", ""Qin P"", ""Iqbal J"", ""Deng Y"", ""Qing H""], ""title"": ""Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property."", ""doi"": ""10.1016/j.bbadis.2015.12.002""}","{""Anatomy"": [""dentate gyrus granule cell layer""], ""Confidence"": [""Medium""], ""Disease"": [""Alzheimer's disease""], ""mesh"": [""Glycosylation"", ""Humans"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Protein Isoforms"", ""Protein Processing, Post-Translational"", ""Recombinant Proteins"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Protein Aggregates"", ""Protein Isoforms"", ""Recombinant Proteins"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,42738,42624,2015.0,25681350,False,False,False,"In these cells, basal expression of YKL-40 is RelB-, p65-, and STAT3-independent, implicating other unknown factors.",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Cell"": [""chondrocyte""], ""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,6709,36132,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,1650,8450,2009.0,19293145,False,False,False,"Abeta action on nAChRs depends on subunit composition; it has been reported to block alpha7, transiently potentiate alpha4beta2 before blocking, and to have no action on alpha3beta4 (Pym et al., 2005). However, in contrast to its reported transient enhancement when expressed in oocytes, an inhibition of alpha4beta2 has been reported when expressed in human SH-EP1 cells (Wu et al., 2004).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,14488,7161,2008.0,18450518,False,False,False,"The phase II trial of tarenflurbil1 was designed to show slowing of cognitive and functional decline in mild to moderate AD, with enrolment of about 200 patients in a 1-year trial. The primary analysis failed: there was no overall effect on the primary outcomes. But planned analyses nonetheless suggested that the drug had an influence on the outcome measures: there was a significant interactive effect of treatment and baseline cognitive function on change in outcomes. Do these results prove the efficacy of tarenflurbil in slowing decline in mild AD? Noâ€”the data are consistent with a beneficial effect of tarenflurbil in mild AD, but are hardly conclusive.",#59:5,,"{""full_journal_name"": ""The Lancet. Neurology"", ""pub_date"": ""2008-07-25"", ""ref"": ""18450518"", ""pub_year"": 2008, ""last_author"": ""Aisen PS"", ""type"": ""PubMed"", ""author_list"": [""Aisen PS""], ""title"": ""Tarenflurbil: a shot on goal."", ""doi"": ""10.1016/S1474-4422(08)70091-7""}","{""DiseaseState"": [""Mild AD""], ""FDASTATUS"": [""Phase 2""], ""Subgraph"": [""Inflammatory response subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Brain"", ""Clinical Trials, Phase II as Topic"", ""Clinical Trials, Phase III as Topic"", ""Enzyme Inhibitors"", ""Flurbiprofen"", ""Humans"", ""Plaque, Amyloid"", ""Treatment Outcome""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Enzyme Inhibitors"", ""Flurbiprofen"", ""Amyloid Precursor Protein Secretases""]}",False
CAUSES_NO_CHANGE,7260,5956,2009.0,18986241,False,False,False,"Single cell gene array studies have shown that synaptic transcripts are selectively downregulated in CBF neurons in AD, with significant reductions in synaptophysin and synaptotagmin but not synaptobrevin or SNAP29 mRNA [134,135]. Intriguingly, synaptotagmin function is related to vesicle-presynaptic membrane fusion and neurotransmitter release, suggesting that perturbations in presynaptic vesicle trafficking comprise a common event in vulnerable neuronal populations in AD. In contrast to synaptic transcripts, mRNAs encoding APP and Notch were unchanged between control and AD subjects, whereas acid hydrolase cathepsin D mRNA was upregulated in AD [134–136].",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,20824,8271,2020.0,30686764,False,False,False,"Interestingly, in these APP null neurons, simvastatin still reduced pThr231Tau/tTau in a dose dependent manner identical to that of its isogenic control lines (Figure 3H).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,26435,10269,2017.0,28669544,False,False,False,"We confirmed that Tardbp transcript levels were significantly downregulated specifically in microglia isolated from cKO mice upon tamoxifen administration compared to WT controls, whereas overall cortical levels remained unchanged (Figures S4A and S4B).",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
CAUSES_NO_CHANGE,41007,33753,2017.0,28148553,False,False,False,"However, similar to the situation in PSP, 4R tau (but not 3R tau or mCherry) suppressed EIF2A at the protein level. pEIF2A was reduced by both 4R and 3R tau.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,37298,5120,2011.0,21734277,False,False,False,Neither 6D nor 6P tau (Fig. 2D) had an effect on retrograde FAT,#69:76,PMC3391724,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2011-09-09"", ""ref"": ""21734277"", ""pub_year"": 2011, ""last_author"": ""Binder LI"", ""type"": ""PubMed"", ""author_list"": [""Kanaan NM"", ""Morfini GA"", ""LaPointe NE"", ""Pigino GF"", ""Patterson KR"", ""Song Y"", ""Andreadis A"", ""Fu Y"", ""Brady ST"", ""Binder LI""], ""title"": ""Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases."", ""doi"": ""10.1523/JNEUROSCI.0560-11.2011""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Axonal Transport"", ""Axons"", ""Brain"", ""Decapodiformes"", ""Enzyme Inhibitors"", ""Enzyme-Linked Immunosorbent Assay"", ""Glycogen Synthase Kinase 3"", ""Humans"", ""In Vitro Techniques"", ""Kinesins"", ""Models, Biological"", ""Mutagenesis"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Phosphotransferases"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Enzyme Inhibitors"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""tau Proteins"", ""neuropeptide Y4 receptor"", ""Phosphotransferases"", ""Glycogen Synthase Kinase 3"", ""Kinesins""]}",False
CAUSES_NO_CHANGE,6824,7229,2018.0,30027901,False,False,False,"GABAergic strategies have included muscimol, a potent GABA mimetic agonist (Shoulson et al. 1978). In this double-blind study,muscimol treatment did not lead to any improvement in motor and cognitive deficits in 10 HD patients. However, administration of muscimol ameliorated chorea in the most severely affected hyperkinetic patients. It also heightened dystonia, particularly in the early onset patients who had predominant parkinsonism and dystonic features.",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,12730,12401,2015.0,25887395,False,False,False,"Within the limits of our detection, neither monomer nor dimer was internalized (Fig. 5, A and B). By contrast, trimers and larger species were readily internalized, with trimer uptake being slightly less efficient (Fig. 5, A and B). We did not observe an upper limit of size in terms of uptake.",#58:58,PMC4463437,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-09-10"", ""ref"": ""25887395"", ""pub_year"": 2015, ""last_author"": ""Diamond MI"", ""type"": ""PubMed"", ""author_list"": [""Mirbaha H"", ""Holmes BB"", ""Sanders DW"", ""Bieschke J"", ""Diamond MI""], ""title"": ""Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation."", ""doi"": ""10.1074/jbc.M115.652693""}","{""Confidence"": [""Medium""], ""mesh"": [""Biopolymers"", ""Chromatography, Gel"", ""HEK293 Cells"", ""Humans"", ""Spectrometry, Fluorescence"", ""tau Proteins""], ""substances"": [""Biopolymers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11942,1952,2016.0,23393546,False,False,False,"Addition of pizotifen, cyproheptadine, or loxapine to the ST Hdh Q7/Q7 cells after serum withdrawal had no effect on ATP levels, indicating that the drugs do not have a general effect on viability but rather correct a deficit specific to the ST Hdh Q111/Q111 cells (Figure 2 A ).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,11492,28785,2011.0,21745645,False,False,False,"The LTP induced by the preceding SO stimulation (100 ms) was completely blocked by MLA (10 nM), whereas DHβE (1 μM) and atropine (5 μM) were ineffective(Figure 2A).Similarly the induction of STD by SO 10 ms before SC was also blocked by MLA, with DHβE and atropine also having no effect(Figure 2B).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,11165,6064,2009.0,19277525,False,False,False,Neither mutation of the carboxy-terminal Leu residue nor removal of the carboxy-terminal 14 amino acids of the catalytic subunit prevented formation of heterotrimeric holoenzymes involving the B or B′ subunits,#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""Medium""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,20164,1780,2017.0,27167578,False,False,False,"In a7345–348A expressing cells, treatment with PNU-282987 was also unable to attenuate neurite length (data not shown), suggesting that a loss in G protein coupling impairs the capacity of the a7 nAChR to modulate growth.",#65:18,,"{""full_journal_name"": ""Journal of neurochemistry"", ""pub_date"": ""2017-06-20"", ""ref"": ""27167578"", ""pub_year"": 2017, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Kabbani N""], ""title"": ""Alpha 7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth."", ""doi"": ""10.1111/jnc.13660""}","{""Assay"": [""fluorescence microscopy""], ""CellLine"": [""PC12""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Animals"", ""Benzamides"", ""Bridged Bicyclo Compounds"", ""Calcium Signaling"", ""Cytoskeleton"", ""Enzyme Activation"", ""Female"", ""Growth Cones"", ""Heterotrimeric GTP-Binding Proteins"", ""Male"", ""Mice, Inbred C57BL"", ""Microtubules"", ""Neurogenesis"", ""Neurons"", ""Nicotinic Agonists"", ""PC12 Cells"", ""Rats"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""rhoA GTP-Binding Protein""], ""substances"": [""Benzamides"", ""Bridged Bicyclo Compounds"", ""Nicotinic Agonists"", ""PNU-282987"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Heterotrimeric GTP-Binding Proteins"", ""rhoA GTP-Binding Protein""]}",False
CAUSES_NO_CHANGE,42541,10722,2009.0,19126755,False,False,False,"The concept that beta2-containing nAChRs are involved in the reinforcing effects of nicotine was supported by the findings that these mice lacked the high-affinity nicotine binding site, exhibited poor nicotine self-administration, and failed to develop behaviors related to reinforcement (378). The demonstration that these mice developed symptoms of the nicotine withdrawal syndrome similar to those observed in wild-type mice led to the conclusion that beta2-containing nAChRs do not contribute to the physical dependence on nicotine (57).",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,1744,37426,2005.0,15673661,False,False,False,"We observed that APP mRNA expression was transiently induced in neonates, but exhibited a delayed overexpression 20 months after exposure to Pb had ceased. This upregulation in APP mRNA expression was commensurate with a rise in activity of the transcription factor Sp1, one of the regulators of the APP gene. Furthermore, the increase in APP gene expression in old age was accompanied by an elevation in APP and its amyloidogenic Abeta product. In contrast, APP expression, Sp1 activity, as well as APP and Abeta protein levels were unresponsive to Pb exposure during old age.",#59:5,PMC6725614,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2005-08-31"", ""ref"": ""15673661"", ""pub_year"": 2005, ""last_author"": ""Zawia NH"", ""type"": ""PubMed"", ""author_list"": [""Basha MR"", ""Wei W"", ""Bakheet SA"", ""Benitez N"", ""Siddiqi HK"", ""Ge YW"", ""Lahiri DK"", ""Zawia NH""], ""title"": ""The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.""}","{""Species"": [""10090""], ""Subgraph"": [""Epigenetic modification subgraph""], ""mesh"": [""Aging"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Newborn"", ""Brain"", ""Female"", ""Gene Expression Regulation, Developmental"", ""Humans"", ""Lead"", ""Male"", ""PC12 Cells"", ""Promoter Regions, Genetic"", ""RNA, Small Interfering"", ""Rats"", ""Rats, Long-Evans"", ""Sp1 Transcription Factor""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""RNA, Small Interfering"", ""Sp1 Transcription Factor"", ""Lead""]}",False
CAUSES_NO_CHANGE,43753,43323,2011.0,21339331,False,False,False,"The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40–65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",#62:7,PMC3044115,"{""full_journal_name"": ""The Journal of cell biology"", ""pub_date"": ""2011-04-25"", ""ref"": ""21339331"", ""pub_year"": 2011, ""last_author"": ""Brandt R"", ""type"": ""PubMed"", ""author_list"": [""Gauthier-Kemper A"", ""Weissmann C"", ""Golovyashkina N"", ""Seb\u00f6-Lemke Z"", ""Drewes G"", ""Gerke V"", ""Heinisch JJ"", ""Brandt R""], ""title"": ""The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner."", ""doi"": ""10.1083/jcb.201007161""}","{""Confidence"": [""Medium""], ""Method"": [""Confocal Microscopy, Laser Scanning"", ""Immunocytochemistry"", ""Mass Spectrometry"", ""Pull-down Assay, GFP"", ""RNA Interference, shRNA"", ""Tandem Affinity Purification, TAP""], ""mesh"": [""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Animals"", ""Annexin A2"", ""Binding Sites"", ""Cell Membrane"", ""Humans"", ""Microtubules"", ""Molecular Sequence Data"", ""Neurites"", ""PC12 Cells"", ""Phosphorylation"", ""Rats"", ""tau Proteins""], ""substances"": [""Annexin A2"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,27890,9655,2000.0,10887109,False,False,False,"In marked contrast, the phosphorylated Y358 peptide bound SHP-2 well but did not bind significant amounts of SHP-1.",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""Confidence"": [""Medium""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,6709,39329,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,2091,7208,2017.0,27794524,False,False,False,"However, clinical trials of lamotrigine in patients with progressive multiple sclerosis did not show advantages over placebo with respect to neuroprotection (Hayton et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,41708,40357,2019.0,30935091,False,False,False,There was minimal S45 phosphorylation at baseline but increased K49 acetylation with HDAC6i was mirrored by increased S45 phosphorylation without any impact on phosphorylation of S33/S37/T41 [103].,#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,11577,5120,2017.0,27373205,False,False,False,"As previously reported, perfusion of hT40 monomer had no effect on the rate of anterograde FAT in the squid axoplasm (Fig. 5A), whereas perfusion of hT40 aggregates significantly inhibited anterograde FAT as compared to hT40 monomer (Fig. 5B; Fig. 6A; p = 0.003) (LaPointe et al., 2009b). Neither hT40 monomers nor hT40 aggregates altered the rate of retrograde FAT (Fig. 5A, B; Fig. 6B).",#69:78,PMC4992631,"{""full_journal_name"": ""Experimental neurology"", ""pub_date"": ""2017-05-05"", ""ref"": ""27373205"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Tiernan CT"", ""Combs B"", ""Cox K"", ""Morfini G"", ""Brady ST"", ""Counts SE"", ""Kanaan NM""], ""title"": ""Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport."", ""doi"": ""10.1016/j.expneurol.2016.06.030""}","{""Confidence"": [""Medium""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Axonal Transport"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Frontal Lobe"", ""Humans"", ""Male"", ""Phosphorylation"", ""Serine"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""Serine""]}",False
CAUSES_NO_CHANGE,11512,1287,2017.0,27956442,False,False,False,"There are a large number of phase III trials using agents such azathioprine, ciclosporin, β-interferon, dirucotide (myelin basic protein), immunoglobulins and cladribine, as well as other immunomodulators, in progressive MS that have been reported over the last 25 years. Unfortunately, the results have essentially been negative. [10]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,27995,32391,2017.0,28760828,False,False,False,"However, the pseudoacetylated K321Q mutant was resistant to MARK2-mediated phosphorylation at Ser-324, whereas phosphorylation at the 12E8 epitope was unaffected (Fig. 3b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,31469,5108,2017.0,27594586,False,False,False,"When measuring cell viability using the MTT assay, we found that patient-specific neurons are more sensitive than control neurons to cell death induced by rapamycin (Figure 3B) but not by staurosporine or rotenone (Figures S3B and S3C), suggesting compromised function in the mTOR pathway or related molecular pathways",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""CellStructure"": [""Extracellular Space""], ""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,6558,2423,2019.0,30270813,False,False,False,"No differences were detected in the total interaction time with objects (two-way ANOVA, F (1, 31) = 0.6425, p = 0.4289) (Fig. 2b), indicating that cisplatin and ACY-1083 had no effect on locomotor activity or interest in the objects..",#63:68,PMC6166273,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2019-06-06"", ""ref"": ""30270813"", ""pub_year"": 2019, ""last_author"": ""Heijnen CJ"", ""type"": ""PubMed"", ""author_list"": [""Ma J"", ""Huo X"", ""Jarpe MB"", ""Kavelaars A"", ""Heijnen CJ""], ""title"": ""Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment."", ""doi"": ""10.1186/s40478-018-0604-3""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antineoplastic Agents"", ""Cisplatin"", ""Cognitive Dysfunction"", ""Disease Models, Animal"", ""Disks Large Homolog 4 Protein"", ""Dose-Response Relationship, Drug"", ""Enzyme Inhibitors"", ""Green Fluorescent Proteins"", ""Histone Deacetylase 6"", ""Hydroxamic Acids"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Microscopy, Electron, Transmission"", ""Mitochondria"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Synaptosomes"", ""Tauopathies"", ""Time Factors"", ""Tubulin"", ""tau Proteins""], ""substances"": [""Antineoplastic Agents"", ""Disks Large Homolog 4 Protein"", ""Enzyme Inhibitors"", ""Hydroxamic Acids"", ""Pyrimidines"", ""Recombinant Fusion Proteins"", ""Tubulin"", ""synaptopHIuorin"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Cisplatin"", ""ricolinostat""]}",False
CAUSES_NO_CHANGE,1751,6901,2018.0,29626319,False,False,False,"By measuring Aβ levels in superior vena cava and inferior vena cava, it is clear that Aβ levels are getting lower and lower along the direction of the vein blood flow, and the contents of Aβ40 and total Aβ in artery are significantly less than those in vein, suggesting a part of Aβ40 and total Aβ can be cleared by peripheral organs and tissues, such as the liver, kidney, skin, and the gastrointestinal tract, although there is no change in Aβ42 concentrations (Xiang et al. 2015)",#70:59,,"{""full_journal_name"": ""Neurotoxicity research"", ""pub_date"": ""2018-11-06"", ""ref"": ""29626319"", ""pub_year"": 2018, ""last_author"": ""Tan L"", ""type"": ""PubMed"", ""author_list"": [""Xin SH"", ""Tan L"", ""Cao X"", ""Yu JT"", ""Tan L""], ""title"": ""Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy."", ""doi"": ""10.1007/s12640-018-9895-1""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Arteries""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,4946,5124,2017.0,27181519,False,False,False,"Moreover, selective autophagy is particularly well-suited to clearance of large (> 2 um) protein aggregates and RNP granules that need to be disassembled, in part because large protein aggregates and persistent RNP granules are known to be resistant to ubiquitin-proteasome degradation (Venkatraman et al., 2004).",#65:50,PMC5055418,"{""full_journal_name"": ""Brain research"", ""pub_date"": ""2017-05-16"", ""ref"": ""27181519"", ""pub_year"": 2017, ""last_author"": ""Pandey UB"", ""type"": ""PubMed"", ""author_list"": [""Monahan Z"", ""Shewmaker F"", ""Pandey UB""], ""title"": ""Stress granules at the intersection of autophagy and ALS."", ""doi"": ""10.1016/j.brainres.2016.05.022""}","{""Confidence"": [""Medium""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Adenosine Triphosphatases"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Autophagy-Related Proteins"", ""C9orf72 Protein"", ""Cell Cycle Proteins"", ""Cytoplasmic Granules"", ""DNA-Binding Proteins"", ""Disease Models, Animal"", ""Heterogeneous-Nuclear Ribonucleoprotein Group A-B"", ""Humans"", ""Membrane Transport Proteins"", ""Nuclear Matrix-Associated Proteins"", ""Protein Serine-Threonine Kinases"", ""Proteins"", ""RNA-Binding Protein FUS"", ""RNA-Binding Proteins"", ""Transcription Factor TFIIIA"", ""Ubiquitins"", ""Valosin Containing Protein""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Autophagy-Related Proteins"", ""C9orf72 Protein"", ""C9orf72 protein, human"", ""Cell Cycle Proteins"", ""DNA-Binding Proteins"", ""Heterogeneous-Nuclear Ribonucleoprotein Group A-B"", ""MATR3 protein, human"", ""Membrane Transport Proteins"", ""Nuclear Matrix-Associated Proteins"", ""OPTN protein, human"", ""Proteins"", ""RNA-Binding Protein FUS"", ""RNA-Binding Proteins"", ""TARDBP protein, human"", ""Transcription Factor TFIIIA"", ""UBQLN2 protein, human"", ""Ubiquitins"", ""hnRNP A2"", ""Protein Serine-Threonine Kinases"", ""TBK1 protein, human"", ""Adenosine Triphosphatases"", ""Valosin Containing Protein""]}",False
CAUSES_NO_CHANGE,43292,1650,2007.0,17293005,False,False,False,"Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,37138,6755,2018.0,29202785,False,False,False,"This was in striking contrast to the pro-aggregant TauRDΔK slices where there was no significant difference in the number of BrdU positive cells compared to the age matched controls (Fig. 6b, bar 3, 6, and 9)",#59:39,PMC5715613,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2018-10-18"", ""ref"": ""29202785"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Joseph M"", ""Anglada-Huguet M"", ""Paesler K"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Anti-aggregant tau mutant promotes neurogenesis."", ""doi"": ""10.1186/s13024-017-0230-8""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal"", ""CA3 Region, Hippocampal"", ""Dentate Gyrus""], ""Species"": [""10090""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Astrocytes"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutant Proteins"", ""Neural Stem Cells"", ""Neurogenesis"", ""Proline"", ""Protein Aggregation, Pathological"", ""Protein Conformation"", ""Protein Conformation, beta-Strand"", ""Protein Domains"", ""Repetitive Sequences, Amino Acid"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mutant Proteins"", ""tau Proteins"", ""Proline""]}",False
CAUSES_NO_CHANGE,1934,1484,2020.0,30837838,False,False,False,"Notably, the zinc ions could induce inclusion bodies formation and aggregation in the neuronal cell cultures, and this effect was not observed with copper or iron, indicating zinc-specific effects (Caragounis et al., 2010).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Cell"": [""neuron""], ""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,6753,1897,2017.0,28148553,False,False,False,Total tau protein (HT7 antibody) was not altered by treatment with annonacin or the PERK activator (Fig 3A and D).,#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,11640,7850,2018.0,27671637,False,False,False,"Furthermore, we did not see colocalization of the grains of Tau and presynaptic marker synaptophysin (Fig. S3)",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,1411,43738,2016.0,27013968,False,False,False,"Striatal BDNF and fl-TrkB levels were found to be similar in R6/2 and WT mice (Figures 1C,D).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,15419,14223,2019.0,30232325,False,False,False,"Dkk1 resulted in substantial loss of dendritic spines, which was blocked by 10µM fasudil treatment (Fig. 3e, f).",#64:35,PMC6145937,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-03-14"", ""ref"": ""30232325"", ""pub_year"": 2019, ""last_author"": ""Killick R"", ""type"": ""PubMed"", ""author_list"": [""Elliott C"", ""Rojo AI"", ""Ribe E"", ""Broadstock M"", ""Xia W"", ""Morin P"", ""Semenov M"", ""Baillie G"", ""Cuadrado A"", ""Al-Shawi R"", ""Ballard CG"", ""Simons P"", ""Killick R""], ""title"": ""A role for APP in Wnt signalling links synapse loss with \u03b2-amyloid production."", ""doi"": ""10.1038/s41398-018-0231-6""}","{""Confidence"": [""High""], ""mesh"": [""1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"", ""Alzheimer Disease"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Cells, Cultured"", ""Disease Models, Animal"", ""Female"", ""HEK293 Cells"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Intracellular Signaling Peptides and Proteins"", ""Low Density Lipoprotein Receptor-Related Protein-6"", ""Male"", ""Membrane Proteins"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Neurons"", ""Protein Kinase Inhibitors"", ""Rats"", ""Rats, Sprague-Dawley"", ""Synapses"", ""Wnt Signaling Pathway""], ""substances"": [""Amyloid beta-Protein Precursor"", ""DKK1 protein, human"", ""Intercellular Signaling Peptides and Proteins"", ""Intracellular Signaling Peptides and Proteins"", ""LRP6 protein, human"", ""Low Density Lipoprotein Receptor-Related Protein-6"", ""Membrane Proteins"", ""Protein Kinase Inhibitors"", ""VANGL2 protein, human"", ""1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"", ""fasudil""]}",False
CAUSES_NO_CHANGE,33507,39813,2014.0,23164821,False,False,False,"Dkk4 and Dkk1 induced EGR1 (Figure 6b) and FOS (data not shown) whereas Dkk2 and Dkk3 did not, mirroring the abilities of the Dkk1 family to antagonise canonical wnt.",#59:5,PMC3873038,"{""full_journal_name"": ""Molecular psychiatry"", ""pub_date"": ""2014-08-26"", ""ref"": ""23164821"", ""pub_year"": 2014, ""last_author"": ""Lovestone S"", ""type"": ""PubMed"", ""author_list"": [""Killick R"", ""Ribe EM"", ""Al-Shawi R"", ""Malik B"", ""Hooper C"", ""Fernandes C"", ""Dobson R"", ""Nolan PM"", ""Lourdusamy A"", ""Furney S"", ""Lin K"", ""Breen G"", ""Wroe R"", ""To AW"", ""Leroy K"", ""Causevic M"", ""Usardi A"", ""Robinson M"", ""Noble W"", ""Williamson R"", ""Lunnon K"", ""Kellie S"", ""Reynolds CH"", ""Bazenet C"", ""Hodges A"", ""Brion JP"", ""Stephenson J"", ""Simons JP"", ""Lovestone S""], ""title"": ""Clusterin regulates \u03b2-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway."", ""doi"": ""10.1038/mp.2012.163""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""DKK1 subgraph""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Clusterin"", ""Embryo, Mammalian"", ""Enzyme Inhibitors"", ""Female"", ""Gene Expression Regulation"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""MAP Kinase Signaling System"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""Rats"", ""Rats, Sprague-Dawley"", ""Wnt Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Clusterin"", ""DKK1 protein, human"", ""Enzyme Inhibitors"", ""Intercellular Signaling Peptides and Proteins"", ""Wnt Proteins""]}",False
CAUSES_NO_CHANGE,1791,1654,2007.0,17640819,False,False,False,"4OH-GTS-21 had no effect on cholinergic cell size in the unlesioned sides of the septa of the wild type or PS1 mice, but did cause atrophy of these neurons in the APP/PS1 mice",#57:56,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,7642,35112,2017.0,28148553,False,False,False,"Upon 3R tau overexpression, PERK modulation showed no significant changes",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,35124,16620,2019.0,30562574,False,False,False,"LAMP2A down-regulation decreased total lysosomal proteolysis (NH4Cl- sensitive) as well as CMA-dependent proteolysis [(NH4Cl-3MA)-sensitive], without affecting macroautophagy-dependent (3MA-sensitive) proteolysis, further verifying the importance of LAMP2A as the ratelimiting step of the CMA pathway in this culture system (Suppl. Fig. 1A-C). LC3 lipidation and macroautophagic substrate SQSTM1/p62 abundance was similarly unchanged (Suppl. Fig. 1D).",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,14403,2361,2011.0,21745645,False,False,False,"Consistent with the results from electrical SO stimulation, when cholinergic input was activated 100 ms (i.e., light exposure 120 ms to take into account the 20 ms delay) before SC stimulation, LTP was induced, which was blocked by the a7 nAChR antagonist MLA, but not by DHbE or atropine (Figures 5I and 5H)",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""100 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,2721,7407,2019.0,29758300,False,False,False,"Lastly, macroautophagy, but not UPS or CMA can clear protein aggregates.",#69:35,,"{""full_journal_name"": ""Neuroscience letters"", ""pub_date"": ""2019-07-24"", ""ref"": ""29758300"", ""pub_year"": 2019, ""last_author"": ""Yu WH"", ""type"": ""PubMed"", ""author_list"": [""Chung KM"", ""Hern\u00e1ndez N"", ""Sproul AA"", ""Yu WH""], ""title"": ""Alzheimer's disease and the autophagic-lysosomal system."", ""doi"": ""10.1016/j.neulet.2018.05.017""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Autophagy"", ""Biological Transport"", ""Humans"", ""Lysosomes"", ""Neurodegenerative Diseases"", ""Neurons"", ""Proteasome Endopeptidase Complex"", ""Protein Folding"", ""Proteolysis"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,1744,31089,2005.0,15673661,False,False,False,"We observed that APP mRNA expression was transiently induced in neonates, but exhibited a delayed overexpression 20 months after exposure to Pb had ceased. This upregulation in APP mRNA expression was commensurate with a rise in activity of the transcription factor Sp1, one of the regulators of the APP gene. Furthermore, the increase in APP gene expression in old age was accompanied by an elevation in APP and its amyloidogenic Abeta product. In contrast, APP expression, Sp1 activity, as well as APP and Abeta protein levels were unresponsive to Pb exposure during old age.",#59:5,PMC6725614,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2005-08-31"", ""ref"": ""15673661"", ""pub_year"": 2005, ""last_author"": ""Zawia NH"", ""type"": ""PubMed"", ""author_list"": [""Basha MR"", ""Wei W"", ""Bakheet SA"", ""Benitez N"", ""Siddiqi HK"", ""Ge YW"", ""Lahiri DK"", ""Zawia NH""], ""title"": ""The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.""}","{""Species"": [""10090""], ""Subgraph"": [""Epigenetic modification subgraph""], ""mesh"": [""Aging"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Newborn"", ""Brain"", ""Female"", ""Gene Expression Regulation, Developmental"", ""Humans"", ""Lead"", ""Male"", ""PC12 Cells"", ""Promoter Regions, Genetic"", ""RNA, Small Interfering"", ""Rats"", ""Rats, Long-Evans"", ""Sp1 Transcription Factor""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""RNA, Small Interfering"", ""Sp1 Transcription Factor"", ""Lead""]}",False
CAUSES_NO_CHANGE,5009,2882,2001.0,11230871,False,False,False,"The levels of alpha4 and alpha7 nAChR mRNA showed a decrease with aging, whereas the levels of alpha3 mRNA were unchanged in the elderly brain relative to the fetal brain (Hellstro¨m-Lindahl et al 1998)",#65:45,,"{""full_journal_name"": ""Biological psychiatry"", ""pub_date"": ""2001-06-07"", ""ref"": ""11230871"", ""pub_year"": 2001, ""last_author"": ""Nordberg A"", ""type"": ""PubMed"", ""author_list"": [""Nordberg A""], ""title"": ""Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Brain""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Brain"", ""Cholinergic Agents"", ""Humans"", ""Receptors, Nicotinic"", ""Treatment Outcome""], ""substances"": [""Cholinergic Agents"", ""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,41520,30968,2019.0,30664622,False,False,False,"In females, hippocampal VGLUT1 was not affected by the Adnp genotype or NAP treatment (Supplemental Fig. S4A)",#69:15,PMC6341082,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-06-10"", ""ref"": ""30664622"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Sragovich S"", ""Malishkevich A"", ""Piontkewitz Y"", ""Giladi E"", ""Touloumi O"", ""Lagoudaki R"", ""Grigoriadis N"", ""Gozes I""], ""title"": ""The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse."", ""doi"": ""10.1038/s41398-018-0357-6""}","{""Confidence"": [""High""], ""Gender"": [""Female""], ""MeSHAnatomy"": [""Hippocampus""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Brain"", ""Diffusion Tensor Imaging"", ""Disease Models, Animal"", ""Female"", ""Haploinsufficiency"", ""Homeodomain Proteins"", ""Magnetic Resonance Imaging"", ""Male"", ""Mice"", ""Mice, 129 Strain"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Neuroprotection"", ""Oligopeptides"", ""Synapses"", ""Vesicular Glutamate Transport Protein 1""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Oligopeptides"", ""Slc17a7 protein, mouse"", ""Vesicular Glutamate Transport Protein 1"", ""davunetide""]}",False
CAUSES_NO_CHANGE,7981,14070,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,33061,35112,2017.0,28148553,False,False,False,"Upon 3R tau overexpression, PERK modulation showed no significant changes",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,39104,2211,2017.0,27574109,False,False,False,"hT40, hT34, hT24, hT37 and hT23 aggregates did not significantly impair retrograde FAT when compared to the respective monomers, but hT39 aggregates elicited a mild inhibitory effect on retrograde FAT (Fig. 4B)",#70:49,PMC5075521,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-10-17"", ""ref"": ""27574109"", ""pub_year"": 2017, ""last_author"": ""Kanaan NM"", ""type"": ""PubMed"", ""author_list"": [""Cox K"", ""Combs B"", ""Abdelmesih B"", ""Morfini G"", ""Brady ST"", ""Kanaan NM""], ""title"": ""Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition."", ""doi"": ""10.1016/j.neurobiolaging.2016.07.015""}","{""mesh"": [""Alzheimer Disease"", ""Animals"", ""Axonal Transport"", ""Decapodiformes"", ""Humans"", ""In Vitro Techniques"", ""Polymerization"", ""Protein Aggregates"", ""Protein Domains"", ""Protein Isoforms"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Protein Aggregates"", ""Protein Isoforms"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,43559,41708,2012.0,22372633,False,False,False,"Blocking the dynein motor proteins does not affect the localization of HDAC6, while it does impair SG formation (42).",#57:37,,"{""full_journal_name"": ""Traffic (Copenhagen, Denmark)"", ""pub_date"": ""2012-10-04"", ""ref"": ""22372633"", ""pub_year"": 2012, ""last_author"": ""Van Den Bosch L"", ""type"": ""PubMed"", ""author_list"": [""d'Ydewalle C"", ""Bogaert E"", ""Van Den Bosch L""], ""title"": ""HDAC6 at the Intersection of Neuroprotection and Neurodegeneration."", ""doi"": ""10.1111/j.1600-0854.2012.01347.x""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Animals"", ""Autophagy"", ""Cytoskeleton"", ""Gene Expression Regulation, Enzymologic"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Humans"", ""Microtubules"", ""Models, Biological"", ""Models, Genetic"", ""Neurodegenerative Diseases"", ""Neuroprotective Agents"", ""Protein Binding"", ""Protein Conformation"", ""Ubiquitin""], ""substances"": [""Neuroprotective Agents"", ""Ubiquitin"", ""HDAC6 protein, human"", ""Histone Deacetylase 6"", ""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,6576,44312,2020.0,30985105,False,False,False,"In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",#70:0,,"{""full_journal_name"": ""ACS chemical neuroscience"", ""pub_date"": ""2020-05-21"", ""ref"": ""30985105"", ""pub_year"": 2020, ""last_author"": ""Rudrawar S"", ""type"": ""PubMed"", ""author_list"": [""Ryan P"", ""Xu M"", ""Davey AK"", ""Danon JJ"", ""Mellick GD"", ""Kassiou M"", ""Rudrawar S""], ""title"": ""O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease."", ""doi"": ""10.1021/acschemneuro.9b00143""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Acetylglucosamine"", ""Animals"", ""Brain"", ""Humans"", ""Neurodegenerative Diseases"", ""Protein Aggregation, Pathological"", ""Protein Folding"", ""Protein Processing, Post-Translational""], ""substances"": [""Acetylglucosamine""]}",False
CAUSES_NO_CHANGE,11560,1174,2015.0,25639674,False,False,False,"The α4β2 nAChR PAM, NS-9283, administered alone did not affect mechanical allodynia in the spinal nerve ligation test (a model of neuropathic pain), nor on nociception and inflammation in various rodent models of pain [185, 186].",#59:10,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons"", ""Spinal Cord""], ""MeSHDisease"": [""Pain""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,4920,8696,2017.0,27299292,False,False,False,"Conversely, constitutively active versions of Rags lead to TFEB retention in the cytoplasm, irrespective of the nutrient status of the cell.[28]",#63:52,PMC5032832,"{""full_journal_name"": ""Annals of the New York Academy of Sciences"", ""pub_date"": ""2017-07-19"", ""ref"": ""27299292"", ""pub_year"": 2017, ""last_author"": ""Sardiello M"", ""type"": ""PubMed"", ""author_list"": [""Sardiello M""], ""title"": ""Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases."", ""doi"": ""10.1111/nyas.13131""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Humans"", ""Lysosomal Storage Diseases"", ""Lysosomes"", ""Models, Biological"", ""Molecular Targeted Therapy"", ""Signal Transduction""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors""]}",False
CAUSES_NO_CHANGE,12007,7335,2018.0,28843454,False,False,False,"Despite this, oral tobacco use has not been associated with elevated risk for MS, which suggests that nicotine is not the responsible agent (39).",#58:12,,"{""full_journal_name"": ""Pediatric neurology"", ""pub_date"": ""2018-05-17"", ""ref"": ""28843454"", ""pub_year"": 2018, ""last_author"": ""Brenton JN"", ""type"": ""PubMed"", ""author_list"": [""Cappa R"", ""Theroux L"", ""Brenton JN""], ""title"": ""Pediatric Multiple Sclerosis: Genes, Environment, and a Comprehensive Therapeutic Approach."", ""doi"": ""10.1016/j.pediatrneurol.2017.07.005""}","{""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Environment"", ""Environmental Exposure"", ""Genome-Wide Association Study"", ""Humans"", ""Multiple Sclerosis"", ""Pediatrics""]}",False
CAUSES_NO_CHANGE,6709,36745,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,6880,3555,2014.0,24590577,False,False,False,"Moreover, AF102B administration decreased the total CSF Abeta levels by 22% in 14 of 19 AD patients without affecting sAPPalpha levels. However, AF102B has serious side effects including gastrointestinal symptoms, diaphoresis, confusion, diarrhea, and asthenia",#69:61,PMC5562652,"{""full_journal_name"": ""Neuroscience bulletin"", ""pub_date"": ""2014-12-03"", ""ref"": ""24590577"", ""pub_year"": 2014, ""last_author"": ""Zhang YW"", ""type"": ""PubMed"", ""author_list"": [""Jiang S"", ""Li Y"", ""Zhang C"", ""Zhao Y"", ""Bu G"", ""Xu H"", ""Zhang YW""], ""title"": ""M1 muscarinic acetylcholine receptor in Alzheimer's disease."", ""doi"": ""10.1007/s12264-013-1406-z""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""Receptor, Muscarinic M1""], ""substances"": [""Receptor, Muscarinic M1""]}",False
CAUSES_NO_CHANGE,6709,29043,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,6884,4980,2015.0,26088141,False,False,False,"As shown in Fig. 5, A–C, barium replacement had little to no effect on the peak and total calcium transient observed in α7 (peak: 1474.83% ΔF/Fθ ± 162.00%; AUC: 693.5% ΔF/Fθ2 × s ± 154.15%) and α7345–348A expressing cells (peak: 794% ΔF/Fθ ± 81.36%; AUC: 543.5% ΔF/Fθ2 × s ± 89.59%).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,1832,1440,2012.0,22791904,False,False,False,Posiphen 80 mg was determined as the no observed adverse effect level (table 1).,#70:20,PMC3415310,"{""full_journal_name"": ""Journal of neurology, neurosurgery, and psychiatry"", ""pub_date"": ""2012-10-29"", ""ref"": ""22791904"", ""pub_year"": 2012, ""last_author"": ""Greig NH"", ""type"": ""PubMed"", ""author_list"": [""Maccecchini ML"", ""Chang MY"", ""Pan C"", ""John V"", ""Zetterberg H"", ""Greig NH""], ""title"": ""Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-\u03b2 peptide and \u03c4 levels: target engagement, tolerability and pharmacokinetics in humans."", ""doi"": ""10.1136/jnnp-2012-302589""}","{""ArticleCompoundNumber"": [""1""], ""Confidence"": [""High""], ""MeasurementType"": [""dose""], ""MeasurementUnits"": [""mg""], ""MeasurementValue"": [""80""], ""Page"": [""896""], ""mesh"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Cognitive Dysfunction"", ""Dose-Response Relationship, Drug"", ""Double-Blind Method"", ""Female"", ""Humans"", ""Inflammation Mediators"", ""Male"", ""Peptide Fragments"", ""Physostigmine"", ""Rats"", ""Rats, Inbred F344"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Inflammation Mediators"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Physostigmine"", ""phenserine""]}",False
CAUSES_NO_CHANGE,29150,1314,2020.0,30837838,False,False,False,"Several of these interactions were unperturbed by the ALS-linked mutations, A315T and M337V (Freibaum et al., 2010; Kim et al., 2010).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""]}",False
CAUSES_NO_CHANGE,44629,1650,2007.0,17293005,False,False,False,"Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,37138,39422,2018.0,29202785,False,False,False,"By contrast, pro-aggregant TauRDΔK slices showed no overall increase in endogenous mouse Tau (rather a 20% decrease), yet pronounced mislocalization (Fig. 5, A3).",#59:39,PMC5715613,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2018-10-18"", ""ref"": ""29202785"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Joseph M"", ""Anglada-Huguet M"", ""Paesler K"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Anti-aggregant tau mutant promotes neurogenesis."", ""doi"": ""10.1186/s13024-017-0230-8""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Astrocytes"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutant Proteins"", ""Neural Stem Cells"", ""Neurogenesis"", ""Proline"", ""Protein Aggregation, Pathological"", ""Protein Conformation"", ""Protein Conformation, beta-Strand"", ""Protein Domains"", ""Repetitive Sequences, Amino Acid"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mutant Proteins"", ""tau Proteins"", ""Proline""]}",False
CAUSES_NO_CHANGE,14323,16749,2019.0,30935091,False,False,False,"While human NPCs had minimal Ac-K49- beta-catenin at baseline, treatment with the pan-HDACi SAHA and another broadly selective HDACi crebinostat led to a marked increase in Ac-K49-beta -catenin levels, without affecting overall beta-catenin levels [103].",#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,32618,30751,2012.0,22419736,False,False,False,"AK1 overexpression markedly decreased AMPK phosphorylation at Thr172 in the primary neurons, whereas AK1 R132A mutant failed to do so",#72:19,,"{""full_journal_name"": ""Human molecular genetics"", ""pub_date"": ""2012-10-09"", ""ref"": ""22419736"", ""pub_year"": 2012, ""last_author"": ""Jung YK"", ""type"": ""PubMed"", ""author_list"": [""Park H"", ""Kam TI"", ""Kim Y"", ""Choi H"", ""Gwon Y"", ""Kim C"", ""Koh JY"", ""Jung YK""], ""title"": ""Neuropathogenic role of adenylate kinase-1 in A\u03b2-mediated tau phosphorylation via AMPK and GSK3\u03b2."", ""doi"": ""10.1093/hmg/dds100""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Neurons""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Genetically Modified"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Drosophila"", ""Drosophila Proteins"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Green Fluorescent Proteins"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microscopy, Fluorescence"", ""Neurodegenerative Diseases"", ""Neurons"", ""Peptide Fragments"", ""Phosphorylation"", ""RNA Interference"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Drosophila Proteins"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""adenylate kinase 1""]}",False
CAUSES_NO_CHANGE,42894,38804,2012.0,22179319,False,False,False,Overexpression of SIRT1 maintained the activated phospho-Trk-B (Fig. 2e-f) but not total TrkB levels (Fig.2g).,#66:20,PMC4551453,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2012-03-14"", ""ref"": ""22179319"", ""pub_year"": 2012, ""last_author"": ""Duan W"", ""type"": ""PubMed"", ""author_list"": [""Jiang M"", ""Wang J"", ""Fu J"", ""Du L"", ""Jeong H"", ""West T"", ""Xiang L"", ""Peng Q"", ""Hou Z"", ""Cai H"", ""Seredenina T"", ""Arbez N"", ""Zhu S"", ""Sommers K"", ""Qian J"", ""Zhang J"", ""Mori S"", ""Yang XW"", ""Tamashiro KL"", ""Aja S"", ""Moran TH"", ""Luthi-Carter R"", ""Martin B"", ""Maudsley S"", ""Mattson MP"", ""Cichewicz RH"", ""Ross CA"", ""Holtzman DM"", ""Krainc D"", ""Duan W""], ""title"": ""Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets."", ""doi"": ""10.1038/nm.2558""}","{""Cell"": [""striatum neuron""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Disease Models, Animal"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""Gene Expression Regulation"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins"", ""Rats"", ""Receptor, trkB"", ""Signal Transduction"", ""Sirtuin 1""], ""substances"": [""Brain-Derived Neurotrophic Factor"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""FoxO3 protein, mouse"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Ppp1r1b protein, mouse"", ""Receptor, trkB"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,16913,212,2013.0,23758787,False,False,False,"However, DUBA does not affect NF-κB2 activation, which is entirely dependent on K48-linked degradative ubiquitination of TRAF3 [128,185,216].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""]}",False
CAUSES_NO_CHANGE,7761,1625,2020.0,30837838,False,False,False,"Several of these interactions were unperturbed by the ALS-linked mutations, A315T and M337V (Freibaum et al., 2010; Kim et al., 2010).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""]}",False
CAUSES_NO_CHANGE,14403,21816,2011.0,21745645,False,False,False,"Consistent with the results from electrical SO stimulation, when cholinergic input was activated 100 ms (i.e., light exposure 120 ms to take into account the 20 ms delay) before SC stimulation, LTP was induced, which was blocked by the a7 nAChR antagonist MLA, but not by DHbE or atropine (Figures 5I and 5H)",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""100 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,16858,40602,2017.0,28083634,False,False,False,Analysis of a catalytically dead mutant with a C91A mutation revealed no effect on Lys48-linked polyubiquitination of Tau,#64:64,PMC5390007,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2017-04-20"", ""ref"": ""28083634"", ""pub_year"": 2017, ""last_author"": ""Dewachter I"", ""type"": ""PubMed"", ""author_list"": [""Wang P"", ""Joberty G"", ""Buist A"", ""Vanoosthuyse A"", ""Stancu IC"", ""Vasconcelos B"", ""Pierrot N"", ""Faelth-Savitski M"", ""Kienlen-Campard P"", ""Octave JN"", ""Bantscheff M"", ""Drewes G"", ""Moechars D"", ""Dewachter I""], ""title"": ""Tau interactome mapping\u00a0based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo."", ""doi"": ""10.1007/s00401-016-1663-9""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Deubiquitinating Enzymes"", ""Humans"", ""Mice, Transgenic"", ""Neurofibrillary Tangles"", ""Neurons"", ""Tauopathies"", ""Ubiquitin"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Ubiquitin"", ""tau Proteins"", ""Deubiquitinating Enzymes"", ""Cysteine Endopeptidases"", ""Otub1 protein, mouse""]}",False
CAUSES_NO_CHANGE,44128,40328,2002.0,11810404,False,False,False,"Finally, CaM kinase II is present in neurons but not in glial cells, thus suggesting no role of CaM kinase II in tau phosphorylation of glial cells. These observations, together with previous results of in vitro studies, support the idea that several MAPK/ERK, SAPK/JNK, p38 and CaM kinase II may participate in tau phosphorylation in tauopathies",#59:5,,"{""full_journal_name"": ""Journal of neural transmission (Vienna, Austria : 1996)"", ""pub_date"": ""2002-03-07"", ""ref"": ""11810404"", ""pub_year"": 2002, ""last_author"": ""Puig B"", ""type"": ""PubMed"", ""author_list"": [""Ferrer I"", ""Blanco R"", ""Carmona M"", ""Puig B""], ""title"": ""Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.""}","{""MeSHAnatomy"": [""Microglia""], ""Subgraph"": [""Tau protein subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Brain"", ""Calcium-Calmodulin-Dependent Protein Kinase Type 2"", ""Calcium-Calmodulin-Dependent Protein Kinases"", ""Caspase 3"", ""Caspases"", ""DNA Fragmentation"", ""Female"", ""Humans"", ""Immunohistochemistry"", ""In Situ Nick-End Labeling"", ""Male"", ""Middle Aged"", ""Mitogen-Activated Protein Kinase 8"", ""Mitogen-Activated Protein Kinases"", ""Neuroglia"", ""Neurons"", ""Phosphorylation"", ""Pick Disease of the Brain"", ""Supranuclear Palsy, Progressive"", ""Tauopathies"", ""p38 Mitogen-Activated Protein Kinases"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""CAMK2A protein, human"", ""Calcium-Calmodulin-Dependent Protein Kinase Type 2"", ""Calcium-Calmodulin-Dependent Protein Kinases"", ""Mitogen-Activated Protein Kinase 8"", ""Mitogen-Activated Protein Kinases"", ""p38 Mitogen-Activated Protein Kinases"", ""CASP3 protein, human"", ""Caspase 3"", ""Caspases""]}",False
CAUSES_NO_CHANGE,14214,18995,2018.0,28901280,False,False,False,α9 and α9-α10 nAChRs have a number of interesting characteristics: they are acti- vated by ACh but not by the classical agonist nicotine. Cho- line is also a potent selective agonist of the α9 subtype,#61:2,PMC6018187,"{""full_journal_name"": ""Current neuropharmacology"", ""pub_date"": ""2018-09-13"", ""ref"": ""28901280"", ""pub_year"": 2018, ""last_author"": ""Gotti C"", ""type"": ""PubMed"", ""author_list"": [""Zoli M"", ""Pucci S"", ""Vilella A"", ""Gotti C""], ""title"": ""Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors."", ""doi"": ""10.2174/1570159X15666170912110450""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Binding Sites"", ""Humans"", ""Neurons"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,32673,39813,2014.0,23164821,False,False,False,"Dkk4 and Dkk1 induced EGR1 (Figure 6b) and FOS (data not shown) whereas Dkk2 and Dkk3 did not, mirroring the abilities of the Dkk1 family to antagonise canonical wnt.",#59:5,PMC3873038,"{""full_journal_name"": ""Molecular psychiatry"", ""pub_date"": ""2014-08-26"", ""ref"": ""23164821"", ""pub_year"": 2014, ""last_author"": ""Lovestone S"", ""type"": ""PubMed"", ""author_list"": [""Killick R"", ""Ribe EM"", ""Al-Shawi R"", ""Malik B"", ""Hooper C"", ""Fernandes C"", ""Dobson R"", ""Nolan PM"", ""Lourdusamy A"", ""Furney S"", ""Lin K"", ""Breen G"", ""Wroe R"", ""To AW"", ""Leroy K"", ""Causevic M"", ""Usardi A"", ""Robinson M"", ""Noble W"", ""Williamson R"", ""Lunnon K"", ""Kellie S"", ""Reynolds CH"", ""Bazenet C"", ""Hodges A"", ""Brion JP"", ""Stephenson J"", ""Simons JP"", ""Lovestone S""], ""title"": ""Clusterin regulates \u03b2-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway."", ""doi"": ""10.1038/mp.2012.163""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""DKK1 subgraph""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Clusterin"", ""Embryo, Mammalian"", ""Enzyme Inhibitors"", ""Female"", ""Gene Expression Regulation"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""MAP Kinase Signaling System"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""Rats"", ""Rats, Sprague-Dawley"", ""Wnt Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Clusterin"", ""DKK1 protein, human"", ""Enzyme Inhibitors"", ""Intercellular Signaling Peptides and Proteins"", ""Wnt Proteins""]}",False
CAUSES_NO_CHANGE,11560,1334,2015.0,25639674,False,False,False,"The α4β2 nAChR PAM, NS-9283, administered alone did not affect mechanical allodynia in the spinal nerve ligation test (a model of neuropathic pain), nor on nociception and inflammation in various rodent models of pain [185, 186].",#60:18,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""MeSHAnatomy"": [""Neurons"", ""Spinal Cord""], ""MeSHDisease"": [""Pain""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,33061,33314,2017.0,28148553,False,False,False,"Upon 3R tau overexpression, PERK modulation showed no significant changes",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,26554,30929,2018.0,27671637,False,False,False,"Having observed that 64627 restores presynaptic functioning (i.e., PPF, Fig. 4F), neuronal activity (induction of Fos, Fig. 4D), and dendritic spine levels in proaggregant Tau transgenic organotypic slices (Fig. 5 A and B), we tested whether we could restore long-term spatial memory in proaggregant Tau transgenic mice as well",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Axons""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,40139,39647,2017.0,28760828,False,False,False,"Of note, all of tau’s KXGS motifs were responsive to HDAC6 in vitro with the exception of Lys-290 in the second microtubule binding repeat domain, which could not be determined, given that p300 did not acetylate this site under the current conditions.",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,7040,12390,2017.0,28408124,False,False,False,"The 40E8, 4E4, and p396 antibodies also reduced neuronal tau uptake by 40% to 80%, despite their low-immunodepletion efficiency (Figure 2). This finding suggests that they interacted with tau species that are prone to cellular uptake, which account for only a small fraction of all soluble tau species in the brain extract. Notably, Tau46 had little effect on tau uptake (Figure 2, B and C).",#59:9,PMC5455060,"{""full_journal_name"": ""The American journal of pathology"", ""pub_date"": ""2017-08-08"", ""ref"": ""28408124"", ""pub_year"": 2017, ""last_author"": ""Takeda S"", ""type"": ""PubMed"", ""author_list"": [""Nobuhara CK"", ""DeVos SL"", ""Commins C"", ""Wegmann S"", ""Moore BD"", ""Roe AD"", ""Costantino I"", ""Frosch MP"", ""Pitstick R"", ""Carlson GA"", ""Hock C"", ""Nitsch RM"", ""Montrasio F"", ""Grimm J"", ""Cheung AE"", ""Dunah AW"", ""Wittmann M"", ""Bussiere T"", ""Weinreb PH"", ""Hyman BT"", ""Takeda S""], ""title"": ""Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in\u00a0Vitro."", ""doi"": ""10.1016/j.ajpath.2017.01.022""}","{""Confidence"": [""Medium""], ""HasQuantitativeInformation"": [""True""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Tauopathies""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Antibodies, Monoclonal"", ""Brain"", ""Cells, Cultured"", ""Epitopes"", ""Female"", ""Humans"", ""Interneurons"", ""Male"", ""Mice, Transgenic"", ""Microfluidic Analytical Techniques"", ""Molecular Targeted Therapy"", ""Neurofibrillary Tangles"", ""Neurons"", ""Phosphorylation"", ""tau Proteins""], ""substances"": [""Antibodies, Monoclonal"", ""Epitopes"", ""MAPT protein, human"", ""Mapt protein, mouse"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11813,2582,2018.0,30027901,False,False,False,"In an interesting study, HD patients having gait abnormalities and choreiform movements were treated with haloperidol. Although, there was a decrease in choreiform movement, yet it did not correct gait abnormalities (Koller and Trimble 1985). Long-term treatment of haloperidol is known to cause aggravated parkinsonism, tardive dyskinesis, difficulties in swallowing and dysphasia (Emerich et al. 1991).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,11566,33326,2020.0,30686764,False,False,False,"Inhibition of the respective non-sterol isoprenoid pathways (by geranyl- or farnesyl- transferase inhibitors GGTI-298 and FTI-227, respectively) did not significantly reduce pThr231Tau/ tTau (Figures 2C, S2F, and S2G).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,7981,30841,2016.0,26702100,False,False,False,"In our observations, knockdown of TDP-43 significantly increased wild- type (WT) TFEB, but not TFEBD30 or TFEB-Q10A/L11A lysosomal localization (Figs 3E and EV3C and D), suggesting that Rag GTPases, but not TDP-43, are critical for the association of TFEB with lysosomes",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,43284,36139,2019.0,29844403,False,False,False,"As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",#71:1,PMC5974403,"{""full_journal_name"": ""Cell death & disease"", ""pub_date"": ""2019-12-10"", ""ref"": ""29844403"", ""pub_year"": 2019, ""last_author"": ""Yang CR"", ""type"": ""PubMed"", ""author_list"": [""Fan SJ"", ""Huang FI"", ""Liou JP"", ""Yang CR""], ""title"": ""The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model."", ""doi"": ""10.1038/s41419-018-0688-5""}","{""CellLine"": [""Neuro-2a cell"", ""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Benzamides"", ""Cell Line, Tumor"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3 beta"", ""Histone Deacetylase Inhibitors"", ""Memory Disorders"", ""Models, Biological"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Aggregates"", ""Proteolysis"", ""Quinolines"", ""Rats, Sprague-Dawley"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Benzamides"", ""Histone Deacetylase Inhibitors"", ""MPT0G211"", ""Neuroprotective Agents"", ""Protein Aggregates"", ""Quinolines"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,2017,18674,2019.0,28391535,False,False,False,"In antagonism tests, (-)-nicotine failed to block the stimulus effects of mecamylamine",#63:58,,"{""full_journal_name"": ""Current topics in behavioral neurosciences"", ""pub_date"": ""2019-01-31"", ""ref"": ""28391535"", ""pub_year"": 2019, ""last_author"": ""Young R"", ""type"": ""PubMed"", ""author_list"": [""Rosecrans JA"", ""Young R""], ""title"": ""Discriminative Stimulus Properties of S(-)-Nicotine: \""A Drug for All Seasons\""."", ""doi"": ""10.1007/7854_2017_3""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Central Nervous System Stimulants"", ""Humans"", ""Nicotine"", ""Nicotinic Agonists"", ""Smoking Cessation"", ""Stereoisomerism"", ""Tobacco""], ""substances"": [""Central Nervous System Stimulants"", ""Nicotinic Agonists"", ""Nicotine""]}",False
CAUSES_NO_CHANGE,11960,15258,2014.0,24590577,False,False,False,"During the past few years, the M1 mAChR allosteric agonists VU0184670 and VU0357017 have been screened out, and have more exciting properties. Both compounds have high solubility in aqueous solutions as well as good CNS penetration, without any agonist or antagonist activity for the M2 and M5 subtypes",#69:61,PMC5562652,"{""full_journal_name"": ""Neuroscience bulletin"", ""pub_date"": ""2014-12-03"", ""ref"": ""24590577"", ""pub_year"": 2014, ""last_author"": ""Zhang YW"", ""type"": ""PubMed"", ""author_list"": [""Jiang S"", ""Li Y"", ""Zhang C"", ""Zhao Y"", ""Bu G"", ""Xu H"", ""Zhang YW""], ""title"": ""M1 muscarinic acetylcholine receptor in Alzheimer's disease."", ""doi"": ""10.1007/s12264-013-1406-z""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""Receptor, Muscarinic M1""], ""substances"": [""Receptor, Muscarinic M1""]}",False
CAUSES_NO_CHANGE,38200,20824,2000.0,10656250,False,False,False,"However, expression of either of the Asp 2 mutants does not produce the increase in the secretion of sAPPb (Fig. 2b) seen for wild-type Asp 2. In contrast to this clear effect on sAPPb, Asp 2 has no effect on the secretion of soluble APPa or on full-length APP in the cell (data not shown).",#64:10,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2000-02-17"", ""ref"": ""10656250"", ""pub_year"": 2000, ""last_author"": ""Christie G"", ""type"": ""PubMed"", ""author_list"": [""Hussain I"", ""Powell D"", ""Howlett DR"", ""Tew DG"", ""Meek TD"", ""Chapman C"", ""Gloger IS"", ""Murphy KE"", ""Southan CD"", ""Ryan DM"", ""Smith TS"", ""Simmons DL"", ""Walsh FS"", ""Dingwall C"", ""Christie G""], ""title"": ""Identification of a novel aspartic protease (Asp 2) as beta-secretase.""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amino Acid Substitution"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""COS Cells"", ""Cathepsin D"", ""Cell Line"", ""Cell Membrane"", ""Endopeptidases"", ""Female"", ""Hippocampus"", ""Humans"", ""Middle Aged"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Papain"", ""Recombinant Proteins"", ""Sequence Alignment"", ""Sequence Homology, Amino Acid"", ""Transfection""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Recombinant Proteins"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Papain"", ""Aspartic Acid Endopeptidases"", ""BACE2 protein, human"", ""BACE1 protein, human"", ""Cathepsin D""]}",False
CAUSES_NO_CHANGE,4177,42256,2017.0,27594586,False,False,False,"Moreover, the total expression levels of tau and PSD-95 were the same in 1-month-old neurons derived from control and patient iPSCs (Figure 1B)",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,15569,20341,2009.0,19293145,False,False,False,"In addition to Abeta acting upon nAChRs, nAChRs in turn regulate Abeta secretion. Nicotine or epibatidine applied to the human SHEP1 cell line stably transfected with human alpha4beta2 nAChRs and human APP decreases the secretion and intracellular accumulation of Abeta without significantly affecting the APP mRNA, suggesting that these effects are post-translational (Nie et al., 2007).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,6709,40789,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,6884,10760,2015.0,26088141,False,False,False,"As shown in Fig. 5, A–C, barium replacement had little to no effect on the peak and total calcium transient observed in α7 (peak: 1474.83% ΔF/Fθ ± 162.00%; AUC: 693.5% ΔF/Fθ2 × s ± 154.15%) and α7345–348A expressing cells (peak: 794% ΔF/Fθ ± 81.36%; AUC: 543.5% ΔF/Fθ2 × s ± 89.59%).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,1822,10722,2019.0,28391535,False,False,False,Table 5 presents results of MLA/(-)-nicotine combination studies and shows that MLA failed to alter the stimulus effects of (-)-nicotine in rats or mice (but see partial antagonism reported by Quarta et al. [126]),#63:58,,"{""full_journal_name"": ""Current topics in behavioral neurosciences"", ""pub_date"": ""2019-01-31"", ""ref"": ""28391535"", ""pub_year"": 2019, ""last_author"": ""Young R"", ""type"": ""PubMed"", ""author_list"": [""Rosecrans JA"", ""Young R""], ""title"": ""Discriminative Stimulus Properties of S(-)-Nicotine: \""A Drug for All Seasons\""."", ""doi"": ""10.1007/7854_2017_3""}","{""Confidence"": [""High""], ""Species"": [""10090"", ""10116""], ""mesh"": [""Animals"", ""Central Nervous System Stimulants"", ""Humans"", ""Nicotine"", ""Nicotinic Agonists"", ""Smoking Cessation"", ""Stereoisomerism"", ""Tobacco""], ""substances"": [""Central Nervous System Stimulants"", ""Nicotinic Agonists"", ""Nicotine""]}",False
CAUSES_NO_CHANGE,11479,14393,2007.0,17640819,False,False,False,"Septal parvalbumin-staining GABAergic neurons were not protected by this treatment, although they also express 7 nicotinic receptors, suggesting an indirect, nerve growth factor (NGF)–mediated mechanism.",#65:41,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""MouseStrain"": [""C57BL/6J""], ""Species"": [""10090""], ""TextLocation"": [""Abstract""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,40413,20343,2015.0,25681350,False,False,False,"In contrast to astrocytes and U373 cells, we found that basal expression of YKL-40 and RelB mRNA was very high in primary human chondrocytes and not stimulated by IL-1 or OSM (Supplementary Fig 3).",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Cell"": [""chondrocyte""], ""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,1854,4766,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,11589,2452,2011.0,20847424,False,False,False,"In a direct investigation of the acute effects of extracellular and intracellular Abeta42 peptides on synaptic transmission, Moreno et al. [194] noticed inhibition of synaptic transmission by nanomolar concentrations of intra-axonal oligomeric Abeta42, but not oligomeric Abeta40 or extracellular oligomeric Abeta42",#63:30,PMC3079354,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2011-06-09"", ""ref"": ""20847424"", ""pub_year"": 2011, ""last_author"": ""Brewer GJ"", ""type"": ""PubMed"", ""author_list"": [""Parihar MS"", ""Brewer GJ""], ""title"": ""Amyloid-\u03b2 as a modulator of synaptic plasticity."", ""doi"": ""10.3233/JAD-2010-101020""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Axons""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Neuronal Plasticity"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,35124,21246,2019.0,30562574,False,False,False,"Moreover, assessment of cell survival by nuclear counts assay carried out at the same time-point, revealed no detectable cytotoxicity stemming from LAMP2A down-regulation (Fig. 1C). To exclude any aberrant effects that might precede cell death per se, but might still confound our analysis, we measured gross levels of two established neuronal markers: the axon-associated tubulin beta-3 chain (TUBB3/TUJ-1) (Fig. 1D), and the dendritic marker microtubule- associated protein 2(MAP2) (Fig. 1E) - both of which showed no significant changes.",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,14488,7161,2010.0,20170836,False,False,False,"A recent report by Green and colleagues3 presents the results of this phase 3 trial of tarenflurbil in patients with mild Alzheimer's disease, in which there were no significant effects on any of the primary endpoints",#59:5,,"{""full_journal_name"": ""The Lancet. Neurology"", ""pub_date"": ""2010-03-19"", ""ref"": ""20170836"", ""pub_year"": 2010, ""last_author"": ""Vellas B"", ""type"": ""PubMed"", ""author_list"": [""Vellas B""], ""title"": ""Tarenflurbil for Alzheimer's disease: a \""shot on goal\"" that missed."", ""doi"": ""10.1016/S1474-4422(10)70030-2""}","{""DiseaseState"": [""Mild AD""], ""FDASTATUS"": [""Phase 3""], ""Subgraph"": [""Inflammatory response subgraph""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Clinical Trials, Phase III as Topic"", ""Flurbiprofen"", ""Goals"", ""Humans""], ""substances"": [""tarenflurbil"", ""Flurbiprofen""]}",False
CAUSES_NO_CHANGE,7260,20593,2009.0,18986241,False,False,False,"Cortical and CBF neurons display NFT formation in the MCI brain [9,139,140], suggesting a concomitant alteration in tau gene expression during the early stage of AD. The adult human brain contains six tau isoforms ranging from 48 to 67 kDa, which are expressed through alternative splicing of a single tau gene on chromosome 17 [141,142]. Three of these tau isoforms contain three tandem repeats in the carboxy-terminus end of the molecule (3Rtau), while three isoforms display four tandem repeats (4Rtau) in this region. Expression levels of the six tau transcripts within CBF neurons do not differ significantly during the progression of AD [6]",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""Disease"": [""Alzheimer's disease""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Cholinergic Neurons""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,11474,2666,2010.0,20392114,False,False,False,"Finally,to evaluate possible major toxicities associated with the ATPZs, all test compounds were evaluated in a cytotoxicity assay that employs rapidly dividing HEK293. All compounds were found to be nontoxic at 100 microM.",#61:0,PMC2872922,"{""full_journal_name"": ""Journal of medicinal chemistry"", ""pub_date"": ""2010-06-11"", ""ref"": ""20392114"", ""pub_year"": 2010, ""last_author"": ""Smith AB"", ""type"": ""PubMed"", ""author_list"": [""Ballatore C"", ""Brunden KR"", ""Piscitelli F"", ""James MJ"", ""Crowe A"", ""Yao Y"", ""Hyde E"", ""Trojanowski JQ"", ""Lee VM"", ""Smith AB""], ""title"": ""Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation."", ""doi"": ""10.1021/jm100138f""}","{""Assay"": [""cytotoxicity assay""], ""CellLine"": [""HEK293""], ""TextLocation"": [""Results""], ""mesh"": [""Administration, Oral"", ""Animals"", ""Biological Availability"", ""Blood-Brain Barrier"", ""Drug Discovery"", ""Mice"", ""Protein Multimerization"", ""Pyridazines"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Pyridazines"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,11702,1411,2018.0,30027901,False,False,False,"Coenzyme Q10, a principle mitochondrial cofactor involved in complex-I activity has been studied as a neuroprotective agent in HD animal models (Matthews et al. 1998). In a multicentre, parallel group, double blind, randomized clinical trial on coenzyme Q10 along with ramacemide (NMDA antagonist) in early HD patients, conducted by Huntington Study Group (2001), neither remacemide nor coenzymeQ10, produced significant slowing in functional decline in early HD even after 30 months. To add to these negative data, there was an increased frequency of nausea, vomiting and dizziness with remacemide; and increased frequency of stomach upset with coenzyme Q10.",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,14403,2361,2011.0,21745645,False,False,False,"The LTP induced by the preceding SO stimulation (100 ms) was completely blocked by MLA (10 nM), whereas DHβE (1 μM) and atropine (5 μM) were ineffective(Figure 2A).Similarly the induction of STD by SO 10 ms before SC was also blocked by MLA, with DHβE and atropine also having no effect(Figure 2B).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Anatomy"": [""hippocampus stratum oriens""], ""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Custom_Anatomy"": [""schaffer collaterals""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""100 milliseconds""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,44081,6573,2015.0,25437566,False,False,False,"These included all subunits of the CCT/TRiC complex (except CCT5); HSP40 and HSP70 family members DNAJA1 (HDJ-2), DNAJA4, HSPA8 (HSC70), and HSPA14 (Figures 5B and 5C); and the TPR-domain APC/C subunits CDC23 and CDC27 that, upon knockdown, led to signiﬁcantly elevated aggregation (Figure S5B).",#68:29,PMC4255334,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2015-07-23"", ""ref"": ""25437566"", ""pub_year"": 2015, ""last_author"": ""Morimoto RI"", ""type"": ""PubMed"", ""author_list"": [""Brehme M"", ""Voisine C"", ""Rolland T"", ""Wachi S"", ""Soper JH"", ""Zhu Y"", ""Orton K"", ""Villella A"", ""Garza D"", ""Vidal M"", ""Ge H"", ""Morimoto RI""], ""title"": ""A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease."", ""doi"": ""10.1016/j.celrep.2014.09.042""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain""], ""MeSHDisease"": [""Alzheimer Disease"", ""Huntington Disease"", ""Parkinson Disease""], ""mesh"": [""Aging"", ""Animals"", ""Brain"", ""Caenorhabditis elegans"", ""Disease Models, Animal"", ""Gene Regulatory Networks"", ""Humans"", ""Huntingtin Protein"", ""Models, Biological"", ""Molecular Chaperones"", ""Nerve Tissue Proteins"", ""Neurodegenerative Diseases"", ""Protein Aggregation, Pathological"", ""Protein Folding"", ""Proteostasis Deficiencies""], ""substances"": [""HTT protein, human"", ""Huntingtin Protein"", ""Molecular Chaperones"", ""Nerve Tissue Proteins""]}",False
CAUSES_NO_CHANGE,11044,5120,2011.0,21734277,False,False,False,"Consistent with our model, Δ144 –273 tau monomers significantly inhibited anterograde FAT (Fig. 6 B, C), while retrograde FAT remained unaffected (Fig. 6 B, D).",#69:76,PMC3391724,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2011-09-09"", ""ref"": ""21734277"", ""pub_year"": 2011, ""last_author"": ""Binder LI"", ""type"": ""PubMed"", ""author_list"": [""Kanaan NM"", ""Morfini GA"", ""LaPointe NE"", ""Pigino GF"", ""Patterson KR"", ""Song Y"", ""Andreadis A"", ""Fu Y"", ""Brady ST"", ""Binder LI""], ""title"": ""Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases."", ""doi"": ""10.1523/JNEUROSCI.0560-11.2011""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Axonal Transport"", ""Axons"", ""Brain"", ""Decapodiformes"", ""Enzyme Inhibitors"", ""Enzyme-Linked Immunosorbent Assay"", ""Glycogen Synthase Kinase 3"", ""Humans"", ""In Vitro Techniques"", ""Kinesins"", ""Models, Biological"", ""Mutagenesis"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Phosphotransferases"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Enzyme Inhibitors"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""tau Proteins"", ""neuropeptide Y4 receptor"", ""Phosphotransferases"", ""Glycogen Synthase Kinase 3"", ""Kinesins""]}",False
CAUSES_NO_CHANGE,6753,35432,2017.0,28148553,False,False,False,"Consistent with previous work (Bruch et al, 2014), annonacin increased 4R tau, but not 3R tau levels, both at the protein and mRNA level (Fig 3A, D and E). The PERK activator reduced the amount of 4R tau mRNA and protein, and almost completely reversed the effect of annonacin on the 3R/4R ratio (Fig 3A, D and E).",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,37138,1754,2018.0,28528849,False,False,False,"By contrast, there was no significant increase in the calcium level in cells treated with TauRDΔK monomers even at higher concentration (10 mM) (Fig. 5E and F, green curves).",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""Medium""], ""Species"": [""10116""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,1976,7229,2018.0,30027901,False,False,False,"In another study, 18 patients with Huntington’s chorea were examined before and after treatment with three neuroleptic drugs, pimozide, haloperidol and tiapride. Pimozide and haloperidol gave relief from hyperkinesias but none of the drug improved motor performance significantly (Girotti et al. 1984).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,1682,11171,2015.0,25125464,False,False,False,"CRF-OE mice had significantly elevated tau-P compared to wild type (WT) mice at the AT8 (S202/T204), PHF-1 (S396/404), S262, and S422 sites. Treating CRF-OE mice with R121919 blocked phosphorylation at the AT8 (S202/T204) and PHF-1 (S396/404) sites, but not at the S262 and S422 sites and reduced phosphorylation of c-Jun N Terminal Kinase (JNK).",#60:23,PMC4258165,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-08-21"", ""ref"": ""25125464"", ""pub_year"": 2015, ""last_author"": ""Rissman RA"", ""type"": ""PubMed"", ""author_list"": [""Campbell SN"", ""Zhang C"", ""Monte L"", ""Roe AD"", ""Rice KC"", ""Tach\u00e9 Y"", ""Masliah E"", ""Rissman RA""], ""title"": ""Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor."", ""doi"": ""10.3233/JAD-141281""}","{""Anatomy"": [""hippocampal formation""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Corticotropin-Releasing Hormone"", ""Hippocampus"", ""Mice"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Aggregation, Pathological"", ""Receptors, Corticotropin-Releasing Hormone"", ""tau Proteins""], ""substances"": [""Receptors, Corticotropin-Releasing Hormone"", ""tau Proteins"", ""CRF receptor type 1"", ""Corticotropin-Releasing Hormone""]}",False
CAUSES_NO_CHANGE,7085,43823,2016.0,23393546,False,False,False,"We did not detect any changes in the levels of Htt protein or localization in the R6/2 mouse model suggesting that the mechanism is not mediated through clearance pathways (Figure 9, and data not shown).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,11790,36135,2009.0,19237574,False,False,False,"We next studied the potential effect of metformin on the levels of 2 enzymes known to degrade Abeta, neprilysin and insulin-degrading enzyme (IDE). Metformin had no effect on both enzymes, including protein levels and their activities (Fig. S2 A and B). Moreover, metformin had no effect on Abeta degradation as measured by pulseâ€“chase assay (Fig. S2C). We also found that the increased Abeta production caused by metformin was not due to increased APP expression, because the total APP level was unaltered (Fig. 1D).",#59:5,PMC2656178,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2009-03-26"", ""ref"": ""19237574"", ""pub_year"": 2009, ""last_author"": ""Liao FF"", ""type"": ""PubMed"", ""author_list"": [""Chen Y"", ""Zhou K"", ""Wang R"", ""Liu Y"", ""Kwak YD"", ""Ma T"", ""Thompson RC"", ""Zhao Y"", ""Smith L"", ""Gasparini L"", ""Luo Z"", ""Xu H"", ""Liao FF""], ""title"": ""Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription."", ""doi"": ""10.1073/pnas.0807991106""}","{""Subgraph"": [""Insulin signal transduction""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Base Sequence"", ""Binding Sites"", ""Enzyme Activation"", ""Glucose"", ""Hypoglycemic Agents"", ""Insulin"", ""Metformin"", ""Mice"", ""Molecular Sequence Data"", ""Peptides"", ""Promoter Regions, Genetic"", ""Rats"", ""Signal Transduction"", ""Transcription, Genetic"", ""Up-Regulation""], ""substances"": [""Amyloid beta-Peptides"", ""Hypoglycemic Agents"", ""Insulin"", ""Peptides"", ""Metformin"", ""AMP-Activated Protein Kinases"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Glucose""]}",False
CAUSES_NO_CHANGE,35124,30857,2019.0,30562574,False,False,False,"LAMP2A down-regulation decreased total lysosomal proteolysis (NH4Cl- sensitive) as well as CMA-dependent proteolysis [(NH4Cl-3MA)-sensitive], without affecting macroautophagy-dependent (3MA-sensitive) proteolysis, further verifying the importance of LAMP2A as the ratelimiting step of the CMA pathway in this culture system (Suppl. Fig. 1A-C). LC3 lipidation and macroautophagic substrate SQSTM1/p62 abundance was similarly unchanged (Suppl. Fig. 1D).",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,6709,38837,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,1783,1222,2009.0,19293145,False,False,False,"The loss of nAChR subunits, as determined by [3H]- epibatidine binding, seems to take place after the transition from mild cognitive impairment (MCI) to AD (Sabbagh et al., 2006), although the loss of epibatidine binding did not correlate with decline in memory, cognitive performance, or with the development of neurofibrillary tangles or plaques (Sabbagh et al., 2001).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,14406,1501,,0,False,False,False,"Compared to age matched wild-type mice, 32 week-old Tg Tau P301S mice did not show spatial learning impairment in the RAWM (data not shown)",#68:7,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""10.4172/2168-975X.1000126"", ""title"": """", ""type"": ""DOI""}","{""Confidence"": [""High""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,1491,1604,2017.0,27794524,False,False,False,"In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,11566,43753,2020.0,30686764,False,False,False,"Inhibition of the respective non-sterol isoprenoid pathways (by geranyl- or farnesyl- transferase inhibitors GGTI-298 and FTI-227, respectively) did not significantly reduce pThr231Tau/ tTau (Figures 2C, S2F, and S2G).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,4177,11830,2017.0,27594586,False,False,False,The percentages of VGLUT1-positive excitatory and GABA-positive inhibitory neurons were similar in neuronal cultures differentiated from control and patient iPSCs (Figures S2B and S2C),#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,32311,41815,2015.0,25546293,False,False,False,"Our results in the human NPCs are supportive of this latter model as HDAC6 inhibition-induced increase in Lys49 acetylation was accompanied by increase in Ser45 phosphorylation but increased Ser45 phosphorylation was not accompanied by increased phosphorylation of Ser33, Ser37, and Thr41.",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,35177,20824,2015.0,25069841,False,False,False,Western blot analysis revealed no appreciable changes of APP levels in TFEB-injected wild-type or 5xFAD mice as compared to uninjected controls (Supplementary Fig S2A and B).,#72:5,PMC4197862,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2015-05-22"", ""ref"": ""25069841"", ""pub_year"": 2015, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Polito VA"", ""Li H"", ""Martini-Stoica H"", ""Wang B"", ""Yang L"", ""Xu Y"", ""Swartzlander DB"", ""Palmieri M"", ""di Ronza A"", ""Lee VM"", ""Sardiello M"", ""Ballabio A"", ""Zheng H""], ""title"": ""Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB."", ""doi"": ""10.15252/emmm.201303671""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyloid Neuropathies""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Gene Expression Regulation"", ""Lysosomes"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""PTEN Phosphohydrolase"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Mapt protein, mouse"", ""Tcfeb protein, mouse"", ""tau Proteins"", ""PTEN Phosphohydrolase"", ""Pten protein, mouse""]}",False
CAUSES_NO_CHANGE,41708,11151,2019.0,30935091,False,False,False,There was minimal S45 phosphorylation at baseline but increased K49 acetylation with HDAC6i was mirrored by increased S45 phosphorylation without any impact on phosphorylation of S33/S37/T41 [103].,#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,18566,28838,2017.0,27209302,False,False,False,"However, we proved that fAβ stimulation failed to inhibit mTORC1 activity which was previously reported to facilitate TFEB nuclear translocation (Fig. S2B), for the reason that fAβ stimulation could not inhibit the phorsphorylation status at specific sites of mTORC1 substrates as compared with the obvious inhibitory effects induced by mTORC1 inhibitor Torin1.",#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,14446,1287,2017.0,27956442,False,False,False,"There are a large number of phase III trials using agents such azathioprine, ciclosporin, β-interferon, dirucotide (myelin basic protein), immunoglobulins and cladribine, as well as other immunomodulators, in progressive MS that have been reported over the last 25 years. Unfortunately, the results have essentially been negative. [10]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,36416,16531,2013.0,23178521,False,False,False,"Following this 15 mins of stimulation with TNFa,an increased p65 NFkB phosphorylation (Mann–Whitney U=0,Z=-2.309,P=0.021) without a noticeable increase in STAT3 phosphorylation(Mann–Whitney U=7, Z=-0.289, P=0.773) was observed compared to the control conditions(Fig.1).",#70:21,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2013-06-10"", ""ref"": ""23178521"", ""pub_year"": 2013, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Abdullah L"", ""Bachmeier C"", ""Ait-Ghezala G"", ""Reed J"", ""Verma M"", ""Crawford F"", ""Mullan M""], ""title"": ""Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation."", ""doi"": ""10.1016/j.ejphar.2012.11.017""}","{""Assay"": [""western blot""], ""CellLine"": [""SH-SY5Y cell""], ""Custom_Timeline"": [""15 Minute""], ""Species"": [""9606""], ""TextLocation"": [""Results""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Animals"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Brain"", ""Cytokines"", ""HEK293 Cells"", ""Humans"", ""Inflammation"", ""Mice"", ""Mice, Inbred C57BL"", ""Phosphorylation"", ""Pyridines"", ""STAT3 Transcription Factor""], ""substances"": [""Alkaloids"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Cytokines"", ""Pyridines"", ""STAT3 Transcription Factor"", ""anatabine""]}",False
CAUSES_NO_CHANGE,40413,18455,2015.0,25681350,False,False,False,"In contrast to astrocytes and U373 cells, we found that basal expression of YKL-40 and RelB mRNA was very high in primary human chondrocytes and not stimulated by IL-1 or OSM (Supplementary Fig 3).",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Cell"": [""chondrocyte""], ""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,1854,19084,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,11508,20824,2014.0,24590577,False,False,False,"Administration of AF267B and AF102B (Cevimeline, EVOXACTM), an M1 mAChRselective agonist once prescribed for the treatment of Sjogren’s syndrome, decreases Abeta42 levels in the cerebral spinal fluid (CSF) of rabbits without affecting APP",#69:61,PMC5562652,"{""full_journal_name"": ""Neuroscience bulletin"", ""pub_date"": ""2014-12-03"", ""ref"": ""24590577"", ""pub_year"": 2014, ""last_author"": ""Zhang YW"", ""type"": ""PubMed"", ""author_list"": [""Jiang S"", ""Li Y"", ""Zhang C"", ""Zhao Y"", ""Bu G"", ""Xu H"", ""Zhang YW""], ""title"": ""M1 muscarinic acetylcholine receptor in Alzheimer's disease."", ""doi"": ""10.1007/s12264-013-1406-z""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""Receptor, Muscarinic M1""], ""substances"": [""Receptor, Muscarinic M1""]}",False
CAUSES_NO_CHANGE,32673,40878,2014.0,23164821,False,False,False,"Dkk4 and Dkk1 induced EGR1 (Figure 6b) and FOS (data not shown) whereas Dkk2 and Dkk3 did not, mirroring the abilities of the Dkk1 family to antagonise canonical wnt.",#59:5,PMC3873038,"{""full_journal_name"": ""Molecular psychiatry"", ""pub_date"": ""2014-08-26"", ""ref"": ""23164821"", ""pub_year"": 2014, ""last_author"": ""Lovestone S"", ""type"": ""PubMed"", ""author_list"": [""Killick R"", ""Ribe EM"", ""Al-Shawi R"", ""Malik B"", ""Hooper C"", ""Fernandes C"", ""Dobson R"", ""Nolan PM"", ""Lourdusamy A"", ""Furney S"", ""Lin K"", ""Breen G"", ""Wroe R"", ""To AW"", ""Leroy K"", ""Causevic M"", ""Usardi A"", ""Robinson M"", ""Noble W"", ""Williamson R"", ""Lunnon K"", ""Kellie S"", ""Reynolds CH"", ""Bazenet C"", ""Hodges A"", ""Brion JP"", ""Stephenson J"", ""Simons JP"", ""Lovestone S""], ""title"": ""Clusterin regulates \u03b2-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway."", ""doi"": ""10.1038/mp.2012.163""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""DKK1 subgraph"", ""Gamma secretase subgraph""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Clusterin"", ""Embryo, Mammalian"", ""Enzyme Inhibitors"", ""Female"", ""Gene Expression Regulation"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""MAP Kinase Signaling System"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""Rats"", ""Rats, Sprague-Dawley"", ""Wnt Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Clusterin"", ""DKK1 protein, human"", ""Enzyme Inhibitors"", ""Intercellular Signaling Peptides and Proteins"", ""Wnt Proteins""]}",False
CAUSES_NO_CHANGE,7260,13907,2009.0,18986241,False,False,False,"Conversely, M1 subunit gene expression in single CBF neurons is preserved during the progression of AD (Table 1) [119,126]. The M1 receptor is a most interesting drug target as it links several of the major hallmarks of this disorder, including cholinergic deficiency, cognitive dysfunctions, Ab and tau pathologies.",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""Disease"": [""Alzheimer's disease""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,25330,32340,2015.0,25116835,False,False,False,"In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",#67:28,PMC4150238,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2015-08-19"", ""ref"": ""25116835"", ""pub_year"": 2015, ""last_author"": ""Delabar JM"", ""type"": ""PubMed"", ""author_list"": [""Janel N"", ""Sarazin M"", ""Corlier F"", ""Corne H"", ""de Souza LC"", ""Hamelin L"", ""Aka A"", ""Lagarde J"", ""Blehaut H"", ""Hindi\u00e9 V"", ""Rain JC"", ""Arbones ML"", ""Dubois B"", ""Potier MC"", ""Bottlaender M"", ""Delabar JM""], ""title"": ""Plasma DYRK1A as a novel risk factor for Alzheimer's disease."", ""doi"": ""10.1038/tp.2014.61""}","{""Anatomy"": [""cerebrospinal fluid""], ""MeSHDisease"": [""Alzheimer Disease""], ""Published"": [""CDR story""], ""Subgraph"": [""DYRK1A subgraph""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Animals"", ""Biomarkers"", ""Brain"", ""Disease Models, Animal"", ""Female"", ""Genetic Association Studies"", ""Genetic Markers"", ""Humans"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Middle Aged"", ""Positron-Emission Tomography"", ""Predictive Value of Tests"", ""Protein Serine-Threonine Kinases"", ""Protein-Tyrosine Kinases""], ""substances"": [""Biomarkers"", ""Genetic Markers"", ""Dyrk kinase"", ""Protein-Tyrosine Kinases"", ""Protein Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,6938,1543,2017.0,27794524,False,False,False,"In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,1658,1897,2017.0,28148553,False,False,False,Total tau protein (HT7 antibody) was not altered by treatment with annonacin or the PERK activator (Fig 3A and D).,#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,23051,12467,2019.0,29590627,False,False,False,"These independent assays confirmed the same differential effects of the two inhibitors observed by live imaging of pHrodo-tau: at the 3-hr assay point, dynamin inhibition had no effect on the number of monomeric tau-Dylightpositive punctae within neurons, whereas inhibition of actin polymerization reduced the amount of intracellular tau by over half (Figure S6).",#57:66,PMC5896171,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2019-11-05"", ""ref"": ""29590627"", ""pub_year"": 2019, ""last_author"": ""Livesey FJ"", ""type"": ""PubMed"", ""author_list"": [""Evans LD"", ""Wassmer T"", ""Fraser G"", ""Smith J"", ""Perkinton M"", ""Billinton A"", ""Livesey FJ""], ""title"": ""Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways."", ""doi"": ""10.1016/j.celrep.2018.03.021""}","{""mesh"": [""Cerebral Cortex"", ""Dynamins"", ""Endocytosis"", ""Human Embryonic Stem Cells"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregation, Pathological"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,11813,7229,2018.0,30027901,False,False,False,"In another study, 18 patients with Huntington’s chorea were examined before and after treatment with three neuroleptic drugs, pimozide, haloperidol and tiapride. Pimozide and haloperidol gave relief from hyperkinesias but none of the drug improved motor performance significantly (Girotti et al. 1984).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,25391,3242,2014.0,24227736,False,False,False,Treatment with interferons (IFN-γ or IFN-α) did not change Siglece transcription as determined by qRT-PCR (data not shown) but slightly increased the cell-surface expression of Siglec-E (Fig. 1B).,#57:0,PMC3828472,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2014-01-06"", ""ref"": ""24227736"", ""pub_year"": 2014, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Claude J"", ""Linnartz-Gerlach B"", ""Kudin AP"", ""Kunz WS"", ""Neumann H""], ""title"": ""Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst."", ""doi"": ""10.1523/JNEUROSCI.2211-13.2013""}","{""Assay"": [""qRT-PCR""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cells, Cultured"", ""Coculture Techniques"", ""Female"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Microglia"", ""Neurons"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Protein Binding"", ""Respiratory Burst"", ""Sialic Acid Binding Ig-like Lectin 3""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cd33 protein, mouse"", ""Neuroprotective Agents"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Siglece protein, mouse""]}",False
CAUSES_NO_CHANGE,6595,5367,2018.0,30027901,False,False,False,"Verbessem and colleagues treated 26 HD patients with 5mg/kg creatine and 15 patients with placebo for one year and found no significant differences in measures of strength, neurological status, or cognitive function (Verbessem et al. 2003).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,11492,21816,2011.0,21745645,False,False,False,"When cholinergic input was activated 10 ms before SC stimulation, STD was induced, which was also sensitive to MLA but not to DHβE or atropine (Figures 5J and 5H).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""10 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,35124,12060,2019.0,30562574,False,False,False,"LAMP2A down-regulation decreased total lysosomal proteolysis (NH4Cl- sensitive) as well as CMA-dependent proteolysis [(NH4Cl-3MA)-sensitive], without affecting macroautophagy-dependent (3MA-sensitive) proteolysis, further verifying the importance of LAMP2A as the ratelimiting step of the CMA pathway in this culture system (Suppl. Fig. 1A-C). LC3 lipidation and macroautophagic substrate SQSTM1/p62 abundance was similarly unchanged (Suppl. Fig. 1D).",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,6709,38523,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,11699,11956,2009.0,19126755,False,False,False,"In contrast, the NMDA receptor antagonist 7-chloro-KYNA has no significant ef- fect on the extracellular levels of dopamine in the rat striatum (391).",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Corpus Striatum""], ""Species"": [""10116""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,41520,1609,2019.0,30008470,False,False,False,"Importantly, Adnp+/− females showed higher alcohol consumption and preference, compared to female Adnp+/+ controls, whereas no difference was observed in males.",#65:46,PMC6300527,"{""full_journal_name"": ""Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"", ""pub_date"": ""2019-02-11"", ""ref"": ""30008470"", ""pub_year"": 2019, ""last_author"": ""Barak S"", ""type"": ""PubMed"", ""author_list"": [""Ziv Y"", ""Rahamim N"", ""Lezmy N"", ""Even-Chen O"", ""Shaham O"", ""Malishkevich A"", ""Giladi E"", ""Elkon R"", ""Gozes I"", ""Barak S""], ""title"": ""Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice."", ""doi"": ""10.1038/s41386-018-0132-7""}","{""Confidence"": [""High""], ""Gender"": [""Male""], ""Species"": [""10090""], ""mesh"": [""Alcohol Drinking"", ""Animals"", ""Disease Models, Animal"", ""Ethanol"", ""Female"", ""Gene Expression"", ""Haploinsufficiency"", ""Hippocampus"", ""Homeodomain Proteins"", ""Male"", ""Mice"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Sex Factors""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Ethanol""]}",False
CAUSES_NO_CHANGE,21756,7623,2012.0,22040696,False,False,False,"Furthermore, nicotinic stimulation rapidly induced SNARE-dependent vesicular endocytosis accompanied by receptor internalization [166]. However, the number of surface α7 AChRs was not modiﬁed since a SNARE- dependent pro- cess also recruited receptors to the cell surface from internal pools (Fig. 5).",#60:6,,"{""full_journal_name"": ""Biochimica et biophysica acta"", ""pub_date"": ""2012-04-24"", ""ref"": ""22040696"", ""pub_year"": 2012, ""last_author"": ""Barrantes FJ"", ""type"": ""PubMed"", ""author_list"": [""Vall\u00e9s AS"", ""Barrantes FJ""], ""title"": ""Chaperoning \u03b17 neuronal nicotinic acetylcholine receptors."", ""doi"": ""10.1016/j.bbamem.2011.10.012""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Caenorhabditis elegans"", ""Caenorhabditis elegans Proteins"", ""Gene Expression Regulation"", ""Humans"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Chaperones"", ""Protein Transport"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Caenorhabditis elegans Proteins"", ""Chrna7 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Chaperones"", ""RIC3 protein, human"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""ric-3 protein, C elegans""]}",False
CAUSES_NO_CHANGE,5394,2728,2020.0,30967783,False,False,False,"However, speciﬁc deletion of MHCII in microglia does not aﬀect disease progression,suggesting that microglia are not important in reactivating eﬃcient T cells in the CNS (Wolf et al., 2018).",#70:13,PMC6438858,"{""full_journal_name"": ""Frontiers in pharmacology"", ""pub_date"": ""2020-09-30"", ""ref"": ""30967783"", ""pub_year"": 2020, ""last_author"": ""He Q"", ""type"": ""PubMed"", ""author_list"": [""Wang J"", ""Wang J"", ""Wang J"", ""Yang B"", ""Weng Q"", ""He Q""], ""title"": ""Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis."", ""doi"": ""10.3389/fphar.2019.00286""}","{""Anatomy"": [""central nervous system""], ""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,6709,43505,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,7260,43610,2009.0,19293145,False,False,False,"Tg2576 mice expressing human Abeta show reduced [3H]cytisine binding (a label of nAChRs) in the cortex at 17 months after birth (Apelt et al., 2002). In contrast, however, levels of alpha7 or alpha4 subunits were unchanged in double-mutant Swedish APP/PS-1 mice as determined by radiolabeled cytosine (alpha4beta2) or alpha-bungarotoxin (alpha7) binding (Marutle et al., 2002).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,42729,11995,2020.0,30515821,False,False,False,"In Shields et al.’s report, they found that mice lacking Drp1 in CA1 and other forebrain neurons had impaired synaptic transmission and memory leading to neuronal cell death followed by swelling mitochondria but no change in the number of mitochondria in individual synaptic terminals.",#65:66,,"{""full_journal_name"": ""Journal of cellular physiology"", ""pub_date"": ""2020-05-04"", ""ref"": ""30515821"", ""pub_year"": 2020, ""last_author"": ""Chen L"", ""type"": ""PubMed"", ""author_list"": [""Qi Z"", ""Huang Z"", ""Xie F"", ""Chen L""], ""title"": ""Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases."", ""doi"": ""10.1002/jcp.27866""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Basal Forebrain"", ""CA1 Region, Hippocampal""], ""Species"": [""10090""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Dynamins"", ""Humans"", ""Huntingtin Protein"", ""Mitochondria"", ""Mitochondrial Dynamics"", ""Nerve Degeneration"", ""Nervous System"", ""Neurodegenerative Diseases"", ""Protein Processing, Post-Translational"", ""Signal Transduction"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Huntingtin Protein"", ""tau Proteins"", ""DNM1L protein, human"", ""Dnm1l protein, mouse"", ""Dynamins""]}",False
CAUSES_NO_CHANGE,35177,2306,2015.0,25069841,False,False,False,"Because the uninjected and injected wildtype mice exhibited similar behavioral performance, we collected parallel recordings only on the uninjected group.",#72:5,PMC4197862,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2015-05-22"", ""ref"": ""25069841"", ""pub_year"": 2015, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Polito VA"", ""Li H"", ""Martini-Stoica H"", ""Wang B"", ""Yang L"", ""Xu Y"", ""Swartzlander DB"", ""Palmieri M"", ""di Ronza A"", ""Lee VM"", ""Sardiello M"", ""Ballabio A"", ""Zheng H""], ""title"": ""Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB."", ""doi"": ""10.15252/emmm.201303671""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyloid Neuropathies""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Gene Expression Regulation"", ""Lysosomes"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""PTEN Phosphohydrolase"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Mapt protein, mouse"", ""Tcfeb protein, mouse"", ""tau Proteins"", ""PTEN Phosphohydrolase"", ""Pten protein, mouse""]}",False
CAUSES_NO_CHANGE,2017,7335,2018.0,28843454,False,False,False,"Despite this, oral tobacco use has not been associated with elevated risk for MS, which suggests that nicotine is not the responsible agent (39).",#58:12,,"{""full_journal_name"": ""Pediatric neurology"", ""pub_date"": ""2018-05-17"", ""ref"": ""28843454"", ""pub_year"": 2018, ""last_author"": ""Brenton JN"", ""type"": ""PubMed"", ""author_list"": [""Cappa R"", ""Theroux L"", ""Brenton JN""], ""title"": ""Pediatric Multiple Sclerosis: Genes, Environment, and a Comprehensive Therapeutic Approach."", ""doi"": ""10.1016/j.pediatrneurol.2017.07.005""}","{""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Environment"", ""Environmental Exposure"", ""Genome-Wide Association Study"", ""Humans"", ""Multiple Sclerosis"", ""Pediatrics""]}",False
CAUSES_NO_CHANGE,6709,34489,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,6901,40435,2012.0,22419736,False,False,False,"Interestingly, treatment with Ab42 decreased the phosphorylation of AMPK at Thr172, whereas the total amount of AMPK was not altered in primary cortical neurons",#72:19,,"{""full_journal_name"": ""Human molecular genetics"", ""pub_date"": ""2012-10-09"", ""ref"": ""22419736"", ""pub_year"": 2012, ""last_author"": ""Jung YK"", ""type"": ""PubMed"", ""author_list"": [""Park H"", ""Kam TI"", ""Kim Y"", ""Choi H"", ""Gwon Y"", ""Kim C"", ""Koh JY"", ""Jung YK""], ""title"": ""Neuropathogenic role of adenylate kinase-1 in A\u03b2-mediated tau phosphorylation via AMPK and GSK3\u03b2."", ""doi"": ""10.1093/hmg/dds100""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Neurons""], ""mesh"": [""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Genetically Modified"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Drosophila"", ""Drosophila Proteins"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Green Fluorescent Proteins"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microscopy, Fluorescence"", ""Neurodegenerative Diseases"", ""Neurons"", ""Peptide Fragments"", ""Phosphorylation"", ""RNA Interference"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Drosophila Proteins"", ""Peptide Fragments"", ""amyloid beta-protein (1-42)"", ""tau Proteins"", ""Green Fluorescent Proteins"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""AMP-Activated Protein Kinases"", ""Adenylate Kinase"", ""adenylate kinase 1""]}",False
CAUSES_NO_CHANGE,1697,3798,2019.0,30935091,False,False,False,"The antidepressant-like effects of 5-HT2A receptor antagonist ketanserin and the SSRI fluoxetine in rats were accompanied by increase in the membrane fraction of β-catenin and a parallel increase in N-cadherin, but without any change in levels of nuclear β-catenin [122].",#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""Species"": [""10116""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,14319,20982,2017.0,27209302,False,False,False,"As we expected, in contrast with wildtype TFEB (TFEB-WT), acetylation level of K116R mutant (TFEB-K116R) can no longer be elevated by NAM treatment (Fig. 3E).",#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,2379,8521,2019.0,29255009,False,False,False,"Nevertheless, the lack of change in mTOR pathway gene expression suggests that FKBP1b’s genomic effects were not mediated by the mTOR pathway.",#57:36,PMC5783960,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2019-03-07"", ""ref"": ""29255009"", ""pub_year"": 2019, ""last_author"": ""Landfield PW"", ""type"": ""PubMed"", ""author_list"": [""Gant JC"", ""Blalock EM"", ""Chen KC"", ""Kadish I"", ""Thibault O"", ""Porter NM"", ""Landfield PW""], ""title"": {""#text"": ""FK506-Binding Protein 12.6/1b, a Negative Regulator of [Ca], Rescues Memory and Restores Genomic Regulation in the Hippocampus of Aging Rats."", ""sup"": ""2+""}, ""doi"": ""10.1523/JNEUROSCI.2234-17.2017""}","{""Confidence"": [""High""], ""mesh"": [""Aging"", ""Animals"", ""Calcium Signaling"", ""Gene Expression Regulation"", ""Hippocampus"", ""Male"", ""Memory"", ""Memory Disorders"", ""Rats"", ""Rats, Inbred F344"", ""Rats, Transgenic"", ""Tacrolimus Binding Proteins""], ""substances"": [""FKBP1b protein, rat"", ""Tacrolimus Binding Proteins""]}",False
CAUSES_NO_CHANGE,41600,25454,2017.0,28148553,False,False,False,"None of the lentiviral models significantly increased PERK or pPERK, showing that tau overload per se is not sufficient to activate the UPR.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,39699,21540,2018.0,29202785,False,False,False,"The antiaggregant TauRDΔKPP slices had ramified form of microglia with 6-7 branches on an average indicating that the microglial cells were in their normal physiologically active form and there is no sign of inflammation (Fig 3d, bars 1 and 2).",#59:39,PMC5715613,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2018-10-18"", ""ref"": ""29202785"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Joseph M"", ""Anglada-Huguet M"", ""Paesler K"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Anti-aggregant tau mutant promotes neurogenesis."", ""doi"": ""10.1186/s13024-017-0230-8""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Amino Acid Motifs"", ""Animals"", ""Astrocytes"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutant Proteins"", ""Neural Stem Cells"", ""Neurogenesis"", ""Proline"", ""Protein Aggregation, Pathological"", ""Protein Conformation"", ""Protein Conformation, beta-Strand"", ""Protein Domains"", ""Repetitive Sequences, Amino Acid"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mutant Proteins"", ""tau Proteins"", ""Proline""]}",False
CAUSES_NO_CHANGE,19033,895,2013.0,23356410,False,False,False,"HDAC6 and tau co-localised within the perinuclear aggresome-like compartment, independently of the tubulin deacetylase activity of HDAC6.",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,34694,4941,2018.0,28528849,False,False,False,"Consistent with this, NeuN staining of the slices fixed after 48 hours of treatment with TauRDΔK oligomers revealed no reduction in the neuronal number in all regions of the hippocampus (CA1, CA3, and DG) (Fig. 3C and D, Supplementary Fig. 7), confirming that TauRDΔK oligomers do not cause cell death in the OHSC model as well.",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""CA1 Region, Hippocampal"", ""CA2 Region, Hippocampal"", ""CA3 Region, Hippocampal""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,11687,5288,2019.0,29687724,False,False,False,"Results from 2016 showed that pridopidine did not improve the motor symptoms of HD; however, there was a statistically significant improvement in the Total Functional Capacity score, which could be interpreted as delay in functional decline.[7]",#61:41,,"{""full_journal_name"": ""Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists"", ""pub_date"": ""2019-04-05"", ""ref"": ""29687724"", ""pub_year"": 2019, ""last_author"": ""Looi JC"", ""type"": ""PubMed"", ""author_list"": [""Loi SM"", ""Walterfang M"", ""Velakoulis D"", ""Looi JC""], ""title"": ""Huntington's disease: Managing neuropsychiatric symptoms in Huntington's disease."", ""doi"": ""10.1177/1039856218766120""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Huntington Disease""], ""mesh"": [""Behavioral Symptoms"", ""Bipolar Disorder"", ""Humans"", ""Huntington Disease"", ""Mood Disorders"", ""Psychiatric Rehabilitation"", ""Psychotherapy"", ""Psychotic Disorders""]}",False
CAUSES_NO_CHANGE,1638,34507,2017.0,27429982,False,False,False,CX3CL1 is expressed with particularly high levels in hippocampal and cortical neurons constitutively but none on microglia [15].,#57:0,PMC4939332,"{""full_journal_name"": ""BioMed research international"", ""pub_date"": ""2017-02-22"", ""ref"": ""27429982"", ""pub_year"": 2017, ""last_author"": ""Yin M"", ""type"": ""PubMed"", ""author_list"": [""Chen P"", ""Zhao W"", ""Guo Y"", ""Xu J"", ""Yin M""], ""title"": ""CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection."", ""doi"": ""10.1155/2016/8090918""}","{""PublicationType"": [""Review""], ""Section"": [""CX3CL1/CX3CR1 and Microglia""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Chemokine CX3CL1"", ""Humans"", ""Microglia"", ""Neuronal Plasticity"", ""Neuroprotection"", ""Receptors, Chemokine""], ""substances"": [""Chemokine CX3CL1"", ""Receptors, Chemokine""]}",False
CAUSES_NO_CHANGE,39747,32340,2014.0,24189376,False,False,False,"Eleven AD patients and 7 healthy volunteers (HV) underwent combined [Â¹â�¸F]MK-9470 PET and [Â¹Â¹C]PIB PET scans to assess CBâ‚�R availability and amyloid deposition, respectively, and T1 volumetric MRI for partial volume correction. We found no difference in CBâ‚�R availability between AD and HV, VOI-based fractional uptake values (FUR) were 0.043Â±0.01 for AD and 0.045Â±0.01 for controls (p=0.9). CBâ‚�R availability did not correlate with neuropsychological test scores and was not modulated by ApoE genotype. As expected, global [Â¹Â¹C]PIB SUVR (standardized uptake value ratio) was increased in AD (SUVR 1.9Â±0.3) compared to HV (1.2Â±0.1) with p<0.001, but no correlation was found between amyloid beta (Abeta) deposition and CBâ‚�R availability.",#64:9,,"{""full_journal_name"": ""European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology"", ""pub_date"": ""2014-10-21"", ""ref"": ""24189376"", ""pub_year"": 2014, ""last_author"": ""Vandenbulcke M"", ""type"": ""PubMed"", ""author_list"": [""Ahmad R"", ""Goffin K"", ""Van den Stock J"", ""De Winter FL"", ""Cleeren E"", ""Bormans G"", ""Tournoy J"", ""Persoons P"", ""Van Laere K"", ""Vandenbulcke M""], ""title"": ""In vivo type 1 cannabinoid receptor availability in Alzheimer's disease."", ""doi"": ""10.1016/j.euroneuro.2013.10.002""}","{""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Aniline Compounds"", ""Apolipoproteins E"", ""Benzothiazoles"", ""Brain"", ""Cognition"", ""Female"", ""Humans"", ""Magnetic Resonance Imaging"", ""Male"", ""Middle Aged"", ""Neuropsychological Tests"", ""Positron-Emission Tomography"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptor, Cannabinoid, CB1"", ""Thiazoles""], ""substances"": [""2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole"", ""Amyloid beta-Peptides"", ""Aniline Compounds"", ""Apolipoproteins E"", ""Benzothiazoles"", ""CNR1 protein, human"", ""MK-9470"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptor, Cannabinoid, CB1"", ""Thiazoles""]}",False
CAUSES_NO_CHANGE,7313,646,2015.0,25639674,False,False,False,"In a study carried out on adult post-mortem autistic brains using quantitative RT-PCR for measuring mRNA expression together with protein level expression and specific radioligand receptor binding, it was found that there was a decrease of 40–50% in the expression of the α3, α4, and β2 nAChR subunits in the cerebral cortex, while there was no change in the expression of the α7 subunit [120].",#60:18,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""MeSHAnatomy"": [""Brain"", ""Cerebral Cortex""], ""MeSHDisease"": [""Autism Spectrum Disorder""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,23414,33314,2017.0,28148553,False,False,False,"In the presence of annonacin (Fig EV2D and E), the PERK activator increased pNRF2, but not pEIF2A; the PERK inhibitor reduced pEIF2A levels significantly.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Cell"": [""neuroblast""], ""CellLine"": [""immortal human fetal membrane-derived cell line cell""], ""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
CAUSES_NO_CHANGE,41851,5120,2011.0,21734277,False,False,False,Neither 6D nor 6P tau (Fig. 2D) had an effect on retrograde FAT,#69:76,PMC3391724,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2011-09-09"", ""ref"": ""21734277"", ""pub_year"": 2011, ""last_author"": ""Binder LI"", ""type"": ""PubMed"", ""author_list"": [""Kanaan NM"", ""Morfini GA"", ""LaPointe NE"", ""Pigino GF"", ""Patterson KR"", ""Song Y"", ""Andreadis A"", ""Fu Y"", ""Brady ST"", ""Binder LI""], ""title"": ""Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases."", ""doi"": ""10.1523/JNEUROSCI.0560-11.2011""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Axonal Transport"", ""Axons"", ""Brain"", ""Decapodiformes"", ""Enzyme Inhibitors"", ""Enzyme-Linked Immunosorbent Assay"", ""Glycogen Synthase Kinase 3"", ""Humans"", ""In Vitro Techniques"", ""Kinesins"", ""Models, Biological"", ""Mutagenesis"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Phosphotransferases"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Enzyme Inhibitors"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""tau Proteins"", ""neuropeptide Y4 receptor"", ""Phosphotransferases"", ""Glycogen Synthase Kinase 3"", ""Kinesins""]}",False
CAUSES_NO_CHANGE,1854,21547,,0,False,False,False,"Paroxetine hydrochloride and paroxetine mesylate belong to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize a- or Abeta-adrenergic, dopamine D2 or histamine H1 receptors. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""DB00715"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,7464,13752,2019.0,30562574,False,False,False,"As Park7/DJ1 mRNA levels were unchanged this stemmed from accelerated protein clearance (Fig. 3B). When we assessed the impact of LAMP2A overexpression on PARK7/DJ-1 abundance in the same cellular system, we found a significant increase(50±15%) of PARK7/DJ-1 protein levels compared to the control EGFP-treated cultures (Fig. 3C)",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,3830,5448,2018.0,27176073,False,False,False,"More specifically, carriers of BamI and TaqI polymorphisms presented with worse cognitive functioning unlike carrier of the ApaI variant. Examination of ApaI and TaqI gene polymorphisms in 255 AD cases and 260 cognitively screened elderly controls revealed that the presence of each of these haplotypes was associated with the risk of AD.",#59:5,PMC4969697,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2018-01-25"", ""ref"": ""27176073"", ""pub_year"": 2018, ""last_author"": ""F\u00e9ron F"", ""type"": ""PubMed"", ""author_list"": [""Landel V"", ""Annweiler C"", ""Millet P"", ""Morello M"", ""F\u00e9ron F""], ""title"": ""Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails."", ""doi"": ""10.3233/JAD-150943""}","{""Confidence"": [""High""], ""Subgraph"": [""Vitamin subgraph""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cognition Disorders"", ""Dietary Supplements"", ""Humans"", ""Vitamin D"", ""Vitamin D Deficiency""], ""substances"": [""Vitamin D""]}",False
CAUSES_NO_CHANGE,11784,23589,2016.0,25881725,False,False,False,"Also, no alterations in the expression of a7 nAChR mRNA were observed in pretreatment with normal saline or MLA in PHA- or Gal-treated groups (p>0.05). In the same way, the pattern of mRNA expression in the cortex (data not shown) was similar to the hippocampus (Fig. 7).",#61:66,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2016-03-21"", ""ref"": ""25881725"", ""pub_year"": 2016, ""last_author"": ""Shanehbandi D"", ""type"": ""PubMed"", ""author_list"": [""Sadigh-Eteghad S"", ""Talebi M"", ""Mahmoudi J"", ""Babri S"", ""Shanehbandi D""], ""title"": ""Selective activation of \u03b17 nicotinic acetylcholine receptor by PHA-543613 improves A\u03b225-35-mediated cognitive deficits in mice."", ""doi"": ""10.1016/j.neuroscience.2015.04.017""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Hippocampus""], ""Species"": [""10090""], ""mesh"": [""Aconitine"", ""Amyloid beta-Peptides"", ""Animals"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Cholinesterase Inhibitors"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Galantamine"", ""Gene Expression Regulation"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred BALB C"", ""Nicotinic Agonists"", ""Nicotinic Antagonists"", ""Peptide Fragments"", ""Psychomotor Performance"", ""Quinuclidines"", ""RNA, Messenger"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Cholinesterase Inhibitors"", ""N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide"", ""Nicotinic Agonists"", ""Nicotinic Antagonists"", ""Peptide Fragments"", ""Quinuclidines"", ""RNA, Messenger"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""amyloid beta-protein (25-35)"", ""Galantamine"", ""methyllycaconitine"", ""Aconitine""]}",False
CAUSES_NO_CHANGE,44629,12153,2007.0,17293005,False,False,False,"BI-1 treatment dose-dependently inhibited the release of both sAPPa and sAPPb in the conditioned medium (Figs. 2A and 3A). The 50% inhibitory concentrations (IC50) of BI-1 were about 1.5 mM for sAPPa and 0.9 mM for APPb, respectively. But BI-2, which is mainly composed of the core region BACE1 69–73, did not show the inhibitory effects",#62:77,,"{""full_journal_name"": ""Peptides"", ""pub_date"": ""2007-05-21"", ""ref"": ""17293005"", ""pub_year"": 2007, ""last_author"": ""Kim TY"", ""type"": ""PubMed"", ""author_list"": [""Yeon SW"", ""Jeon YJ"", ""Hwang EM"", ""Kim TY""], ""title"": ""Effects of peptides derived from BACE1 catalytic domain on APP processing.""}","{""mesh"": [""Alzheimer Disease"", ""Amino Acid Sequence"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Aspartic Acid Endopeptidases"", ""Blotting, Western"", ""Catalytic Domain"", ""Cell Line"", ""Humans"", ""Molecular Weight"", ""Peptides"", ""Protein Processing, Post-Translational""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Peptides"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,30983,25138,2017.0,28669544,False,False,False,"The decrease in PSD95 was significant despite no changes in MAP2 levels, indicative of a selective synapse loss rather than general neuronal death (Figures 4A and 4E).",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""Confidence"": [""High""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
CAUSES_NO_CHANGE,36269,21289,2017.0,28760828,False,False,False,"Of note, whereas mimicking acetylation at most non-KXGS sites had minimal impact on tau aggregation, K274Q also significantly decreased tau assembly in vitro, albeit to a lesser extent than K321Q (Fig. 1b).",#61:36,PMC5602388,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2017-09-27"", ""ref"": ""28760828"", ""pub_year"": 2017, ""last_author"": ""Cook C"", ""type"": ""PubMed"", ""author_list"": [""Carlomagno Y"", ""Chung DC"", ""Yue M"", ""Castanedes-Casey M"", ""Madden BJ"", ""Dunmore J"", ""Tong J"", ""DeTure M"", ""Dickson DW"", ""Petrucelli L"", ""Cook C""], ""title"": ""An acetylation-phosphorylation switch that regulates tau aggregation propensity and function."", ""doi"": ""10.1074/jbc.M117.794602""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Alzheimer Disease"", ""Amino Acid Substitution"", ""Animals"", ""Animals, Newborn"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Female"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lysine"", ""Male"", ""Mice, Transgenic"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Serine"", ""Tauopathies"", ""Tissue Banks"", ""tau Proteins""], ""substances"": [""Histone Deacetylase Inhibitors"", ""tau Proteins"", ""Serine"", ""HDAC6 protein, human"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,40844,5120,2011.0,21734277,False,False,False,"Soluble AT8 tau monomers inhibited anterograde FAT (Fig. 6 A, C), while retrograde trans- port was unaffected (Fig. 6 A, D). These data indicate that phosphorylation of tau at the AT8 epitope, which is associated with hyperphosphorylation of tau in AD and other tauopathies, renders soluble monomeric tau capable of inhibiting antero- grade FAT.",#69:76,PMC3391724,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2011-09-09"", ""ref"": ""21734277"", ""pub_year"": 2011, ""last_author"": ""Binder LI"", ""type"": ""PubMed"", ""author_list"": [""Kanaan NM"", ""Morfini GA"", ""LaPointe NE"", ""Pigino GF"", ""Patterson KR"", ""Song Y"", ""Andreadis A"", ""Fu Y"", ""Brady ST"", ""Binder LI""], ""title"": ""Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases."", ""doi"": ""10.1523/JNEUROSCI.0560-11.2011""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Axonal Transport"", ""Axons"", ""Brain"", ""Decapodiformes"", ""Enzyme Inhibitors"", ""Enzyme-Linked Immunosorbent Assay"", ""Glycogen Synthase Kinase 3"", ""Humans"", ""In Vitro Techniques"", ""Kinesins"", ""Models, Biological"", ""Mutagenesis"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Phosphotransferases"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Enzyme Inhibitors"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""tau Proteins"", ""neuropeptide Y4 receptor"", ""Phosphotransferases"", ""Glycogen Synthase Kinase 3"", ""Kinesins""]}",False
CAUSES_NO_CHANGE,41708,16660,2019.0,30935091,False,False,False,There was minimal S45 phosphorylation at baseline but increased K49 acetylation with HDAC6i was mirrored by increased S45 phosphorylation without any impact on phosphorylation of S33/S37/T41 [103].,#70:17,PMC6480207,"{""full_journal_name"": ""International journal of molecular sciences"", ""pub_date"": ""2019-07-26"", ""ref"": ""30935091"", ""pub_year"": 2019, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Xuan L"", ""Karmacharya R""], ""title"": ""HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons."", ""doi"": ""10.3390/ijms20071605""}","{""Confidence"": [""High""], ""mesh"": [""Cell Differentiation"", ""Hippocampus"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Humans"", ""Neurons"", ""Signal Transduction""], ""substances"": [""Histone Deacetylase Inhibitors"", ""Histone Deacetylase 6""]}",False
CAUSES_NO_CHANGE,1936,12380,2019.0,29686391,False,False,False,"Further, human iPS-derived neurons also showed a preference for smaller structures of tau, with fibrillized tau showing nearly no uptake (Fig. 1d)",#57:71,PMC5913225,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2019-10-22"", ""ref"": ""29686391"", ""pub_year"": 2019, ""last_author"": ""Kosik KS"", ""type"": ""PubMed"", ""author_list"": [""Rauch JN"", ""Chen JJ"", ""Sorum AW"", ""Miller GM"", ""Sharf T"", ""See SK"", ""Hsieh-Wilson LC"", ""Kampmann M"", ""Kosik KS""], ""title"": ""Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs)."", ""doi"": ""10.1038/s41598-018-24904-z""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""mesh"": [""Animals"", ""Brain"", ""CRISPR-Cas Systems"", ""Dynamin II"", ""Genomics"", ""Glioma"", ""Heparan Sulfate Proteoglycans"", ""Humans"", ""Mice"", ""N-Acetylglucosaminyltransferases"", ""Protein Structure, Quaternary"", ""Sulfotransferases"", ""Sulfur"", ""Tumor Cells, Cultured"", ""tau Proteins""], ""substances"": [""Heparan Sulfate Proteoglycans"", ""tau Proteins"", ""Sulfur"", ""N-Acetylglucosaminyltransferases"", ""exostosin-2"", ""Sulfotransferases"", ""heparan sulfate 6-O-sulfotransferase"", ""Dynamin II""]}",False
CAUSES_NO_CHANGE,3459,1650,2019.0,30046111,False,False,False,"Moreover, viral expression of mVEGF-C did not significantly affect the diameter of meningeal lymphatic vessels, the level of amyloid-β in the CSF, or amyloid-β deposition in the hippocampus (Extended Data Fig. 8g–n)",#67:25,PMC6085146,"{""full_journal_name"": ""Nature"", ""pub_date"": ""2019-02-08"", ""ref"": ""30046111"", ""pub_year"": 2019, ""last_author"": ""Kipnis J"", ""type"": ""PubMed"", ""author_list"": [""Da Mesquita S"", ""Louveau A"", ""Vaccari A"", ""Smirnov I"", ""Cornelison RC"", ""Kingsmore KM"", ""Contarino C"", ""Onengut-Gumuscu S"", ""Farber E"", ""Raper D"", ""Viar KE"", ""Powell RD"", ""Baker W"", ""Dabhi N"", ""Bai R"", ""Cao R"", ""Hu S"", ""Rich SS"", ""Munson JM"", ""Lopes MB"", ""Overall CC"", ""Acton ST"", ""Kipnis J""], ""title"": ""Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease."", ""doi"": ""10.1038/s41586-018-0368-8""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebrospinal Fluid"", ""Hippocampus""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid"", ""Amyloid beta-Peptides"", ""Animals"", ""Brain"", ""Cognition"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Extracellular Fluid"", ""Female"", ""Homeostasis"", ""Humans"", ""Lymph Nodes"", ""Lymphatic Vessels"", ""Male"", ""Meninges"", ""Mice"", ""Mice, Transgenic"", ""Perfusion""], ""substances"": [""Amyloid"", ""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,6709,40045,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,11749,2054,2020.0,30967783,False,False,False,"Inﬁltrating monocytes accumulate at the nodes of Ranvier during early stages of EAE and actively initiate the demyelination of axons (Yamasakietal.,2014), similar to microglia, but they do not aﬀect CNS- resident microglia (Ajami et al., 2011).",#70:13,PMC6438858,"{""full_journal_name"": ""Frontiers in pharmacology"", ""pub_date"": ""2020-09-30"", ""ref"": ""30967783"", ""pub_year"": 2020, ""last_author"": ""He Q"", ""type"": ""PubMed"", ""author_list"": [""Wang J"", ""Wang J"", ""Wang J"", ""Yang B"", ""Weng Q"", ""He Q""], ""title"": ""Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis."", ""doi"": ""10.3389/fphar.2019.00286""}","{""Anatomy"": [""central nervous system""], ""Confidence"": [""High""]}",False
CAUSES_NO_CHANGE,6709,32696,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,24127,2545,2014.0,24590577,False,False,False,"though there are contradictory findings showing that the alpha- secretase-mediated APP processing via M1 mAChR stimulation is not modulated by the ERK1/MEK cascade[71]. On the other hand, loss of M1 mAChR increases amyloidogenic APP processing in neurons and promotes brain Abeta plaque pathology in a mouse model of AD",#69:61,PMC5562652,"{""full_journal_name"": ""Neuroscience bulletin"", ""pub_date"": ""2014-12-03"", ""ref"": ""24590577"", ""pub_year"": 2014, ""last_author"": ""Zhang YW"", ""type"": ""PubMed"", ""author_list"": [""Jiang S"", ""Li Y"", ""Zhang C"", ""Zhao Y"", ""Bu G"", ""Xu H"", ""Zhang YW""], ""title"": ""M1 muscarinic acetylcholine receptor in Alzheimer's disease."", ""doi"": ""10.1007/s12264-013-1406-z""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""Receptor, Muscarinic M1""], ""substances"": [""Receptor, Muscarinic M1""]}",False
CAUSES_NO_CHANGE,14445,1650,2012.0,21958873,False,False,False,"Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",#71:26,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2012-02-27"", ""ref"": ""21958873"", ""pub_year"": 2012, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Bachmeier C"", ""Reed J"", ""Ait-Ghezala G"", ""Bishop A"", ""Chao J"", ""Mathura V"", ""Crawford F"", ""Mullan M""], ""title"": ""Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo."", ""doi"": ""10.1016/j.ejphar.2011.09.019""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Brain"", ""CHO Cells"", ""Cricetinae"", ""Cricetulus"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Humans"", ""Mice"", ""Mice, Transgenic"", ""NF-kappa B"", ""Pyridines""], ""substances"": [""Alkaloids"", ""Amyloid beta-Peptides"", ""NF-kappa B"", ""Pyridines"", ""anatabine"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human""]}",False
CAUSES_NO_CHANGE,35403,5300,2015.0,26088141,False,False,False,The findings confirm that the mutation in α7345–348A does not interfere with the trafficking or expression of the nAChR.,#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""Medium""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,6945,6707,2020.0,30686764,False,False,False,"24-Hydroxycholesterol (a direct downstream metabolite of cholesterol) was increased in media from efavirenz-treated neurons, was decreased in AY-9944-treated samples, and was unaltered in atorvastatin- and T0901317-treated neurons (Figure S2P).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,8165,43753,2017.0,27594586,False,False,False,"Moreover, the total expression levels of tau and PSD-95 were the same in 1-month-old neurons derived from control and patient iPSCs (Figure 1B)",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,3473,12053,2020.0,30606258,False,False,False,"We were unable to detect phosphorylation (activation) of inositol- requiring enzyme 1α (IRE1α) in any of the three cell lines and there were no differences in the total amount of IRE1α present (Fig. 6c, d), suggesting that this branch of the UPR is not activated by either Tau35 or FL-tau.",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,2721,7350,2019.0,29024336,False,False,False,The most notable difference between the two tau mutants was the inability of P301L to undergo degradation by CMA or by macroautophagy,#61:23,PMC5770880,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2019-07-30"", ""ref"": ""29024336"", ""pub_year"": 2019, ""last_author"": ""Cuervo AM"", ""type"": ""PubMed"", ""author_list"": [""Caballero B"", ""Wang Y"", ""Diaz A"", ""Tasset I"", ""Juste YR"", ""Stiller B"", ""Mandelkow EM"", ""Mandelkow E"", ""Cuervo AM""], ""title"": ""Interplay of pathogenic forms of human tau with different autophagic pathways."", ""doi"": ""10.1111/acel.12692""}","{""CellStructure"": [""Multivesicular Bodies""], ""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Brain""], ""mesh"": [""Animals"", ""Autophagy"", ""Brain"", ""Humans"", ""Male"", ""Mutation"", ""Neurodegenerative Diseases"", ""Neurons"", ""Phosphorylation"", ""Proteolysis"", ""Rats, Wistar"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
CAUSES_NO_CHANGE,33662,342,2013.0,23356410,False,False,False,"Moreover, the expression of the mammalian HDAC4 in the neuronal nuclei of the worm was able to impair neuronal function, but not in the cytosol, suggesting that HDAC4 could impair memory formation through inhibition of gene transcription [59].",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,43753,5108,2019.0,29238289,False,False,False,CSF tau in APP transgenic mice is increased in an age- dependent manner without a global neuronal loss,#57:25,PMC5712583,"{""full_journal_name"": ""Frontiers in neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""29238289"", ""pub_year"": 2020, ""last_author"": ""Yamada K"", ""type"": ""PubMed"", ""author_list"": [""Yamada K""], ""title"": ""Extracellular Tau and Its Potential Role in the Propagation of Tau Pathology."", ""doi"": ""10.3389/fnins.2017.00667""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,16786,1411,2018.0,30027901,False,False,False,"Coenzyme Q10, a principle mitochondrial cofactor involved in complex-I activity has been studied as a neuroprotective agent in HD animal models (Matthews et al. 1998). In a multicentre, parallel group, double blind, randomized clinical trial on coenzyme Q10 along with ramacemide (NMDA antagonist) in early HD patients, conducted by Huntington Study Group (2001), neither remacemide nor coenzymeQ10, produced significant slowing in functional decline in early HD even after 30 months. To add to these negative data, there was an increased frequency of nausea, vomiting and dizziness with remacemide; and increased frequency of stomach upset with coenzyme Q10.",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,37305,11926,2016.0,26582367,False,False,False,At the applied concentration of 1 μM amyloid-β1–42 alone had no neurite reducing effect (Fig. 7b).,#57:0,PMC4652165,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2016-09-12"", ""ref"": ""26582367"", ""pub_year"": 2016, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Shahraz A"", ""Kopatz J"", ""Mathy R"", ""Kappler J"", ""Winter D"", ""Kapoor S"", ""Sch\u00fctza V"", ""Scheper T"", ""Gieselmann V"", ""Neumann H""], ""title"": ""Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages."", ""doi"": ""10.1038/srep16800""}","{""MeSHAnatomy"": [""Neurons""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""TimePoint"": [""2 days""], ""mesh"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Cell Line"", ""Chromatography, High Pressure Liquid"", ""Homeostasis"", ""Humans"", ""Lectins"", ""Lipopolysaccharides"", ""Macrophages"", ""Membrane Proteins"", ""Microspheres"", ""Molecular Weight"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Polymerization"", ""Respiratory Burst"", ""Sialic Acids"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neuroprotective Agents"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""TNF protein, human"", ""Tumor Necrosis Factor-alpha"", ""polysialic acid""]}",False
CAUSES_NO_CHANGE,44564,6244,2009.0,19277525,False,False,False,This analysis further suggests that the B subunit may form a relatively stable complex with the isolated scaffold subunit and does not seem to support the notion that the catalytic subunit is required for interaction between the scaffold and the B subunits,#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""Medium""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,7161,21159,2013.0,21875409,False,False,False,"The APP ratio was slightly but not significantly decreased in AD patients, whereas CD40L and serotonin were unchanged.",#59:5,,"{""full_journal_name"": ""Current Alzheimer research"", ""pub_date"": ""2013-06-21"", ""ref"": ""21875409"", ""pub_year"": 2013, ""last_author"": ""Humpel C"", ""type"": ""PubMed"", ""author_list"": [""Hochstrasser T"", ""Ehrlich D"", ""Marksteiner J"", ""Sperner-Unterweger B"", ""Humpel C""], ""title"": ""Matrix metalloproteinase-2 and epidermal growth factor are decreased in platelets of Alzheimer patients.""}","{""Subgraph"": [""T cells signaling""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Biomarkers"", ""Blood Platelets"", ""Blotting, Western"", ""Chromatography, High Pressure Liquid"", ""Enzyme-Linked Immunosorbent Assay"", ""Epidermal Growth Factor"", ""Female"", ""Humans"", ""Immunohistochemistry"", ""Male"", ""Matrix Metalloproteinase 2""], ""substances"": [""Biomarkers"", ""Epidermal Growth Factor"", ""MMP2 protein, human"", ""Matrix Metalloproteinase 2""]}",False
CAUSES_NO_CHANGE,35124,30983,2019.0,30562574,False,False,False,"Moreover, assessment of cell survival by nuclear counts assay carried out at the same time-point, revealed no detectable cytotoxicity stemming from LAMP2A down-regulation (Fig. 1C). To exclude any aberrant effects that might precede cell death per se, but might still confound our analysis, we measured gross levels of two established neuronal markers: the axon-associated tubulin beta-3 chain (TUBB3/TUJ-1) (Fig. 1D), and the dendritic marker microtubule- associated protein 2(MAP2) (Fig. 1E) - both of which showed no significant changes.",#65:35,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2019-04-11"", ""ref"": ""30562574"", ""pub_year"": 2019, ""last_author"": ""Stefanis L"", ""type"": ""PubMed"", ""author_list"": [""Brekk OR"", ""Makridakis M"", ""Mavroeidi P"", ""Vlahou A"", ""Xilouri M"", ""Stefanis L""], ""title"": ""Impairment of chaperone-mediated autophagy affects neuronal homeostasis through altered expression of DJ-1 and CRMP-2 proteins."", ""doi"": ""10.1016/j.mcn.2018.12.006""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Autophagy"", ""Cells, Cultured"", ""Female"", ""HEK293 Cells"", ""Homeostasis"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""Neurons"", ""Protein Deglycase DJ-1"", ""Rats"", ""Rats, Wistar""], ""substances"": [""Intercellular Signaling Peptides and Proteins"", ""Lysosomal-Associated Membrane Protein 2"", ""Nerve Tissue Proteins"", ""collapsin response mediator protein-2"", ""PARK7 protein, rat"", ""Protein Deglycase DJ-1""]}",False
CAUSES_NO_CHANGE,34770,1488,2004.0,14657037,False,False,False,"XIAP expression in motor neurons significantly slows disease progression, whereas p35, a broad caspase inhibitory protein, does not. However, p35, which potently inhibits capase-3, does not slow disease progression in mouse ALS. There are two explanations for this apparent discrepancy. Since caspase-9 remains active in the presence of p35, procaspase-3 may be continuously processed into active caspase-3, finally overriding inhibition by p35. Alternatively, caspase-9 may utilize a substrate other than caspase-3, leading to caspase-3-independent cell death",#59:5,PMC291829,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2004-03-02"", ""ref"": ""14657037"", ""pub_year"": 2004, ""last_author"": ""Takahashi R"", ""type"": ""PubMed"", ""author_list"": [""Inoue H"", ""Tsukita K"", ""Iwasato T"", ""Suzuki Y"", ""Tomioka M"", ""Tateno M"", ""Nagao M"", ""Kawata A"", ""Saido TC"", ""Miura M"", ""Misawa H"", ""Itohara S"", ""Takahashi R""], ""title"": ""The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.""}","{""Species"": [""10090""], ""Subgraph"": [""Caspase subgraph"", ""Electron transport chain"", ""XIAP subgraph""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Base Sequence"", ""Cysteine Proteinase Inhibitors"", ""DNA Primers"", ""Disease Models, Animal"", ""Genotype"", ""Immunohistochemistry"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Proteins"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""Spinal Cord"", ""Superoxide Dismutase"", ""Superoxide Dismutase-1"", ""X-Linked Inhibitor of Apoptosis Protein""], ""substances"": [""Cysteine Proteinase Inhibitors"", ""DNA Primers"", ""Proteins"", ""SOD1 protein, human"", ""X-Linked Inhibitor of Apoptosis Protein"", ""Sod1 protein, mouse"", ""Superoxide Dismutase"", ""Superoxide Dismutase-1""]}",False
CAUSES_NO_CHANGE,2088,23589,2016.0,25881725,False,False,False,"Also, no alterations in the expression of a7 nAChR mRNA were observed in pretreatment with normal saline or MLA in PHA- or Gal-treated groups (p>0.05). In the same way, the pattern of mRNA expression in the cortex (data not shown) was similar to the hippocampus (Fig. 7).",#61:66,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2016-03-21"", ""ref"": ""25881725"", ""pub_year"": 2016, ""last_author"": ""Shanehbandi D"", ""type"": ""PubMed"", ""author_list"": [""Sadigh-Eteghad S"", ""Talebi M"", ""Mahmoudi J"", ""Babri S"", ""Shanehbandi D""], ""title"": ""Selective activation of \u03b17 nicotinic acetylcholine receptor by PHA-543613 improves A\u03b225-35-mediated cognitive deficits in mice."", ""doi"": ""10.1016/j.neuroscience.2015.04.017""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Hippocampus""], ""Species"": [""10090""], ""mesh"": [""Aconitine"", ""Amyloid beta-Peptides"", ""Animals"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Cholinesterase Inhibitors"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Galantamine"", ""Gene Expression Regulation"", ""Male"", ""Maze Learning"", ""Mice"", ""Mice, Inbred BALB C"", ""Nicotinic Agonists"", ""Nicotinic Antagonists"", ""Peptide Fragments"", ""Psychomotor Performance"", ""Quinuclidines"", ""RNA, Messenger"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Cholinesterase Inhibitors"", ""N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide"", ""Nicotinic Agonists"", ""Nicotinic Antagonists"", ""Peptide Fragments"", ""Quinuclidines"", ""RNA, Messenger"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""amyloid beta-protein (25-35)"", ""Galantamine"", ""methyllycaconitine"", ""Aconitine""]}",False
CAUSES_NO_CHANGE,6957,2452,2011.0,20847424,False,False,False,"In a direct investigation of the acute effects of extracellular and intracellular Aβ42 peptides on synaptic transmission, Moreno et al. [194] noticed inhibition of synaptic transmission by nanomolar concentrations of intra-axonal oligomeric Aβ42, but not oligomeric Aβ40 or extracellular oligomeric Aβ42",#63:63,PMC3079354,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2011-06-09"", ""ref"": ""20847424"", ""pub_year"": 2011, ""last_author"": ""Brewer GJ"", ""type"": ""PubMed"", ""author_list"": [""Parihar MS"", ""Brewer GJ""], ""title"": ""Amyloid-\u03b2 as a modulator of synaptic plasticity."", ""doi"": ""10.3233/JAD-2010-101020""}","{""MeSHAnatomy"": [""Axons""], ""MeSHDisease"": [""Hippocampus""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Neuronal Plasticity"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides""]}",False
CAUSES_NO_CHANGE,14462,1553,2015.0,25639674,False,False,False,"However other agonists that target α7 nAChRs, such as SSR-180711 and tropisetron, fail to induce analgesia when tested in the formalin model for pain [168], suggesting that targeting α7* nAChRs for pain relief is modality selective.",#60:18,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""MeSHDisease"": [""Pain""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,32572,13145,2020.0,30606258,False,False,False,"In contrast, increased α-tubulin acetylation resulted in little microtubule bundling and the extent of co-localization of acetylated α-tubulin with tau was also limited in CHO-Tau35 cells (Fig. 3a), demonstrating that the reduced microtubule-binding ability of Tau35 in not restored by increasing tubulin acetylation.",#65:15,PMC6318896,"{""full_journal_name"": ""Acta neuropathologica communications"", ""pub_date"": ""2020-04-02"", ""ref"": ""30606258"", ""pub_year"": 2020, ""last_author"": ""Hanger DP"", ""type"": ""PubMed"", ""author_list"": [""Guo T"", ""Dakkak D"", ""Rodriguez-Martin T"", ""Noble W"", ""Hanger DP""], ""title"": ""A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."", ""doi"": ""10.1186/s40478-018-0651-9""}","{""CellLine"": [""CHO cell""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""CHO Cells"", ""Cricetulus"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Insulin"", ""Microtubules"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Signal Transduction"", ""Unfolded Protein Response"", ""tau Proteins""], ""substances"": [""Insulin"", ""MAPT protein, human"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proto-Oncogene Proteins c-akt""]}",False
CAUSES_NO_CHANGE,43069,5120,2011.0,21734277,False,False,False,"The PAD peptide selectively inhibited anterograde FAT (Fig. 4 B, D), but not retrograde FAT (Fig. 4B,E).",#69:76,PMC3391724,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2011-09-09"", ""ref"": ""21734277"", ""pub_year"": 2011, ""last_author"": ""Binder LI"", ""type"": ""PubMed"", ""author_list"": [""Kanaan NM"", ""Morfini GA"", ""LaPointe NE"", ""Pigino GF"", ""Patterson KR"", ""Song Y"", ""Andreadis A"", ""Fu Y"", ""Brady ST"", ""Binder LI""], ""title"": ""Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases."", ""doi"": ""10.1523/JNEUROSCI.0560-11.2011""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Analysis of Variance"", ""Animals"", ""Axonal Transport"", ""Axons"", ""Brain"", ""Decapodiformes"", ""Enzyme Inhibitors"", ""Enzyme-Linked Immunosorbent Assay"", ""Glycogen Synthase Kinase 3"", ""Humans"", ""In Vitro Techniques"", ""Kinesins"", ""Models, Biological"", ""Mutagenesis"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Phosphotransferases"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""Signal Transduction"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Enzyme Inhibitors"", ""Peptide Fragments"", ""Phosphorus Isotopes"", ""Proto-Oncogene Proteins c-jun"", ""Receptors, Neuropeptide Y"", ""tau Proteins"", ""neuropeptide Y4 receptor"", ""Phosphotransferases"", ""Glycogen Synthase Kinase 3"", ""Kinesins""]}",False
CAUSES_NO_CHANGE,44178,7850,2019.0,29540553,False,False,False,"No significant synaptophysin loss was detected in tauP301S mice or in mice lacking SIRT1 alone in the frontal cortex and hippocampus (Fig. 3B,C).",#68:33,PMC5895994,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2019-10-03"", ""ref"": ""29540553"", ""pub_year"": 2019, ""last_author"": ""Gan L"", ""type"": ""PubMed"", ""author_list"": [""Min SW"", ""Sohn PD"", ""Li Y"", ""Devidze N"", ""Johnson JR"", ""Krogan NJ"", ""Masliah E"", ""Mok SA"", ""Gestwicki JE"", ""Gan L""], ""title"": ""SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy."", ""doi"": ""10.1523/JNEUROSCI.2369-17.2018""}","{""Anatomy"": [""frontal cortex"", ""hippocampal field""], ""CellLine"": [""HEK293""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Female"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Male"", ""Maze Learning"", ""Mice"", ""Sirtuin 1"", ""Synaptic Transmission"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Mapt protein, mouse"", ""tau Proteins"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,12730,11577,2015.0,25887395,False,False,False,"Next we analyzed fractions for seeding activity in the P301S- Nluc/Cluc HEK293 cell lines by a split-luciferase complemen- tation assay, comparing AD and control brains. Trimers and larger BD Tau assemblies induced intracellular aggregation, but not monomer or dimer.",#58:58,PMC4463437,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-09-10"", ""ref"": ""25887395"", ""pub_year"": 2015, ""last_author"": ""Diamond MI"", ""type"": ""PubMed"", ""author_list"": [""Mirbaha H"", ""Holmes BB"", ""Sanders DW"", ""Bieschke J"", ""Diamond MI""], ""title"": ""Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation."", ""doi"": ""10.1074/jbc.M115.652693""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Brain""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Biopolymers"", ""Chromatography, Gel"", ""HEK293 Cells"", ""Humans"", ""Spectrometry, Fluorescence"", ""tau Proteins""], ""substances"": [""Biopolymers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,1349,13356,2014.0,23516100,False,False,False,"Active caspase-6, and not caspase-3, is observed in early stages of HD and the caspase-6 levels correlated with the length of the poly Q tract [148].",#71:22,,"{""full_journal_name"": ""Molecular neurobiology"", ""pub_date"": ""2014-06-18"", ""ref"": ""23516100"", ""pub_year"": 2014, ""last_author"": ""Novak M"", ""type"": ""PubMed"", ""author_list"": [""Jadhav S"", ""Zilka N"", ""Novak M""], ""title"": ""Protein truncation as a common denominator of human neurodegenerative foldopathies."", ""doi"": ""10.1007/s12035-013-8440-8""}","{""Confidence"": [""High""], ""mesh"": [""Calpain"", ""Caspases"", ""Humans"", ""Intrinsically Disordered Proteins"", ""Neurodegenerative Diseases"", ""Protein Folding"", ""Proteolysis""], ""substances"": [""Intrinsically Disordered Proteins"", ""Calpain"", ""Caspases""]}",False
CAUSES_NO_CHANGE,14226,13478,2020.0,30686764,False,False,False,"The reduction of both pTau as well as tTau could indicate a proteostatic regulatory event, rather than altered Tau phosphorylation and dephosphorylation events. This was further substantiated by the finding that activity of GSK3b (a major Tau kinase) was not affected by statin-mediated CE reduction (Figure S5E).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,8165,2380,2017.0,27594586,False,False,False,"Thus, both molecular and electrophysiological analyses suggest MAPT mutations do not affect early neuronal differentiation",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,31885,21289,2012.0,22372633,False,False,False,"Inhibition of the proteasome system in cellular models potentiates the interaction between HDAC6 and Tau, and facilitates perinuclear aggregation of Tau independently of the deacetylase activity (15).",#57:37,,"{""full_journal_name"": ""Traffic (Copenhagen, Denmark)"", ""pub_date"": ""2012-10-04"", ""ref"": ""22372633"", ""pub_year"": 2012, ""last_author"": ""Van Den Bosch L"", ""type"": ""PubMed"", ""author_list"": [""d'Ydewalle C"", ""Bogaert E"", ""Van Den Bosch L""], ""title"": ""HDAC6 at the Intersection of Neuroprotection and Neurodegeneration."", ""doi"": ""10.1111/j.1600-0854.2012.01347.x""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Animals"", ""Autophagy"", ""Cytoskeleton"", ""Gene Expression Regulation, Enzymologic"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""Humans"", ""Microtubules"", ""Models, Biological"", ""Models, Genetic"", ""Neurodegenerative Diseases"", ""Neuroprotective Agents"", ""Protein Binding"", ""Protein Conformation"", ""Ubiquitin""], ""substances"": [""Neuroprotective Agents"", ""Ubiquitin"", ""HDAC6 protein, human"", ""Histone Deacetylase 6"", ""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,6576,20908,2020.0,30985105,False,False,False,Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased Aβ and plaque levels while not affecting tau phosphorylation,#70:0,,"{""full_journal_name"": ""ACS chemical neuroscience"", ""pub_date"": ""2020-05-21"", ""ref"": ""30985105"", ""pub_year"": 2020, ""last_author"": ""Rudrawar S"", ""type"": ""PubMed"", ""author_list"": [""Ryan P"", ""Xu M"", ""Davey AK"", ""Danon JJ"", ""Mellick GD"", ""Kassiou M"", ""Rudrawar S""], ""title"": ""O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease."", ""doi"": ""10.1021/acschemneuro.9b00143""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Acetylglucosamine"", ""Animals"", ""Brain"", ""Humans"", ""Neurodegenerative Diseases"", ""Protein Aggregation, Pathological"", ""Protein Folding"", ""Protein Processing, Post-Translational""], ""substances"": [""Acetylglucosamine""]}",False
CAUSES_NO_CHANGE,29150,1625,2020.0,30837838,False,False,False,"Several of these interactions were unperturbed by the ALS-linked mutations, A315T and M337V (Freibaum et al., 2010; Kim et al., 2010).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""]}",False
CAUSES_NO_CHANGE,15419,1650,2019.0,30232325,False,False,False,"Notably, in parallel with the protective effect of fasudil on synapses (Fig. 3e, f), treatment with fasudil reversed the stimulatory effects of Dkk1 on Aβ production (Fig. 3g).",#60:10,PMC6145937,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-03-14"", ""ref"": ""30232325"", ""pub_year"": 2019, ""last_author"": ""Killick R"", ""type"": ""PubMed"", ""author_list"": [""Elliott C"", ""Rojo AI"", ""Ribe E"", ""Broadstock M"", ""Xia W"", ""Morin P"", ""Semenov M"", ""Baillie G"", ""Cuadrado A"", ""Al-Shawi R"", ""Ballard CG"", ""Simons P"", ""Killick R""], ""title"": ""A role for APP in Wnt signalling links synapse loss with \u03b2-amyloid production."", ""doi"": ""10.1038/s41398-018-0231-6""}","{""Confidence"": [""Medium""], ""mesh"": [""1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"", ""Alzheimer Disease"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Cells, Cultured"", ""Disease Models, Animal"", ""Female"", ""HEK293 Cells"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""Intracellular Signaling Peptides and Proteins"", ""Low Density Lipoprotein Receptor-Related Protein-6"", ""Male"", ""Membrane Proteins"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Neurons"", ""Protein Kinase Inhibitors"", ""Rats"", ""Rats, Sprague-Dawley"", ""Synapses"", ""Wnt Signaling Pathway""], ""substances"": [""Amyloid beta-Protein Precursor"", ""DKK1 protein, human"", ""Intercellular Signaling Peptides and Proteins"", ""Intracellular Signaling Peptides and Proteins"", ""LRP6 protein, human"", ""Low Density Lipoprotein Receptor-Related Protein-6"", ""Membrane Proteins"", ""Protein Kinase Inhibitors"", ""VANGL2 protein, human"", ""1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine"", ""fasudil""]}",False
CAUSES_NO_CHANGE,4177,30968,2017.0,27594586,False,False,False,The percentages of VGLUT1-positive excitatory and GABA-positive inhibitory neurons were similar in neuronal cultures differentiated from control and patient iPSCs (Figures S2B and S2C),#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,43284,11430,2019.0,29844403,False,False,False,"As demonstrated, phosphorylation of tau Ser396 and Ser404 significantly increased in the cells transfected with the plasmids, but no increases or mild increases in the phosphorylation of other sites (Ser262 and Ser356) were observed (Fig. 5a).",#71:1,PMC5974403,"{""full_journal_name"": ""Cell death & disease"", ""pub_date"": ""2019-12-10"", ""ref"": ""29844403"", ""pub_year"": 2019, ""last_author"": ""Yang CR"", ""type"": ""PubMed"", ""author_list"": [""Fan SJ"", ""Huang FI"", ""Liou JP"", ""Yang CR""], ""title"": ""The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model."", ""doi"": ""10.1038/s41419-018-0688-5""}","{""CellLine"": [""Neuro-2a cell"", ""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Benzamides"", ""Cell Line, Tumor"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3 beta"", ""Histone Deacetylase Inhibitors"", ""Memory Disorders"", ""Models, Biological"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Aggregates"", ""Proteolysis"", ""Quinolines"", ""Rats, Sprague-Dawley"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Benzamides"", ""Histone Deacetylase Inhibitors"", ""MPT0G211"", ""Neuroprotective Agents"", ""Protein Aggregates"", ""Quinolines"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,33507,40878,2014.0,23164821,False,False,False,"Dkk4 and Dkk1 induced EGR1 (Figure 6b) and FOS (data not shown) whereas Dkk2 and Dkk3 did not, mirroring the abilities of the Dkk1 family to antagonise canonical wnt.",#59:5,PMC3873038,"{""full_journal_name"": ""Molecular psychiatry"", ""pub_date"": ""2014-08-26"", ""ref"": ""23164821"", ""pub_year"": 2014, ""last_author"": ""Lovestone S"", ""type"": ""PubMed"", ""author_list"": [""Killick R"", ""Ribe EM"", ""Al-Shawi R"", ""Malik B"", ""Hooper C"", ""Fernandes C"", ""Dobson R"", ""Nolan PM"", ""Lourdusamy A"", ""Furney S"", ""Lin K"", ""Breen G"", ""Wroe R"", ""To AW"", ""Leroy K"", ""Causevic M"", ""Usardi A"", ""Robinson M"", ""Noble W"", ""Williamson R"", ""Lunnon K"", ""Kellie S"", ""Reynolds CH"", ""Bazenet C"", ""Hodges A"", ""Brion JP"", ""Stephenson J"", ""Simons JP"", ""Lovestone S""], ""title"": ""Clusterin regulates \u03b2-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway."", ""doi"": ""10.1038/mp.2012.163""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""DKK1 subgraph"", ""Gamma secretase subgraph""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Clusterin"", ""Embryo, Mammalian"", ""Enzyme Inhibitors"", ""Female"", ""Gene Expression Regulation"", ""Humans"", ""Intercellular Signaling Peptides and Proteins"", ""MAP Kinase Signaling System"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""Rats"", ""Rats, Sprague-Dawley"", ""Wnt Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Clusterin"", ""DKK1 protein, human"", ""Enzyme Inhibitors"", ""Intercellular Signaling Peptides and Proteins"", ""Wnt Proteins""]}",False
CAUSES_NO_CHANGE,4195,35403,2015.0,26088141,False,False,False,Studies in N2a cells indicate that transfection with α7345–348A yields a similar α7 nAChR expression as the wild-type (α7) and supports the finding that mutation at the GPBC does not impact the synthesis of the nAChR in cells.,#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""CellLine"": [""Neuro-2a cell""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
CAUSES_NO_CHANGE,20824,8271,2020.0,30686764,False,False,False,"Interestingly, in these APP null neurons, simvastatin still reduced pThr231Tau/tTau in a dose dependent manner identical to that of its isogenic control lines (Figure 3H).",#72:31,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,7761,1314,2020.0,30837838,False,False,False,"Several of these interactions were unperturbed by the ALS-linked mutations, A315T and M337V (Freibaum et al., 2010; Kim et al., 2010).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""]}",False
CAUSES_NO_CHANGE,30767,32034,2009.0,19277525,False,False,False,"A portion of cellular PP2A stably associated with PME-1 and was catalytically inactive [80]; intriguingly, this inactive portion of PP2A could be re-activated by PP2A phosphatase activator (PTPA), but not by LCMT1, ruling out the possibility that inactivation was solely caused by demethylation",#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""High""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,6709,42416,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,38127,21740,2018.0,28445721,False,False,False,"NACHO does not affect function of ion channels gated by numerous other ligands including glutamate, GABA, serotonin, and capsaicin, suggesting that NACHO represents the only essential client-specific chaperone yet identified for any mammalian neurotransmitter receptor (Gu et al., 2016)",#64:74,,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2018-01-19"", ""ref"": ""28445721"", ""pub_year"": 2018, ""last_author"": ""Bredt DS"", ""type"": ""PubMed"", ""author_list"": [""Matta JA"", ""Gu S"", ""Davini WB"", ""Lord B"", ""Siuda ER"", ""Harrington AW"", ""Bredt DS""], ""title"": ""NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain."", ""doi"": ""10.1016/j.celrep.2017.04.008""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Binding Sites"", ""Brain"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Cell Line"", ""Cognitive Dysfunction"", ""Conotoxins"", ""Humans"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Mice"", ""Mice, Knockout"", ""Molecular Chaperones"", ""Neurons"", ""Nicotine"", ""Protein Binding"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic""], ""substances"": [""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Conotoxins"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Molecular Chaperones"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic"", ""Ric-3 protein, mouse"", ""Nicotine"", ""Iodine-125"", ""epibatidine""]}",False
CAUSES_NO_CHANGE,37926,7161,2005.0,15080568,False,False,False,"In conclusion, the involvement of GSTP1 alleles in individual susceptibility to AD was not confirmed as statistically significant in the tested Croatian Caucasian population.",#59:5,,"{""full_journal_name"": ""Clinical chemistry and laboratory medicine"", ""pub_date"": ""2005-01-28"", ""ref"": ""15080568"", ""pub_year"": 2005, ""last_author"": ""Demarin V"", ""type"": ""PubMed"", ""author_list"": [""Zuntar I"", ""Kalanj-Bognar S"", ""Topi\u0107 E"", ""Petlevski R"", ""Stefanovi\u0107 M"", ""Demarin V""], ""title"": ""The glutathione S-transferase polymorphisms in a control population and in Alzheimer's disease patients.""}","{""Subgraph"": [""Glutathione reductase subgraph""], ""mesh"": [""Adolescent"", ""Adult"", ""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Chromatography, Agarose"", ""Croatia"", ""Exons"", ""Female"", ""Gene Frequency"", ""Genetic Predisposition to Disease"", ""Genotype"", ""Glutathione Transferase"", ""Haplotypes"", ""Humans"", ""Male"", ""Middle Aged"", ""Polymerase Chain Reaction"", ""Polymorphism, Restriction Fragment Length"", ""Polymorphism, Single Nucleotide""], ""substances"": [""Glutathione Transferase""]}",False
CAUSES_NO_CHANGE,7260,18090,2009.0,18986241,False,False,False,"Single cell gene array studies have shown that synaptic transcripts are selectively downregulated in CBF neurons in AD, with significant reductions in synaptophysin and synaptotagmin but not synaptobrevin or SNAP29 mRNA [134,135]. Intriguingly, synaptotagmin function is related to vesicle-presynaptic membrane fusion and neurotransmitter release, suggesting that perturbations in presynaptic vesicle trafficking comprise a common event in vulnerable neuronal populations in AD. In contrast to synaptic transcripts, mRNAs encoding APP and Notch were unchanged between control and AD subjects, whereas acid hydrolase cathepsin D mRNA was upregulated in AD [134–136].",#68:4,PMC2631573,"{""full_journal_name"": ""Expert review of neurotherapeutics"", ""pub_date"": ""2009-02-20"", ""ref"": ""18986241"", ""pub_year"": 2009, ""last_author"": ""Ginsberg SD"", ""type"": ""PubMed"", ""author_list"": [""Mufson EJ"", ""Counts SE"", ""Perez SE"", ""Ginsberg SD""], ""title"": ""Cholinergic system during the progression of Alzheimer's disease: therapeutic implications."", ""doi"": ""10.1586/14737175.8.11.1703""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cholinergic Fibers"", ""Disease Progression"", ""Gene Expression"", ""Genetic Therapy"", ""Humans"", ""Nerve Growth Factor"", ""Receptors, Nerve Growth Factor""], ""substances"": [""Receptors, Nerve Growth Factor"", ""Nerve Growth Factor""]}",False
CAUSES_NO_CHANGE,3884,7260,2009.0,18191876,False,False,False,"A2M allele and genotype frequencies were similar between AD patients and controls, also after stratification for late onset (≥70 years) and early onset (<70 years) or APOE epsilon4 status. However, there was evidence in support of LD between the OLR1 + 1071, the OLR1 + 1073, and the rs669 SNPs, with T-C-A haplotype being associated with significant increased risk of AD in both the whole sample and when we stratified according to early and late onset AD subjects, with the allelic association with AD predominantly from the OLR1 + 1073 SNP, further supporting the role of OLR1 as a candidate risk gene for sporadic AD.",#64:44,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2009-10-09"", ""ref"": ""18191876"", ""pub_year"": 2009, ""last_author"": ""Panza F"", ""type"": ""PubMed"", ""author_list"": [""Colacicco AM"", ""Solfrizzi V"", ""D'Introno A"", ""Capurso C"", ""Kehoe PG"", ""Seripa D"", ""Pilotto A"", ""Santamato A"", ""Capurso A"", ""Panza F""], ""title"": ""Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease."", ""doi"": ""10.1016/j.neurobiolaging.2007.11.015""}","{""Confidence"": [""Medium""], ""Subgraph"": [""Alpha 2 macroglobulin subgraph"", ""Low density lipoprotein subgraph""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Apolipoprotein E4"", ""Brain"", ""Chromosomes, Human, Pair 12"", ""Cohort Studies"", ""DNA Mutational Analysis"", ""Female"", ""Gene Frequency"", ""Genetic Predisposition to Disease"", ""Genetic Testing"", ""Genotype"", ""Haplotypes"", ""Humans"", ""Male"", ""Middle Aged"", ""Mutation"", ""Polymorphism, Genetic"", ""Receptors, Opioid"", ""Risk Factors"", ""alpha-Macroglobulins"", ""Nociceptin Receptor""], ""substances"": [""Apolipoprotein E4"", ""Receptors, Opioid"", ""alpha-Macroglobulins"", ""Nociceptin Receptor"", ""OPRL1 protein, human""]}",False
CAUSES_NO_CHANGE,3452,822,2009.0,19277525,False,False,False,Neither mutation of the carboxy-terminal Leu residue nor removal of the carboxy-terminal 14 amino acids of the catalytic subunit prevented formation of heterotrimeric holoenzymes involving the B or B′ subunits,#57:33,,"{""full_journal_name"": ""Science in China. Series C, Life sciences"", ""pub_date"": ""2009-05-19"", ""ref"": ""19277525"", ""pub_year"": 2009, ""last_author"": ""Shi Y"", ""type"": ""PubMed"", ""author_list"": [""Shi Y""], ""title"": ""Assembly and structure of protein phosphatase 2A."", ""doi"": ""10.1007/s11427-009-0018-3""}","{""Confidence"": [""Medium""], ""mesh"": [""Biopolymers"", ""Catalytic Domain"", ""Models, Molecular"", ""Protein Conformation"", ""Protein Phosphatase 2""], ""substances"": [""Biopolymers"", ""Protein Phosphatase 2""]}",False
CAUSES_NO_CHANGE,11479,1768,2007.0,17640819,False,False,False,"4OH-GTS-21 had no effect on cholinergic cell size in the unlesioned sides of the septa of the wild type or PS1 mice, but did cause atrophy of these neurons in the APP/PS1 mice.",#65:41,,"{""full_journal_name"": ""Neuroscience"", ""pub_date"": ""2007-12-14"", ""ref"": ""17640819"", ""pub_year"": 2007, ""last_author"": ""Meyer EM"", ""type"": ""PubMed"", ""author_list"": [""Ren K"", ""King MA"", ""Liu J"", ""Siemann J"", ""Altman M"", ""Meyers C"", ""Hughes JA"", ""Meyer EM""], ""title"": ""The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.""}","{""Assay"": [""Immunochemistry""], ""MeSHAnatomy"": [""Septum of Brain""], ""MouseStrain"": [""C57BL/6J"", ""PS1M146L""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Alzheimer Disease"", ""Amyloid"", ""Anabasine"", ""Animals"", ""Axotomy"", ""Cell Survival"", ""Cholinergic Fibers"", ""Disease Models, Animal"", ""Female"", ""Fornix, Brain"", ""Hippocampus"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""Septal Nuclei"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid""], ""substances"": [""3-(4-hydroxy-2-methoxybenzylidene)anabaseine"", ""Amyloid"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Neuroprotective Agents"", ""Nicotinic Agonists"", ""Receptors, Nerve Growth Factor"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""gamma-Aminobutyric Acid"", ""Anabasine""]}",False
CAUSES_NO_CHANGE,16858,7596,2017.0,28083634,False,False,False,"We found that Tau degradation was significantly impaired in primary neurons infected with Otub1 WT, but not with catalytically dead mutant C91A, compared with GFP control.",#64:64,PMC5390007,"{""full_journal_name"": ""Acta neuropathologica"", ""pub_date"": ""2017-04-20"", ""ref"": ""28083634"", ""pub_year"": 2017, ""last_author"": ""Dewachter I"", ""type"": ""PubMed"", ""author_list"": [""Wang P"", ""Joberty G"", ""Buist A"", ""Vanoosthuyse A"", ""Stancu IC"", ""Vasconcelos B"", ""Pierrot N"", ""Faelth-Savitski M"", ""Kienlen-Campard P"", ""Octave JN"", ""Bantscheff M"", ""Drewes G"", ""Moechars D"", ""Dewachter I""], ""title"": ""Tau interactome mapping\u00a0based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo."", ""doi"": ""10.1007/s00401-016-1663-9""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Cysteine Endopeptidases"", ""Deubiquitinating Enzymes"", ""Humans"", ""Mice, Transgenic"", ""Neurofibrillary Tangles"", ""Neurons"", ""Tauopathies"", ""Ubiquitin"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Ubiquitin"", ""tau Proteins"", ""Deubiquitinating Enzymes"", ""Cysteine Endopeptidases"", ""Otub1 protein, mouse""]}",False
CAUSES_NO_CHANGE,7161,7406,2013.0,23153928,False,False,False,"Murine double minute 2 (MDM2) protein levels were decreased in AD cells relative to control lymphoblasts, suggesting an impairment of FOXO3a degradation.",#59:5,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2013-08-01"", ""ref"": ""23153928"", ""pub_year"": 2013, ""last_author"": ""Mart\u00edn-Requero A"", ""type"": ""PubMed"", ""author_list"": [""Esteras N"", ""Alqu\u00e9zar C"", ""Bermejo-Pareja F"", ""Bialopiotrowicz E"", ""Wojda U"", ""Mart\u00edn-Requero A""], ""title"": ""Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer's disease patients."", ""doi"": ""10.1016/j.neurobiolaging.2012.10.014""}","{""MeSHDisease"": [""Alzheimer Disease""], ""Species"": [""10090""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Calcium"", ""Calcium-Calmodulin-Dependent Protein Kinase Type 2"", ""Cell Line"", ""Cell Survival"", ""Cyclin-Dependent Kinase Inhibitor p21"", ""Female"", ""Humans"", ""Lymphocytes"", ""Male"", ""Middle Aged"", ""Mitogen-Activated Protein Kinase 1"", ""Mitogen-Activated Protein Kinase 3""], ""substances"": [""Cyclin-Dependent Kinase Inhibitor p21"", ""Calcium-Calmodulin-Dependent Protein Kinase Type 2"", ""MAPK1 protein, human"", ""Mitogen-Activated Protein Kinase 1"", ""Mitogen-Activated Protein Kinase 3"", ""Calcium""]}",False
CAUSES_NO_CHANGE,40529,2310,2012.0,22179319,False,False,False,"Whether SIRT1 has protective role in mammalian HD remains undefined, however, as results from lower organisms such as Caenorhabditis elegans [13] and Drosophila melanogaster [14] are contradictory; for example, overexpression of sir2, an ortholog of human SIRT1, suppressed mutant huntingtin (Htt)-induced neurotoxicity [13], whereas overexpression of sir2 in drosophila showed no significant protection [15].",#66:20,PMC4551453,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2012-03-14"", ""ref"": ""22179319"", ""pub_year"": 2012, ""last_author"": ""Duan W"", ""type"": ""PubMed"", ""author_list"": [""Jiang M"", ""Wang J"", ""Fu J"", ""Du L"", ""Jeong H"", ""West T"", ""Xiang L"", ""Peng Q"", ""Hou Z"", ""Cai H"", ""Seredenina T"", ""Arbez N"", ""Zhu S"", ""Sommers K"", ""Qian J"", ""Zhang J"", ""Mori S"", ""Yang XW"", ""Tamashiro KL"", ""Aja S"", ""Moran TH"", ""Luthi-Carter R"", ""Martin B"", ""Maudsley S"", ""Mattson MP"", ""Cichewicz RH"", ""Ross CA"", ""Holtzman DM"", ""Krainc D"", ""Duan W""], ""title"": ""Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets."", ""doi"": ""10.1038/nm.2558""}","{""Confidence"": [""Low""], ""Species"": [""7227""], ""mesh"": [""Animals"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Disease Models, Animal"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""Gene Expression Regulation"", ""Humans"", ""Huntingtin Protein"", ""Huntington Disease"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins"", ""Rats"", ""Receptor, trkB"", ""Signal Transduction"", ""Sirtuin 1""], ""substances"": [""Brain-Derived Neurotrophic Factor"", ""Dopamine and cAMP-Regulated Phosphoprotein 32"", ""Forkhead Box Protein O3"", ""Forkhead Transcription Factors"", ""FoxO3 protein, mouse"", ""Htt protein, mouse"", ""Huntingtin Protein"", ""Nerve Tissue Proteins"", ""Nuclear Proteins"", ""Ppp1r1b protein, mouse"", ""Receptor, trkB"", ""Sirt1 protein, mouse"", ""Sirtuin 1""]}",False
CAUSES_NO_CHANGE,11577,6912,2018.0,28528849,False,False,False,"In our hands, these aggregated tau species formed in different conditions did not show any significant release of LDH when applied on the differentiated SH-SY5Y cells (Supplementary Fig. 8A), and they did not show a significant reduction in cell viability by the MTTassay (Supplementary Fig. 8B).",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""CellLine"": [""SH-SY5Y""], ""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,7085,2342,2016.0,23393546,False,False,False,"Addition of pizotifen, cyproheptadine, or loxapine to the ST Hdh Q7/Q7 cells after serum withdrawal had no effect on ATP levels, indicating that the drugs do not have a general effect on viability but rather correct a deficit specific to the ST Hdh Q111/Q111 cells (Figure 2 A ).",#57:42,PMC3564659,"{""full_journal_name"": ""Journal of Huntington's disease"", ""pub_date"": ""2016-02-23"", ""ref"": ""23393546"", ""pub_year"": 2016, ""last_author"": ""Hughes RE"", ""type"": ""PubMed"", ""author_list"": [""Sarantos MR"", ""Papanikolaou T"", ""Ellerby LM"", ""Hughes RE""], ""title"": ""Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease."", ""doi"": ""10.3233/JHD-120033""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Apoptosis"", ""Cells, Cultured"", ""Corpus Striatum"", ""Dose-Response Relationship, Drug"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Mice"", ""Mice, Transgenic"", ""Neurons"", ""Neuroprotective Agents"", ""Pizotyline"", ""Treatment Outcome""], ""substances"": [""Neuroprotective Agents"", ""Pizotyline""]}",False
CAUSES_NO_CHANGE,36397,14369,2019.0,29158945,False,False,False,"Although p105 deficiency has no T-cell intrinsic effect on Th17 cell differentiation, the aberrant activation of NF-κB renders innate immune cells hyperresponsive to TLR stimulation for production of IL-6, a major cytokine-promoting Th17 differentiation.43",#57:0,PMC5661633,"{""full_journal_name"": ""Signal transduction and targeted therapy"", ""pub_date"": ""2021-02-02"", ""ref"": ""29158945"", ""pub_year"": 2021, ""last_author"": ""Sun SC"", ""type"": ""PubMed"", ""author_list"": [""Liu T"", ""Zhang L"", ""Joo D"", ""Sun SC""], ""title"": ""NF-\u03baB signaling in inflammation."", ""doi"": ""10.1038/sigtrans.2017.23""}","{""PublicationType"": [""Review""], ""Section"": [""NF-\u03baB function in T cells""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,41324,3152,2015.0,25681350,False,False,False,"Surprisingly, knockdown of p65 had no effect on YKL-40 mRNA expression (Fig. 3A), but did drastically diminish the expression of IL-8 mRNA, which is p65-dependent (Fig. 3B).",#59:70,PMC4355396,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2015-06-19"", ""ref"": ""25681350"", ""pub_year"": 2015, ""last_author"": ""Kordula T"", ""type"": ""PubMed"", ""author_list"": [""Bhardwaj R"", ""Yester JW"", ""Singh SK"", ""Biswas DD"", ""Surace MJ"", ""Waters MR"", ""Hauser KF"", ""Yao Z"", ""Boyce BF"", ""Kordula T""], ""title"": ""RelB/p50 complexes regulate cytokine-induced YKL-40 expression."", ""doi"": ""10.4049/jimmunol.1400874""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Adipokines"", ""Animals"", ""Astrocytes"", ""Blotting, Western"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Female"", ""Gene Expression"", ""Glycoproteins"", ""Humans"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Male"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""Oncostatin M"", ""Promoter Regions, Genetic"", ""Protein Binding"", ""RNA Interference"", ""Reverse Transcriptase Polymerase Chain Reaction"", ""STAT3 Transcription Factor"", ""Transcription Factor RelB""], ""substances"": [""Adipokines"", ""CHI3L1 protein, human"", ""Chil1 protein, mouse"", ""Chitinase-3-Like Protein 1"", ""Cytokines"", ""Glycoproteins"", ""Interleukin-1"", ""Interleukin-6"", ""Lectins"", ""Multiprotein Complexes"", ""NF-kappa B p50 Subunit"", ""STAT3 Transcription Factor"", ""Oncostatin M"", ""Transcription Factor RelB""]}",False
CAUSES_NO_CHANGE,28239,8464,2017.0,27167578,False,False,False,"As shown in Fig. 3b, choline treatment was found to increase active-RhoA levels in these cells. In cells transfected with a7345–348A, choline treatment did not increase active-RhoA expression.",#65:18,,"{""full_journal_name"": ""Journal of neurochemistry"", ""pub_date"": ""2017-06-20"", ""ref"": ""27167578"", ""pub_year"": 2017, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Kabbani N""], ""title"": ""Alpha 7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth."", ""doi"": ""10.1111/jnc.13660""}","{""CellLine"": [""PC12""], ""Custom_Assay"": [""Rhotekin pull-down assay""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Animals"", ""Benzamides"", ""Bridged Bicyclo Compounds"", ""Calcium Signaling"", ""Cytoskeleton"", ""Enzyme Activation"", ""Female"", ""Growth Cones"", ""Heterotrimeric GTP-Binding Proteins"", ""Male"", ""Mice, Inbred C57BL"", ""Microtubules"", ""Neurogenesis"", ""Neurons"", ""Nicotinic Agonists"", ""PC12 Cells"", ""Rats"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""rhoA GTP-Binding Protein""], ""substances"": [""Benzamides"", ""Bridged Bicyclo Compounds"", ""Nicotinic Agonists"", ""PNU-282987"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Heterotrimeric GTP-Binding Proteins"", ""rhoA GTP-Binding Protein""]}",False
CAUSES_NO_CHANGE,10729,28803,2009.0,19293145,False,False,False,"For example, non-alpha7 nAChRs protect cultured nigral dopaminergic neurons from toxicity induced by 1-methyl-4-phenylpyridinium, a neurotoxin that selectively damages nigrostriatal dopaminergic neurons (Jeyarasasingam et al., 2002), and this effect is not mediated by alpha7 receptors.",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Dopaminergic Neurons""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,14217,33326,2020.0,30686764,False,False,False,"Activation of homologous nuclear receptors such as PPARa (by GW50156) and PPARg (by Rosiglitazone), which regulate fatty acid metabolism but not cholesterol export, did not decrease pThr231Tau/tTau (Figures 2C, S2F, and S2G).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,2036,15258,2014.0,24590577,False,False,False,"During the past few years, the M1 mAChR allosteric agonists VU0184670 and VU0357017 have been screened out, and have more exciting properties. Both compounds have high solubility in aqueous solutions as well as good CNS penetration, without any agonist or antagonist activity for the M2 and M5 subtypes",#69:61,PMC5562652,"{""full_journal_name"": ""Neuroscience bulletin"", ""pub_date"": ""2014-12-03"", ""ref"": ""24590577"", ""pub_year"": 2014, ""last_author"": ""Zhang YW"", ""type"": ""PubMed"", ""author_list"": [""Jiang S"", ""Li Y"", ""Zhang C"", ""Zhao Y"", ""Bu G"", ""Xu H"", ""Zhang YW""], ""title"": ""M1 muscarinic acetylcholine receptor in Alzheimer's disease."", ""doi"": ""10.1007/s12264-013-1406-z""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Humans"", ""Receptor, Muscarinic M1""], ""substances"": [""Receptor, Muscarinic M1""]}",False
CAUSES_NO_CHANGE,36416,33620,2013.0,23178521,False,False,False,"Following this 15 mins of stimulation with TNFa, an increased p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, P=0.021) without a noticeable increase in STAT3 phosphorylation (Mann–Whitney U=7, Z=-0.289, P=0.773) was observed compared to the control conditions (Fig. 1)",#62:72,,"{""full_journal_name"": ""European journal of pharmacology"", ""pub_date"": ""2013-06-10"", ""ref"": ""23178521"", ""pub_year"": 2013, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Beaulieu-Abdelahad D"", ""Abdullah L"", ""Bachmeier C"", ""Ait-Ghezala G"", ""Reed J"", ""Verma M"", ""Crawford F"", ""Mullan M""], ""title"": ""Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation."", ""doi"": ""10.1016/j.ejphar.2012.11.017""}","{""CellLine"": [""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alkaloids"", ""Alzheimer Disease"", ""Animals"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Brain"", ""Cytokines"", ""HEK293 Cells"", ""Humans"", ""Inflammation"", ""Mice"", ""Mice, Inbred C57BL"", ""Phosphorylation"", ""Pyridines"", ""STAT3 Transcription Factor""], ""substances"": [""Alkaloids"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Cytokines"", ""Pyridines"", ""STAT3 Transcription Factor"", ""anatabine""]}",False
CAUSES_NO_CHANGE,3518,1588,2020.0,30837838,False,False,False,"Several mutations in the RRMs are shown to disrupt the RNA binding capability while not significantly interfering with the RNA recognition (Lukavsky et al., 2013).",#61:11,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}",{},False
CAUSES_NO_CHANGE,11655,34770,2019.0,29844403,False,False,False,"MPT0G211 treatment significantly attenuated the phosphorylation of tau Ser396 and Ser404 in both cell lines (Fig. 5a); no marked changes in CDK5, p25, or p35 expression were associated with MPT0G211-induced phospho-tau downregulation; however, significant phospho-GSK3β increases on Ser9 through Akt phosphorylation were associated with the inhibition of phospho-tau Ser396 in response to MPT0G211 treatment (Fig. 5b).In addition, a decrease in phospho-GSK3β on Ser216 was also observed.",#71:1,PMC5974403,"{""full_journal_name"": ""Cell death & disease"", ""pub_date"": ""2019-12-10"", ""ref"": ""29844403"", ""pub_year"": 2019, ""last_author"": ""Yang CR"", ""type"": ""PubMed"", ""author_list"": [""Fan SJ"", ""Huang FI"", ""Liou JP"", ""Yang CR""], ""title"": ""The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model."", ""doi"": ""10.1038/s41419-018-0688-5""}","{""CellLine"": [""Neuro-2a cell"", ""SH-SY5Y""], ""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Benzamides"", ""Cell Line, Tumor"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3 beta"", ""Histone Deacetylase Inhibitors"", ""Memory Disorders"", ""Models, Biological"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Aggregates"", ""Proteolysis"", ""Quinolines"", ""Rats, Sprague-Dawley"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Benzamides"", ""Histone Deacetylase Inhibitors"", ""MPT0G211"", ""Neuroprotective Agents"", ""Protein Aggregates"", ""Quinolines"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,32957,5108,2017.0,27594586,False,False,False,"When measuring cell viability using the MTT assay, we found that patient-specific neurons are more sensitive than control neurons to cell death induced by rapamycin (Figure 3B) but not by staurosporine or rotenone (Figures S3B and S3C), suggesting compromised function in the mTOR pathway or related molecular pathways",#63:37,PMC5032669,"{""full_journal_name"": ""Stem cell reports"", ""pub_date"": ""2017-11-21"", ""ref"": ""27594586"", ""pub_year"": 2017, ""last_author"": ""Gao FB"", ""type"": ""PubMed"", ""author_list"": [""Biswas MHU"", ""Almeida S"", ""Lopez-Gonzalez R"", ""Mao W"", ""Zhang Z"", ""Karydas A"", ""Geschwind MD"", ""Biernat J"", ""Mandelkow EM"", ""Futai K"", ""Miller BL"", ""Gao FB""], ""title"": ""MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations."", ""doi"": ""10.1016/j.stemcr.2016.08.006""}","{""CellStructure"": [""Extracellular Space""], ""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cerebral Cortex"", ""Neurons""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""mesh"": [""Aged"", ""Cell Death"", ""Cell Differentiation"", ""Cell Survival"", ""Cellular Reprogramming"", ""Cellular Reprogramming Techniques"", ""Enzyme Activation"", ""Extracellular Signal-Regulated MAP Kinases"", ""Frontotemporal Dementia"", ""Gene Expression Regulation"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Male"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9"", ""Mutation"", ""Neurons"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Extracellular Signal-Regulated MAP Kinases"", ""Matrix Metalloproteinase 2"", ""Matrix Metalloproteinase 9""]}",False
CAUSES_NO_CHANGE,4481,39861,2015.0,25546293,False,False,False,"In the presence of the HDAC6 inhibitor ACY-1215, the increased levels of Ac-Lys49 β-catenin had no effect on the levels for β-catenin phosphorylated at Ser33, Ser37, and Thr41 (Figure 3A, B).",#68:52,PMC4372110,"{""full_journal_name"": ""ACS chemical biology"", ""pub_date"": ""2015-12-07"", ""ref"": ""25546293"", ""pub_year"": 2015, ""last_author"": ""Karmacharya R"", ""type"": ""PubMed"", ""author_list"": [""Iaconelli J"", ""Huang JH"", ""Berkovitch SS"", ""Chattopadhyay S"", ""Mazitschek R"", ""Schreiber SL"", ""Haggarty SJ"", ""Karmacharya R""], ""title"": ""HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of \u03b2-catenin in human iPSC-derived neuronal cells."", ""doi"": ""10.1021/cb500838r""}","{""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Binding Sites"", ""Cell Differentiation"", ""Cell Membrane"", ""Cells, Cultured"", ""Gene Expression"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Induced Pluripotent Stem Cells"", ""Isoenzymes"", ""Kinetics"", ""Lysine"", ""Models, Molecular"", ""Neurons"", ""Phosphorylation"", ""Proteasome Endopeptidase Complex"", ""Protein Processing, Post-Translational"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Signal Transduction"", ""Structure-Activity Relationship"", ""Ubiquitination"", ""beta Catenin""], ""substances"": [""CTNNB1 protein, human"", ""Histone Deacetylase Inhibitors"", ""Isoenzymes"", ""beta Catenin"", ""Proteasome Endopeptidase Complex"", ""Histone Deacetylases"", ""Lysine""]}",False
CAUSES_NO_CHANGE,6826,6901,2018.0,29626319,False,False,False,"By measuring Aβ levels in superior vena cava and inferior vena cava, it is clear that Aβ levels are getting lower and lower along the direction of the vein blood flow, and the contents of Aβ40 and total Aβ in artery are significantly less than those in vein, suggesting a part of Aβ40 and total Aβ can be cleared by peripheral organs and tissues, such as the liver, kidney, skin, and the gastrointestinal tract, although there is no change in Aβ42 concentrations (Xiang et al. 2015)",#70:59,,"{""full_journal_name"": ""Neurotoxicity research"", ""pub_date"": ""2018-11-06"", ""ref"": ""29626319"", ""pub_year"": 2018, ""last_author"": ""Tan L"", ""type"": ""PubMed"", ""author_list"": [""Xin SH"", ""Tan L"", ""Cao X"", ""Yu JT"", ""Tan L""], ""title"": ""Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy."", ""doi"": ""10.1007/s12640-018-9895-1""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Arteries""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,15251,41587,2000.0,10887109,False,False,False,"These experiments determined that Lck, but not Syk or Zap70, was capable of mediating phosphorylation of CD33 in vivo (Figure 2A).",#63:25,,"{""full_journal_name"": ""Blood"", ""pub_date"": ""2000-08-17"", ""ref"": ""10887109"", ""pub_year"": 2000, ""last_author"": ""McVicar DW"", ""type"": ""PubMed"", ""author_list"": [""Paul SP"", ""Taylor LS"", ""Stansbury EK"", ""McVicar DW""], ""title"": ""Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Blotting, Western"", ""Cell Line"", ""Gene Expression"", ""Gene Transfer Techniques"", ""Humans"", ""Immunosorbent Techniques"", ""Intracellular Signaling Peptides and Proteins"", ""Molecular Sequence Data"", ""Mutagenesis, Site-Directed"", ""Peptide Fragments"", ""Phosphorylation"", ""Phosphotyrosine"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Structure-Activity Relationship""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Peptide Fragments"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Phosphotyrosine"", ""PTPN11 protein, human"", ""PTPN6 protein, human"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 11"", ""Protein Tyrosine Phosphatase, Non-Receptor Type 6"", ""Protein Tyrosine Phosphatases""]}",False
CAUSES_NO_CHANGE,13012,342,2014.0,24368848,False,False,False,"We found that in the visual cortex, neurons containing conspicuous quantities of mislocalized and aggregated tau nonetheless appear to have a normal capacity to integrate dendritic inputs and respond robustly to visual stimuli and also maintain normal somatic baseline calcium levels. In particular, we show that individual NFT-bearing neurons can respond robustly after integrating sensory inputs and are functionally indistinguishable from neighboring non–NFT-bearing neurons. These results demonstrate that NFT-bearing neurons remain functionally integrated in cortical circuits.",#60:71,PMC3890777,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2014-03-12"", ""ref"": ""24368848"", ""pub_year"": 2014, ""last_author"": ""Hyman BT"", ""type"": ""PubMed"", ""author_list"": [""Kuchibhotla KV"", ""Wegmann S"", ""Kopeikina KJ"", ""Hawkes J"", ""Rudinskiy N"", ""Andermann ML"", ""Spires-Jones TL"", ""Bacskai BJ"", ""Hyman BT""], ""title"": ""Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo."", ""doi"": ""10.1073/pnas.1318807111""}","{""Anatomy"": [""visual cortex""], ""Confidence"": [""High""], ""MeSHDisease"": [""Frontotemporal Dementia""], ""Method"": [""In-vivo two photon calcium imaging""], ""MouseStrain"": [""rTg4510""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Calcium"", ""Dependovirus"", ""Humans"", ""Image Processing, Computer-Assisted"", ""Mice"", ""Mice, Transgenic"", ""Microscopy, Fluorescence"", ""Models, Neurological"", ""Mutation"", ""Neurofibrillary Tangles"", ""Neurons"", ""Photons"", ""Tauopathies"", ""Transgenes"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,7180,7106,2017.0,27794524,False,False,False,"In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""cortex""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,43517,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,2104,10435,2009.0,19126755,False,False,False,"Surprisingly, however, activation of nAChRs by galantamine or physostigmine was insensitive to blockade by competitive nAChR antagonists, was detected even when the receptors were desensitized by high agonist concentrations, and was inhibited by the monoclonal antibody FK1 (350, 370, 372, 413, 428, 429).",#69:53,PMC2713585,"{""full_journal_name"": ""Physiological reviews"", ""pub_date"": ""2009-02-26"", ""ref"": ""19126755"", ""pub_year"": 2009, ""last_author"": ""Rogers SW"", ""type"": ""PubMed"", ""author_list"": [""Albuquerque EX"", ""Pereira EF"", ""Alkondon M"", ""Rogers SW""], ""title"": ""Mammalian nicotinic acetylcholine receptors: from structure to function."", ""doi"": ""10.1152/physrev.00015.2008""}","{""Confidence"": [""High""], ""TextLocation"": [""Review""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Brain"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Humans"", ""Parkinson Disease"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,6709,36954,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}","{""Subgraph"": [""Serotonergic subgraph""]}",False
CAUSES_NO_CHANGE,38127,27212,2018.0,28445721,False,False,False,"NACHO does not affect function of ion channels gated by numerous other ligands including glutamate, GABA, serotonin, and capsaicin, suggesting that NACHO represents the only essential client-specific chaperone yet identified for any mammalian neurotransmitter receptor (Gu et al., 2016)",#64:74,,"{""full_journal_name"": ""Cell reports"", ""pub_date"": ""2018-01-19"", ""ref"": ""28445721"", ""pub_year"": 2018, ""last_author"": ""Bredt DS"", ""type"": ""PubMed"", ""author_list"": [""Matta JA"", ""Gu S"", ""Davini WB"", ""Lord B"", ""Siuda ER"", ""Harrington AW"", ""Bredt DS""], ""title"": ""NACHO Mediates Nicotinic Acetylcholine Receptor Function throughout the Brain."", ""doi"": ""10.1016/j.celrep.2017.04.008""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Binding Sites"", ""Brain"", ""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Cell Line"", ""Cognitive Dysfunction"", ""Conotoxins"", ""Humans"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Mice"", ""Mice, Knockout"", ""Molecular Chaperones"", ""Neurons"", ""Nicotine"", ""Protein Binding"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic""], ""substances"": [""Bridged Bicyclo Compounds, Heterocyclic"", ""Bungarotoxins"", ""Conotoxins"", ""Iodine Radioisotopes"", ""Membrane Proteins"", ""Molecular Chaperones"", ""Protein Subunits"", ""Pyridines"", ""Radiopharmaceuticals"", ""Receptors, Nicotinic"", ""Ric-3 protein, mouse"", ""Nicotine"", ""Iodine-125"", ""epibatidine""]}",False
CAUSES_NO_CHANGE,6945,6707,2020.0,30686764,False,False,False,"24-Hydroxycholesterol (a direct downstream metabolite of cholesterol) was increased in media from efavirenz-treated neurons, was decreased in AY-9944-treated samples, and was unaltered in atorvastatin- and T0901317-treated neurons (Figure S2P).",#58:5,PMC6414424,"{""full_journal_name"": ""Cell stem cell"", ""pub_date"": ""2020-04-23"", ""ref"": ""30686764"", ""pub_year"": 2020, ""last_author"": ""Goldstein LSB"", ""type"": ""PubMed"", ""author_list"": [""van der Kant R"", ""Langness VF"", ""Herrera CM"", ""Williams DA"", ""Fong LK"", ""Leestemaker Y"", ""Steenvoorden E"", ""Rynearson KD"", ""Brouwers JF"", ""Helms JB"", ""Ovaa H"", ""Giera M"", ""Wagner SL"", ""Bang AG"", ""Goldstein LSB""], ""title"": ""Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-\u03b2 in iPSC-Derived Alzheimer's Disease Neurons."", ""doi"": ""10.1016/j.stem.2018.12.013""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cells, Cultured"", ""Cholesterol"", ""Induced Pluripotent Stem Cells"", ""Mice"", ""Mice, Inbred C57BL"", ""Neurons"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Cholesterol""]}",False
CAUSES_NO_CHANGE,2070,40648,2018.0,28901280,False,False,False,"whereas phosphocholine (PC) does not evoke ion current responses in Xenopus oocytes expressing functional ho- momeric α9 or heteromeric α9-α10 nAChRs [121]. How- ever, preincubation with PC attenuates choline-induced ion current changes, thus suggesting that PC is a silent agonist of these two subtypes",#61:2,PMC6018187,"{""full_journal_name"": ""Current neuropharmacology"", ""pub_date"": ""2018-09-13"", ""ref"": ""28901280"", ""pub_year"": 2018, ""last_author"": ""Gotti C"", ""type"": ""PubMed"", ""author_list"": [""Zoli M"", ""Pucci S"", ""Vilella A"", ""Gotti C""], ""title"": ""Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors."", ""doi"": ""10.2174/1570159X15666170912110450""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Binding Sites"", ""Humans"", ""Neurons"", ""Receptors, Nicotinic""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,40458,11963,2015.0,25171717,False,False,False,"We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",#67:28,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-08-18"", ""ref"": ""25171717"", ""pub_year"": 2015, ""last_author"": ""Karsdal MA"", ""type"": ""PubMed"", ""author_list"": [""Henriksen K"", ""Byrjalsen I"", ""Christiansen C"", ""Karsdal MA""], ""title"": ""Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease."", ""doi"": ""10.3233/JAD-140984""}","{""mesh"": [""Aged"", ""Alzheimer Disease"", ""Biomarkers"", ""Clinical Trials, Phase III as Topic"", ""Disease Progression"", ""Enzyme-Linked Immunosorbent Assay"", ""Female"", ""Humans"", ""Linear Models"", ""Male"", ""Mental Status Schedule"", ""Severity of Illness Index"", ""Time Factors"", ""tau Proteins""], ""substances"": [""Biomarkers"", ""MAPT protein, human"", ""tau Proteins""]}",False
CAUSES_NO_CHANGE,6769,12009,2018.0,27671637,False,False,False,"Indeed, the reduced level of spines seen in proaggregant Tau transgenic slices are normalized when treated with 64627, whereas no significant changes are found in antiaggregant Tau transgenic slices or littermate controls (Fig. 5 A and B)",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,1411,2312,2016.0,27013968,False,False,False,"Furthermore, DARPP-32+ staining indicated a similar sized population of MSN-like cells in WT and R6/2 cultures after 7 DIV in basal media (40 ± 8 and 40 ± 5 cells/mm2, respectively; Figures 2A,B).",#65:61,PMC4783409,"{""full_journal_name"": ""Frontiers in cellular neuroscience"", ""pub_date"": ""2016-03-25"", ""ref"": ""27013968"", ""pub_year"": 2016, ""last_author"": ""Sadikot AF"", ""type"": ""PubMed"", ""author_list"": [""Nguyen KQ"", ""Rymar VV"", ""Sadikot AF""], ""title"": ""Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease."", ""doi"": ""10.3389/fncel.2016.00037""}","{""Anatomy"": [""striatum""], ""Cell"": [""medium spiny neuron""], ""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,11577,4941,2018.0,28528849,False,False,False,"In our hands, these aggregated tau species formed in different conditions did not show any significant release of LDH when applied on the differentiated SH-SY5Y cells (Supplementary Fig. 8A), and they did not show a significant reduction in cell viability by the MTTassay (Supplementary Fig. 8B).",#57:77,,"{""full_journal_name"": ""Alzheimer's & dementia : the journal of the Alzheimer's Association"", ""pub_date"": ""2018-06-18"", ""ref"": ""28528849"", ""pub_year"": 2018, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Kaniyappan S"", ""Chandupatla RR"", ""Mandelkow EM"", ""Mandelkow E""], ""title"": ""Extracellular low-n oligomers of tau cause selective synaptotoxicity without affecting cell viability."", ""doi"": ""10.1016/j.jalz.2017.04.002""}","{""CellLine"": [""SH-SY5Y""], ""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Calcium"", ""Cell Line, Tumor"", ""Cell Survival"", ""Circular Dichroism"", ""Dendritic Spines"", ""Extracellular Fluid"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Microscopy, Atomic Force"", ""Microscopy, Electron, Transmission"", ""Neuroblastoma"", ""Neurons"", ""Organ Culture Techniques"", ""PC12 Cells"", ""Peptide Fragments"", ""Rats"", ""Reactive Oxygen Species"", ""Spectrophotometry"", ""Synapses"", ""tau Proteins""], ""substances"": [""Peptide Fragments"", ""Reactive Oxygen Species"", ""tau Proteins"", ""Calcium""]}",False
CAUSES_NO_CHANGE,31450,7246,2018.0,30027901,False,False,False,"In a double-blind crossover trial involving four treatments of haloperidol, haloperidol and lithium carbonate, lithium carbonate and placebo carried out for three weeks, none of the treatments provided effective relief from choreiform movements.",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""High""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,34507,1650,2017.0,27429982,False,False,False,"Overexpression of soluble CX3CL1 by adeno-associated viral (AAV) vectors plays an active role in reducing tau pathology and neuron loss, while it has no effect on Aβ deposition indicating that additional CX3CL1 signaling has no additive effect on Aβ deposition [26, 33].",#57:0,PMC4939332,"{""full_journal_name"": ""BioMed research international"", ""pub_date"": ""2017-02-22"", ""ref"": ""27429982"", ""pub_year"": 2017, ""last_author"": ""Yin M"", ""type"": ""PubMed"", ""author_list"": [""Chen P"", ""Zhao W"", ""Guo Y"", ""Xu J"", ""Yin M""], ""title"": ""CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection."", ""doi"": ""10.1155/2016/8090918""}","{""ProteinExpressionMethod"": [""adeno-associated viral vectors""], ""PublicationType"": [""Review""], ""Section"": [""CX3CL1/CX3CR1 and Microglia""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Chemokine CX3CL1"", ""Humans"", ""Microglia"", ""Neuronal Plasticity"", ""Neuroprotection"", ""Receptors, Chemokine""], ""substances"": [""Chemokine CX3CL1"", ""Receptors, Chemokine""]}",False
CAUSES_NO_CHANGE,40594,37057,2020.0,31413141,False,False,False,"CSF sTREM2 concentrations were significantly lower in p.L211P carriers (2578 ± 1444 pg/ml) compared to noncarriers (3903 ± 1919 pg/ml; P = 0.026; fig. S2). CSF sTREM2 concentrations were significantly elevated in p.R47H carriers (4852 ± 1172 pg/ml) compared to p.L211P carriers (P = 0.029) and p.D87N carriers (2082 ± 239 pg/ml; P = 0.041), but were not significantly different from noncarriers (P = 0.223; fig. S2).",#59:17,PMC6697053,"{""full_journal_name"": ""Science translational medicine"", ""pub_date"": ""2020-07-27"", ""ref"": ""31413141"", ""pub_year"": 2020, ""last_author"": ""Cruchaga C"", ""type"": ""PubMed"", ""author_list"": [""Deming Y"", ""Filipello F"", ""Cignarella F"", ""Cantoni C"", ""Hsu S"", ""Mikesell R"", ""Li Z"", ""Del-Aguila JL"", ""Dube U"", ""Farias FG"", ""Bradley J"", ""Budde J"", ""Ibanez L"", ""Fernandez MV"", ""Blennow K"", ""Zetterberg H"", ""Heslegrave A"", ""Johansson PM"", ""Svensson J"", ""Nellg\u00e5rd B"", ""Lleo A"", ""Alcolea D"", ""Clarimon J"", ""Rami L"", ""Molinuevo JL"", ""Su\u00e1rez-Calvet M"", ""Morenas-Rodr\u00edguez E"", ""Kleinberger G"", ""Ewers M"", ""Harari O"", ""Haass C"", ""Brett TJ"", ""Benitez BA"", ""Karch CM"", ""Piccio L"", ""Cruchaga C""], ""title"": {""#text"": ""The  gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk."", ""i"": ""MS4A""}, ""doi"": ""10.1126/scitranslmed.aau2291""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Cerebrospinal Fluid""], ""mesh"": [""Alzheimer Disease"", ""Female"", ""Genome-Wide Association Study"", ""Humans"", ""Macrophages"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Meta-Analysis as Topic"", ""Multigene Family"", ""Receptors, Immunologic""], ""substances"": [""MS4A4A protein, human"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
CAUSES_NO_CHANGE,11492,21816,2011.0,21745645,False,False,False,"Consistent with the results from electrical SO stimulation, when cholinergic input was activated 100 ms (i.e., light exposure 120 ms to take into account the 20 ms delay) before SC stimulation, LTP was induced, which was blocked by the a7 nAChR antagonist MLA, but not by DHbE or atropine (Figures 5I and 5H)",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Optogenetic Stimulation"", ""patch clamp""], ""Custom_MouseStrain"": [""Chat-Cre Transgenic""], ""Custom_SOStimulation"": [""before SC stimulation""], ""Custom_Timeline"": [""100 milliseconds""], ""MeSHAnatomy"": [""Spine""], ""Species"": [""10090""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,4946,7407,2019.0,29758300,False,False,False,"Lastly, macroautophagy, but not UPS or CMA can clear protein aggregates.",#69:35,,"{""full_journal_name"": ""Neuroscience letters"", ""pub_date"": ""2019-07-24"", ""ref"": ""29758300"", ""pub_year"": 2019, ""last_author"": ""Yu WH"", ""type"": ""PubMed"", ""author_list"": [""Chung KM"", ""Hern\u00e1ndez N"", ""Sproul AA"", ""Yu WH""], ""title"": ""Alzheimer's disease and the autophagic-lysosomal system."", ""doi"": ""10.1016/j.neulet.2018.05.017""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Autophagy"", ""Biological Transport"", ""Humans"", ""Lysosomes"", ""Neurodegenerative Diseases"", ""Neurons"", ""Proteasome Endopeptidase Complex"", ""Protein Folding"", ""Proteolysis"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""tau Proteins"", ""Proteasome Endopeptidase Complex""]}",False
CAUSES_NO_CHANGE,7161,6950,2013.0,21875409,False,False,False,"The APP ratio was slightly but not significantly decreased in AD patients, whereas CD40L and serotonin were unchanged.",#59:5,,"{""full_journal_name"": ""Current Alzheimer research"", ""pub_date"": ""2013-06-21"", ""ref"": ""21875409"", ""pub_year"": 2013, ""last_author"": ""Humpel C"", ""type"": ""PubMed"", ""author_list"": [""Hochstrasser T"", ""Ehrlich D"", ""Marksteiner J"", ""Sperner-Unterweger B"", ""Humpel C""], ""title"": ""Matrix metalloproteinase-2 and epidermal growth factor are decreased in platelets of Alzheimer patients.""}","{""Subgraph"": [""T cells signaling""], ""mesh"": [""Aged"", ""Alzheimer Disease"", ""Biomarkers"", ""Blood Platelets"", ""Blotting, Western"", ""Chromatography, High Pressure Liquid"", ""Enzyme-Linked Immunosorbent Assay"", ""Epidermal Growth Factor"", ""Female"", ""Humans"", ""Immunohistochemistry"", ""Male"", ""Matrix Metalloproteinase 2""], ""substances"": [""Biomarkers"", ""Epidermal Growth Factor"", ""MMP2 protein, human"", ""Matrix Metalloproteinase 2""]}",False
CAUSES_NO_CHANGE,37647,27181,2017.0,27522251,False,False,False,"We did not detect any glia or microglia activation in WT-APP (Fig. 3C and F) compared with WT-GFP (Fig. 3B and E), meaning that the neuroinflammation does not play a role in the memory deficit we observed",#68:77,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2017-09-28"", ""ref"": ""27522251"", ""pub_year"": 2017, ""last_author"": ""Maskos U"", ""type"": ""PubMed"", ""author_list"": [""Lombardo S"", ""Catteau J"", ""Besson M"", ""Maskos U""], ""title"": ""A role for \u03b22* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus."", ""doi"": ""10.1016/j.neurobiolaging.2016.06.005""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Dentate Gyrus""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Dentate Gyrus"", ""Disease Models, Animal"", ""Hippocampus"", ""Male"", ""Memory Disorders"", ""Mice, Inbred C57BL"", ""Receptors, Nicotinic""], ""substances"": [""Amyloid beta-Peptides"", ""Receptors, Nicotinic"", ""nicotinic receptor beta2""]}",False
CAUSES_NO_CHANGE,6894,30968,2019.0,30664622,False,False,False,"In the cerebral cortex, female Adnp+/− mice exhibited significantly reduced VGLUT1 expression, with no effect for NAP (Supplemental Fig. S4B).",#69:15,PMC6341082,"{""full_journal_name"": ""Translational psychiatry"", ""pub_date"": ""2019-06-10"", ""ref"": ""30664622"", ""pub_year"": 2019, ""last_author"": ""Gozes I"", ""type"": ""PubMed"", ""author_list"": [""Sragovich S"", ""Malishkevich A"", ""Piontkewitz Y"", ""Giladi E"", ""Touloumi O"", ""Lagoudaki R"", ""Grigoriadis N"", ""Gozes I""], ""title"": ""The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse."", ""doi"": ""10.1038/s41398-018-0357-6""}","{""Confidence"": [""High""], ""Gender"": [""Female""], ""MeSHAnatomy"": [""Cerebral Cortex""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Brain"", ""Diffusion Tensor Imaging"", ""Disease Models, Animal"", ""Female"", ""Haploinsufficiency"", ""Homeodomain Proteins"", ""Magnetic Resonance Imaging"", ""Male"", ""Mice"", ""Mice, 129 Strain"", ""Mice, Inbred C57BL"", ""Mice, Knockout"", ""Nerve Tissue Proteins"", ""Neuroprotection"", ""Oligopeptides"", ""Synapses"", ""Vesicular Glutamate Transport Protein 1""], ""substances"": [""Adnp protein, mouse"", ""Homeodomain Proteins"", ""Nerve Tissue Proteins"", ""Oligopeptides"", ""Slc17a7 protein, mouse"", ""Vesicular Glutamate Transport Protein 1"", ""davunetide""]}",False
CAUSES_NO_CHANGE,7981,13687,2016.0,26702100,False,False,False,"Downregulation of raptor mRNA was observed in TDP-43-depleted cells, whereas mRNA levels of other known members of mTOR-associated machinery on the lysosomes, such as mTOR itself, RagB, p18, MP1, p14, HBXIP, C7orf59, RagA, RagC, RagD, and FLCN, were not changed (Figs 2E and EV1C).",#61:71,PMC4718457,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2016-05-23"", ""ref"": ""26702100"", ""pub_year"": 2016, ""last_author"": ""Wang G"", ""type"": ""PubMed"", ""author_list"": [""Xia Q"", ""Wang H"", ""Hao Z"", ""Fu C"", ""Hu Q"", ""Gao F"", ""Ren H"", ""Chen D"", ""Han J"", ""Ying Z"", ""Wang G""], ""title"": ""TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion."", ""doi"": ""10.15252/embj.201591998""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Cell Line"", ""Cell Line, Tumor"", ""DNA-Binding Proteins"", ""Drosophila"", ""Frontotemporal Lobar Degeneration"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Lysosomes"", ""Mechanistic Target of Rapamycin Complex 1"", ""Mice"", ""Models, Biological"", ""Multiprotein Complexes"", ""Rats"", ""TOR Serine-Threonine Kinases""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""DNA-Binding Proteins"", ""Multiprotein Complexes"", ""TFEB protein, human"", ""Tcfeb protein, mouse"", ""Mechanistic Target of Rapamycin Complex 1"", ""TOR Serine-Threonine Kinases""]}",False
CAUSES_NO_CHANGE,29150,1314,2020.0,30837838,False,False,False,"Several of these interactions were unperturbed by the ALS-linked mutations, A315T and M337V (Freibaum et al., 2010; Kim et al., 2010).",#60:15,PMC6382748,"{""full_journal_name"": ""Frontiers in molecular neuroscience"", ""pub_date"": ""2020-10-01"", ""ref"": ""30837838"", ""pub_year"": 2020, ""last_author"": ""Patel BK"", ""type"": ""PubMed"", ""author_list"": [""Prasad A"", ""Bharathi V"", ""Sivalingam V"", ""Girdhar A"", ""Patel BK""], ""title"": ""Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis."", ""doi"": ""10.3389/fnmol.2019.00025""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyotrophic Lateral Sclerosis""]}",False
CAUSES_NO_CHANGE,6709,7823,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,1783,2391,2009.0,19293145,False,False,False,"The loss of nAChR subunits, as determined by [3H]- epibatidine binding, seems to take place after the transition from mild cognitive impairment (MCI) to AD (Sabbagh et al., 2006), although the loss of epibatidine binding did not correlate with decline in memory, cognitive performance, or with the development of neurofibrillary tangles or plaques (Sabbagh et al., 2001).",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,14406,43753,,0,False,False,False,"No effect of the anatabine treatment was observed on tau expression (T-test, P>0.05) in Tg Tau P301S mice (Figure 4).",#68:7,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""10.4172/2168-975X.1000126"", ""title"": """", ""type"": ""DOI""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain"", ""Spinal Cord""], ""Species"": [""10090""]}",False
CAUSES_NO_CHANGE,1650,14838,2011.0,21745645,False,False,False,"Here we show that the α7 nAChR-dependent LTP and STD were largely blocked in slices preexposed to 10 nM Aβ for 2 hr (Figures 6A, 6B, and 6D); our Aβ preparation contains oligomeric, as well as monomeric, Aβ (Lambert et al., 1998). The mAChR-mediated LTP is relatively resistant to 0.1 μM Aβ, but was blocked by higher concentrations of Aβ pre-exposure (partial blockade by 0.3 and complete blockade by 1 μM) (Figures 6C and 6D).",#66:21,PMC3134790,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2011-09-19"", ""ref"": ""21745645"", ""pub_year"": 2011, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Gu Z"", ""Yakel JL""], ""title"": ""Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity."", ""doi"": ""10.1016/j.neuron.2011.04.026""}","{""Assay"": [""Electric Stimulation"", ""patch clamp""], ""Dosage"": [""0.1 microMolar""], ""Species"": [""10116""], ""TextLocation"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""Choline O-Acetyltransferase"", ""Cholinergic Fibers"", ""Dose-Response Relationship, Drug"", ""Electric Stimulation"", ""Excitatory Postsynaptic Potentials"", ""Hippocampus"", ""Mice"", ""Mice, Knockout"", ""Mice, Transgenic"", ""Neural Inhibition"", ""Neuronal Plasticity"", ""Photic Stimulation"", ""Rats"", ""Rats, Wistar"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""Septum of Brain"", ""Synaptic Transmission"", ""Time Factors"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""Amyloid beta-Peptides"", ""Chrna7 protein, human"", ""Chrna7 protein, mouse"", ""Chrna7 protein, rat"", ""Receptors, Muscarinic"", ""Receptors, Nicotinic"", ""alpha7 Nicotinic Acetylcholine Receptor"", ""Choline O-Acetyltransferase""]}",False
CAUSES_NO_CHANGE,1380,3330,2019.0,30962309,False,False,False,"The three miRNAs miR-223 (100), miR-155-5p (101), and miR-146a (102) are upregulated in synovial tissue from RA patients compared with osteoarthritis synovium, and two of them, miR-155-5p and miR-146a-5p, are elevated in PBMCs of RA patients (103, 104).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Cell"": [""synovial cell""], ""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
CAUSES_NO_CHANGE,6709,21054,,0,False,False,False,"Fluvoxamine has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of Fluvoxamine was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Fluvoxamine does not inhibit monoamine oxidase.",#59:5,,"{""author_list"": """", ""comment"": """", ""pub_date"": """", ""ref"": ""ATC Code: DB00176"", ""title"": ""AD_HBP"", ""type"": ""Online Resource""}",{},False
CAUSES_NO_CHANGE,29995,18396,2009.0,19293145,False,False,False,"In addition, APP or APP/PS-1 double-mutant mice have normal or even enhanced levels of ChAT and an unchanged cholinergic cell count (Hernandez et al., 2001). However, a double-mutant mouse expressing the Swedish APP and overexpressing human AChE showed enhanced mRNA levels of alpha7 in brain and adrenal medulla, although in brain tissue this enhancement declined with age. In this same mouse, there was no alteration in mRNA levels for alpha4, and an increase in alpha3 has also been observed in the brain and the adrenal medulla (Mousavi and Nordberg, 2006), a pattern similar to that seen in Abeta single- mutant mice (Bednar et al., 2002), suggesting that it is not attributable to the human AChE.",#72:23,PMC2830120,"{""full_journal_name"": ""Pharmacological reviews"", ""pub_date"": ""2009-05-14"", ""ref"": ""19293145"", ""pub_year"": 2009, ""last_author"": ""Sattelle DB"", ""type"": ""PubMed"", ""author_list"": [""Buckingham SD"", ""Jones AK"", ""Brown LA"", ""Sattelle DB""], ""title"": ""Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection."", ""doi"": ""10.1124/pr.108.000562""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Adrenal Medulla"", ""Brain""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""Signal Transduction""], ""substances"": [""Amyloid beta-Peptides"", ""Peptide Fragments"", ""Receptors, Nicotinic"", ""amyloid beta-protein (1-42)""]}",False
CAUSES_NO_CHANGE,6947,5073,2018.0,30027901,False,False,False,"Fluoxetine, an SSRI that is widely used as an antidepressant has been shown to be effective in HD transgenic mice (Grote et al. 2005) but when administered in randomized, double-blind, placebo-controlled trial of this medication in depressed and nondepressed HD patients, no differences between the treatment groups were found in total functional capacity, neurological, or cognitive ratings (Como et al. 1997).",#69:41,,"{""full_journal_name"": ""Journal of genetics"", ""pub_date"": ""2018-10-29"", ""ref"": ""30027901"", ""pub_year"": 2018, ""last_author"": ""Rajamma U"", ""type"": ""PubMed"", ""author_list"": [""Pandey M"", ""Rajamma U""], ""title"": ""Huntington's disease: the coming of age.""}","{""Confidence"": [""Medium""], ""Disease"": [""Huntington's disease""], ""mesh"": [""Animals"", ""Humans"", ""Huntington Disease"", ""Mutation"", ""Neuroprotection"", ""Prevalence""]}",False
CAUSES_NO_CHANGE,32645,36056,2015.0,25069841,False,False,False,"As expected, enhanced TFEB-dependent PTEN upregulation is associated with reduced pAkt (S473), pP70SK6 (T389) and pULK1 (S757), but not their total protein levels (Supplementary Fig S10).",#72:5,PMC4197862,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2015-05-22"", ""ref"": ""25069841"", ""pub_year"": 2015, ""last_author"": ""Zheng H"", ""type"": ""PubMed"", ""author_list"": [""Polito VA"", ""Li H"", ""Martini-Stoica H"", ""Wang B"", ""Yang L"", ""Xu Y"", ""Swartzlander DB"", ""Palmieri M"", ""di Ronza A"", ""Lee VM"", ""Sardiello M"", ""Ballabio A"", ""Zheng H""], ""title"": ""Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB."", ""doi"": ""10.15252/emmm.201303671""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyloid Neuropathies""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Autophagy"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Gene Expression Regulation"", ""Lysosomes"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Nerve Degeneration"", ""Neurofibrillary Tangles"", ""PTEN Phosphohydrolase"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Mapt protein, mouse"", ""Tcfeb protein, mouse"", ""tau Proteins"", ""PTEN Phosphohydrolase"", ""Pten protein, mouse""]}",False
CAUSES_NO_CHANGE,1491,7106,2017.0,27794524,False,False,False,"In both cases, diffuse meningeal inflammation and cortical neuronal pathology may be significant contributors to clinical progression, suggesting similar pathogenic mechanisms, irrespective of a prior relapsing-remitting course or the presence of follicle-like structures (Choi et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""cortex""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
CAUSES_NO_CHANGE,7313,39329,2015.0,25639674,False,False,False,"In a study carried out on adult post-mortem autistic brains using quantitative RT-PCR for measuring mRNA expression together with protein level expression and specific radioligand receptor binding, it was found that there was a decrease of 40–50% in the expression of the α3, α4, and β2 nAChR subunits in the cerebral cortex, while there was no change in the expression of the α7 subunit [120].",#59:10,PMC4324614,"{""full_journal_name"": ""Trends in pharmacological sciences"", ""pub_date"": ""2015-08-21"", ""ref"": ""25639674"", ""pub_year"": 2015, ""last_author"": ""Yakel JL"", ""type"": ""PubMed"", ""author_list"": [""Dineley KT"", ""Pandya AA"", ""Yakel JL""], ""title"": ""Nicotinic ACh receptors as therapeutic targets in CNS disorders."", ""doi"": ""10.1016/j.tips.2014.12.002""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain"", ""Cerebral Cortex""], ""MeSHDisease"": [""Autism Spectrum Disorder""], ""mesh"": [""Animals"", ""Autistic Disorder"", ""Central Nervous System Diseases"", ""Humans"", ""Pain"", ""Receptors, Nicotinic"", ""Schizophrenia""], ""substances"": [""Receptors, Nicotinic""]}",False
CAUSES_NO_CHANGE,26554,1180,2018.0,27671637,False,False,False,"64627 reestablished novel arm preference in proaggregant mice, suggesting that 64627 restores spatial memory in these animals",#65:55,PMC5068267,"{""full_journal_name"": ""Proceedings of the National Academy of Sciences of the United States of America"", ""pub_date"": ""2018-01-30"", ""ref"": ""27671637"", ""pub_year"": 2018, ""last_author"": ""Mandelkow EM"", ""type"": ""PubMed"", ""author_list"": [""Dennissen FJ"", ""Anglada-Huguet M"", ""Sydow A"", ""Mandelkow E"", ""Mandelkow EM""], ""title"": ""Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Axons""], ""Species"": [""10090""], ""mesh"": [""Adenosine A1 Receptor Antagonists"", ""Adenosine Triphosphate"", ""Animals"", ""Axons"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""Gene Expression"", ""Hippocampus"", ""Humans"", ""Memory, Long-Term"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Neurons"", ""Phosphorylation"", ""Protein Aggregates"", ""Protein Aggregation, Pathological"", ""Sequence Deletion"", ""Synaptic Transmission"", ""Tauopathies"", ""Xanthines"", ""tau Proteins""], ""substances"": [""Adenosine A1 Receptor Antagonists"", ""Protein Aggregates"", ""Xanthines"", ""tau Proteins"", ""rolofylline"", ""Adenosine Triphosphate""]}",False
CAUSES_NO_CHANGE,41743,11668,2013.0,23356410,False,False,False,"In contrast, in mature neurons, a decrease of HDAC2 levels alone attenuated basal excitatory transmission without changing the number of detectable nerve terminals.",#64:49,PMC3615964,"{""full_journal_name"": ""Molecular neurodegeneration"", ""pub_date"": ""2013-09-20"", ""ref"": ""23356410"", ""pub_year"": 2013, ""last_author"": ""Cuendet M"", ""type"": ""PubMed"", ""author_list"": [""Sim\u00f5es-Pires C"", ""Zwick V"", ""Nurisso A"", ""Schenker E"", ""Carrupt PA"", ""Cuendet M""], ""title"": ""HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?"", ""doi"": ""10.1186/1750-1326-8-7""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Hippocampus""], ""mesh"": [""Animals"", ""Histone Deacetylases"", ""Humans"", ""Neurodegenerative Diseases""], ""substances"": [""Histone Deacetylases""]}",False
CAUSES_NO_CHANGE,12015,5253,2017.0,27623715,False,False,False,"Only middle-aged Tet-mev-1 mice showed JNK/MARK activation and Ca2+ overload, particularly in astrocytes with decreased hippocampal GFAP and S100ß, but without pathological features such as apoptosis, amyloidosis, and lactic acidosis in neurons and astrocytes. This led to decreasing levels of glial fibrillary acidic protein and S100β in the hippocampal area.",#60:23,PMC5242301,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2017-06-05"", ""ref"": ""27623715"", ""pub_year"": 2017, ""last_author"": ""Ishii N"", ""type"": ""PubMed"", ""author_list"": [""Ishii T"", ""Takanashi Y"", ""Sugita K"", ""Miyazawa M"", ""Yanagihara R"", ""Yasuda K"", ""Onouchi H"", ""Kawabe N"", ""Nakata M"", ""Yamamoto Y"", ""Hartman PS"", ""Ishii N""], ""title"": ""Endogenous reactive oxygen species cause astrocyte defects and neuronal dysfunctions in the hippocampus: a new model for aging brain."", ""doi"": ""10.1111/acel.12523""}","{""Anatomy"": [""hippocampal formation""], ""Cell"": [""astrocyte"", ""neuron""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""Study_Group"": [""Tet-mev-1 mice""], ""mesh"": [""Aging"", ""Animals"", ""Astrocytes"", ""Biomarkers"", ""Calcium"", ""Cyclic AMP Response Element-Binding Protein"", ""Disease Models, Animal"", ""Glial Fibrillary Acidic Protein"", ""Hippocampus"", ""JNK Mitogen-Activated Protein Kinases"", ""Membrane Proteins"", ""Memory"", ""Mice, Inbred C57BL"", ""Mitochondria"", ""Models, Biological"", ""Mutation"", ""Neurons"", ""Oxidation-Reduction"", ""Phosphorylation"", ""Reactive Oxygen Species"", ""S100 Proteins"", ""Signal Transduction"", ""Superoxide Dismutase""], ""substances"": [""Biomarkers"", ""Cyclic AMP Response Element-Binding Protein"", ""Glial Fibrillary Acidic Protein"", ""Membrane Proteins"", ""Reactive Oxygen Species"", ""S100 Proteins"", ""SDHC protein, mouse"", ""Superoxide Dismutase"", ""JNK Mitogen-Activated Protein Kinases"", ""Calcium""]}",False
